ES2552247T3 - Agentes antibacterianos - Google Patents
Agentes antibacterianos Download PDFInfo
- Publication number
- ES2552247T3 ES2552247T3 ES10179798.3T ES10179798T ES2552247T3 ES 2552247 T3 ES2552247 T3 ES 2552247T3 ES 10179798 T ES10179798 T ES 10179798T ES 2552247 T3 ES2552247 T3 ES 2552247T3
- Authority
- ES
- Spain
- Prior art keywords
- amino
- hydroxyamino
- carbonyl
- benzamide
- phenyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 239000003242 anti bacterial agent Substances 0.000 title description 7
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 claims abstract description 24
- 150000001875 compounds Chemical class 0.000 claims abstract description 24
- 125000000623 heterocyclic group Chemical group 0.000 claims abstract description 16
- 125000003118 aryl group Chemical group 0.000 claims abstract description 9
- 150000002148 esters Chemical class 0.000 claims abstract description 9
- 125000001072 heteroaryl group Chemical group 0.000 claims abstract description 8
- 125000006413 ring segment Chemical group 0.000 claims abstract description 8
- 150000003839 salts Chemical class 0.000 claims abstract description 8
- 229910052760 oxygen Inorganic materials 0.000 claims abstract description 5
- 229910052717 sulfur Inorganic materials 0.000 claims abstract description 5
- 208000035143 Bacterial infection Diseases 0.000 claims 1
- 208000022362 bacterial infectious disease Diseases 0.000 claims 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract description 219
- 125000000217 alkyl group Chemical group 0.000 abstract description 9
- 125000004429 atom Chemical group 0.000 abstract description 5
- 125000003342 alkenyl group Chemical group 0.000 abstract description 4
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 abstract description 2
- 229910052799 carbon Inorganic materials 0.000 abstract description 2
- 125000004432 carbon atom Chemical group C* 0.000 abstract description 2
- 125000006552 (C3-C8) cycloalkyl group Chemical group 0.000 abstract 1
- 125000000882 C2-C6 alkenyl group Chemical group 0.000 abstract 1
- 125000000304 alkynyl group Chemical group 0.000 abstract 1
- 125000006165 cyclic alkyl group Chemical group 0.000 abstract 1
- 125000004122 cyclic group Chemical group 0.000 abstract 1
- 125000000753 cycloalkyl group Chemical group 0.000 abstract 1
- 125000005842 heteroatom Chemical group 0.000 abstract 1
- 125000002349 hydroxyamino group Chemical group [H]ON([H])[*] 0.000 description 623
- KXDAEFPNCMNJSK-UHFFFAOYSA-N Benzamide Chemical compound NC(=O)C1=CC=CC=C1 KXDAEFPNCMNJSK-UHFFFAOYSA-N 0.000 description 514
- -1 alkanoic Chemical class 0.000 description 499
- 125000004202 aminomethyl group Chemical group [H]N([H])C([H])([H])* 0.000 description 324
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 description 286
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 265
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 184
- 125000002534 ethynyl group Chemical group [H]C#C* 0.000 description 175
- HSFWRNGVRCDJHI-UHFFFAOYSA-N alpha-acetylene Natural products C#C HSFWRNGVRCDJHI-UHFFFAOYSA-N 0.000 description 174
- UOAKXWFFWPSORV-APPZFPTMSA-N n-[(2s,3r)-3-hydroxy-1-(hydroxyamino)-1-oxobutan-2-yl]benzamide Chemical compound ONC(=O)[C@H]([C@H](O)C)NC(=O)C1=CC=CC=C1 UOAKXWFFWPSORV-APPZFPTMSA-N 0.000 description 75
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 59
- 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 description 32
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 21
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 18
- MYFRGPJFFHHEAG-UHFFFAOYSA-N n-(2-phenylethynyl)benzamide Chemical compound C=1C=CC=CC=1C(=O)NC#CC1=CC=CC=C1 MYFRGPJFFHHEAG-UHFFFAOYSA-N 0.000 description 12
- 125000004356 hydroxy functional group Chemical group O* 0.000 description 10
- 125000003630 glycyl group Chemical group [H]N([H])C([H])([H])C(*)=O 0.000 description 9
- GRVDJDISBSALJP-UHFFFAOYSA-N methyloxidanyl Chemical group [O]C GRVDJDISBSALJP-UHFFFAOYSA-N 0.000 description 9
- DNSISZSEWVHGLH-UHFFFAOYSA-N butanamide Chemical compound CCCC(N)=O DNSISZSEWVHGLH-UHFFFAOYSA-N 0.000 description 8
- MYSWGUAQZAJSOK-UHFFFAOYSA-N ciprofloxacin Chemical compound C12=CC(N3CCNCC3)=C(F)C=C2C(=O)C(C(=O)O)=CN1C1CC1 MYSWGUAQZAJSOK-UHFFFAOYSA-N 0.000 description 8
- 239000003112 inhibitor Substances 0.000 description 8
- BSCNGAWAVOXWJV-QMMMGPOBSA-N n-[(2s)-3-amino-1-(hydroxyamino)-1-oxopropan-2-yl]benzamide Chemical compound ONC(=O)[C@H](CN)NC(=O)C1=CC=CC=C1 BSCNGAWAVOXWJV-QMMMGPOBSA-N 0.000 description 8
- 125000000022 2-aminoethyl group Chemical group [H]C([*])([H])C([H])([H])N([H])[H] 0.000 description 7
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 7
- DZZKZKMVWFISEJ-UHFFFAOYSA-N n-(trifluoromethoxy)benzamide Chemical compound FC(F)(F)ONC(=O)C1=CC=CC=C1 DZZKZKMVWFISEJ-UHFFFAOYSA-N 0.000 description 7
- 239000000651 prodrug Substances 0.000 description 7
- 229940002612 prodrug Drugs 0.000 description 7
- ULGZDMOVFRHVEP-RWJQBGPGSA-N Erythromycin Chemical compound O([C@@H]1[C@@H](C)C(=O)O[C@@H]([C@@]([C@H](O)[C@@H](C)C(=O)[C@H](C)C[C@@](C)(O)[C@H](O[C@H]2[C@@H]([C@H](C[C@@H](C)O2)N(C)C)O)[C@H]1C)(C)O)CC)[C@H]1C[C@@](C)(OC)[C@@H](O)[C@H](C)O1 ULGZDMOVFRHVEP-RWJQBGPGSA-N 0.000 description 6
- 241000588724 Escherichia coli Species 0.000 description 6
- 239000002253 acid Substances 0.000 description 6
- 125000004029 hydroxymethyl group Chemical group [H]OC([H])([H])* 0.000 description 6
- BDPMFUMNOLZQCQ-HZGVNTEJSA-N 2-[(2s,3r)-3-hydroxy-1-(hydroxyamino)-1-oxobutan-2-yl]benzamide Chemical compound ONC(=O)[C@H]([C@H](O)C)C1=CC=CC=C1C(N)=O BDPMFUMNOLZQCQ-HZGVNTEJSA-N 0.000 description 5
- 241000894006 Bacteria Species 0.000 description 5
- 230000000844 anti-bacterial effect Effects 0.000 description 5
- UKJLNMAFNRKWGR-UHFFFAOYSA-N cyclohexatrienamine Chemical group NC1=CC=C=C[CH]1 UKJLNMAFNRKWGR-UHFFFAOYSA-N 0.000 description 5
- 125000000031 ethylamino group Chemical group [H]C([H])([H])C([H])([H])N([H])[*] 0.000 description 5
- YNTOKMNHRPSGFU-UHFFFAOYSA-N n-Propyl carbamate Chemical compound CCCOC(N)=O YNTOKMNHRPSGFU-UHFFFAOYSA-N 0.000 description 5
- 125000004860 4-ethylphenyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1*)C([H])([H])C([H])([H])[H] 0.000 description 4
- 125000001255 4-fluorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C([H])=C1F 0.000 description 4
- WZPBZJONDBGPKJ-UHFFFAOYSA-N Antibiotic SQ 26917 Natural products O=C1N(S(O)(=O)=O)C(C)C1NC(=O)C(=NOC(C)(C)C(O)=O)C1=CSC(N)=N1 WZPBZJONDBGPKJ-UHFFFAOYSA-N 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N acetic acid Substances CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 4
- WZPBZJONDBGPKJ-VEHQQRBSSA-N aztreonam Chemical compound O=C1N(S([O-])(=O)=O)[C@@H](C)[C@@H]1NC(=O)C(=N/OC(C)(C)C(O)=O)\C1=CSC([NH3+])=N1 WZPBZJONDBGPKJ-VEHQQRBSSA-N 0.000 description 4
- 229960003644 aztreonam Drugs 0.000 description 4
- 229960000484 ceftazidime Drugs 0.000 description 4
- NMVPEQXCMGEDNH-TZVUEUGBSA-N ceftazidime pentahydrate Chemical compound O.O.O.O.O.S([C@@H]1[C@@H](C(N1C=1C([O-])=O)=O)NC(=O)\C(=N/OC(C)(C)C(O)=O)C=2N=C(N)SC=2)CC=1C[N+]1=CC=CC=C1 NMVPEQXCMGEDNH-TZVUEUGBSA-N 0.000 description 4
- 229960003405 ciprofloxacin Drugs 0.000 description 4
- PBQZQTQFQFYBNJ-UHFFFAOYSA-N n-methoxybenzamide Chemical compound CONC(=O)C1=CC=CC=C1 PBQZQTQFQFYBNJ-UHFFFAOYSA-N 0.000 description 4
- MMRINLZOZVAPDZ-LSGRDSQZSA-N (6r,7r)-7-[[(2z)-2-(2-amino-1,3-thiazol-4-yl)-2-methoxyiminoacetyl]amino]-3-[(1-methylpyrrolidin-1-ium-1-yl)methyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid;chloride Chemical compound Cl.S([C@@H]1[C@@H](C(N1C=1C([O-])=O)=O)NC(=O)\C(=N/OC)C=2N=C(N)SC=2)CC=1C[N+]1(C)CCCC1 MMRINLZOZVAPDZ-LSGRDSQZSA-N 0.000 description 3
- 125000004215 2,4-difluorophenyl group Chemical group [H]C1=C([H])C(*)=C(F)C([H])=C1F 0.000 description 3
- LJGHYPLBDBRCRZ-UHFFFAOYSA-N 3-(3-aminophenyl)sulfonylaniline Chemical group NC1=CC=CC(S(=O)(=O)C=2C=C(N)C=CC=2)=C1 LJGHYPLBDBRCRZ-UHFFFAOYSA-N 0.000 description 3
- 125000004180 3-fluorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C(F)=C1[H] 0.000 description 3
- 125000003349 3-pyridyl group Chemical group N1=C([H])C([*])=C([H])C([H])=C1[H] 0.000 description 3
- OEJYZUMESQZYFQ-BMIGLBTASA-N 4-(4-bromophenyl)-n-[(2s,3r)-3-hydroxy-1-(hydroxyamino)-1-oxobutan-2-yl]benzamide Chemical compound C1=CC(C(=O)N[C@@H]([C@H](O)C)C(=O)NO)=CC=C1C1=CC=C(Br)C=C1 OEJYZUMESQZYFQ-BMIGLBTASA-N 0.000 description 3
- LUQVCHRDAGWYMG-UHFFFAOYSA-N 4-phenylbenzamide Chemical compound C1=CC(C(=O)N)=CC=C1C1=CC=CC=C1 LUQVCHRDAGWYMG-UHFFFAOYSA-N 0.000 description 3
- 125000000319 biphenyl-4-yl group Chemical group [H]C1=C([H])C([H])=C([H])C([H])=C1C1=C([H])C([H])=C([*])C([H])=C1[H] 0.000 description 3
- 229960002100 cefepime Drugs 0.000 description 3
- 125000002147 dimethylamino group Chemical group [H]C([H])([H])N(*)C([H])([H])[H] 0.000 description 3
- 229960003276 erythromycin Drugs 0.000 description 3
- 238000001727 in vivo Methods 0.000 description 3
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 3
- 125000003854 p-chlorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C([H])=C1Cl 0.000 description 3
- 229960000707 tobramycin Drugs 0.000 description 3
- NLVFBUXFDBBNBW-PBSUHMDJSA-S tobramycin(5+) Chemical compound [NH3+][C@@H]1C[C@H](O)[C@@H](C[NH3+])O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H]([NH3+])[C@H](O)[C@@H](CO)O2)O)[C@H]([NH3+])C[C@@H]1[NH3+] NLVFBUXFDBBNBW-PBSUHMDJSA-S 0.000 description 3
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 description 3
- YFIKCGAYKHZRBO-UHFFFAOYSA-N 2,2-dihydroxybutanamide Chemical compound CCC(O)(O)C(N)=O YFIKCGAYKHZRBO-UHFFFAOYSA-N 0.000 description 2
- ZYHQGITXIJDDKC-UHFFFAOYSA-N 2-[2-(2-aminophenyl)ethyl]aniline Chemical group NC1=CC=CC=C1CCC1=CC=CC=C1N ZYHQGITXIJDDKC-UHFFFAOYSA-N 0.000 description 2
- 125000004198 2-fluorophenyl group Chemical group [H]C1=C([H])C(F)=C(*)C([H])=C1[H] 0.000 description 2
- 125000000175 2-thienyl group Chemical group S1C([*])=C([H])C([H])=C1[H] 0.000 description 2
- 125000004208 3-hydroxyphenyl group Chemical group [H]OC1=C([H])C([H])=C([H])C(*)=C1[H] 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 241000589513 Burkholderia cepacia Species 0.000 description 2
- FERIUCNNQQJTOY-UHFFFAOYSA-N Butyric acid Chemical compound CCCC(O)=O FERIUCNNQQJTOY-UHFFFAOYSA-N 0.000 description 2
- GXCLVBGFBYZDAG-UHFFFAOYSA-N N-[2-(1H-indol-3-yl)ethyl]-N-methylprop-2-en-1-amine Chemical compound CN(CCC1=CNC2=C1C=CC=C2)CC=C GXCLVBGFBYZDAG-UHFFFAOYSA-N 0.000 description 2
- DFPAKSUCGFBDDF-UHFFFAOYSA-N Nicotinamide Chemical compound NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 description 2
- XBDQKXXYIPTUBI-UHFFFAOYSA-N Propionic acid Chemical class CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 2
- 230000001580 bacterial effect Effects 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 125000006311 cyclobutyl amino group Chemical group [H]N(*)C1([H])C([H])([H])C([H])([H])C1([H])[H] 0.000 description 2
- 125000001559 cyclopropyl group Chemical group [H]C1([H])C([H])([H])C1([H])* 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 244000000058 gram-negative pathogen Species 0.000 description 2
- FUZZWVXGSFPDMH-UHFFFAOYSA-N hexanoic acid group Chemical group C(CCCCC)(=O)O FUZZWVXGSFPDMH-UHFFFAOYSA-N 0.000 description 2
- DMJNNHOOLUXYBV-PQTSNVLCSA-N meropenem Chemical compound C=1([C@H](C)[C@@H]2[C@H](C(N2C=1C(O)=O)=O)[C@H](O)C)S[C@@H]1CN[C@H](C(=O)N(C)C)C1 DMJNNHOOLUXYBV-PQTSNVLCSA-N 0.000 description 2
- 229960002260 meropenem Drugs 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 125000000250 methylamino group Chemical group [H]N(*)C([H])([H])[H] 0.000 description 2
- 125000004170 methylsulfonyl group Chemical group [H]C([H])([H])S(*)(=O)=O 0.000 description 2
- BRCSFXWSUNPOQB-JTQLQIEISA-N n-[(2s)-3-amino-1-(hydroxyamino)-1-oxopropan-2-yl]-4-ethynylbenzamide Chemical compound ONC(=O)[C@H](CN)NC(=O)C1=CC=C(C#C)C=C1 BRCSFXWSUNPOQB-JTQLQIEISA-N 0.000 description 2
- ILFNBIRTJSBNIM-ACJLOTCBSA-N n-[(2s,3r)-3-hydroxy-1-(hydroxyamino)-1-oxobutan-2-yl]-4-(4-propylphenyl)benzamide Chemical compound C1=CC(CCC)=CC=C1C1=CC=C(C(=O)N[C@@H]([C@@H](C)O)C(=O)NO)C=C1 ILFNBIRTJSBNIM-ACJLOTCBSA-N 0.000 description 2
- CHFMPWNWPUAWCT-UHFFFAOYSA-N n-phenoxybenzamide Chemical compound C=1C=CC=CC=1C(=O)NOC1=CC=CC=C1 CHFMPWNWPUAWCT-UHFFFAOYSA-N 0.000 description 2
- BSCCSDNZEIHXOK-UHFFFAOYSA-N phenyl carbamate Chemical compound NC(=O)OC1=CC=CC=C1 BSCCSDNZEIHXOK-UHFFFAOYSA-N 0.000 description 2
- 125000001325 propanoyl group Chemical group O=C([*])C([H])([H])C([H])([H])[H] 0.000 description 2
- QLNJFJADRCOGBJ-UHFFFAOYSA-N propionamide Chemical compound CCC(N)=O QLNJFJADRCOGBJ-UHFFFAOYSA-N 0.000 description 2
- VLJNHYLEOZPXFW-UHFFFAOYSA-N pyrrolidine-2-carboxamide Chemical compound NC(=O)C1CCCN1 VLJNHYLEOZPXFW-UHFFFAOYSA-N 0.000 description 2
- 241000894007 species Species 0.000 description 2
- NQRYJNQNLNOLGT-UHFFFAOYSA-N tetrahydropyridine hydrochloride Natural products C1CCNCC1 NQRYJNQNLNOLGT-UHFFFAOYSA-N 0.000 description 2
- GNFBUJLAZROELK-KLHWPWHYSA-N (1r,2r)-n-[(2s,3r)-3-hydroxy-1-(hydroxyamino)-1-oxobutan-2-yl]-2-phenylcyclopropane-1-carboxamide Chemical compound ONC(=O)[C@H]([C@H](O)C)NC(=O)[C@@H]1C[C@H]1C1=CC=CC=C1 GNFBUJLAZROELK-KLHWPWHYSA-N 0.000 description 1
- ABAYEUSKMBRFNH-IIWLOGEXSA-N (2e,4e)-n-[(2s,3r)-3-hydroxy-1-(hydroxyamino)-1-oxobutan-2-yl]-5-phenylpenta-2,4-dienamide Chemical compound ONC(=O)[C@H]([C@H](O)C)NC(=O)\C=C\C=C\C1=CC=CC=C1 ABAYEUSKMBRFNH-IIWLOGEXSA-N 0.000 description 1
- IOUOOPIEYQCKGU-BLLLJJGKSA-N (2r,3s)-n,3-dihydroxy-2-[(4-phenylphenyl)methylamino]butanamide Chemical compound C1=CC(CN[C@H]([C@@H](O)C)C(=O)NO)=CC=C1C1=CC=CC=C1 IOUOOPIEYQCKGU-BLLLJJGKSA-N 0.000 description 1
- RWYNUKDGPZPRDM-MGAJPHDKSA-N (2r,5s)-n-[(2s,3r)-3-hydroxy-1-(hydroxyamino)-1-oxobutan-2-yl]-5-phenylpyrrolidine-2-carboxamide Chemical compound N1[C@@H](C(=O)N[C@@H]([C@H](O)C)C(=O)NO)CC[C@H]1C1=CC=CC=C1 RWYNUKDGPZPRDM-MGAJPHDKSA-N 0.000 description 1
- RVQQBLXYCMHRAO-ZVAWYAOSSA-N (2s)-1-[4-(4-ethylphenyl)benzoyl]-n,4-dihydroxypyrrolidine-2-carboxamide Chemical compound C1=CC(CC)=CC=C1C1=CC=C(C(=O)N2[C@@H](CC(O)C2)C(=O)NO)C=C1 RVQQBLXYCMHRAO-ZVAWYAOSSA-N 0.000 description 1
- LGYOVKQRNOTNJT-BUVFEPMLSA-N (2s)-n-[(2s,3r)-3-hydroxy-1-(hydroxyamino)-1-oxobutan-2-yl]-4-methyl-2-[[2-(4-phenylphenyl)acetyl]amino]pentanamide Chemical compound C1=CC(CC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)NO)=CC=C1C1=CC=CC=C1 LGYOVKQRNOTNJT-BUVFEPMLSA-N 0.000 description 1
- NOIXMTSFTKQJNG-SFTDATJTSA-N (2s)-n-[4-[2-[4-[[(2s)-3-amino-1-(hydroxyamino)-1-oxopropan-2-yl]carbamoyl]phenyl]ethynyl]phenyl]piperidine-2-carboxamide Chemical compound C1=CC(C(=O)N[C@@H](CN)C(=O)NO)=CC=C1C#CC(C=C1)=CC=C1NC(=O)[C@H]1NCCCC1 NOIXMTSFTKQJNG-SFTDATJTSA-N 0.000 description 1
- AAKSCVAZNYVHHJ-PMACEKPBSA-N (2s)-n-[4-[2-[4-[[(2s)-3-amino-1-(hydroxyamino)-1-oxopropan-2-yl]carbamoyl]phenyl]ethynyl]phenyl]pyrrolidine-2-carboxamide Chemical compound C1=CC(C(=O)N[C@@H](CN)C(=O)NO)=CC=C1C#CC(C=C1)=CC=C1NC(=O)[C@H]1NCCC1 AAKSCVAZNYVHHJ-PMACEKPBSA-N 0.000 description 1
- BPJIVFCHVCZJTA-NQERJWCQSA-N (2s)-n-[4-[2-[4-[[(2s,3r)-3-hydroxy-1-(hydroxyamino)-1-oxobutan-2-yl]carbamoyl]phenyl]ethynyl]phenyl]pyrrolidine-2-carboxamide Chemical compound C1=CC(C(=O)N[C@@H]([C@H](O)C)C(=O)NO)=CC=C1C#CC(C=C1)=CC=C1NC(=O)[C@H]1NCCC1 BPJIVFCHVCZJTA-NQERJWCQSA-N 0.000 description 1
- FYIDWQNFAUHRRO-WBMJQRKESA-N (2s,3r)-2-[(2,2-diphenylacetyl)amino]-n,3-dihydroxybutanamide Chemical compound C=1C=CC=CC=1C(C(=O)N[C@@H]([C@H](O)C)C(=O)NO)C1=CC=CC=C1 FYIDWQNFAUHRRO-WBMJQRKESA-N 0.000 description 1
- IFBMYGPEQWYQDO-GKOVRZRLSA-N (2s,3r)-2-[1-[4-(4-bromophenyl)phenyl]ethylamino]-n,3-dihydroxybutanamide Chemical compound C1=CC(C(C)N[C@@H]([C@H](O)C)C(=O)NO)=CC=C1C1=CC=C(Br)C=C1 IFBMYGPEQWYQDO-GKOVRZRLSA-N 0.000 description 1
- GYNQBYOUYRHQPP-ACJLOTCBSA-N (2s,3r)-2-[[4-(4-ethoxyphenyl)phenyl]methylamino]-n,3-dihydroxybutanamide Chemical compound C1=CC(OCC)=CC=C1C1=CC=C(CN[C@@H]([C@@H](C)O)C(=O)NO)C=C1 GYNQBYOUYRHQPP-ACJLOTCBSA-N 0.000 description 1
- CXEUCFFRJQZLCP-PXAZEXFGSA-N (2s,3r)-2-[[4-[4-(aminomethyl)phenyl]phenyl]methylamino]-n,3-dihydroxybutanamide Chemical compound C1=CC(CN[C@@H]([C@H](O)C)C(=O)NO)=CC=C1C1=CC=C(CN)C=C1 CXEUCFFRJQZLCP-PXAZEXFGSA-N 0.000 description 1
- SZPYDALSJCSPSM-YJYMSZOUSA-N (2s,3r)-2-[[5-(4-ethoxyphenyl)-2-methoxyphenyl]methylamino]-n,3-dihydroxybutanamide Chemical compound C1=CC(OCC)=CC=C1C1=CC=C(OC)C(CN[C@@H]([C@@H](C)O)C(=O)NO)=C1 SZPYDALSJCSPSM-YJYMSZOUSA-N 0.000 description 1
- AFTFCSDKOUXTTN-DYVFJYSZSA-N (2s,3r)-3-amino-2-[[4-(2-phenylethynyl)benzoyl]amino]butanoic acid Chemical compound C1=CC(C(=O)N[C@@H]([C@H](N)C)C(O)=O)=CC=C1C#CC1=CC=CC=C1 AFTFCSDKOUXTTN-DYVFJYSZSA-N 0.000 description 1
- NENQABJQPNYPBU-WBMJQRKESA-N (2s,3r)-3-hydroxy-2-[(4-phenylphenyl)methylamino]butanoic acid Chemical compound C1=CC(CN[C@@H]([C@H](O)C)C(O)=O)=CC=C1C1=CC=CC=C1 NENQABJQPNYPBU-WBMJQRKESA-N 0.000 description 1
- OQYGXXTXJPIVSQ-DYVFJYSZSA-N (2s,3r)-3-hydroxy-2-[[4-(2-phenylethynyl)benzoyl]amino]butanoic acid Chemical compound C1=CC(C(=O)N[C@@H]([C@H](O)C)C(O)=O)=CC=C1C#CC1=CC=CC=C1 OQYGXXTXJPIVSQ-DYVFJYSZSA-N 0.000 description 1
- RWGONMYRYXRRKM-PDXHDDNESA-N (2s,3r)-n,3-dihydroxy-2-[[(2s)-3-(1h-imidazol-5-yl)-2-[[2-(4-phenylphenyl)acetyl]amino]propanoyl]amino]butanamide Chemical compound C([C@@H](C(=O)N[C@@H]([C@H](O)C)C(=O)NO)NC(=O)CC=1C=CC(=CC=1)C=1C=CC=CC=1)C1=CNC=N1 RWGONMYRYXRRKM-PDXHDDNESA-N 0.000 description 1
- MADPSBDYGCJTRU-LAMXGVLKSA-N (2s,3r)-n,3-dihydroxy-2-[[(2s)-3-(4-hydroxyphenyl)-2-[[2-(4-phenylphenyl)acetyl]amino]propanoyl]amino]butanamide Chemical compound C([C@@H](C(=O)N[C@@H]([C@H](O)C)C(=O)NO)NC(=O)CC=1C=CC(=CC=1)C=1C=CC=CC=1)C1=CC=C(O)C=C1 MADPSBDYGCJTRU-LAMXGVLKSA-N 0.000 description 1
- UXOONWUHFOEMNA-DPQOWFAMSA-N (2s,3r)-n,3-dihydroxy-2-[[(2s)-3-phenyl-2-[[2-(4-phenylphenyl)acetyl]amino]propanoyl]amino]butanamide Chemical compound C([C@@H](C(=O)N[C@@H]([C@H](O)C)C(=O)NO)NC(=O)CC=1C=CC(=CC=1)C=1C=CC=CC=1)C1=CC=CC=C1 UXOONWUHFOEMNA-DPQOWFAMSA-N 0.000 description 1
- LQMBJHYDWOLMTL-IYWFGIAKSA-N (2s,3r)-n,3-dihydroxy-2-[[(e)-3-phenylprop-2-enoyl]amino]butanamide Chemical compound ONC(=O)[C@H]([C@H](O)C)NC(=O)\C=C\C1=CC=CC=C1 LQMBJHYDWOLMTL-IYWFGIAKSA-N 0.000 description 1
- NZKFUBQRAWPZJP-BXKLGIMVSA-N (2s,3r,4s,5s,6r)-4-amino-2-[(1s,2s,3r,4s,6r)-4,6-diamino-3-[(2r,3r,5s,6r)-3-amino-6-(aminomethyl)-5-hydroxyoxan-2-yl]oxy-2-hydroxycyclohexyl]oxy-6-(hydroxymethyl)oxane-3,5-diol;sulfuric acid Chemical compound OS(O)(=O)=O.OS(O)(=O)=O.OS(O)(=O)=O.OS(O)(=O)=O.OS(O)(=O)=O.N[C@@H]1C[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N.N[C@@H]1C[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N NZKFUBQRAWPZJP-BXKLGIMVSA-N 0.000 description 1
- DAPZTHCKAHFPJE-SFTDATJTSA-N (2s,3s)-1-[4-(4-ethylphenyl)benzoyl]-3-hydroxy-n-[(2-methylpropan-2-yl)oxy]pyrrolidine-2-carboxamide Chemical compound C1=CC(CC)=CC=C1C1=CC=C(C(=O)N2[C@@H]([C@@H](O)CC2)C(=O)NOC(C)(C)C)C=C1 DAPZTHCKAHFPJE-SFTDATJTSA-N 0.000 description 1
- QIQIDAGTOLUIFX-ROUUACIJSA-N (2s,3s)-1-[4-(4-ethylphenyl)benzoyl]-3-hydroxypyrrolidine-2-carboxylic acid Chemical compound C1=CC(CC)=CC=C1C1=CC=C(C(=O)N2[C@@H]([C@@H](O)CC2)C(O)=O)C=C1 QIQIDAGTOLUIFX-ROUUACIJSA-N 0.000 description 1
- LQBQLDLUUNLGKS-ROUUACIJSA-N (2s,3s)-1-[4-(4-ethylphenyl)benzoyl]-n,3-dihydroxypyrrolidine-2-carboxamide Chemical compound C1=CC(CC)=CC=C1C1=CC=C(C(=O)N2[C@@H]([C@@H](O)CC2)C(=O)NO)C=C1 LQBQLDLUUNLGKS-ROUUACIJSA-N 0.000 description 1
- IOUOOPIEYQCKGU-LRDDRELGSA-N (2s,3s)-n,3-dihydroxy-2-[(4-phenylphenyl)methylamino]butanamide Chemical compound C1=CC(CN[C@@H]([C@@H](O)C)C(=O)NO)=CC=C1C1=CC=CC=C1 IOUOOPIEYQCKGU-LRDDRELGSA-N 0.000 description 1
- MJAKRIURGSKVMD-XEZLXBQYSA-N (2s,4s)-n-[(2s,3r)-3-hydroxy-1-(hydroxyamino)-1-oxobutan-2-yl]-4-phenylpyrrolidine-2-carboxamide Chemical compound C1N[C@H](C(=O)N[C@@H]([C@H](O)C)C(=O)NO)C[C@H]1C1=CC=CC=C1 MJAKRIURGSKVMD-XEZLXBQYSA-N 0.000 description 1
- RWYNUKDGPZPRDM-XEZLXBQYSA-N (2s,5r)-n-[(2s,3r)-3-hydroxy-1-(hydroxyamino)-1-oxobutan-2-yl]-5-phenylpyrrolidine-2-carboxamide Chemical compound N1[C@H](C(=O)N[C@@H]([C@H](O)C)C(=O)NO)CC[C@@H]1C1=CC=CC=C1 RWYNUKDGPZPRDM-XEZLXBQYSA-N 0.000 description 1
- KUJJJYMXBLREOZ-QKCSRTOESA-N (3r)-3-amino-n-[(2s,3r)-3-hydroxy-1-(hydroxyamino)-1-oxobutan-2-yl]-5-phenylpentanamide Chemical compound ONC(=O)[C@H]([C@H](O)C)NC(=O)C[C@H](N)CCC1=CC=CC=C1 KUJJJYMXBLREOZ-QKCSRTOESA-N 0.000 description 1
- HDEFQBGAFYLLBM-LROUJFHJSA-N (3s)-2-[4-(4-ethylphenyl)benzoyl]-n-[(2s,3r)-3-hydroxy-1-(hydroxyamino)-1-oxobutan-2-yl]-3,4-dihydro-1h-isoquinoline-3-carboxamide Chemical compound C1=CC(CC)=CC=C1C1=CC=C(C(=O)N2[C@@H](CC3=CC=CC=C3C2)C(=O)N[C@@H]([C@@H](C)O)C(=O)NO)C=C1 HDEFQBGAFYLLBM-LROUJFHJSA-N 0.000 description 1
- KUJJJYMXBLREOZ-OSMZGAPFSA-N (3s)-3-amino-n-[(2s,3r)-3-hydroxy-1-(hydroxyamino)-1-oxobutan-2-yl]-5-phenylpentanamide Chemical compound ONC(=O)[C@H]([C@H](O)C)NC(=O)C[C@@H](N)CCC1=CC=CC=C1 KUJJJYMXBLREOZ-OSMZGAPFSA-N 0.000 description 1
- FMUWQXGFENFQGR-VOWSPCBNSA-N (3s)-4-[[(2s,3r)-3-hydroxy-1-(hydroxyamino)-1-oxobutan-2-yl]amino]-4-oxo-3-[[2-(4-phenylphenyl)acetyl]amino]butanoic acid Chemical compound C1=CC(CC(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H]([C@H](O)C)C(=O)NO)=CC=C1C1=CC=CC=C1 FMUWQXGFENFQGR-VOWSPCBNSA-N 0.000 description 1
- IXJYISOCYLCSKB-VAQLEPBLSA-N (3s)-n-[(2s,3r)-3-hydroxy-1-(hydroxyamino)-1-oxobutan-2-yl]-2-[2-(4-phenylphenyl)acetyl]-3,4-dihydro-1h-isoquinoline-3-carboxamide Chemical compound C([C@H]1C(=O)N[C@@H]([C@H](O)C)C(=O)NO)C2=CC=CC=C2CN1C(=O)CC(C=C1)=CC=C1C1=CC=CC=C1 IXJYISOCYLCSKB-VAQLEPBLSA-N 0.000 description 1
- PVALOHBLYYAPGI-LLVKDONJSA-N (4r)-2-(4-fluoro-3-prop-2-enylphenyl)-n-hydroxy-4,5-dihydro-1,3-oxazole-4-carboxamide Chemical compound ONC(=O)[C@H]1COC(C=2C=C(CC=C)C(F)=CC=2)=N1 PVALOHBLYYAPGI-LLVKDONJSA-N 0.000 description 1
- HQFKAJSOJUDSMF-QGZVFWFLSA-N (4r)-4-[[4-(4-ethylphenyl)benzoyl]amino]-5-(hydroxyamino)-5-oxopentanoic acid Chemical compound C1=CC(CC)=CC=C1C1=CC=C(C(=O)N[C@H](CCC(O)=O)C(=O)NO)C=C1 HQFKAJSOJUDSMF-QGZVFWFLSA-N 0.000 description 1
- UYEHNCJRUNXJEM-CYBMUJFWSA-N (4r)-n-hydroxy-2-[4-[2-(trifluoromethoxy)phenyl]phenyl]-4,5-dihydro-1,3-oxazole-4-carboxamide Chemical compound ONC(=O)[C@H]1COC(C=2C=CC(=CC=2)C=2C(=CC=CC=2)OC(F)(F)F)=N1 UYEHNCJRUNXJEM-CYBMUJFWSA-N 0.000 description 1
- QHYOWOKCMNPPEQ-SSDOTTSWSA-N (4r)-n-hydroxy-2-[4-methoxy-3-(trifluoromethoxy)phenyl]-4,5-dihydro-1,3-oxazole-4-carboxamide Chemical compound C1=C(OC(F)(F)F)C(OC)=CC=C1C1=N[C@@H](C(=O)NO)CO1 QHYOWOKCMNPPEQ-SSDOTTSWSA-N 0.000 description 1
- IKHDNEFKDPOBJK-RFVSGWPVSA-N (4s)-4-[[4-(4-ethylphenyl)benzoyl]amino]-5-[[(2s,3r)-3-hydroxy-1-(hydroxyamino)-1-oxobutan-2-yl]amino]-5-oxopentanoic acid Chemical compound C1=CC(CC)=CC=C1C1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)NO)C=C1 IKHDNEFKDPOBJK-RFVSGWPVSA-N 0.000 description 1
- QHYOWOKCMNPPEQ-ZETCQYMHSA-N (4s)-n-hydroxy-2-[4-methoxy-3-(trifluoromethoxy)phenyl]-4,5-dihydro-1,3-oxazole-4-carboxamide Chemical compound C1=C(OC(F)(F)F)C(OC)=CC=C1C1=N[C@H](C(=O)NO)CO1 QHYOWOKCMNPPEQ-ZETCQYMHSA-N 0.000 description 1
- SUURNVLQOJQTIX-UHFFFAOYSA-N 1-[4-(4-ethylphenyl)benzoyl]-n-hydroxypiperazine-2-carboxamide Chemical compound C1=CC(CC)=CC=C1C1=CC=C(C(=O)N2C(CNCC2)C(=O)NO)C=C1 SUURNVLQOJQTIX-UHFFFAOYSA-N 0.000 description 1
- CMEQLZPYWFNPQY-KQDJYFMNSA-N 2,3,5,6-tetrafluoro-n-[(2s,3r)-3-hydroxy-1-(hydroxyamino)-1-oxobutan-2-yl]-4-prop-2-enylbenzamide Chemical compound ONC(=O)[C@H]([C@H](O)C)NC(=O)C1=C(F)C(F)=C(CC=C)C(F)=C1F CMEQLZPYWFNPQY-KQDJYFMNSA-N 0.000 description 1
- SCXONGNMBIUGOQ-UHFFFAOYSA-N 2-(3-fluoro-4-methoxy-5-prop-2-enylphenyl)-n-hydroxy-4,5-dihydro-1,3-oxazole-4-carboxamide Chemical compound C1=C(CC=C)C(OC)=C(F)C=C1C1=NC(C(=O)NO)CO1 SCXONGNMBIUGOQ-UHFFFAOYSA-N 0.000 description 1
- LWYJIXKZBYQOJN-MRVPVSSYSA-N 2-[(2S)-3-amino-1-(hydroxyamino)-1-oxopropan-2-yl]benzamide Chemical compound NC[C@@H](C(=O)NO)C1=C(C(=O)N)C=CC=C1 LWYJIXKZBYQOJN-MRVPVSSYSA-N 0.000 description 1
- HVKFVEMLANHHMY-FUBQLUNQSA-N 2-[2-[[(2s)-3-(hydroxyamino)-3-oxo-2-[[4-(2-phenylethynyl)benzoyl]amino]propyl]amino]-2-oxoethyl]sulfanylpropanoic acid Chemical compound C1=CC(C(=O)N[C@@H](CNC(=O)CSC(C)C(O)=O)C(=O)NO)=CC=C1C#CC1=CC=CC=C1 HVKFVEMLANHHMY-FUBQLUNQSA-N 0.000 description 1
- AFBBOLKXUGQJKQ-YJYMSZOUSA-N 2-[4-[2-[4-[[(2s,3r)-3-hydroxy-1-(hydroxyamino)-1-oxobutan-2-yl]carbamoyl]phenyl]ethynyl]phenyl]acetic acid Chemical compound C1=CC(C(=O)N[C@@H]([C@H](O)C)C(=O)NO)=CC=C1C#CC1=CC=C(CC(O)=O)C=C1 AFBBOLKXUGQJKQ-YJYMSZOUSA-N 0.000 description 1
- GGZQMMBHRPRXII-UHFFFAOYSA-N 2-[[4-(4-ethylphenyl)benzoyl]amino]-3-hydroxy-3-methylbutanoic acid Chemical compound C1=CC(CC)=CC=C1C1=CC=C(C(=O)NC(C(O)=O)C(C)(C)O)C=C1 GGZQMMBHRPRXII-UHFFFAOYSA-N 0.000 description 1
- ZPZTYELXWHQHRE-UHFFFAOYSA-N 2-[[4-(4-ethylphenyl)benzoyl]amino]-3-hydroxy-4-methylpentanoic acid Chemical compound C1=CC(CC)=CC=C1C1=CC=C(C(=O)NC(C(O)C(C)C)C(O)=O)C=C1 ZPZTYELXWHQHRE-UHFFFAOYSA-N 0.000 description 1
- 125000001731 2-cyanoethyl group Chemical group [H]C([H])(*)C([H])([H])C#N 0.000 description 1
- YXFZJXLQGULFAG-UHFFFAOYSA-N 2-hydroxypentanediamide Chemical compound NC(=O)CCC(O)C(N)=O YXFZJXLQGULFAG-UHFFFAOYSA-N 0.000 description 1
- JXQZFPIBOYZPSH-UHFFFAOYSA-N 2-hydroxypiperidine-1,4-dicarboxamide Chemical compound NC(=O)C1CCN(C(N)=O)C(O)C1 JXQZFPIBOYZPSH-UHFFFAOYSA-N 0.000 description 1
- 125000000094 2-phenylethyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])C([H])([H])* 0.000 description 1
- QRQIPZOKEWWDNR-UHFFFAOYSA-N 3-(dimethylamino)-2-[[4-(4-ethylphenyl)benzoyl]amino]propanoic acid Chemical compound C1=CC(CC)=CC=C1C1=CC=C(C(=O)NC(CN(C)C)C(O)=O)C=C1 QRQIPZOKEWWDNR-UHFFFAOYSA-N 0.000 description 1
- RIRJRCJJUABITJ-UHFFFAOYSA-N 3-[2-(hydroxyamino)-2-oxoethyl]-4-phenylbenzamide Chemical compound ONC(CC1=C(C=CC(=C1)C(=O)N)C1=CC=CC=C1)=O RIRJRCJJUABITJ-UHFFFAOYSA-N 0.000 description 1
- 125000006275 3-bromophenyl group Chemical group [H]C1=C([H])C(Br)=C([H])C(*)=C1[H] 0.000 description 1
- 125000004179 3-chlorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C(Cl)=C1[H] 0.000 description 1
- REBAAWJJWZVJMM-PSLIRLAXSA-N 3-fluoro-4-(3-fluorophenyl)-n-[(2s,3r)-3-hydroxy-1-(hydroxyamino)-1-oxobutan-2-yl]benzamide Chemical compound FC1=CC(C(=O)N[C@@H]([C@H](O)C)C(=O)NO)=CC=C1C1=CC=CC(F)=C1 REBAAWJJWZVJMM-PSLIRLAXSA-N 0.000 description 1
- ZRRSITZUIJGCRM-PSLIRLAXSA-N 4-(2,4-difluorophenyl)-n-[(2s,3r)-3-hydroxy-1-(hydroxyamino)-1-oxobutan-2-yl]benzamide Chemical compound C1=CC(C(=O)N[C@@H]([C@H](O)C)C(=O)NO)=CC=C1C1=CC=C(F)C=C1F ZRRSITZUIJGCRM-PSLIRLAXSA-N 0.000 description 1
- BUYMZAQOVUSJPV-UHFFFAOYSA-N 4-(2-phenylethynyl)benzamide Chemical compound C1=CC(C(=O)N)=CC=C1C#CC1=CC=CC=C1 BUYMZAQOVUSJPV-UHFFFAOYSA-N 0.000 description 1
- OYPONJPRGKAILJ-DIFFPNOSSA-N 4-(3,4-dimethoxyphenyl)-n-[(2s,3r)-3-hydroxy-1-(hydroxyamino)-1-oxobutan-2-yl]benzamide Chemical compound C1=C(OC)C(OC)=CC=C1C1=CC=C(C(=O)N[C@@H]([C@@H](C)O)C(=O)NO)C=C1 OYPONJPRGKAILJ-DIFFPNOSSA-N 0.000 description 1
- JEEZLVNEEXCOSG-BZNIZROVSA-N 4-(3-cyanophenyl)-n-[(2s,3r)-3-hydroxy-1-(hydroxyamino)-1-oxobutan-2-yl]benzamide Chemical compound C1=CC(C(=O)N[C@@H]([C@H](O)C)C(=O)NO)=CC=C1C1=CC=CC(C#N)=C1 JEEZLVNEEXCOSG-BZNIZROVSA-N 0.000 description 1
- UESYSCNFEWENAU-PXAZEXFGSA-N 4-(3-ethoxyphenyl)-n-[(2s,3r)-3-hydroxy-1-(hydroxyamino)-1-oxobutan-2-yl]benzamide Chemical compound CCOC1=CC=CC(C=2C=CC(=CC=2)C(=O)N[C@@H]([C@@H](C)O)C(=O)NO)=C1 UESYSCNFEWENAU-PXAZEXFGSA-N 0.000 description 1
- CMVRHFYUOHVZPK-BZNIZROVSA-N 4-(3-fluoro-4-methylphenyl)-n-[(2s,3r)-3-hydroxy-1-(hydroxyamino)-1-oxobutan-2-yl]benzamide Chemical compound C1=CC(C(=O)N[C@@H]([C@H](O)C)C(=O)NO)=CC=C1C1=CC=C(C)C(F)=C1 CMVRHFYUOHVZPK-BZNIZROVSA-N 0.000 description 1
- BTXLCZLZWLYJBN-DIFFPNOSSA-N 4-(3-formyl-4-methoxyphenyl)-n-[(2s,3r)-3-hydroxy-1-(hydroxyamino)-1-oxobutan-2-yl]benzamide Chemical compound C1=C(C=O)C(OC)=CC=C1C1=CC=C(C(=O)N[C@@H]([C@@H](C)O)C(=O)NO)C=C1 BTXLCZLZWLYJBN-DIFFPNOSSA-N 0.000 description 1
- MQLDRPSAWFDIOK-PXAZEXFGSA-N 4-(4-ethoxyphenyl)-n-[(2s,3r)-3-hydroxy-1-(hydroxyamino)-1-oxobutan-2-yl]benzamide Chemical compound C1=CC(OCC)=CC=C1C1=CC=C(C(=O)N[C@@H]([C@@H](C)O)C(=O)NO)C=C1 MQLDRPSAWFDIOK-PXAZEXFGSA-N 0.000 description 1
- WBXQBGNEVAMPCD-MRXNPFEDSA-N 4-(4-ethylphenyl)-n-[(2r)-3-hydroxy-1-(hydroxyamino)-1-oxopropan-2-yl]benzamide Chemical compound C1=CC(CC)=CC=C1C1=CC=C(C(=O)N[C@H](CO)C(=O)NO)C=C1 WBXQBGNEVAMPCD-MRXNPFEDSA-N 0.000 description 1
- PKJSSYOXFPKWPB-FZKQIMNGSA-N 4-(4-ethylphenyl)-n-[(2r,3r)-1-(hydroxyamino)-3-methoxy-1-oxobutan-2-yl]benzamide Chemical compound C1=CC(CC)=CC=C1C1=CC=C(C(=O)N[C@H]([C@@H](C)OC)C(=O)NO)C=C1 PKJSSYOXFPKWPB-FZKQIMNGSA-N 0.000 description 1
- VTXKLWNBKDFFMS-KBMIEXCESA-N 4-(4-ethylphenyl)-n-[(2r,3r)-1-(hydroxyamino)-3-phenylmethoxybutan-2-yl]benzamide Chemical compound C1=CC(CC)=CC=C1C1=CC=C(C(=O)N[C@H](CNO)[C@@H](C)OCC=2C=CC=CC=2)C=C1 VTXKLWNBKDFFMS-KBMIEXCESA-N 0.000 description 1
- XOWPRTHNPSQNQS-AUUYWEPGSA-N 4-(4-ethylphenyl)-n-[(2r,3r)-1-[formyl(hydroxy)amino]-3-hydroxybutan-2-yl]benzamide Chemical compound C1=CC(CC)=CC=C1C1=CC=C(C(=O)N[C@H](CN(O)C=O)[C@@H](C)O)C=C1 XOWPRTHNPSQNQS-AUUYWEPGSA-N 0.000 description 1
- XNQMSHKDWOITKC-FZKQIMNGSA-N 4-(4-ethylphenyl)-n-[(2r,3r)-3-hydroxy-1-(hydroxyamino)butan-2-yl]benzamide Chemical compound C1=CC(CC)=CC=C1C1=CC=C(C(=O)N[C@H](CNO)[C@@H](C)O)C=C1 XNQMSHKDWOITKC-FZKQIMNGSA-N 0.000 description 1
- KUPOXKHYLPHHAS-FOIQADDNSA-N 4-(4-ethylphenyl)-n-[(2r,3r)-3-hydroxy-1-[hydroxy(2-hydroxyethylcarbamoyl)amino]butan-2-yl]benzamide Chemical compound C1=CC(CC)=CC=C1C1=CC=C(C(=O)N[C@H](CN(O)C(=O)NCCO)[C@@H](C)O)C=C1 KUPOXKHYLPHHAS-FOIQADDNSA-N 0.000 description 1
- ZZUFFIKSGFKGOY-HOYKHHGWSA-N 4-(4-ethylphenyl)-n-[(2r,3r)-3-hydroxy-1-[hydroxy(pyridin-3-ylmethylcarbamoyl)amino]butan-2-yl]benzamide Chemical compound C1=CC(CC)=CC=C1C1=CC=C(C(=O)N[C@H](CN(O)C(=O)NCC=2C=NC=CC=2)[C@@H](C)O)C=C1 ZZUFFIKSGFKGOY-HOYKHHGWSA-N 0.000 description 1
- PWSLYNNPQIRNBP-NTKDMRAZSA-N 4-(4-ethylphenyl)-n-[(2r,3r)-3-hydroxy-1-[hydroxy-[3-(2-oxopyrrolidin-1-yl)propylcarbamoyl]amino]butan-2-yl]benzamide Chemical compound C1=CC(CC)=CC=C1C1=CC=C(C(=O)N[C@H](CN(O)C(=O)NCCCN2C(CCC2)=O)[C@@H](C)O)C=C1 PWSLYNNPQIRNBP-NTKDMRAZSA-N 0.000 description 1
- QULTWXKJNWURIC-IBGZPJMESA-N 4-(4-ethylphenyl)-n-[(2s)-1-(hydroxyamino)-1-oxo-3-(propan-2-ylamino)propan-2-yl]benzamide Chemical compound C1=CC(CC)=CC=C1C1=CC=C(C(=O)N[C@@H](CNC(C)C)C(=O)NO)C=C1 QULTWXKJNWURIC-IBGZPJMESA-N 0.000 description 1
- RVZDZNJIJCVBIF-IBGZPJMESA-N 4-(4-ethylphenyl)-n-[(2s)-1-(hydroxyamino)-3-(1h-imidazol-5-yl)-1-oxopropan-2-yl]benzamide Chemical compound C1=CC(CC)=CC=C1C1=CC=C(C(=O)N[C@@H](CC=2NC=NC=2)C(=O)NO)C=C1 RVZDZNJIJCVBIF-IBGZPJMESA-N 0.000 description 1
- RSXINJBOFKAEMW-NRFANRHFSA-N 4-(4-ethylphenyl)-n-[(2s)-1-(hydroxyamino)-3-(oxan-4-ylamino)-1-oxopropan-2-yl]benzamide Chemical compound C1=CC(CC)=CC=C1C1=CC=C(C(=O)N[C@@H](CNC2CCOCC2)C(=O)NO)C=C1 RSXINJBOFKAEMW-NRFANRHFSA-N 0.000 description 1
- IETLBHZACGYNCN-IBGZPJMESA-N 4-(4-ethylphenyl)-n-[(2s)-1-(hydroxyamino)-3-[2-(methylamino)ethylamino]-1-oxopropan-2-yl]benzamide Chemical compound C1=CC(CC)=CC=C1C1=CC=C(C(=O)N[C@@H](CNCCNC)C(=O)NO)C=C1 IETLBHZACGYNCN-IBGZPJMESA-N 0.000 description 1
- ZCZSCZODDWTEEP-YDFBLROQSA-N 4-(4-ethylphenyl)-n-[(2s)-1-[[(2s,3r)-3-hydroxy-1-(hydroxyamino)-1-oxobutan-2-yl]amino]-3-(1h-imidazol-5-yl)-1-oxopropan-2-yl]benzamide Chemical compound C1=CC(CC)=CC=C1C1=CC=C(C(=O)N[C@@H](CC=2N=CNC=2)C(=O)N[C@@H]([C@@H](C)O)C(=O)NO)C=C1 ZCZSCZODDWTEEP-YDFBLROQSA-N 0.000 description 1
- RVVUWVFHFOHXFX-XATISFHKSA-N 4-(4-ethylphenyl)-n-[(2s)-1-[[(2s,3r)-3-hydroxy-1-(hydroxyamino)-1-oxobutan-2-yl]amino]-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]benzamide Chemical compound C1=CC(CC)=CC=C1C1=CC=C(C(=O)N[C@@H](CC=2C=CC(O)=CC=2)C(=O)N[C@@H]([C@@H](C)O)C(=O)NO)C=C1 RVVUWVFHFOHXFX-XATISFHKSA-N 0.000 description 1
- WBXQBGNEVAMPCD-INIZCTEOSA-N 4-(4-ethylphenyl)-n-[(2s)-3-hydroxy-1-(hydroxyamino)-1-oxopropan-2-yl]benzamide Chemical compound C1=CC(CC)=CC=C1C1=CC=C(C(=O)N[C@@H](CO)C(=O)NO)C=C1 WBXQBGNEVAMPCD-INIZCTEOSA-N 0.000 description 1
- WLCPQPPSDHOWGY-VMDGZTHMSA-N 4-(4-ethylphenyl)-n-[(2s)-3-hydroxy-1-[[(2s,3r)-3-hydroxy-1-(hydroxyamino)-1-oxobutan-2-yl]amino]-1-oxopropan-2-yl]benzamide Chemical compound C1=CC(CC)=CC=C1C1=CC=C(C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)O)C(=O)NO)C=C1 WLCPQPPSDHOWGY-VMDGZTHMSA-N 0.000 description 1
- PKJSSYOXFPKWPB-ACJLOTCBSA-N 4-(4-ethylphenyl)-n-[(2s,3r)-1-(hydroxyamino)-3-methoxy-1-oxobutan-2-yl]benzamide Chemical compound C1=CC(CC)=CC=C1C1=CC=C(C(=O)N[C@@H]([C@@H](C)OC)C(=O)NO)C=C1 PKJSSYOXFPKWPB-ACJLOTCBSA-N 0.000 description 1
- OHTUHSHRSUEECR-XIKOKIGWSA-N 4-(4-ethylphenyl)-n-[(2s,3r)-3-hydroxy-1-(hydroxyamino)-1-oxobutan-2-yl]-3-methoxybenzamide Chemical compound C1=CC(CC)=CC=C1C1=CC=C(C(=O)N[C@@H]([C@@H](C)O)C(=O)NO)C=C1OC OHTUHSHRSUEECR-XIKOKIGWSA-N 0.000 description 1
- WJBHUXQULLPEQE-KUHUBIRLSA-N 4-(4-ethylphenyl)-n-[(2s,3r)-3-hydroxy-1-[2-(hydroxyamino)ethylamino]-1-oxobutan-2-yl]benzamide Chemical compound C1=CC(CC)=CC=C1C1=CC=C(C(=O)N[C@@H]([C@@H](C)O)C(=O)NCCNO)C=C1 WJBHUXQULLPEQE-KUHUBIRLSA-N 0.000 description 1
- PQCCTXMTUVRYNM-IERDGZPVSA-N 4-(4-ethylphenyl)-n-[(2s,3r)-3-hydroxy-1-[2-[hydroxy(2-hydroxyethylcarbamoyl)amino]ethylamino]-1-oxobutan-2-yl]benzamide Chemical compound C1=CC(CC)=CC=C1C1=CC=C(C(=O)N[C@@H]([C@@H](C)O)C(=O)NCCN(O)C(=O)NCCO)C=C1 PQCCTXMTUVRYNM-IERDGZPVSA-N 0.000 description 1
- OVWVENTUCRFBMG-VGSWGCGISA-N 4-(4-ethylphenyl)-n-[(2s,3r)-3-hydroxy-1-[2-[hydroxy(2-methoxyethylcarbamoyl)amino]ethylamino]-1-oxobutan-2-yl]benzamide Chemical compound C1=CC(CC)=CC=C1C1=CC=C(C(=O)N[C@@H]([C@@H](C)O)C(=O)NCCN(O)C(=O)NCCOC)C=C1 OVWVENTUCRFBMG-VGSWGCGISA-N 0.000 description 1
- GNMSBIATNWGZTF-CLOONOSVSA-N 4-(4-ethylphenyl)-n-[(2s,3r)-3-hydroxy-1-[2-[hydroxy(pyridin-3-ylmethylcarbamoyl)amino]ethylamino]-1-oxobutan-2-yl]benzamide Chemical compound C1=CC(CC)=CC=C1C1=CC=C(C(=O)N[C@@H]([C@@H](C)O)C(=O)NCCN(O)C(=O)NCC=2C=NC=CC=2)C=C1 GNMSBIATNWGZTF-CLOONOSVSA-N 0.000 description 1
- UBOHQLRHPWUVAV-NSMLZSOPSA-N 4-(4-ethylphenyl)-n-[(2s,3r)-3-hydroxy-1-[[(2s,3r)-3-hydroxy-1-(hydroxyamino)-1-oxobutan-2-yl]amino]-1-oxobutan-2-yl]benzamide Chemical compound C1=CC(CC)=CC=C1C1=CC=C(C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)O)C(=O)NO)C=C1 UBOHQLRHPWUVAV-NSMLZSOPSA-N 0.000 description 1
- PKJSSYOXFPKWPB-UHFFFAOYSA-N 4-(4-ethylphenyl)-n-[1-(hydroxyamino)-3-methoxy-1-oxobutan-2-yl]benzamide Chemical compound C1=CC(CC)=CC=C1C1=CC=C(C(=O)NC(C(C)OC)C(=O)NO)C=C1 PKJSSYOXFPKWPB-UHFFFAOYSA-N 0.000 description 1
- VWXSOSSIDRHSIA-UHFFFAOYSA-N 4-(4-ethylphenyl)-n-[2-[(2-methylpropan-2-yl)oxyamino]-2-oxo-1-thiophen-2-ylethyl]benzamide Chemical compound C1=CC(CC)=CC=C1C1=CC=C(C(=O)NC(C(=O)NOC(C)(C)C)C=2SC=CC=2)C=C1 VWXSOSSIDRHSIA-UHFFFAOYSA-N 0.000 description 1
- TUVXYKBTTNFLRM-UHFFFAOYSA-N 4-(4-ethylphenyl)-n-[2-[(4-fluorophenyl)methylcarbamoyl-hydroxyamino]ethyl]benzamide Chemical compound C1=CC(CC)=CC=C1C1=CC=C(C(=O)NCCN(O)C(=O)NCC=2C=CC(F)=CC=2)C=C1 TUVXYKBTTNFLRM-UHFFFAOYSA-N 0.000 description 1
- IIKARFZLYNXSKU-YJYMSZOUSA-N 4-(4-ethylphenyl)-n-[2-[[(2s,3r)-3-hydroxy-1-(hydroxyamino)-1-oxobutan-2-yl]amino]-2-oxoethyl]benzamide Chemical compound C1=CC(CC)=CC=C1C1=CC=C(C(=O)NCC(=O)N[C@@H]([C@@H](C)O)C(=O)NO)C=C1 IIKARFZLYNXSKU-YJYMSZOUSA-N 0.000 description 1
- ASOMTMQWRARPAA-UHFFFAOYSA-N 4-(4-ethylphenyl)-n-[2-[hydroxy(3-hydroxypropylcarbamoyl)amino]ethyl]benzamide Chemical compound C1=CC(CC)=CC=C1C1=CC=C(C(=O)NCCN(O)C(=O)NCCCO)C=C1 ASOMTMQWRARPAA-UHFFFAOYSA-N 0.000 description 1
- ZBQKJHPGDXMRCO-UHFFFAOYSA-N 4-(4-ethylphenyl)-n-[2-[hydroxy(3-methoxypropylcarbamoyl)amino]ethyl]benzamide Chemical compound C1=CC(CC)=CC=C1C1=CC=C(C(=O)NCCN(O)C(=O)NCCCOC)C=C1 ZBQKJHPGDXMRCO-UHFFFAOYSA-N 0.000 description 1
- PPRXBSTZFTYSNK-UHFFFAOYSA-N 4-(4-ethylphenyl)-n-[2-[hydroxy(piperidin-3-ylmethylcarbamoyl)amino]ethyl]benzamide Chemical compound C1=CC(CC)=CC=C1C1=CC=C(C(=O)NCCN(O)C(=O)NCC2CNCCC2)C=C1 PPRXBSTZFTYSNK-UHFFFAOYSA-N 0.000 description 1
- PAOZGWRYPDZCNR-UHFFFAOYSA-N 4-(4-ethylphenyl)-n-[2-[hydroxy(pyridin-3-ylmethylcarbamoyl)amino]ethyl]benzamide Chemical compound C1=CC(CC)=CC=C1C1=CC=C(C(=O)NCCN(O)C(=O)NCC=2C=NC=CC=2)C=C1 PAOZGWRYPDZCNR-UHFFFAOYSA-N 0.000 description 1
- IGQJHYITSBDBEQ-UHFFFAOYSA-N 4-(4-ethylphenyl)-n-[2-[hydroxy-[3-(2-oxopyrrolidin-1-yl)propylcarbamoyl]amino]ethyl]benzamide Chemical compound C1=CC(CC)=CC=C1C1=CC=C(C(=O)NCCN(O)C(=O)NCCCN2C(CCC2)=O)C=C1 IGQJHYITSBDBEQ-UHFFFAOYSA-N 0.000 description 1
- SNEHBCGJMBZVCU-UHFFFAOYSA-N 4-(4-ethylphenyl)-n-[3-hydroxy-1-(hydroxyamino)-4-methyl-1-oxopentan-2-yl]benzamide Chemical compound C1=CC(CC)=CC=C1C1=CC=C(C(=O)NC(C(O)C(C)C)C(=O)NO)C=C1 SNEHBCGJMBZVCU-UHFFFAOYSA-N 0.000 description 1
- DDEGTOUIGIFLRN-VFNWGFHPSA-N 4-(4-ethylphenyl)-n-[4-[[(2s,3r)-3-hydroxy-1-(hydroxyamino)-1-oxobutan-2-yl]amino]-4-oxobutyl]benzamide Chemical compound C1=CC(CC)=CC=C1C1=CC=C(C(=O)NCCCC(=O)N[C@@H]([C@@H](C)O)C(=O)NO)C=C1 DDEGTOUIGIFLRN-VFNWGFHPSA-N 0.000 description 1
- WKBLVHJLIRVCGI-UHFFFAOYSA-N 4-(4-ethylphenyl)-n-hydroxybenzamide Chemical compound C1=CC(CC)=CC=C1C1=CC=C(C(=O)NO)C=C1 WKBLVHJLIRVCGI-UHFFFAOYSA-N 0.000 description 1
- PDOOSOPUIHHGSF-UHFFFAOYSA-N 4-(4-ethylphenyl)benzamide Chemical compound C1=CC(CC)=CC=C1C1=CC=C(C(N)=O)C=C1 PDOOSOPUIHHGSF-UHFFFAOYSA-N 0.000 description 1
- PYSGTZJNRDAITO-ACJLOTCBSA-N 4-(4-tert-butylphenyl)-n-[(2s,3r)-3-hydroxy-1-(hydroxyamino)-1-oxobutan-2-yl]benzamide Chemical compound C1=CC(C(=O)N[C@@H]([C@H](O)C)C(=O)NO)=CC=C1C1=CC=C(C(C)(C)C)C=C1 PYSGTZJNRDAITO-ACJLOTCBSA-N 0.000 description 1
- LOLKAJARZKDJTD-UHFFFAOYSA-N 4-Ethoxy-4-oxobutanoic acid Chemical class CCOC(=O)CCC(O)=O LOLKAJARZKDJTD-UHFFFAOYSA-N 0.000 description 1
- YTWJHBUKUCMQPR-UHFFFAOYSA-N 4-[2-(4-ethylphenyl)ethynyl]-n-hydroxybenzamide Chemical compound C1=CC(CC)=CC=C1C#CC1=CC=C(C(=O)NO)C=C1 YTWJHBUKUCMQPR-UHFFFAOYSA-N 0.000 description 1
- YURHMKBZHZYAOA-KRWDZBQOSA-N 4-[2-[4-[(2-aminoacetyl)amino]phenyl]ethynyl]-n-[(2s)-3-amino-1-(hydroxyamino)-1-oxopropan-2-yl]-3-fluorobenzamide Chemical compound FC1=CC(C(=O)N[C@@H](CN)C(=O)NO)=CC=C1C#CC1=CC=C(NC(=O)CN)C=C1 YURHMKBZHZYAOA-KRWDZBQOSA-N 0.000 description 1
- NCBUHWZEVNYEIA-PXAZEXFGSA-N 4-[4-(2-aminoethyl)phenyl]-n-[(2s,3r)-3-hydroxy-1-(hydroxyamino)-1-oxobutan-2-yl]benzamide Chemical compound C1=CC(C(=O)N[C@@H]([C@H](O)C)C(=O)NO)=CC=C1C1=CC=C(CCN)C=C1 NCBUHWZEVNYEIA-PXAZEXFGSA-N 0.000 description 1
- BCJUSWWQXSVHHC-PXAZEXFGSA-N 4-[4-(dimethylamino)phenyl]-n-[(2s,3r)-3-hydroxy-1-(hydroxyamino)-1-oxobutan-2-yl]benzamide Chemical compound C1=CC(C(=O)N[C@@H]([C@H](O)C)C(=O)NO)=CC=C1C1=CC=C(N(C)C)C=C1 BCJUSWWQXSVHHC-PXAZEXFGSA-N 0.000 description 1
- MSCVVHYFHLCHNR-DIFFPNOSSA-N 4-[4-[2-(hydroxyamino)-2-oxoethoxy]phenyl]-n-[(2s,3r)-3-hydroxy-1-(hydroxyamino)-1-oxobutan-2-yl]benzamide Chemical compound C1=CC(C(=O)N[C@@H]([C@H](O)C)C(=O)NO)=CC=C1C1=CC=C(OCC(=O)NO)C=C1 MSCVVHYFHLCHNR-DIFFPNOSSA-N 0.000 description 1
- SPBLVNJGXXCVJC-NQERJWCQSA-N 4-[4-[2-[[(2s)-2,5-diaminopentanoyl]amino]ethyl]phenyl]-n-[(2s,3r)-3-hydroxy-1-(hydroxyamino)-1-oxobutan-2-yl]benzamide Chemical compound C1=CC(C(=O)N[C@@H]([C@H](O)C)C(=O)NO)=CC=C1C1=CC=C(CCNC(=O)[C@@H](N)CCCN)C=C1 SPBLVNJGXXCVJC-NQERJWCQSA-N 0.000 description 1
- KRCZLSYMKLKWDK-BMIGLBTASA-N 4-[4-[[(2s,3r)-3-hydroxy-1-(hydroxyamino)-1-oxobutan-2-yl]carbamoyl]phenyl]benzoic acid Chemical compound C1=CC(C(=O)N[C@@H]([C@H](O)C)C(=O)NO)=CC=C1C1=CC=C(C(O)=O)C=C1 KRCZLSYMKLKWDK-BMIGLBTASA-N 0.000 description 1
- CUOJPVFUUVUXDY-MUWHJKNJSA-N 4-[[(2s,3r)-3-hydroxy-1-(hydroxyamino)-1-oxobutan-2-yl]carbamoyl]benzoic acid Chemical compound ONC(=O)[C@H]([C@H](O)C)NC(=O)C1=CC=C(C(O)=O)C=C1 CUOJPVFUUVUXDY-MUWHJKNJSA-N 0.000 description 1
- WWBXADLEHYZKNV-UHFFFAOYSA-N 4-[[4-(2-phenylethynyl)benzoyl]amino]piperidine-4-carboxylic acid Chemical compound C=1C=C(C#CC=2C=CC=CC=2)C=CC=1C(=O)NC1(C(=O)O)CCNCC1 WWBXADLEHYZKNV-UHFFFAOYSA-N 0.000 description 1
- SQTLUXJWUCHKMT-UHFFFAOYSA-N 4-bromo-n,n-diphenylaniline Chemical compound C1=CC(Br)=CC=C1N(C=1C=CC=CC=1)C1=CC=CC=C1 SQTLUXJWUCHKMT-UHFFFAOYSA-N 0.000 description 1
- 125000004203 4-hydroxyphenyl group Chemical group [H]OC1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 1
- 125000004195 4-methylpiperazin-1-yl group Chemical group [H]C([H])([H])N1C([H])([H])C([H])([H])N(*)C([H])([H])C1([H])[H] 0.000 description 1
- SPZKCUYRQXHSHX-IBGZPJMESA-N 5-[4-[2-[4-[[(2s)-3-amino-1-(hydroxyamino)-1-oxopropan-2-yl]carbamoyl]phenyl]ethynyl]anilino]-5-oxopentanoic acid Chemical compound C1=CC(C(=O)N[C@@H](CN)C(=O)NO)=CC=C1C#CC1=CC=C(NC(=O)CCCC(O)=O)C=C1 SPZKCUYRQXHSHX-IBGZPJMESA-N 0.000 description 1
- GSSGKRBXTULCQS-OTYXRUKQSA-N 5-[4-[[(2s,3r)-3-hydroxy-1-(hydroxyamino)-1-oxobutan-2-yl]carbamoyl]phenyl]pyridine-3-carboxylic acid Chemical compound C1=CC(C(=O)N[C@@H]([C@H](O)C)C(=O)NO)=CC=C1C1=CN=CC(C(O)=O)=C1 GSSGKRBXTULCQS-OTYXRUKQSA-N 0.000 description 1
- LNPQEQZCQALILZ-IBGZPJMESA-N 5-[[(2s)-3-(hydroxyamino)-3-oxo-2-[[4-(2-phenylethynyl)benzoyl]amino]propyl]amino]-5-oxopentanoic acid Chemical compound C1=CC(C(=O)N[C@@H](CNC(=O)CCCC(O)=O)C(=O)NO)=CC=C1C#CC1=CC=CC=C1 LNPQEQZCQALILZ-IBGZPJMESA-N 0.000 description 1
- 241001673062 Achromobacter xylosoxidans Species 0.000 description 1
- 241000588624 Acinetobacter calcoaceticus Species 0.000 description 1
- FQYBTYFKOHPWQT-VGSWGCGISA-N CHIR-090 Chemical compound C1=CC(C(=O)N[C@@H]([C@H](O)C)C(=O)NO)=CC=C1C#CC(C=C1)=CC=C1CN1CCOCC1 FQYBTYFKOHPWQT-VGSWGCGISA-N 0.000 description 1
- OKTJSMMVPCPJKN-NJFSPNSNSA-N Carbon-14 Chemical compound [14C] OKTJSMMVPCPJKN-NJFSPNSNSA-N 0.000 description 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
- 201000003883 Cystic fibrosis Diseases 0.000 description 1
- YZCKVEUIGOORGS-OUBTZVSYSA-N Deuterium Chemical compound [2H] YZCKVEUIGOORGS-OUBTZVSYSA-N 0.000 description 1
- 241000588697 Enterobacter cloacae Species 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
- AVXURJPOCDRRFD-UHFFFAOYSA-N Hydroxylamine Chemical compound ON AVXURJPOCDRRFD-UHFFFAOYSA-N 0.000 description 1
- 241000588915 Klebsiella aerogenes Species 0.000 description 1
- 241000588749 Klebsiella oxytoca Species 0.000 description 1
- 241000588747 Klebsiella pneumoniae Species 0.000 description 1
- 125000003412 L-alanyl group Chemical group [H]N([H])[C@@](C([H])([H])[H])(C(=O)[*])[H] 0.000 description 1
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- KINYYFSTZCFJKG-UHFFFAOYSA-N N'-(2,2,2-trifluoroacetyl)pyrrolidine-1-carbohydrazide Chemical compound FC(C(=O)NNC(=O)N1CCCC1)(F)F KINYYFSTZCFJKG-UHFFFAOYSA-N 0.000 description 1
- PAFJNAUZKPVXOX-UYMSWOSGSA-N N-[(2S,3R)-3-hydroxy-1-(hydroxyamino)-1-oxobutan-2-yl]pyrrolidine-2-carboxamide Chemical compound N1C(CCC1)C(=O)N[C@@H]([C@@H](C)O)C(=O)NO PAFJNAUZKPVXOX-UYMSWOSGSA-N 0.000 description 1
- 101150026476 PAO1 gene Proteins 0.000 description 1
- 241000588770 Proteus mirabilis Species 0.000 description 1
- 241000589517 Pseudomonas aeruginosa Species 0.000 description 1
- 241000607715 Serratia marcescens Species 0.000 description 1
- 241000122973 Stenotrophomonas maltophilia Species 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- YRXPMAFIWJEHEQ-UHFFFAOYSA-N [(4-phenoxyphenyl)methylideneamino]thiourea Chemical compound C1=CC(C=NNC(=S)N)=CC=C1OC1=CC=CC=C1 YRXPMAFIWJEHEQ-UHFFFAOYSA-N 0.000 description 1
- CBGLRILSDNCIFX-UHFFFAOYSA-N [(4-phenoxyphenyl)methylideneamino]urea Chemical compound C1=CC(C=NNC(=O)N)=CC=C1OC1=CC=CC=C1 CBGLRILSDNCIFX-UHFFFAOYSA-N 0.000 description 1
- HDBWOJHYKOZVHO-MWTRTKDXSA-N [4-[4-[[(2s,3r)-1-(cyanomethylamino)-1-oxo-3-propanoyloxybutan-2-yl]carbamoyl]phenyl]phenyl] propanoate Chemical compound C1=CC(C(=O)N[C@@H]([C@@H](C)OC(=O)CC)C(=O)NCC#N)=CC=C1C1=CC=C(OC(=O)CC)C=C1 HDBWOJHYKOZVHO-MWTRTKDXSA-N 0.000 description 1
- HYMPLCHSXHTIEY-DWXRJYCRSA-N [4-[4-[[(2s,3r)-1-[cyanomethyl(propanoyl)amino]-1-oxo-3-propanoyloxybutan-2-yl]carbamoyl]phenyl]phenyl] propanoate Chemical compound C1=CC(C(=O)N[C@@H]([C@@H](C)OC(=O)CC)C(=O)N(CC#N)C(=O)CC)=CC=C1C1=CC=C(OC(=O)CC)C=C1 HYMPLCHSXHTIEY-DWXRJYCRSA-N 0.000 description 1
- JKVKQWWERPWPKQ-BMIGLBTASA-N [4-[4-[[(2s,3r)-3-hydroxy-1-(hydroxyamino)-1-oxobutan-2-yl]carbamoyl]phenyl]phenyl] dihydrogen phosphate Chemical compound C1=CC(C(=O)N[C@@H]([C@H](O)C)C(=O)NO)=CC=C1C1=CC=C(OP(O)(O)=O)C=C1 JKVKQWWERPWPKQ-BMIGLBTASA-N 0.000 description 1
- ZWBJRFHPBPYFIW-UHFFFAOYSA-N [[4-[3-(trifluoromethyl)phenoxy]phenyl]methylideneamino]thiourea Chemical compound C1=CC(C=NNC(=S)N)=CC=C1OC1=CC=CC(C(F)(F)F)=C1 ZWBJRFHPBPYFIW-UHFFFAOYSA-N 0.000 description 1
- 125000000738 acetamido group Chemical group [H]C([H])([H])C(=O)N([H])[*] 0.000 description 1
- 150000001242 acetic acid derivatives Chemical class 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 150000001252 acrylic acid derivatives Chemical class 0.000 description 1
- 125000003647 acryloyl group Chemical group O=C([*])C([H])=C([H])[H] 0.000 description 1
- 150000007933 aliphatic carboxylic acids Chemical class 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 235000003704 aspartic acid Nutrition 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000003385 bacteriostatic effect Effects 0.000 description 1
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 125000003865 brosyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1Br)S(*)(=O)=O 0.000 description 1
- 150000004648 butanoic acid derivatives Chemical class 0.000 description 1
- 125000006309 butyl amino group Chemical group 0.000 description 1
- SKKTUOZKZKCGTB-UHFFFAOYSA-N butyl carbamate Chemical compound CCCCOC(N)=O SKKTUOZKZKCGTB-UHFFFAOYSA-N 0.000 description 1
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- GTCAXTIRRLKXRU-UHFFFAOYSA-N carbamic acid methyl ester Natural products COC(N)=O GTCAXTIRRLKXRU-UHFFFAOYSA-N 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 239000000460 chlorine Substances 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- LDHQCZJRKDOVOX-NSCUHMNNSA-M crotonate Chemical compound C\C=C\C([O-])=O LDHQCZJRKDOVOX-NSCUHMNNSA-M 0.000 description 1
- 125000006317 cyclopropyl amino group Chemical group 0.000 description 1
- 229910052805 deuterium Inorganic materials 0.000 description 1
- 239000000890 drug combination Substances 0.000 description 1
- 238000009510 drug design Methods 0.000 description 1
- 229940092559 enterobacter aerogenes Drugs 0.000 description 1
- 238000001952 enzyme assay Methods 0.000 description 1
- 125000004185 ester group Chemical group 0.000 description 1
- 239000011737 fluorine Substances 0.000 description 1
- 229910052731 fluorine Inorganic materials 0.000 description 1
- 150000004675 formic acid derivatives Chemical class 0.000 description 1
- FATAVLOOLIRUNA-UHFFFAOYSA-N formylmethyl Chemical group [CH2]C=O FATAVLOOLIRUNA-UHFFFAOYSA-N 0.000 description 1
- 235000013922 glutamic acid Nutrition 0.000 description 1
- 239000004220 glutamic acid Substances 0.000 description 1
- 230000009036 growth inhibition Effects 0.000 description 1
- 125000001245 hexylamino group Chemical group [H]N([*])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C(C([H])([H])[H])([H])[H] 0.000 description 1
- BHEPBYXIRTUNPN-UHFFFAOYSA-N hydridophosphorus(.) (triplet) Chemical compound [PH] BHEPBYXIRTUNPN-UHFFFAOYSA-N 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 125000004435 hydrogen atom Chemical class [H]* 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 125000000325 methylidene group Chemical group [H]C([H])=* 0.000 description 1
- 125000002816 methylsulfanyl group Chemical group [H]C([H])([H])S[*] 0.000 description 1
- PBORUIHWIORQDR-PXLJZGITSA-N n,n'-bis[(2s)-3-(hydroxyamino)-3-oxo-2-[[4-(2-phenylethynyl)benzoyl]amino]propyl]pentanediamide Chemical compound N([C@@H](CNC(=O)CCCC(=O)NC[C@@H](C(=O)NO)NC(=O)C=1C=CC(=CC=1)C#CC=1C=CC=CC=1)C(=O)NO)C(=O)C(C=C1)=CC=C1C#CC1=CC=CC=C1 PBORUIHWIORQDR-PXLJZGITSA-N 0.000 description 1
- LAPMTDKMSRBAHM-UHFFFAOYSA-N n-(2-cyanoethyl)-4-(4-ethylphenyl)-3-[2-(hydroxyamino)-2-oxoethyl]benzamide Chemical compound C1=CC(CC)=CC=C1C1=CC=C(C(=O)NCCC#N)C=C1CC(=O)NO LAPMTDKMSRBAHM-UHFFFAOYSA-N 0.000 description 1
- HKIQSDZYZSUJEL-UHFFFAOYSA-N n-(3-aminopropyl)-4-(4-ethylphenyl)-n-[2-(hydroxyamino)-2-oxoethyl]benzamide Chemical compound C1=CC(CC)=CC=C1C1=CC=C(C(=O)N(CCCN)CC(=O)NO)C=C1 HKIQSDZYZSUJEL-UHFFFAOYSA-N 0.000 description 1
- NBYFPDDAAXIPJV-UHFFFAOYSA-N n-(4-phenylphenyl)prop-2-enamide Chemical compound C1=CC(NC(=O)C=C)=CC=C1C1=CC=CC=C1 NBYFPDDAAXIPJV-UHFFFAOYSA-N 0.000 description 1
- YXARDFAOCUJWML-UHFFFAOYSA-N n-(anilinomethyl)benzamide Chemical compound C=1C=CC=CC=1C(=O)NCNC1=CC=CC=C1 YXARDFAOCUJWML-UHFFFAOYSA-N 0.000 description 1
- YBFAJWGMVQUHPR-KKJJZKEWSA-N n-[(1e,2s)-1-(carbamoylhydrazinylidene)-3-methylbutan-2-yl]-4-phenylbenzamide Chemical compound C1=CC(C(=O)N[C@@H](C(C)C)\C=N\NC(N)=O)=CC=C1C1=CC=CC=C1 YBFAJWGMVQUHPR-KKJJZKEWSA-N 0.000 description 1
- BFWUQYMHSKRXSM-MIQLPHMESA-N n-[(1e,2s)-1-hydroxyimino-3-methylbutan-2-yl]-4-phenylbenzamide Chemical compound C1=CC(C(=O)N[C@@H](C(C)C)\C=N\O)=CC=C1C1=CC=CC=C1 BFWUQYMHSKRXSM-MIQLPHMESA-N 0.000 description 1
- ICIHNYASHDEGOW-MRXNPFEDSA-N n-[(2r)-2-amino-3-(hydroxyamino)-3-oxopropyl]-4-(4-ethylphenyl)benzamide Chemical compound C1=CC(CC)=CC=C1C1=CC=C(C(=O)NC[C@@H](N)C(=O)NO)C=C1 ICIHNYASHDEGOW-MRXNPFEDSA-N 0.000 description 1
- YXKNUJFCNQAQMS-QGZVFWFLSA-N n-[(2r)-3-hydroxy-1-(hydroxyamino)-1-oxopropan-2-yl]-4-(4-propylphenyl)benzamide Chemical compound C1=CC(CCC)=CC=C1C1=CC=C(C(=O)N[C@H](CO)C(=O)NO)C=C1 YXKNUJFCNQAQMS-QGZVFWFLSA-N 0.000 description 1
- VZUGUQPLXNWZOI-VGOFRKELSA-N n-[(2r,3r)-1-[2-(dimethylamino)ethylcarbamoyl-hydroxyamino]-3-hydroxybutan-2-yl]-4-(4-ethylphenyl)benzamide Chemical compound C1=CC(CC)=CC=C1C1=CC=C(C(=O)N[C@H](CN(O)C(=O)NCCN(C)C)[C@@H](C)O)C=C1 VZUGUQPLXNWZOI-VGOFRKELSA-N 0.000 description 1
- KCRUAERTKSCBQH-IIBYNOLFSA-N n-[(2r,3r)-1-[2-cyanoethylcarbamoyl(hydroxy)amino]-3-hydroxybutan-2-yl]-4-(4-ethylphenyl)benzamide Chemical compound C1=CC(CC)=CC=C1C1=CC=C(C(=O)N[C@H](CN(O)C(=O)NCCC#N)[C@@H](C)O)C=C1 KCRUAERTKSCBQH-IIBYNOLFSA-N 0.000 description 1
- SYVUFVJGDRHULW-FZKQIMNGSA-N n-[(2r,3r)-1-[carbamoyl(hydroxy)amino]-3-hydroxybutan-2-yl]-4-(4-ethylphenyl)benzamide Chemical compound C1=CC(CC)=CC=C1C1=CC=C(C(=O)N[C@H](CN(O)C(N)=O)[C@@H](C)O)C=C1 SYVUFVJGDRHULW-FZKQIMNGSA-N 0.000 description 1
- MKHVAPDKUBVZRN-QVKFZJNVSA-N n-[(2r,3r)-1-[cyclopropylcarbamoyl(hydroxy)amino]-3-hydroxybutan-2-yl]-4-(4-ethylphenyl)benzamide Chemical compound C1=CC(CC)=CC=C1C1=CC=C(C(=O)N[C@H](CN(O)C(=O)NC2CC2)[C@@H](C)O)C=C1 MKHVAPDKUBVZRN-QVKFZJNVSA-N 0.000 description 1
- CILGEEMWXPJKCI-WZONZLPQSA-N n-[(2r,3r)-2-[[4-(4-ethylphenyl)benzoyl]amino]-3-hydroxybutyl]-n-hydroxy-4-methylpiperazine-1-carboxamide Chemical compound C1=CC(CC)=CC=C1C1=CC=C(C(=O)N[C@H](CN(O)C(=O)N2CCN(C)CC2)[C@@H](C)O)C=C1 CILGEEMWXPJKCI-WZONZLPQSA-N 0.000 description 1
- OTZGBPFHKYZJGO-VGOFRKELSA-N n-[(2r,3r)-2-[[4-(4-ethylphenyl)benzoyl]amino]-3-hydroxybutyl]-n-hydroxymorpholine-4-carboxamide Chemical compound C1=CC(CC)=CC=C1C1=CC=C(C(=O)N[C@H](CN(O)C(=O)N2CCOCC2)[C@@H](C)O)C=C1 OTZGBPFHKYZJGO-VGOFRKELSA-N 0.000 description 1
- ILFNBIRTJSBNIM-SCLBCKFNSA-N n-[(2r,3s)-3-hydroxy-1-(hydroxyamino)-1-oxobutan-2-yl]-4-(4-propylphenyl)benzamide Chemical compound C1=CC(CCC)=CC=C1C1=CC=C(C(=O)N[C@H]([C@H](C)O)C(=O)NO)C=C1 ILFNBIRTJSBNIM-SCLBCKFNSA-N 0.000 description 1
- MDDBEQJWWLLHMB-ZUZCIYMTSA-N n-[(2r,3s)-3-hydroxy-1-(hydroxyamino)-1-oxobutan-2-yl]-4-[3-(trifluoromethyl)phenyl]benzamide Chemical compound C1=CC(C(=O)N[C@H]([C@@H](O)C)C(=O)NO)=CC=C1C1=CC=CC(C(F)(F)F)=C1 MDDBEQJWWLLHMB-ZUZCIYMTSA-N 0.000 description 1
- LOAPADXPVBBNMJ-INIZCTEOSA-N n-[(2s)-1-(hydroxyamino)-3-methyl-1-oxobutan-2-yl]-4-phenylbenzamide Chemical compound C1=CC(C(=O)N[C@@H](C(C)C)C(=O)NO)=CC=C1C1=CC=CC=C1 LOAPADXPVBBNMJ-INIZCTEOSA-N 0.000 description 1
- QBBCVYCZQLZJPT-UGSOOPFHSA-N n-[(2s)-1-[[(2s)-3-amino-1-(hydroxyamino)-1-oxopropan-2-yl]amino]-1-oxopropan-2-yl]-4-(4-ethylphenyl)benzamide Chemical compound C1=CC(CC)=CC=C1C1=CC=C(C(=O)N[C@@H](C)C(=O)N[C@@H](CN)C(=O)NO)C=C1 QBBCVYCZQLZJPT-UGSOOPFHSA-N 0.000 description 1
- NQAWULQFEVUPEX-FQEVSTJZSA-N n-[(2s)-2-[[4-(4-ethylphenyl)benzoyl]amino]-3-(hydroxyamino)-3-oxopropyl]morpholine-4-carboxamide Chemical compound C1=CC(CC)=CC=C1C1=CC=C(C(=O)N[C@@H](CNC(=O)N2CCOCC2)C(=O)NO)C=C1 NQAWULQFEVUPEX-FQEVSTJZSA-N 0.000 description 1
- ICIHNYASHDEGOW-INIZCTEOSA-N n-[(2s)-2-amino-3-(hydroxyamino)-3-oxopropyl]-4-(4-ethylphenyl)benzamide Chemical compound C1=CC(CC)=CC=C1C1=CC=C(C(=O)NC[C@H](N)C(=O)NO)C=C1 ICIHNYASHDEGOW-INIZCTEOSA-N 0.000 description 1
- UKYIKZORNLSSPL-INIZCTEOSA-N n-[(2s)-3-(diaminomethylideneamino)-1-(hydroxyamino)-1-oxopropan-2-yl]-4-(4-ethylphenyl)benzamide Chemical compound C1=CC(CC)=CC=C1C1=CC=C(C(=O)N[C@@H](CNC(N)=N)C(=O)NO)C=C1 UKYIKZORNLSSPL-INIZCTEOSA-N 0.000 description 1
- RWYONPOJXWTCMR-FQEVSTJZSA-N n-[(2s)-3-(diethylamino)-1-(hydroxyamino)-1-oxopropan-2-yl]-4-(4-ethylphenyl)benzamide Chemical compound C1=CC(C(=O)N[C@@H](CN(CC)CC)C(=O)NO)=CC=C1C1=CC=C(CC)C=C1 RWYONPOJXWTCMR-FQEVSTJZSA-N 0.000 description 1
- LKABCHRMOIYWEC-SFHVURJKSA-N n-[(2s)-3-(dimethylamino)-1-(hydroxyamino)-1-oxopropan-2-yl]-4-(4-ethylphenyl)benzamide Chemical compound C1=CC(CC)=CC=C1C1=CC=C(C(=O)N[C@@H](CN(C)C)C(=O)NO)C=C1 LKABCHRMOIYWEC-SFHVURJKSA-N 0.000 description 1
- XEIKPDKXLLNYRR-SFHVURJKSA-N n-[(2s)-3-acetamido-1-(hydroxyamino)-1-oxopropan-2-yl]-4-(4-ethylphenyl)benzamide Chemical compound C1=CC(CC)=CC=C1C1=CC=C(C(=O)N[C@@H](CNC(C)=O)C(=O)NO)C=C1 XEIKPDKXLLNYRR-SFHVURJKSA-N 0.000 description 1
- RBVOPBUYVNEZBS-INIZCTEOSA-N n-[(2s)-3-amino-1-(hydroxyamino)-1-oxopropan-2-yl]-4-(4-ethylphenyl)-3-fluorobenzamide Chemical compound C1=CC(CC)=CC=C1C1=CC=C(C(=O)N[C@@H](CN)C(=O)NO)C=C1F RBVOPBUYVNEZBS-INIZCTEOSA-N 0.000 description 1
- LECNGMZSHXXTPO-INIZCTEOSA-N n-[(2s)-3-amino-1-(hydroxyamino)-1-oxopropan-2-yl]-4-(4-ethylphenyl)benzamide Chemical compound C1=CC(CC)=CC=C1C1=CC=C(C(=O)N[C@@H](CN)C(=O)NO)C=C1 LECNGMZSHXXTPO-INIZCTEOSA-N 0.000 description 1
- SNCKDXASRSRARQ-KRWDZBQOSA-N n-[(2s)-3-amino-1-(hydroxyamino)-1-oxopropan-2-yl]-4-(4-propylphenyl)benzamide Chemical compound C1=CC(CCC)=CC=C1C1=CC=C(C(=O)N[C@@H](CN)C(=O)NO)C=C1 SNCKDXASRSRARQ-KRWDZBQOSA-N 0.000 description 1
- CXCDDNMWTWBAGF-SFHVURJKSA-N n-[(2s)-3-amino-1-(hydroxyamino)-1-oxopropan-2-yl]-4-[2-(4-ethylphenyl)ethynyl]-3-fluorobenzamide Chemical compound C1=CC(CC)=CC=C1C#CC1=CC=C(C(=O)N[C@@H](CN)C(=O)NO)C=C1F CXCDDNMWTWBAGF-SFHVURJKSA-N 0.000 description 1
- XTWANXAFWRUZGN-QFIPXVFZSA-N n-[(2s)-3-amino-1-(hydroxyamino)-1-oxopropan-2-yl]-4-[2-[4-[(2-piperidin-1-ylacetyl)amino]phenyl]ethynyl]benzamide Chemical compound C1=CC(C(=O)N[C@@H](CN)C(=O)NO)=CC=C1C#CC(C=C1)=CC=C1NC(=O)CN1CCCCC1 XTWANXAFWRUZGN-QFIPXVFZSA-N 0.000 description 1
- YOCMJCFPKUXQBC-SFHVURJKSA-N n-[(2s)-3-amino-1-(hydroxyamino)-1-oxopropan-2-yl]-4-[2-[4-[[2-(2,2,2-trifluoroethylamino)acetyl]amino]phenyl]ethynyl]benzamide Chemical compound C1=CC(C(=O)N[C@@H](CN)C(=O)NO)=CC=C1C#CC1=CC=C(NC(=O)CNCC(F)(F)F)C=C1 YOCMJCFPKUXQBC-SFHVURJKSA-N 0.000 description 1
- FHPTVENPWBLJDZ-CLOONOSVSA-N n-[(2s)-3-amino-1-(hydroxyamino)-1-oxopropan-2-yl]-4-[2-[4-[[2-[[(1r)-1-phenylethyl]amino]acetyl]amino]phenyl]ethynyl]benzamide Chemical compound N([C@H](C)C=1C=CC=CC=1)CC(=O)NC(C=C1)=CC=C1C#CC1=CC=C(C(=O)N[C@@H](CN)C(=O)NO)C=C1 FHPTVENPWBLJDZ-CLOONOSVSA-N 0.000 description 1
- FHPTVENPWBLJDZ-DFBJGRDBSA-N n-[(2s)-3-amino-1-(hydroxyamino)-1-oxopropan-2-yl]-4-[2-[4-[[2-[[(1s)-1-phenylethyl]amino]acetyl]amino]phenyl]ethynyl]benzamide Chemical compound N([C@@H](C)C=1C=CC=CC=1)CC(=O)NC(C=C1)=CC=C1C#CC1=CC=C(C(=O)N[C@@H](CN)C(=O)NO)C=C1 FHPTVENPWBLJDZ-DFBJGRDBSA-N 0.000 description 1
- HEDWVOGFGXBEAQ-SANMLTNESA-N n-[(2s)-3-amino-1-(hydroxyamino)-1-oxopropan-2-yl]-4-[2-[4-[[2-[methyl-[(4-methylphenyl)methyl]amino]acetyl]amino]phenyl]ethynyl]benzamide Chemical compound C=1C=C(C)C=CC=1CN(C)CC(=O)NC(C=C1)=CC=C1C#CC1=CC=C(C(=O)N[C@@H](CN)C(=O)NO)C=C1 HEDWVOGFGXBEAQ-SANMLTNESA-N 0.000 description 1
- SXTNCXOBMUMGER-ZDUSSCGKSA-N n-[(2s)-3-amino-1-(hydroxyamino)-1-oxopropan-2-yl]-4-pentylbenzamide Chemical compound CCCCCC1=CC=C(C(=O)N[C@@H](CN)C(=O)NO)C=C1 SXTNCXOBMUMGER-ZDUSSCGKSA-N 0.000 description 1
- WNMPXZZMBSIXCW-VMDGZTHMSA-N n-[(2s)-3-amino-1-[[(2s,3r)-3-hydroxy-1-(hydroxyamino)-1-oxobutan-2-yl]amino]-1-oxopropan-2-yl]-4-(4-ethylphenyl)benzamide Chemical compound C1=CC(CC)=CC=C1C1=CC=C(C(=O)N[C@@H](CN)C(=O)N[C@@H]([C@@H](C)O)C(=O)NO)C=C1 WNMPXZZMBSIXCW-VMDGZTHMSA-N 0.000 description 1
- SIZDSTMPJRTOMJ-QGZVFWFLSA-N n-[(2s)-3-methyl-1-oxobutan-2-yl]-4-phenylbenzamide Chemical compound C1=CC(C(=O)N[C@@H](C(C)C)C=O)=CC=C1C1=CC=CC=C1 SIZDSTMPJRTOMJ-QGZVFWFLSA-N 0.000 description 1
- FCESQMZEXCXVAP-KRWDZBQOSA-N n-[(2s)-4-amino-1-(hydroxyamino)-1-oxobutan-2-yl]-4-(4-ethylphenyl)benzamide Chemical compound C1=CC(CC)=CC=C1C1=CC=C(C(=O)N[C@@H](CCN)C(=O)NO)C=C1 FCESQMZEXCXVAP-KRWDZBQOSA-N 0.000 description 1
- RDANWEXIVHKZPB-SFHVURJKSA-N n-[(2s)-4-cyano-1-(hydroxyamino)-1-oxobutan-2-yl]-4-(4-ethylphenyl)benzamide Chemical compound C1=CC(CC)=CC=C1C1=CC=C(C(=O)N[C@@H](CCC#N)C(=O)NO)C=C1 RDANWEXIVHKZPB-SFHVURJKSA-N 0.000 description 1
- MKVTVKRLSSVSSQ-SFHVURJKSA-N n-[(2s)-5-amino-1-(hydroxyamino)-1-oxopentan-2-yl]-4-(4-ethylphenyl)benzamide Chemical compound C1=CC(CC)=CC=C1C1=CC=C(C(=O)N[C@@H](CCCN)C(=O)NO)C=C1 MKVTVKRLSSVSSQ-SFHVURJKSA-N 0.000 description 1
- YQMPNHOBNHGWAW-IBGZPJMESA-N n-[(2s)-6-amino-1-(hydroxyamino)-1-oxohexan-2-yl]-4-(4-ethylphenyl)benzamide Chemical compound C1=CC(CC)=CC=C1C1=CC=C(C(=O)N[C@@H](CCCCN)C(=O)NO)C=C1 YQMPNHOBNHGWAW-IBGZPJMESA-N 0.000 description 1
- OCBVWQBRSWDZTR-PXAZEXFGSA-N n-[(2s,3r)-1-(cyanomethylamino)-3-hydroxy-1-oxobutan-2-yl]-4-(4-hydroxyphenyl)benzamide Chemical compound C1=CC(C(=O)N[C@@H]([C@H](O)C)C(=O)NCC#N)=CC=C1C1=CC=C(O)C=C1 OCBVWQBRSWDZTR-PXAZEXFGSA-N 0.000 description 1
- HNZPIHSKXYFTTC-IERDGZPVSA-N n-[(2s,3r)-1-(hydroxyamino)-3-[(2-methylpropan-2-yl)oxy]-1-oxobutan-2-yl]-4-(4-propylphenyl)benzamide Chemical compound C1=CC(CCC)=CC=C1C1=CC=C(C(=O)N[C@@H]([C@@H](C)OC(C)(C)C)C(=O)NO)C=C1 HNZPIHSKXYFTTC-IERDGZPVSA-N 0.000 description 1
- XCCSEJVDYNPVHC-JPYJTQIMSA-N n-[(2s,3r)-1-[2-[2-(dimethylamino)ethylcarbamoyl-hydroxyamino]ethylamino]-3-hydroxy-1-oxobutan-2-yl]-4-(4-ethylphenyl)benzamide Chemical compound C1=CC(CC)=CC=C1C1=CC=C(C(=O)N[C@@H]([C@@H](C)O)C(=O)NCCN(O)C(=O)NCCN(C)C)C=C1 XCCSEJVDYNPVHC-JPYJTQIMSA-N 0.000 description 1
- FUCDMYSKKZAHPZ-HXOBKFHXSA-N n-[(2s,3r)-1-[2-[2-acetamidoethylcarbamoyl(hydroxy)amino]ethylamino]-3-hydroxy-1-oxobutan-2-yl]-4-(4-ethylphenyl)benzamide Chemical compound C1=CC(CC)=CC=C1C1=CC=C(C(=O)N[C@@H]([C@@H](C)O)C(=O)NCCN(O)C(=O)NCCNC(C)=O)C=C1 FUCDMYSKKZAHPZ-HXOBKFHXSA-N 0.000 description 1
- OJPDWBYGVFVSRR-VGSWGCGISA-N n-[(2s,3r)-1-[2-[2-cyanoethylcarbamoyl(hydroxy)amino]ethylamino]-3-hydroxy-1-oxobutan-2-yl]-4-(4-ethylphenyl)benzamide Chemical compound C1=CC(CC)=CC=C1C1=CC=C(C(=O)N[C@@H]([C@@H](C)O)C(=O)NCCN(O)C(=O)NCCC#N)C=C1 OJPDWBYGVFVSRR-VGSWGCGISA-N 0.000 description 1
- LYTDTUWCMIOXCN-KUHUBIRLSA-N n-[(2s,3r)-1-[2-[carbamothioyl(hydroxy)amino]ethylamino]-3-hydroxy-1-oxobutan-2-yl]-4-(4-ethylphenyl)benzamide Chemical compound C1=CC(CC)=CC=C1C1=CC=C(C(=O)N[C@@H]([C@@H](C)O)C(=O)NCCN(O)C(N)=S)C=C1 LYTDTUWCMIOXCN-KUHUBIRLSA-N 0.000 description 1
- JDCSEWKYPQXACS-KUHUBIRLSA-N n-[(2s,3r)-1-[2-[carbamoyl(hydroxy)amino]ethylamino]-3-hydroxy-1-oxobutan-2-yl]-4-(4-ethylphenyl)benzamide Chemical compound C1=CC(CC)=CC=C1C1=CC=C(C(=O)N[C@@H]([C@@H](C)O)C(=O)NCCN(O)C(N)=O)C=C1 JDCSEWKYPQXACS-KUHUBIRLSA-N 0.000 description 1
- QGSMGHQFDCSBGZ-ZHRRBRCNSA-N n-[(2s,3r)-1-[2-[cyclopropylcarbamoyl(hydroxy)amino]ethylamino]-3-hydroxy-1-oxobutan-2-yl]-4-(4-ethylphenyl)benzamide Chemical compound C1=CC(CC)=CC=C1C1=CC=C(C(=O)N[C@@H]([C@@H](C)O)C(=O)NCCN(O)C(=O)NC2CC2)C=C1 QGSMGHQFDCSBGZ-ZHRRBRCNSA-N 0.000 description 1
- JSUOZBSFDZKDIS-MHOZMEHISA-N n-[(2s,3r)-1-[[cyano(phenyl)methyl]amino]-3-hydroxy-1-oxobutan-2-yl]-4-(4-hydroxyphenyl)benzamide Chemical compound N([C@@H]([C@H](O)C)C(=O)NC(C#N)C=1C=CC=CC=1)C(=O)C(C=C1)=CC=C1C1=CC=C(O)C=C1 JSUOZBSFDZKDIS-MHOZMEHISA-N 0.000 description 1
- IZFASVHHMWQASM-ACJLOTCBSA-N n-[(2s,3r)-1-hydrazinyl-3-hydroxy-1-oxobutan-2-yl]-4-(4-propylphenyl)benzamide Chemical compound C1=CC(CCC)=CC=C1C1=CC=C(C(=O)N[C@@H]([C@@H](C)O)C(=O)NN)C=C1 IZFASVHHMWQASM-ACJLOTCBSA-N 0.000 description 1
- WLMFPXUSQPGDOC-PXAZEXFGSA-N n-[(2s,3r)-3-amino-1-(hydroxyamino)-1-oxobutan-2-yl]-4-(4-ethylphenyl)benzamide Chemical compound C1=CC(CC)=CC=C1C1=CC=C(C(=O)N[C@@H]([C@@H](C)N)C(=O)NO)C=C1 WLMFPXUSQPGDOC-PXAZEXFGSA-N 0.000 description 1
- AZHWTZZRZDCMQW-LDWIPMOCSA-N n-[(2s,3r)-3-hydroxy-1-(hydroxyamino)-1-oxobutan-2-yl]-1,3-benzodioxole-5-carboxamide Chemical compound ONC(=O)[C@H]([C@H](O)C)NC(=O)C1=CC=C2OCOC2=C1 AZHWTZZRZDCMQW-LDWIPMOCSA-N 0.000 description 1
- WDOBZUAFPRXMAU-HQJQHLMTSA-N n-[(2s,3r)-3-hydroxy-1-(hydroxyamino)-1-oxobutan-2-yl]-1-benzofuran-2-carboxamide Chemical compound C1=CC=C2OC(C(=O)N[C@@H]([C@H](O)C)C(=O)NO)=CC2=C1 WDOBZUAFPRXMAU-HQJQHLMTSA-N 0.000 description 1
- QYCCDYPDKFHDRP-WBMJQRKESA-N n-[(2s,3r)-3-hydroxy-1-(hydroxyamino)-1-oxobutan-2-yl]-4-(2-methylphenyl)benzamide Chemical compound C1=CC(C(=O)N[C@@H]([C@H](O)C)C(=O)NO)=CC=C1C1=CC=CC=C1C QYCCDYPDKFHDRP-WBMJQRKESA-N 0.000 description 1
- AYFYZESPMDETGG-BMIGLBTASA-N n-[(2s,3r)-3-hydroxy-1-(hydroxyamino)-1-oxobutan-2-yl]-4-(3-nitrophenyl)benzamide Chemical compound C1=CC(C(=O)N[C@@H]([C@H](O)C)C(=O)NO)=CC=C1C1=CC=CC([N+]([O-])=O)=C1 AYFYZESPMDETGG-BMIGLBTASA-N 0.000 description 1
- UKMUHNVKFOXADL-BMIGLBTASA-N n-[(2s,3r)-3-hydroxy-1-(hydroxyamino)-1-oxobutan-2-yl]-4-(4-hydroxyphenyl)benzamide Chemical compound C1=CC(C(=O)N[C@@H]([C@H](O)C)C(=O)NO)=CC=C1C1=CC=C(O)C=C1 UKMUHNVKFOXADL-BMIGLBTASA-N 0.000 description 1
- VZIRTHIWXPMFIW-BZNIZROVSA-N n-[(2s,3r)-3-hydroxy-1-(hydroxyamino)-1-oxobutan-2-yl]-4-(4-methoxyphenyl)benzamide Chemical compound C1=CC(OC)=CC=C1C1=CC=C(C(=O)N[C@@H]([C@@H](C)O)C(=O)NO)C=C1 VZIRTHIWXPMFIW-BZNIZROVSA-N 0.000 description 1
- OOCIIAKYUMWFHR-BZNIZROVSA-N n-[(2s,3r)-3-hydroxy-1-(hydroxyamino)-1-oxobutan-2-yl]-4-(4-methylsulfanylphenyl)benzamide Chemical compound C1=CC(SC)=CC=C1C1=CC=C(C(=O)N[C@@H]([C@@H](C)O)C(=O)NO)C=C1 OOCIIAKYUMWFHR-BZNIZROVSA-N 0.000 description 1
- IORIZOYYTXICRF-BMIGLBTASA-N n-[(2s,3r)-3-hydroxy-1-(hydroxyamino)-1-oxobutan-2-yl]-4-(4-nitrophenyl)benzamide Chemical compound C1=CC(C(=O)N[C@@H]([C@H](O)C)C(=O)NO)=CC=C1C1=CC=C([N+]([O-])=O)C=C1 IORIZOYYTXICRF-BMIGLBTASA-N 0.000 description 1
- CWNCUPGGAIKSAZ-VFNWGFHPSA-N n-[(2s,3r)-3-hydroxy-1-(hydroxyamino)-1-oxobutan-2-yl]-4-(4-phenoxyphenyl)benzamide Chemical compound C1=CC(C(=O)N[C@@H]([C@H](O)C)C(=O)NO)=CC=C1C(C=C1)=CC=C1OC1=CC=CC=C1 CWNCUPGGAIKSAZ-VFNWGFHPSA-N 0.000 description 1
- GADKRIPGODDABI-BMIGLBTASA-N n-[(2s,3r)-3-hydroxy-1-(hydroxyamino)-1-oxobutan-2-yl]-4-[2-(trifluoromethoxy)phenyl]benzamide Chemical compound C1=CC(C(=O)N[C@@H]([C@H](O)C)C(=O)NO)=CC=C1C1=CC=CC=C1OC(F)(F)F GADKRIPGODDABI-BMIGLBTASA-N 0.000 description 1
- UGGTZRYSRXRVIS-BCHFMIIMSA-N n-[(2s,3r)-3-hydroxy-1-(hydroxyamino)-1-oxobutan-2-yl]-4-[2-[4-[[2-(2-pyridin-2-ylethylamino)acetyl]amino]phenyl]ethynyl]benzamide Chemical compound C1=CC(C(=O)N[C@@H]([C@H](O)C)C(=O)NO)=CC=C1C#CC(C=C1)=CC=C1NC(=O)CNCCC1=CC=CC=N1 UGGTZRYSRXRVIS-BCHFMIIMSA-N 0.000 description 1
- SSOXBWNYPNBDQR-BCHFMIIMSA-N n-[(2s,3r)-3-hydroxy-1-(hydroxyamino)-1-oxobutan-2-yl]-4-[2-[4-[[2-(2-pyridin-3-ylethylamino)acetyl]amino]phenyl]ethynyl]benzamide Chemical compound C1=CC(C(=O)N[C@@H]([C@H](O)C)C(=O)NO)=CC=C1C#CC(C=C1)=CC=C1NC(=O)CNCCC1=CC=CN=C1 SSOXBWNYPNBDQR-BCHFMIIMSA-N 0.000 description 1
- KLCAVOPGYRXRID-BCHFMIIMSA-N n-[(2s,3r)-3-hydroxy-1-(hydroxyamino)-1-oxobutan-2-yl]-4-[2-[4-[[2-(2-pyridin-4-ylethylamino)acetyl]amino]phenyl]ethynyl]benzamide Chemical compound C1=CC(C(=O)N[C@@H]([C@H](O)C)C(=O)NO)=CC=C1C#CC(C=C1)=CC=C1NC(=O)CNCCC1=CC=NC=C1 KLCAVOPGYRXRID-BCHFMIIMSA-N 0.000 description 1
- XGBLPLXVKHQNDR-PBBNMVCDSA-N n-[(2s,3r)-3-hydroxy-1-(hydroxyamino)-1-oxobutan-2-yl]-4-[2-[4-[[2-(4-morpholin-4-ylanilino)acetyl]amino]phenyl]ethynyl]benzamide Chemical compound C1=CC(C(=O)N[C@@H]([C@H](O)C)C(=O)NO)=CC=C1C#CC(C=C1)=CC=C1NC(=O)CNC1=CC=C(N2CCOCC2)C=C1 XGBLPLXVKHQNDR-PBBNMVCDSA-N 0.000 description 1
- AFJVRQLPWRTXLQ-VKIDHGPPSA-N n-[(2s,3r)-3-hydroxy-1-(hydroxyamino)-1-oxobutan-2-yl]-4-[2-[4-[[2-[[(1s)-1-phenylethyl]amino]acetyl]amino]phenyl]ethynyl]benzamide Chemical compound C1=CC(C(=O)N[C@@H]([C@H](O)C)C(=O)NO)=CC=C1C#CC(C=C1)=CC=C1NC(=O)CN[C@@H](C)C1=CC=CC=C1 AFJVRQLPWRTXLQ-VKIDHGPPSA-N 0.000 description 1
- MLILTUJPYYJATP-PVXMUIKYSA-N n-[(2s,3r)-3-hydroxy-1-(hydroxyamino)-1-oxobutan-2-yl]-4-[3-[(z)-hydroxyiminomethyl]-4-methoxyphenyl]benzamide Chemical compound C1=C(\C=N/O)C(OC)=CC=C1C1=CC=C(C(=O)N[C@@H]([C@@H](C)O)C(=O)NO)C=C1 MLILTUJPYYJATP-PVXMUIKYSA-N 0.000 description 1
- FFYJKSKFIAFOQI-BZNIZROVSA-N n-[(2s,3r)-3-hydroxy-1-(hydroxyamino)-1-oxobutan-2-yl]-4-[4-(hydroxymethyl)phenyl]benzamide Chemical compound C1=CC(C(=O)N[C@@H]([C@H](O)C)C(=O)NO)=CC=C1C1=CC=C(CO)C=C1 FFYJKSKFIAFOQI-BZNIZROVSA-N 0.000 description 1
- ZOZTYDVMILTSTD-BMIGLBTASA-N n-[(2s,3r)-3-hydroxy-1-(hydroxyamino)-1-oxobutan-2-yl]-4-[4-(trifluoromethyl)phenyl]benzamide Chemical compound C1=CC(C(=O)N[C@@H]([C@H](O)C)C(=O)NO)=CC=C1C1=CC=C(C(F)(F)F)C=C1 ZOZTYDVMILTSTD-BMIGLBTASA-N 0.000 description 1
- XYTOLYMLHDQGSB-RHMWETHNSA-N n-[(2s,3r)-3-hydroxy-1-(hydroxyamino)-1-oxobutan-2-yl]-4-[4-[[(2r,3r)-3-hydroxy-1-(hydroxyamino)-1-oxobutan-2-yl]carbamoyl]phenyl]benzamide Chemical compound C1=CC(C(=O)N[C@@H]([C@H](O)C)C(=O)NO)=CC=C1C1=CC=C(C(=O)N[C@H]([C@@H](C)O)C(=O)NO)C=C1 XYTOLYMLHDQGSB-RHMWETHNSA-N 0.000 description 1
- RQZBHCXHUBKMJA-MUWHJKNJSA-N n-[(2s,3r)-3-hydroxy-1-(hydroxyamino)-1-oxobutan-2-yl]-4-iodobenzamide Chemical compound ONC(=O)[C@H]([C@H](O)C)NC(=O)C1=CC=C(I)C=C1 RQZBHCXHUBKMJA-MUWHJKNJSA-N 0.000 description 1
- AJCDRDJTHHOPEJ-PBHICJAKSA-N n-[(2s,3r)-3-hydroxy-1-(hydroxyamino)-1-oxobutan-2-yl]-4-octylbenzamide Chemical compound CCCCCCCCC1=CC=C(C(=O)N[C@@H]([C@@H](C)O)C(=O)NO)C=C1 AJCDRDJTHHOPEJ-PBHICJAKSA-N 0.000 description 1
- FEUMNDJCOHDISV-KRTXAFLBSA-N n-[(2s,3r)-3-hydroxy-1-(hydroxyamino)-1-oxobutan-2-yl]-4-oxochromene-2-carboxamide Chemical compound C1=CC=C2OC(C(=O)N[C@@H]([C@H](O)C)C(=O)NO)=CC(=O)C2=C1 FEUMNDJCOHDISV-KRTXAFLBSA-N 0.000 description 1
- IJRZSLJZYCAZNX-RISCZKNCSA-N n-[(2s,3r)-3-hydroxy-1-(hydroxyamino)-1-oxobutan-2-yl]-4-pentylbenzamide Chemical compound CCCCCC1=CC=C(C(=O)N[C@@H]([C@@H](C)O)C(=O)NO)C=C1 IJRZSLJZYCAZNX-RISCZKNCSA-N 0.000 description 1
- AXQUTBMFDJGETC-ABAIWWIYSA-N n-[(2s,3r)-3-hydroxy-1-(hydroxyamino)-1-oxobutan-2-yl]-4-phenylbenzamide Chemical compound C1=CC(C(=O)N[C@@H]([C@H](O)C)C(=O)NO)=CC=C1C1=CC=CC=C1 AXQUTBMFDJGETC-ABAIWWIYSA-N 0.000 description 1
- AWUMQFCOBKINBL-SKDRFNHKSA-N n-[(2s,3r)-3-hydroxy-1-(hydroxyamino)-1-oxobutan-2-yl]-4-propylbenzamide Chemical compound CCCC1=CC=C(C(=O)N[C@@H]([C@@H](C)O)C(=O)NO)C=C1 AWUMQFCOBKINBL-SKDRFNHKSA-N 0.000 description 1
- LSDRQMPWSLLHQD-YGRLFVJLSA-N n-[(2s,3r)-3-hydroxy-1-(hydroxyamino)-1-oxobutan-2-yl]-4-pyridin-3-ylbenzamide Chemical compound C1=CC(C(=O)N[C@@H]([C@H](O)C)C(=O)NO)=CC=C1C1=CC=CN=C1 LSDRQMPWSLLHQD-YGRLFVJLSA-N 0.000 description 1
- GYLGNVFVCNJQHX-RNCFNFMXSA-N n-[(2s,3r)-3-hydroxy-1-(hydroxyamino)-1-oxobutan-2-yl]-4-pyrimidin-5-ylbenzamide Chemical compound C1=CC(C(=O)N[C@@H]([C@H](O)C)C(=O)NO)=CC=C1C1=CN=CN=C1 GYLGNVFVCNJQHX-RNCFNFMXSA-N 0.000 description 1
- SMJDCTJLFIJIIP-RISCZKNCSA-N n-[(2s,3r)-3-hydroxy-1-(hydroxyamino)-1-oxobutan-2-yl]-5-phenylpentanamide Chemical compound ONC(=O)[C@H]([C@H](O)C)NC(=O)CCCCC1=CC=CC=C1 SMJDCTJLFIJIIP-RISCZKNCSA-N 0.000 description 1
- RJKFUFHLMUANKN-RNCFNFMXSA-N n-[(2s,3r)-3-hydroxy-1-(hydroxyamino)-1-oxobutan-2-yl]-5-phenylthiophene-2-carboxamide Chemical compound S1C(C(=O)N[C@@H]([C@H](O)C)C(=O)NO)=CC=C1C1=CC=CC=C1 RJKFUFHLMUANKN-RNCFNFMXSA-N 0.000 description 1
- OPVZTKIWCNLDCD-YGRLFVJLSA-N n-[(2s,3r)-3-hydroxy-1-(hydroxyamino)-1-oxobutan-2-yl]-6-phenylpyridine-2-carboxamide Chemical compound ONC(=O)[C@H]([C@H](O)C)NC(=O)C1=CC=CC(C=2C=CC=CC=2)=N1 OPVZTKIWCNLDCD-YGRLFVJLSA-N 0.000 description 1
- RXZPSQFGBSHGJZ-HWPZZCPQSA-N n-[(2s,3r)-3-hydroxy-1-(hydroxyamino)-1-oxobutan-2-yl]-9h-fluorene-2-carboxamide Chemical compound C1=CC=C2C3=CC=C(C(=O)N[C@@H]([C@H](O)C)C(=O)NO)C=C3CC2=C1 RXZPSQFGBSHGJZ-HWPZZCPQSA-N 0.000 description 1
- PINNXTQRTNBDJP-WBMJQRKESA-N n-[(2s,3r)-3-hydroxy-1-(hydroxyamino)-1-oxobutan-2-yl]-n-methyl-4-phenylbenzamide Chemical compound C1=CC(C(=O)N(C)[C@@H]([C@H](O)C)C(=O)NO)=CC=C1C1=CC=CC=C1 PINNXTQRTNBDJP-WBMJQRKESA-N 0.000 description 1
- DWKJANVZZAJQBB-PELKAZGASA-N n-[(2s,3r)-3-hydroxy-1-(hydroxyamino)-1-oxobutan-2-yl]quinoline-2-carboxamide Chemical compound C1=CC=CC2=NC(C(=O)N[C@@H]([C@H](O)C)C(=O)NO)=CC=C21 DWKJANVZZAJQBB-PELKAZGASA-N 0.000 description 1
- LIAJDNMRGFUSAB-KUHUBIRLSA-N n-[(2s,3r)-3-hydroxy-1-(methylamino)-1-oxobutan-2-yl]-4-(4-propylphenyl)benzamide Chemical compound C1=CC(CCC)=CC=C1C1=CC=C(C(=O)N[C@@H]([C@@H](C)O)C(=O)NC)C=C1 LIAJDNMRGFUSAB-KUHUBIRLSA-N 0.000 description 1
- AXQUTBMFDJGETC-NHYWBVRUSA-N n-[(2s,3s)-3-hydroxy-1-(hydroxyamino)-1-oxobutan-2-yl]-4-phenylbenzamide Chemical compound C1=CC(C(=O)N[C@@H]([C@@H](O)C)C(=O)NO)=CC=C1C1=CC=CC=C1 AXQUTBMFDJGETC-NHYWBVRUSA-N 0.000 description 1
- LZUDUGSEVUOFDL-UHFFFAOYSA-N n-[(benzylamino)methyl]benzamide Chemical compound C=1C=CC=CC=1C(=O)NCNCC1=CC=CC=C1 LZUDUGSEVUOFDL-UHFFFAOYSA-N 0.000 description 1
- JUPNFLQFLIGXIF-RMOCHZDMSA-N n-[(e)-1-oxobut-2-en-2-yl]-4-(4-propylphenyl)benzamide Chemical compound C1=CC(CCC)=CC=C1C1=CC=C(C(=O)N\C(=C\C)C=O)C=C1 JUPNFLQFLIGXIF-RMOCHZDMSA-N 0.000 description 1
- VBQZBKJCZUJJLN-CFRYKOAASA-N n-[(e,1e)-1-(carbamoylhydrazinylidene)but-2-en-2-yl]-4-(4-propylphenyl)benzamide Chemical compound C1=CC(CCC)=CC=C1C1=CC=C(C(=O)N\C(=C\C)\C=N\NC(N)=O)C=C1 VBQZBKJCZUJJLN-CFRYKOAASA-N 0.000 description 1
- OYRNMCMSMSGGKS-ABRULOCNSA-N n-[(e,1e)-1-hydroxyiminobut-2-en-2-yl]-4-(4-propylphenyl)benzamide Chemical compound C1=CC(CCC)=CC=C1C1=CC=C(C(=O)N\C(=C\C)\C=N\O)C=C1 OYRNMCMSMSGGKS-ABRULOCNSA-N 0.000 description 1
- ZRIJFQHJIYANCB-UHFFFAOYSA-N n-[1-hydroxy-3-(hydroxyamino)-3-oxo-1-phenylpropan-2-yl]-4-phenylbenzamide Chemical compound C=1C=CC=CC=1C(O)C(C(=O)NO)NC(=O)C(C=C1)=CC=C1C1=CC=CC=C1 ZRIJFQHJIYANCB-UHFFFAOYSA-N 0.000 description 1
- NGZWOGLYIMOSDC-UHFFFAOYSA-N n-[2-[(3-aminocyclohexyl)carbamoyl-hydroxyamino]ethyl]-4-(4-ethylphenyl)benzamide Chemical compound C1=CC(CC)=CC=C1C1=CC=C(C(=O)NCCN(O)C(=O)NC2CC(N)CCC2)C=C1 NGZWOGLYIMOSDC-UHFFFAOYSA-N 0.000 description 1
- GWFGMACSHDUNSB-UHFFFAOYSA-N n-[2-[(4-aminothiophen-3-yl)carbamoyl-hydroxyamino]ethyl]-4-(4-ethylphenyl)benzamide Chemical compound C1=CC(CC)=CC=C1C1=CC=C(C(=O)NCCN(O)C(=O)NC=2C(=CSC=2)N)C=C1 GWFGMACSHDUNSB-UHFFFAOYSA-N 0.000 description 1
- UAWAGNLKQFFHLQ-UHFFFAOYSA-N n-[2-[2-(dimethylamino)ethylcarbamoyl-hydroxyamino]ethyl]-4-(4-ethylphenyl)benzamide Chemical compound C1=CC(CC)=CC=C1C1=CC=C(C(=O)NCCN(O)C(=O)NCCN(C)C)C=C1 UAWAGNLKQFFHLQ-UHFFFAOYSA-N 0.000 description 1
- SEFSOBSWRNIUSN-UHFFFAOYSA-N n-[2-[2-acetamidoethylcarbamoyl(hydroxy)amino]ethyl]-4-(4-ethylphenyl)benzamide Chemical compound C1=CC(CC)=CC=C1C1=CC=C(C(=O)NCCN(O)C(=O)NCCNC(C)=O)C=C1 SEFSOBSWRNIUSN-UHFFFAOYSA-N 0.000 description 1
- OSPMFAKPJRZTNT-UHFFFAOYSA-N n-[2-[2-aminoethylcarbamoyl(hydroxy)amino]ethyl]-4-(4-ethylphenyl)benzamide Chemical compound C1=CC(CC)=CC=C1C1=CC=C(C(=O)NCCN(O)C(=O)NCCN)C=C1 OSPMFAKPJRZTNT-UHFFFAOYSA-N 0.000 description 1
- IPCFKVRHKHAJBM-UHFFFAOYSA-N n-[2-[2-cyanoethylcarbamoyl(hydroxy)amino]ethyl]-4-(4-ethylphenyl)benzamide Chemical compound C1=CC(CC)=CC=C1C1=CC=C(C(=O)NCCN(O)C(=O)NCCC#N)C=C1 IPCFKVRHKHAJBM-UHFFFAOYSA-N 0.000 description 1
- KKOQVEDPQVVROB-UHFFFAOYSA-N n-[2-[3-aminopropylcarbamoyl(hydroxy)amino]ethyl]-4-(4-ethylphenyl)benzamide Chemical compound C1=CC(CC)=CC=C1C1=CC=C(C(=O)NCCN(O)C(=O)NCCCN)C=C1 KKOQVEDPQVVROB-UHFFFAOYSA-N 0.000 description 1
- BRTPNYGGUMBAAK-KRWDZBQOSA-N n-[2-[[(2s)-3-amino-1-(hydroxyamino)-1-oxopropan-2-yl]amino]-2-oxoethyl]-4-(4-ethylphenyl)benzamide Chemical compound C1=CC(CC)=CC=C1C1=CC=C(C(=O)NCC(=O)N[C@@H](CN)C(=O)NO)C=C1 BRTPNYGGUMBAAK-KRWDZBQOSA-N 0.000 description 1
- CHHAGYABBDLKAZ-DVECYGJZSA-N n-[2-[[(2s,3r)-2-[[4-(4-ethylphenyl)benzoyl]amino]-3-hydroxybutanoyl]amino]ethyl]-n-hydroxy-4-methylpiperazine-1-carboxamide Chemical compound C1=CC(CC)=CC=C1C1=CC=C(C(=O)N[C@@H]([C@@H](C)O)C(=O)NCCN(O)C(=O)N2CCN(C)CC2)C=C1 CHHAGYABBDLKAZ-DVECYGJZSA-N 0.000 description 1
- KNYCXJCSVRINDR-JPYJTQIMSA-N n-[2-[[(2s,3r)-2-[[4-(4-ethylphenyl)benzoyl]amino]-3-hydroxybutanoyl]amino]ethyl]-n-hydroxymorpholine-4-carboxamide Chemical compound C1=CC(CC)=CC=C1C1=CC=C(C(=O)N[C@@H]([C@@H](C)O)C(=O)NCCN(O)C(=O)N2CCOCC2)C=C1 KNYCXJCSVRINDR-JPYJTQIMSA-N 0.000 description 1
- VIDPJHZQOCVKOG-JPYJTQIMSA-N n-[2-[[(2s,3r)-2-[[4-(4-ethylphenyl)benzoyl]amino]-3-hydroxybutanoyl]amino]ethyl]-n-hydroxypyrrolidine-1-carboxamide Chemical compound C1=CC(CC)=CC=C1C1=CC=C(C(=O)N[C@@H]([C@@H](C)O)C(=O)NCCN(O)C(=O)N2CCCC2)C=C1 VIDPJHZQOCVKOG-JPYJTQIMSA-N 0.000 description 1
- WJJFBAUPJZDEDH-UHFFFAOYSA-N n-[2-[[4-(4-ethylphenyl)benzoyl]amino]ethyl]-n,3-dihydroxypiperidine-1-carboxamide Chemical compound C1=CC(CC)=CC=C1C1=CC=C(C(=O)NCCN(O)C(=O)N2CC(O)CCC2)C=C1 WJJFBAUPJZDEDH-UHFFFAOYSA-N 0.000 description 1
- AYNIVZBFEYWODE-UHFFFAOYSA-N n-[2-[[4-(4-ethylphenyl)benzoyl]amino]ethyl]-n-hydroxy-4-methylpiperazine-1-carboxamide Chemical compound C1=CC(CC)=CC=C1C1=CC=C(C(=O)NCCN(O)C(=O)N2CCN(C)CC2)C=C1 AYNIVZBFEYWODE-UHFFFAOYSA-N 0.000 description 1
- NPZGXOCCWPGGQG-UHFFFAOYSA-N n-[2-[[4-(4-ethylphenyl)benzoyl]amino]ethyl]-n-hydroxy-4-piperidin-1-ylpiperidine-1-carboxamide Chemical compound C1=CC(CC)=CC=C1C1=CC=C(C(=O)NCCN(O)C(=O)N2CCC(CC2)N2CCCCC2)C=C1 NPZGXOCCWPGGQG-UHFFFAOYSA-N 0.000 description 1
- BXGFGVJXXJAUPX-UHFFFAOYSA-N n-[2-[carbamothioyl(hydroxy)amino]ethyl]-4-(4-ethylphenyl)benzamide Chemical compound C1=CC(CC)=CC=C1C1=CC=C(C(=O)NCCN(O)C(N)=S)C=C1 BXGFGVJXXJAUPX-UHFFFAOYSA-N 0.000 description 1
- YXWJPKKIVGDGBT-UHFFFAOYSA-N n-[2-[carbamoyl(hydroxy)amino]ethyl]-4-(4-ethylphenyl)benzamide Chemical compound C1=CC(CC)=CC=C1C1=CC=C(C(=O)NCCN(O)C(N)=O)C=C1 YXWJPKKIVGDGBT-UHFFFAOYSA-N 0.000 description 1
- QGONMZKCXPUHLF-UHFFFAOYSA-N n-[2-[cyclopropylcarbamoyl(hydroxy)amino]ethyl]-4-(4-ethylphenyl)benzamide Chemical compound C1=CC(CC)=CC=C1C1=CC=C(C(=O)NCCN(O)C(=O)NC2CC2)C=C1 QGONMZKCXPUHLF-UHFFFAOYSA-N 0.000 description 1
- YUKHMDKYHZSKLV-UHFFFAOYSA-N n-[2-hydroxy-3-(hydroxyamino)-3-oxopropyl]-4-phenylbenzamide Chemical compound C1=CC(C(=O)NCC(O)C(=O)NO)=CC=C1C1=CC=CC=C1 YUKHMDKYHZSKLV-UHFFFAOYSA-N 0.000 description 1
- LKABCHRMOIYWEC-UHFFFAOYSA-N n-[3-(dimethylamino)-1-(hydroxyamino)-1-oxopropan-2-yl]-4-(4-ethylphenyl)benzamide Chemical compound C1=CC(CC)=CC=C1C1=CC=C(C(=O)NC(CN(C)C)C(=O)NO)C=C1 LKABCHRMOIYWEC-UHFFFAOYSA-N 0.000 description 1
- MNFRBNBEOMZEPA-SFHVURJKSA-N n-[3-[[(2s)-3-amino-1-(hydroxyamino)-1-oxopropan-2-yl]amino]-3-oxopropyl]-4-(4-ethylphenyl)benzamide Chemical compound C1=CC(CC)=CC=C1C1=CC=C(C(=O)NCCC(=O)N[C@@H](CN)C(=O)NO)C=C1 MNFRBNBEOMZEPA-SFHVURJKSA-N 0.000 description 1
- ONIIPIULVVAJTI-UHFFFAOYSA-N n-[3-hydroxy-1-(hydroxyamino)-1-oxopropan-2-yl]-4-methoxy-3-propylbenzamide Chemical compound CCCC1=CC(C(=O)NC(CO)C(=O)NO)=CC=C1OC ONIIPIULVVAJTI-UHFFFAOYSA-N 0.000 description 1
- OOVWCFKXPZLGHX-UHFFFAOYSA-N n-[3-hydroxy-1-(hydroxyamino)-1-oxopropan-2-yl]-4-phenylbenzamide Chemical compound C1=CC(C(=O)NC(CO)C(=O)NO)=CC=C1C1=CC=CC=C1 OOVWCFKXPZLGHX-UHFFFAOYSA-N 0.000 description 1
- MRESDNJGFJMFLM-QWAKEFERSA-N n-[4-[2-[4-[[(2s)-3-amino-1-(hydroxyamino)-1-oxopropan-2-yl]carbamoyl]phenyl]ethynyl]phenyl]piperidine-3-carboxamide Chemical compound C1=CC(C(=O)N[C@@H](CN)C(=O)NO)=CC=C1C#CC(C=C1)=CC=C1NC(=O)C1CNCCC1 MRESDNJGFJMFLM-QWAKEFERSA-N 0.000 description 1
- IAPIZQIGODUQHX-JRSXHVCQSA-N n-[4-[2-[4-[[(2s,3r)-3-hydroxy-1-(hydroxyamino)-1-oxobutan-2-yl]carbamoyl]phenyl]ethynyl]phenyl]piperidine-3-carboxamide Chemical compound C1=CC(C(=O)N[C@@H]([C@H](O)C)C(=O)NO)=CC=C1C#CC(C=C1)=CC=C1NC(=O)C1CNCCC1 IAPIZQIGODUQHX-JRSXHVCQSA-N 0.000 description 1
- ABPBFXQVIKGCBG-UHFFFAOYSA-N n-[4-hydroxy-1-(hydroxyamino)-1-oxobutan-2-yl]-4-phenylbenzamide Chemical compound C1=CC(C(=O)NC(CCO)C(=O)NO)=CC=C1C1=CC=CC=C1 ABPBFXQVIKGCBG-UHFFFAOYSA-N 0.000 description 1
- NNZXNCWCKPWZNT-UHFFFAOYSA-N n-[hydroxy(phenyl)methyl]benzamide Chemical compound C=1C=CC=CC=1C(O)NC(=O)C1=CC=CC=C1 NNZXNCWCKPWZNT-UHFFFAOYSA-N 0.000 description 1
- DJHYIXKERAPBNS-UHFFFAOYSA-N n-benzylsulfanylpyridine-3-carboxamide Chemical compound C=1C=CN=CC=1C(=O)NSCC1=CC=CC=C1 DJHYIXKERAPBNS-UHFFFAOYSA-N 0.000 description 1
- NOYIRKMDQCRCJF-UHFFFAOYSA-N n-hydroxy-2-(3-propan-2-yl-4-prop-2-enoxyphenyl)-4,5-dihydro-1,3-oxazole-4-carboxamide Chemical compound C1=C(OCC=C)C(C(C)C)=CC(C=2OCC(N=2)C(=O)NO)=C1 NOYIRKMDQCRCJF-UHFFFAOYSA-N 0.000 description 1
- DQJYKVARQYEVLU-UHFFFAOYSA-N n-prop-2-enoxybenzamide Chemical compound C=CCONC(=O)C1=CC=CC=C1 DQJYKVARQYEVLU-UHFFFAOYSA-N 0.000 description 1
- 235000005152 nicotinamide Nutrition 0.000 description 1
- 239000011570 nicotinamide Substances 0.000 description 1
- BVOCPVIXARZNQN-UHFFFAOYSA-N nipecotamide Chemical compound NC(=O)C1CCCNC1 BVOCPVIXARZNQN-UHFFFAOYSA-N 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 125000004433 nitrogen atom Chemical group N* 0.000 description 1
- 125000003261 o-tolyl group Chemical group [H]C1=C([H])C(*)=C(C([H])=C1[H])C([H])([H])[H] 0.000 description 1
- 150000002894 organic compounds Chemical class 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 244000045947 parasite Species 0.000 description 1
- 239000008194 pharmaceutical composition Substances 0.000 description 1
- 125000003170 phenylsulfonyl group Chemical group C1(=CC=CC=C1)S(=O)(=O)* 0.000 description 1
- CYJAWBVQRMVFEO-UHFFFAOYSA-N piperazine-2,6-dione Chemical compound O=C1CNCC(=O)N1 CYJAWBVQRMVFEO-UHFFFAOYSA-N 0.000 description 1
- DNUTZBZXLPWRJG-UHFFFAOYSA-M piperidine-1-carboxylate Chemical compound [O-]C(=O)N1CCCCC1 DNUTZBZXLPWRJG-UHFFFAOYSA-M 0.000 description 1
- XIMBESZRBTVIOD-UHFFFAOYSA-N piperidine-2-carboxamide Chemical compound NC(=O)C1CCCCN1 XIMBESZRBTVIOD-UHFFFAOYSA-N 0.000 description 1
- 125000006308 propyl amino group Chemical group 0.000 description 1
- WGYKZJWCGVVSQN-UHFFFAOYSA-N propylamine Chemical group CCCN WGYKZJWCGVVSQN-UHFFFAOYSA-N 0.000 description 1
- 125000006514 pyridin-2-ylmethyl group Chemical group [H]C1=C([H])C([H])=C([H])C(=N1)C([H])([H])* 0.000 description 1
- 125000004528 pyrimidin-5-yl group Chemical group N1=CN=CC(=C1)* 0.000 description 1
- 230000002285 radioactive effect Effects 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 239000011593 sulfur Substances 0.000 description 1
- OFEXGUCZUAKCRO-KEKNWZKVSA-N tert-butyl 4-amino-2-[[2-[[(2s)-3-(hydroxyamino)-3-oxo-2-[[4-(2-phenylethynyl)benzoyl]amino]propyl]amino]-2-oxoethyl]amino]-4-oxobutanoate Chemical compound C1=CC(C(=O)N[C@@H](CNC(=O)CNC(CC(N)=O)C(=O)OC(C)(C)C)C(=O)NO)=CC=C1C#CC1=CC=CC=C1 OFEXGUCZUAKCRO-KEKNWZKVSA-N 0.000 description 1
- DKFFAFCKUDAIJM-ZDUSSCGKSA-N tert-butyl n-[(2s)-2-[(4-ethynylbenzoyl)amino]-3-(hydroxyamino)-3-oxopropyl]carbamate Chemical compound CC(C)(C)OC(=O)NC[C@@H](C(=O)NO)NC(=O)C1=CC=C(C#C)C=C1 DKFFAFCKUDAIJM-ZDUSSCGKSA-N 0.000 description 1
- UEVJEPAMRIQCSY-FQEVSTJZSA-N tert-butyl n-[(2s)-3-(hydroxyamino)-2-[[4-[2-[4-[2-(hydroxyamino)-2-oxoethoxy]phenyl]ethynyl]benzoyl]amino]-3-oxopropyl]carbamate Chemical compound C1=CC(C(=O)N[C@@H](CNC(=O)OC(C)(C)C)C(=O)NO)=CC=C1C#CC1=CC=C(OCC(=O)NO)C=C1 UEVJEPAMRIQCSY-FQEVSTJZSA-N 0.000 description 1
- QSVQBZXAMRXTMA-QHCPKHFHSA-N tert-butyl n-[(2s)-3-(hydroxyamino)-2-[[4-[2-[4-[[2-[(2-methylpropan-2-yl)oxycarbonylamino]acetyl]amino]phenyl]ethynyl]benzoyl]amino]-3-oxopropyl]carbamate Chemical compound C1=CC(C(=O)N[C@@H](CNC(=O)OC(C)(C)C)C(=O)NO)=CC=C1C#CC1=CC=C(NC(=O)CNC(=O)OC(C)(C)C)C=C1 QSVQBZXAMRXTMA-QHCPKHFHSA-N 0.000 description 1
- QITMPDFVHIIICB-FQEVSTJZSA-N tert-butyl n-[2-[[(2s)-3-(hydroxyamino)-3-oxo-2-[[4-(2-phenylethynyl)benzoyl]amino]propyl]amino]-2-oxoethyl]carbamate Chemical compound C1=CC(C(=O)N[C@@H](CNC(=O)CNC(=O)OC(C)(C)C)C(=O)NO)=CC=C1C#CC1=CC=CC=C1 QITMPDFVHIIICB-FQEVSTJZSA-N 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 238000003354 tissue distribution assay Methods 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C233/00—Carboxylic acid amides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C233/00—Carboxylic acid amides
- C07C233/64—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings
- C07C233/81—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups
- C07C233/82—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom
- C07C233/83—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom of an acyclic saturated carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C239/00—Compounds containing nitrogen-to-halogen bonds; Hydroxylamino compounds or ethers or esters thereof
- C07C239/08—Hydroxylamino compounds or their ethers or esters
- C07C239/16—Hydroxylamino compounds or their ethers or esters having nitrogen atoms of hydroxylamino groups further bound to carbon atoms of hydrocarbon radicals substituted by nitrogen atoms not being part of nitro or nitroso groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C251/00—Compounds containing nitrogen atoms doubly-bound to a carbon skeleton
- C07C251/32—Oximes
- C07C251/34—Oximes with oxygen atoms of oxyimino groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals
- C07C251/36—Oximes with oxygen atoms of oxyimino groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals with the carbon atoms of the oxyimino groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C251/40—Oximes with oxygen atoms of oxyimino groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals with the carbon atoms of the oxyimino groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of an unsaturated carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C255/00—Carboxylic acid nitriles
- C07C255/01—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms
- C07C255/24—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms containing cyano groups and singly-bound nitrogen atoms, not being further bound to other hetero atoms, bound to the same saturated acyclic carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C255/00—Carboxylic acid nitriles
- C07C255/01—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms
- C07C255/24—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms containing cyano groups and singly-bound nitrogen atoms, not being further bound to other hetero atoms, bound to the same saturated acyclic carbon skeleton
- C07C255/25—Aminoacetonitriles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C255/00—Carboxylic acid nitriles
- C07C255/01—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms
- C07C255/32—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms having cyano groups bound to acyclic carbon atoms of a carbon skeleton containing at least one six-membered aromatic ring
- C07C255/42—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms having cyano groups bound to acyclic carbon atoms of a carbon skeleton containing at least one six-membered aromatic ring the carbon skeleton being further substituted by singly-bound nitrogen atoms, not being further bound to other hetero atoms
- C07C255/44—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms having cyano groups bound to acyclic carbon atoms of a carbon skeleton containing at least one six-membered aromatic ring the carbon skeleton being further substituted by singly-bound nitrogen atoms, not being further bound to other hetero atoms at least one of the singly-bound nitrogen atoms being acylated
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C255/00—Carboxylic acid nitriles
- C07C255/49—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
- C07C255/57—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton containing cyano groups and carboxyl groups, other than cyano groups, bound to the carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C259/00—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups
- C07C259/04—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups without replacement of the other oxygen atom of the carboxyl group, e.g. hydroxamic acids
- C07C259/06—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups without replacement of the other oxygen atom of the carboxyl group, e.g. hydroxamic acids having carbon atoms of hydroxamic groups bound to hydrogen atoms or to acyclic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C275/00—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
- C07C275/04—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to acyclic carbon atoms
- C07C275/06—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to acyclic carbon atoms of an acyclic and saturated carbon skeleton
- C07C275/14—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to acyclic carbon atoms of an acyclic and saturated carbon skeleton being further substituted by nitrogen atoms not being part of nitro or nitroso groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C275/00—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
- C07C275/04—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to acyclic carbon atoms
- C07C275/06—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to acyclic carbon atoms of an acyclic and saturated carbon skeleton
- C07C275/16—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to acyclic carbon atoms of an acyclic and saturated carbon skeleton being further substituted by carboxyl groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C275/00—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
- C07C275/26—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of rings other than six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C279/00—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
- C07C279/04—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to acyclic carbon atoms of a carbon skeleton
- C07C279/14—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to acyclic carbon atoms of a carbon skeleton being further substituted by carboxyl groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/01—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms
- C07C311/02—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
- C07C311/03—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton having the nitrogen atoms of the sulfonamide groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C311/06—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton having the nitrogen atoms of the sulfonamide groups bound to hydrogen atoms or to acyclic carbon atoms to acyclic carbon atoms of hydrocarbon radicals substituted by carboxyl groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/01—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms
- C07C311/02—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
- C07C311/08—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton having the nitrogen atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/15—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings
- C07C311/16—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the sulfonamide groups bound to hydrogen atoms or to an acyclic carbon atom
- C07C311/19—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the sulfonamide groups bound to hydrogen atoms or to an acyclic carbon atom to an acyclic carbon atom of a hydrocarbon radical substituted by carboxyl groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/15—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings
- C07C311/21—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C317/00—Sulfones; Sulfoxides
- C07C317/26—Sulfones; Sulfoxides having sulfone or sulfoxide groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton
- C07C317/32—Sulfones; Sulfoxides having sulfone or sulfoxide groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton with sulfone or sulfoxide groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
- C07C323/23—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton
- C07C323/24—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton
- C07C323/25—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
- C07C323/23—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton
- C07C323/39—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton at least one of the nitrogen atoms being part of any of the groups, X being a hetero atom, Y being any atom
- C07C323/40—Y being a hydrogen or a carbon atom
- C07C323/41—Y being a hydrogen or an acyclic carbon atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
- C07C323/50—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton
- C07C323/51—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton
- C07C323/60—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton with the carbon atom of at least one of the carboxyl groups bound to nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
- C07C323/50—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton
- C07C323/62—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atom of at least one of the thio groups bound to a carbon atom of a six-membered aromatic ring of the carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C335/00—Thioureas, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
- C07C335/04—Derivatives of thiourea
- C07C335/06—Derivatives of thiourea having nitrogen atoms of thiourea groups bound to acyclic carbon atoms
- C07C335/08—Derivatives of thiourea having nitrogen atoms of thiourea groups bound to acyclic carbon atoms of a saturated carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C337/00—Derivatives of thiocarbonic acids containing functional groups covered by groups C07C333/00 or C07C335/00 in which at least one nitrogen atom of these functional groups is further bound to another nitrogen atom not being part of a nitro or nitroso group
- C07C337/06—Compounds containing any of the groups, e.g. thiosemicarbazides
- C07C337/08—Compounds containing any of the groups, e.g. thiosemicarbazides the other nitrogen atom being further doubly-bound to a carbon atom, e.g. thiosemicarbazones
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C381/00—Compounds containing carbon and sulfur and having functional groups not covered by groups C07C301/00 - C07C337/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D207/08—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by hetero atoms, attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D207/08—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by hetero atoms, attached to ring carbon atoms
- C07D207/09—Radicals substituted by nitrogen atoms, not forming part of a nitro radical
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/14—Nitrogen atoms not forming part of a nitro radical
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/16—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/24—Oxygen or sulfur atoms
- C07D207/26—2-Pyrrolidones
- C07D207/263—2-Pyrrolidones with only hydrogen atoms or radicals containing only hydrogen and carbon atoms directly attached to other ring carbon atoms
- C07D207/27—2-Pyrrolidones with only hydrogen atoms or radicals containing only hydrogen and carbon atoms directly attached to other ring carbon atoms with substituted hydrocarbon radicals directly attached to the ring nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D207/32—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C07D207/325—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms with substituted hydrocarbon radicals directly attached to the ring nitrogen atom
- C07D207/327—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D211/26—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/40—Oxygen atoms
- C07D211/42—Oxygen atoms attached in position 3 or 5
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/56—Nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/56—Nitrogen atoms
- C07D211/58—Nitrogen atoms attached in position 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/60—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D211/62—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals attached in position 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/36—Radicals substituted by singly-bound nitrogen atoms
- C07D213/38—Radicals substituted by singly-bound nitrogen atoms having only hydrogen or hydrocarbon radicals attached to the substituent nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/36—Radicals substituted by singly-bound nitrogen atoms
- C07D213/40—Acylated substituent nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/54—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/54—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/56—Amides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/61—Halogen atoms or nitro radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/74—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/79—Acids; Esters
- C07D213/80—Acids; Esters in position 3
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/81—Amides; Imides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/81—Amides; Imides
- C07D213/82—Amides; Imides in position 3
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/22—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
- C07D217/26—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/06—Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
- C07D235/14—Radicals substituted by nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/26—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/32—One oxygen, sulfur or nitrogen atom
- C07D239/42—One nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
- C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
- C07D241/04—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
- C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
- C07D241/10—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
- C07D241/12—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
- C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
- C07D241/10—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
- C07D241/14—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D241/18—Oxygen or sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
- C07D263/30—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D263/34—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
- C07D285/01—Five-membered rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/12—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms
- C07D295/125—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
- C07D295/13—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/12—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms
- C07D295/135—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/14—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D295/155—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
- C07D295/18—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carboxylic acids, or sulfur or nitrogen analogues thereof
- C07D295/182—Radicals derived from carboxylic acids
- C07D295/192—Radicals derived from carboxylic acids from aromatic carboxylic acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
- C07D295/20—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carbonic acid, or sulfur or nitrogen analogues thereof
- C07D295/215—Radicals derived from nitrogen analogues of carbonic acid
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D307/56—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D307/68—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
- C07D311/22—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
- C07D311/24—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
- C07D317/44—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D317/46—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
- C07D317/48—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
- C07D317/50—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to atoms of the carbocyclic ring
- C07D317/60—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
- C07D317/44—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D317/46—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
- C07D317/48—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
- C07D317/62—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to atoms of the carbocyclic ring
- C07D317/68—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
- C07D333/14—Radicals substituted by singly bound hetero atoms other than halogen
- C07D333/20—Radicals substituted by singly bound hetero atoms other than halogen by nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
- C07D333/24—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D333/30—Hetero atoms other than halogen
- C07D333/32—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D333/30—Hetero atoms other than halogen
- C07D333/36—Nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D333/52—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
- C07D333/54—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
- C07D333/58—Radicals substituted by nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/02—Systems containing only non-condensed rings with a three-membered ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/04—Systems containing only non-condensed rings with a four-membered ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
- C07C2601/14—The ring being saturated
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/18—Systems containing only non-condensed rings with a ring being at least seven-membered
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2602/00—Systems containing two condensed rings
- C07C2602/36—Systems containing two condensed rings the rings having more than two atoms in common
- C07C2602/42—Systems containing two condensed rings the rings having more than two atoms in common the bicyclo ring system containing seven carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2603/00—Systems containing at least three condensed rings
- C07C2603/56—Ring systems containing bridged rings
- C07C2603/58—Ring systems containing bridged rings containing three rings
- C07C2603/70—Ring systems containing bridged rings containing three rings containing only six-membered rings
- C07C2603/74—Adamantanes
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Oncology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Communicable Diseases (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Pulmonology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Hydrogenated Pyridines (AREA)
- Saccharide Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pyrrole Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Quinoline Compounds (AREA)
- Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Heterocyclic Compounds Containing Sulfur Atoms (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
- Furan Compounds (AREA)
- Pyridine Compounds (AREA)
- Pyrane Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
Abstract
Un compuesto de acuerdo con la fórmula I:**Fórmula** o un estereoisómero, sal farmacéuticamente aceptable o éster de la misma, en el que E está ausente o está seleccionado del grupo que consiste en (1) H, (2) alquilo C1-C6 sustituido o sin sustituir, (3) arilo sustituido o sin sustituir, (4) heterociclilo sustituido o sin sustituir, y (5) heteroarilo sustituido o sin sustituir; L está ausente o está seleccionado del grupo que consiste en (1) alquilo C1-C6 sustituido o sin sustituir, (2) -(NH)0-1-(CH2)j-NR3L-(CH2)k-, (3) -(NH)0-1C(R1L, R2L)-NR3L-C(R1L, R2L)-, (4) -C(R1L, R2L)-O-C(R1L, R2L)-, (5) -(CH2)j-NR3L-C(R1L, R2L-CONH-(CH2)k-, (6) -CO-C(R1L, R2L)-NHCO-, (7) -CONH-, (8) -NHCO-, en las que R1L, R2L y R3L están seleccionados independientemente del grupo que consiste en (a) H, (b) alquilo C1-C6 sustituido o sin sustituir, (c) alquilo C1-C6 sustituido con arilo, (d) alquilo C1-C6 sustituido con heterociclilo, y (e) alquilo C1-C6 sustituido con heteroarilo, o R1L y R3L, junto con los átomos a los que están unidos, pueden formar un anillo heterocíclico sustituido o sin sustituir que tiene de 3 a 8 átomos de anillo, en el que 1-2 átomos de anillo del sistema de anillo heterocíclico están seleccionados de N, O y S; j es un número entero de 0-4; k es un número entero de 0-4; D está ausente o está seleccionado del grupo que consiste en (1) cicloalquilo C3-C8 sustituido o sin sustituir, (2) arilo sustituido o sin sustituir, (3) heterociclilo sustituido o sin sustituir, y (4) heteroarilo sustituido o sin sustituir; G está ausente o está seleccionado del grupo que consiste en (1) -C(>=O)-, (2) -C>=C-, (3) -C≡C-C≡C- and (4) -C>=C-; Y está seleccionado del grupo que consiste en (1) cicloalquilo C3-C8 sustituido o sin sustituir, (2) fenilo sustituido o sin sustituir, X está seleccionado del grupo que consiste en (1) -(C>=O)-, (2) -alquilo C1-C6-(C>=O)-, (3) -alquenilo C2-C6-C>=O)-, (4) -alquinilo C2-C6-(C>=O)-, y (5) -CH2-; B está ausente o en la que R1b y R2b están seleccionados independientemente del grupo que consiste en (a) H, (b) alquilo C1-C6 sin sustituir, (c) alquenilo C2-C6 o sin sustituir, (d) alquinilo C2-C6 o sin sustituir, (e) alquilo C1-C6 sustituido con arilo, (f) alquilo C1-C6 sustituido con heterociclilo, y (g) alquilo C1-C6 sustituido con heteroarilo, q es un número entero de 0-4; R3 es H o alquilo C1-C6 sustituido o sin sustituir, R4 es H o alquilo C1-C6 sustituido o sin sustituir, n es 0; A está seleccionado del grupo que consiste en (1) -(CH2)rC(R1a,R2a)N(R4a,R5a), (2) -(CH2)rC(R1a, R2a)N(R4a)COR3a, (3) -(CH2)rC(R1a,R2a)NHCON(R4a,R5a), y (4) -(CH2)rC(R1a, R2a)NHC(>=NH)N(R4a, R5a), en las que R1a, R2a, R3a, R4a y R5a están seleccionados independientemente del grupo que consiste en (a) H, (b) alquilo C1-C6 sin sustituir, (c) alquilo C1-C6 sustituido con heterociclilo, r es 0; Q es -C(>=O)N(R1, R2), R1 es -OH, R2 es H, en las que B está ausente, o E, L, G y B están ausentes, o E, L y G están ausentes, o E, L y B están ausentes, o E, L, D, G y B están ausentes, en la que la frase "alquilo" se refiere a grupos alquilo que no contienen heteroátomos e incluye grupos alquilo de cadena lineal, isómeros de cadena ramificada de grupos alquilo de cadena lineal, grupos alquilo cíclicos y dichos anillos sustituidos con grupos alquilo de cadena lineal o ramificada como se define con anterioridad, la frase "alquenilo" se refiere a grupos de cadena lineal o ramificada y cíclicos como se describe con respecto a los grupos alquilo como se ha definido con anterioridad, excepto que existe al menos un enlace doble entre dos átomos de carbono, y la frase "alquinilo" se refiere a grupos de cadena lineal y ramificada como se ha descrito con respecto a los grupos alquilo como se ha definido con anterioridad, excepto que hay al menos un enlace triple entre dos átomos de carbono.
Description
ejemplo, ácido aspártico y ácido glutámico.
Como se usa en este documento, el término “éster farmacéuticamente aceptable” se refiere a ésteres que se hidrolizan in vivo e incluyen aquellos que se degradan fácilmente en el cuerpo humano para dar el compuesto
5 parental o una sal del mismo. Grupos éster adecuados incluyen, por ejemplo, aquellos derivados de ácidos carboxílicos alifáticos farmacéuticamente aceptables, particularmente ácidos alcanoicos, alquenoicos, cicloalcanoicos y alcanodioicos, en los que cada resto alquilo o alquenilo no tienen ventajosamente más de 6 átomos de carbono. Ejemplos representativos de ésteres particulares incluyen formiatos, acetatos, propionatos, butiratos, acrilatos y etilsuccinatos.
10 El término “profármacos farmacéuticamente aceptables” como se usa en este documento se refiere a aquellos profármacos de los compuestos que, dentro del alcance del criterio médico sensato, son adecuados para su uso en contacto con los tejidos de seres humanos y animales inferiores sin excesiva toxicidad, irritación y respuesta alérgica acorde a una relación de beneficio/riesgo razonable, y eficaces para su uso previsto, además de
15 las formas de ión bipolar, cuando sea posible, de los compuestos. El término “profármaco” se refiere a compuestos que se transforman rápidamente in vivo para dar el compuesto parental, por ejemplo, mediante hidrólisis en la sangre. Se proporciona una sólida discusión en T. Higuchi y V. Stella, Pro-drugs as Novel Delivery Systems, vol. 14 de A.C.S. Symposium Series, y en Edward B. Roche, ed., Bioreversible Carriers in Drug Design, American Pharmaceutical Association and Pergamon Press, 1987.
20 El término “agente antibacteriano” se refiere a agentes sintetizados o modificados en el laboratorio que tienen actividad tanto bactericida como bacteriostática. Un agente “activo” en este contexto inhibirá el crecimiento de
P. aeruginosa y otras bacterias Gram-negativas. El término “inhibir el crecimiento” indica que la tasa de aumento en los números de una población de una bacteria particular se reduce. Por tanto, el término incluye situaciones en las 25 que la población bacteriana aumenta, pero a una tasa reducida, además de situaciones en las que el crecimiento de la población se detiene, además de situaciones en las que los números de bacterias en la población se reducen o la población incluso se elimina. Si se usa un ensayo de actividad enzimática para cribar inhibidores, pueden hacerse modificaciones en la captación/eflujo, solubilidad, semivida, etc. para los compuestos con el fin de establecer una correlación entre inhibición de enzima e inhibición del crecimiento. La actividad de agentes antibacterianos no está
30 necesariamente limitada a bacterias, pero también puede englobar actividad contra parásitos, virus y hongos.
La invención objeto también incluye inhibidores de LpxC isotópicamente marcados que son estructuralmente idénticos a los desvelados anteriormente, pero por el hecho de que uno o más átomos están sustituidos por un átomo que tiene una masa atómica o número másico diferente de la masa atómica o número
35 másico normalmente encontrado en la naturaleza. Ejemplos de isótopos que pueden incorporarse en compuestos de la invención incluyen isótopos de hidrógeno, carbono, nitrógeno, oxígeno, fosforoso, azufre, flúor y cloro tales como2H, 3H, 13C, 14C, 15N, 18O, 17O,31P, 32P, 35S, 18F y 36Cl, respectivamente. Compuestos de la presente invención, y sales farmacéuticamente aceptables de dichos compuestos que contienen los isótopos anteriormente mencionados y/u otros isótopos de otros átomos, están dentro del alcance de la presente invención. Ciertos compuestos
40 isotópicamente marcados de la presente invención, por ejemplo, aquellos en los que se incorporan isótopos radiactivos tales como 3H y 14C, son útiles en ensayos de distribución en tejido de fármaco y/o sustrato. Isótopos tritiados, es decir, 3H, y carbono-14, es decir, 14C, son particularmente preferidos por su facilidad de preparación y detectabilidad. Además, la sustitución con isótopos más pesados tales como deuterio, es decir, 2H, puede proporcionar ciertas ventajas terapéuticas resultantes de mayor estabilidad metabólica, por ejemplo, aumento de la
45 semivida in vivo o reducción de los requisitos de dosificación y, de ahí, que puedan preferirse en algunas circunstancias. Los compuestos isotópicamente marcados de la presente invención pueden prepararse generalmente llevando a cabo procedimientos conocidos o citados y sustituyendo un reactivo isotópicamente marcado fácilmente disponible con un reactivo no isotópicamente marcado.
50 La presente invención proporciona compuestos novedosos, formulaciones farmacéuticas que incluyen los compuestos y su uso en procedimientos para tratar infecciones por bacterias Gram-negativas.
La presente divulgación proporciona compuestos de fórmula I:
55
60
o estereoisómeros, sales farmacéuticamente aceptables, ésteres y profármacos de los mismos, en la que E está ausente o está seleccionado del grupo que consiste en
- (1)
- H,
- (2)
- alquilo C1-C6 sustituido o sin sustituir,
- (2)
- alquilo C1-C6 sustituido o sin sustituir,
- (3)
- alquenilo C2-C6 sustituido o sin sustituir,
- (4)
- alquenilo C2-C6 sustituido o sin sustituir,
- (5)
- arilo sustituido o sin sustituir, 5 (6) heterociclilo sustituido o sin sustituir,
- (7)
- heteroarilo sustituido o sin sustituir,
- (8)
- alquilo C1-C6 sustituido con arilo,
- (9)
- alquilo C1-C6 sustituido con heterociclilo, y
- (10)
- alquilo C1-C6 sustituido con heteroarilo, 10
o R1 y R2, junto con el átomo de N al que están unidos, pueden formar un anillo heterocíclico sustituido o sin sustituir que tiene de 3 a 10 átomos de anillo, en el que 1-4 átomos de anillo del sistema de anillo heterocíclico están seleccionados de N, O y S, R1q, R2q, R3q, R4q y R5q están seleccionados de H o alquilo C1-C6,
15 en las que B está ausente, o E, L, G y B están ausentes, o E, L y G están ausentes, o E, L y B están ausentes, o E, L, D, G y B están ausentes.
En otro aspecto, la presente divulgación proporciona compuestos de fórmula III:
20
25
o estereoisómeros, sales farmacéuticamente aceptables, ésteres y profármacos de los mismos, en la que D-G-Y, en 30 conjunto, está seleccionado del grupo que consiste en
o
o estereoisómeros, sales farmacéuticamente aceptables, ésteres y profármacos de los mismos, en la que D-G-Y, en conjunto, está seleccionado del grupo que consiste en
30 o
35
40
45
50
55
Tabla 3: Actividad antibacteriana frente al panel patrón de organismos (CIM, µg/ml). Tabla 4: Actividad antibacteriana frente a cepas aisladas de fibrosis quística de Pseudomonas aeruginosa (CIM, µg/ml). Las cepas tienen los siguientes fenotipos: 3198 y 3236, sensibles a la mayoría de los agentes antibacterianos; 2196, resistente a ciprofloxacina; 3224, resistente a ceftazidima; 3317, resistente a aztreonam; 1145 y 3206, resistentes a múltiples fármacos.
- Clave de CIM CIM de 6,25 ug/ml o menos = A CIM superior a 6,25 ug/ml a 50 ug/ml = B CIM superior a 50 ug/ml = C
- Cepa bacteriana:
- P. aeruginosa 27853 E. coli 25922 S. aureus 29213 P. aerug. hiper-permeable 35151 P. aeruginosa PAO200 mexAB
- Ejemplo de compuesto nº
- 12
- A A C A A
- 572
- A A C A A
- 481
- A A C A A
- 19
- A A B A A
- 516
- A A C A A
- 280
- A A C A A
- 366
- A A C A A
- 777
- A A C A A
- 315
- A A C A A
- 779
- A A C A A
- 860
- A A C A A
- 801
- A A C A A
- 13
- A A C AA A
- Clave de CIM
- CIM de 6,25 ug/ml o menos = A
- CIM superior a 6,25 ug/ml a 50 ug/ml = B
- CIM superior a 50 ug/ml = C
- Cepa número:
- 3198 3236 2196 3224 3232 3317 1145 3206
- Fenotipo:
- Sensible Sensible Cipro R Tobra R Ceftaz. R Aztr. R MDR MDR
- Inhibidores de LpxC
- 12
- A A B A A A A A
- 481
- A A A A A A A A
- 19
- A A A A A A A A
- 516
- A A A A A A A A
- 280
- A A B A A A A A
- 366
- A A A A A A A A
- 777
- A A A A A A A A
- 315
- A A A A A A A A
- 779
- A A A A A A A A
- 801
- A A A A A A A A
- 13
- A A A A A A A A
- Agentes antibacterianos comparadores
- Tobramicina
- 2 0,5 2 64 1 2 8-32 64
- Aztreonam
- 1 0,5 1 1 1 64 >128 > 128
- Ceftazidima
- 2 0,25 2 2 64 4 >128 > 128
- Cefepima
- 4 2 2 8 2 8 >128 32
- Ciprofloxacina
- 1 0,06 > 8 2 2 0,5 4 >8
Tabla 5: Actividad antibacteriana frente a cepas aisladas clínicas de no FQ de P. aeruginosa y frente a otros patógenos Gram-negativos. Conjunto 1: organismos no fermentantes. P. aer., P. aeruginosa; Acinet. calc., Acinetobacter calcoaceticus; Alcal. xyl., Alcaligenes xylosoxidans; B. cep., Burkholderia cepacia; S. malt., Stenotrophomonas maltophilia Tabla 6: Actividad antibacteriana frente a cepas aisladas clínicas de no FQ de P. aeruginosa y frente a otros patógenos Gram-negativos, continuación. Conjunto 2: organismos entéricos. E. aer., Enterobacter aerogenes; E. clo., Enterobacter cloacae; E. coli, Escherichia coli; K. pneu., Klebsiella pneumoniae; K. oxy., Klebsiella oxytoca; P. mir., Proteus mirabilis; S. marc., Serratia marcescens.
- Clave de CIM CIM de 6,25 ug/ml o menos = A CIM superior a 6,25 ug/ml a 50 ug/ml = B CIM superior a 50 ug/ml = C
- Especies:
- P. aer 27853 P. aer. PAO1 P. aer 12307 P. aer psa6b Acinet. calc. Alcal. xyl. B. cepacia S. malt.
- Inhibidores de LpxC
- 12
- A A A A A A B A
- 481 *
- A A A A C C B C
- 19
- A A A A B B
- 516 *
- A A A C C C C
- 280 *
- A A A A C B B B
- 366 *
- A A A B C A B B
- 777
- A A B A B A C
- 315
- A A A A C B A A
- 779 *
- A A A C A A B
- 801
- A A A B C B C
- 13 *
- A A A C A A B
- Agentes antibacterianos comparadores
- Tobramicina
- 8 2 2 64 64/>128 0,5
- Aztreonam
- 16 32 32 32 64 >128/16
- Ceftazidima
- 4 64 16 1 8/4 1
- Cefepima
- 2 8 8 8 32/16 8/1
- Meropenem
- 0,5 0,25 4 0,5 4 64
- Pip/Tazo
- 4 >128 8 1 64 16
- Ciprofloxacina
- 0,5 2 0,5 0,5
- Clave de CIM
- CIM de 6,25 ug/ml o menos = A
- CIM superior a 6,25 ug/ml a 50 ug/ml = B
- CIM superior a 50 ug/ml = C
- Especies:
- E. aer. E. clo. E. coli 1619 E. coli 2788 K. pneu. K. oxy. P. mir. S. marc.
- Inhibidores de LpxC
- 12
- C A A A A A A A
- 481
- C A A A A A A A
- 19
- A A A A A A A A
- 516
- C B A B C C C A
- 280
- C A A A B C B B
- 366
- C A A A B B A A
- 777
- B A A A A A A A
- 315
- C A A A C C C B
- 779
- C A A A B B B A
- 801
- B A A A A A A A
- 13
- C A A A A A A A
- Agentes antibacterianos
- comparadores
- Tobramicina
- 64 0,06 16/64 0,06/2 64 1 2 2
- Aztreonam
- <= 0,13 128/64 <= 0,13/0,25 2 0,5 <= 0,13 <= 0,13
- Ceftazidima
- 32 0,25 > 128 0,25/<=0,13 8 0,25 <= 0,13 0,25
- Cefepima
- <= 0,13 4/<=0,13 <= 0,13 8 <= 0,13 <= 0,13 <= 0,13
- Meropenem
- 2 <= 0,06 0,25/0,13 <= 0,06 0,13 <= 0,06 0,5 0,13
- Pip/Tazo
- 2 > 128 1 > 128 2 0,25 1
- Ciprofloxacina
- > 8 0,015 2 0,03 0,06 0,03 0,03 0,25
Tabla 7: Resultado de estudios de combinación de fármacos (sinergia)
- Concentración mínima (mg/ml) requerida para inhibir el crecimiento de E. coli 25922
- Eritromicina
- Inhibidor de LpxC 925 *
- Inhibidor de LpxC 925 * solo
- - 6,25
- Eritromicina sola
- 128 -
- Inhibidor de LpxC 925 * + eritromicina
- 2 0,78
Cada uno de los compuestos de ejemplo de la Tabla 1 se sintetizó y se ensayó como se ha descrito anteriormente. Muchos de los compuestos de los Ejemplos 1-1307 mostraron un valor de CI50 inferior a 10 µM con respecto a LpxC. Muchos de estos compuestos mostraron un valor de CI50 inferior a o igual a 1 µM o inferior a o igual a 0,1 µM. Muchos de estos compuestos mostraron valores de CI50 inferiores a o iguales a 0,050 µM, inferiores a o iguales a 0,030 µM, inferiores a o iguales a 0,025 µM o inferiores a o iguales a 0,010 µM.
Debe entenderse que los compuestos orgánicos según la invención pueden presentar el fenómeno de tautomería. Como las estructuras químicas dentro de esta memoria descriptiva sólo pueden representar una de las posibles formas tautómeras, debe entenderse que la invención engloba cualquier forma tautómera de la estructura dibujada.
TABLA 1
- Ejemplo
- Estructura Nombre MH+
- 30
- 3,4-difluoro-N-{(1S,2R)-2-hidroxi-1[(hidroxiamino)carbonil]propil}benzamida 275,2
- 31
-
imagen72 (2S,3R)-N,3-dihidroxi-2-[(4-fenilbutanoil)amino]butanamida 281,3
- 32
- (2S,3R)-N,3-dihidroxi-2-({4-[4(metiloxi)fenil]butanoil}amino)butanamida 311.3
- 33
- N-{(1S,2R)-2-hidroxi-1-[(hidroxiamino)carbonil]propil}-5fenilpentanamida 295,3
- 34
- (2E,4E)-N-{(1S,2R)-2-hidroxi-1[(hidroxiamino)carbonil]propil}-5-fenilpenta-2,4-dienamida 291,3
- 35
- (2E)-N-{(1S,2R)-2-hidroxi-1-[(hidroxiamino)carbonil]propil}-3fenilprop-2-enamida 265,3
- 36
- ácido (2S,3R)-3-hidroxi-2-({(2E)-3-[4-(metiloxifenil]prop-2enoil}amino)butanoico 280,3
- 37
- (3R)-3-amino-N-{(1S,2R)-2-hidroxi-1[(hidroxiamino)carbonil]propil}-5-fenilpentanamida 310,4
- 38
- (2E)-3-(4-fluorofenil)-N-{(1S,2R)-2-hidroxi-1[(hidroxiamino)carbonil]propil}prop-2-enamida 283,3
- Ejemplo
- Estructura Nombre MH+
- 39
-
imagen73 (2E)-3-(3-bromofenil)-N-{(1S,2R)-2-hidroxi-1[(hidroxiamino)carbonil]propil}prop-2-enamida 344,2
- 40
- N-{(1S,2R)-2-hidroxi-1-[(hidroxiamino)carbonil]propil}-4-{[(2feniletil)amino]metil}benzamida 372,4
- 41
- N-{(1S,2R)-2-hidroxi-1-[(hidroxiamino)carbonil]propil}-4-{[(4fenilbutil)amino]metil}benzamida 400,5
- 42
- 4-[(ciclopropilamino)metil]-N-{(1S,2R)-2-hidroxi-1[(hidroxiamino)carbonil]propil}benzamida 308,3
- 43
- 4-[(hexilamino)metil]-N-{(1S,2R)-2-hidroxi-1[(hidroxiamino)carbonil]propil}benzamida 352,4
- 44
- N-{(1S,2R)-2-hidroxi-1-[(hidroxiamino)carbonil]propil}-4-{[(2piridin-2-iletil)amino]metil}benzamida 373,4
- 45
- N-{(1S,2R)-2-hidroxi-1-[(hidroxiamino)carbonil]propil}-4-(4metilpiperazin-1-il)benzamida 337,4
- 46
-
imagen74 N-{(1S,2R)-2-hidroxi-1-[(hidroxiamino)carbonil]propil}-4(piperidin 1-ilmetil)benzamida 336,4
- 47
- N-{(1S,2R)-2-hidroxi-1-[(hidroxiamino)carbonil]propil}-4(morfolin-4-ilmetil)benzamida 338,4
- 48
- N-{(1S,2R)-2-hidroxi-1-[(hidroxiamino)carbonil]propil}-4-({[3(2-oxopirrolidin-1-il)propil]amino}metil)benzamida 393,5
- Ejemplo
- Estructura Nombre MH+
- 49
-
imagen75 N-{(1S,2R)-2-hidroxi-1-[(hidroxiamino)carbonil]propil}-4-{[(3fenilpropil)amino]metil}benzamida 386,5
- 50
- (2S,5R)-N-{(1S,2R)-2-hidroxi-1[(hidroxiamino)carbonil]propil}-5-fenilpirrolidin-2-carboxamida 308,3
- 51
- (2R,5S)-N-{(1S,2R)-2-hidroxi-1[(hidroxiamino)carbonil]propil}-5-fenilpirrolidin-2-carboxamida 308,3
- 52
-
imagen76 (2S,3R)-2-{[(3S)-3-amino-4-fenilbutanoil]amino}-N,3dihidroxibutanamida 296,3
- 53
- (2S,3R)-2-{[(2S)-2-amino-4-fenilbutanoil]amino}-N,3dihidroxibutanamida 296,3
- 54
- N-{(1S,2R)-2-hidroxi-1-[(hidroxiamino)carbonil]propil}-6-(2pirrolidin-1-iletil)piridina-3-carboxamida 337,4
- 55
- ácido 2-{[(4′-etil-1,1′-bifenil-4-il)carbonil]amino}-3-hidroxi-3metilbutanoico 342,4
- 56
- ácido 2-{[4-(4-etilfenil)fenil]carbonilamino}-3-hidroxi-4metilpentanoico 356,4
- 57
- ácido {[(4′-etil-1,1′-bifenil-4-il)carbonil]amino}(tien-2-il)acético 366,5
- 58
- N-(2-{[(1,1-dimetiletil)oxi]amino}-2-oxo-1-tien-2-iletil)-4′-etil1,1′-bifenil-4-carboxamida 437,6
- Ejemplo
- Estructura Nombre MH+
- 59
-
imagen77 ácido 3-(dimetilamino)-2-{[(4′-etil-1,1′-bifenil-4il)carbonil]amino}propanoico 341,4
- 60
- 4′-etil-N-{(1S)-1-[({(1S,2R)-2-hidroxi-1[(hidroxiamino)carbonil]propil}amino) carbonil]-3-metilbutil}1,1′-bifenil-4-carboxamida 456,6
- 61
- 4′-etil-N-[(1S)-2-({(1S,2R)-2-hidroxi-1[(hidroxiamino)carbonil]propil}amino)-2-oxo-1-(fenilmetil)etil]1,1′-bifenil-4-carboxamida 490,6
- 62
- (2S)-1-[(4′-etil-1,1′-bifenil-4-il)carbonil]-N-{(1S,2R)-2-hidroxi-1[(hidroxiamino)carbonil]propil}pirrolidine-2-carboxamida 440,5
- 63
- 4′-etil-N-[(1S)-2-({(1S,2R)-2-hidroxi-1[(hidroxiamino)carbonil]propil}amino)-1-(1H-imidazol-4-ilmetil)2-oxoetil]-1,1′-bifenil-4-carboxamida 480,5
- 64
- (3S)-2-[(4′-etil-1,1′-bifenil-4-il)carbonil]-N-{(1S,2R)-2-hidroxi-1[(hidroxiamino)carbonil]propil}-1,2,3,4-tetrahidroisoquinoline3-carboxamida 502,6
- 65
-
imagen78 (2S)-2-[(1,1′-bifenil-4-ilacetil)amino]-N-{(1S,2R)-2-hidroxi-1[(hidroxiamino)carbonil]propil}-4-metilpentanamida 442,5
- 66
- (2S,3R)-2-({(2S)-2-[(1,1′-bifenil-4-ilacetil)amino]-3fenilpropanoil}amino)-N,3-dihidroxibutanamida 476,5
- 67
- (2S,3R)-2-{[(2S)-2-[(1,1′-bifenil-4-ilacetil)amino]-3-(4hidroxifenil)propanoil]amino}-N,3-dihidroxibutanamida 492,5
- 68
- (2S)-1-(1,1′-bifenil-4-ilacetil)-N-{(1S,2R)-2-hidroxi-1[(hidroxiamino)carbonil]propil}pirrolidine-2-carboxamida 426,5
- 69
- (2S,3R)-2-{[(2S)-2-[(1,1′-bifenil-4-ilacetil)amino]-3-(1Himidazol-4-il)propanoil]amino}-N,3-dihidroxibutanamida 466,5
- Ejemplo
- Estructura Nombre MH+
- 70
- (2S)-2-[(1,1′-bifenil-4-ilacetil)amino]-N~1~-{(1S,2R)-2-hidroxi1-[(hidroxiamino)carbonil]propil} pentanediamida 457,5
- 71
- ácido (3S)-3-[(1,1′-bifenil-4-ilacetil)amino]-4-({(1S,2R)-2hidroxi-1-[(hidroxiamino)carbonil]propil}amino)-4oxobutanoico 444,5
- 72
- (2S,4R)-1-[(4′-etil-1,1′-bifenil-4-il)carbonil]-4-hidroxi-N{(1S,2R)-2-hidroxi-1-[(hidroxiamino)carbonil]propil}pirrolidina2-carboxamida 456,5
- 73
- N-[(1S)-1-(aminometil)-2-({(1S,2R)-2-hidroxi-1[(hidroxiamino)carbonil]propil}amino)-2-oxoetil]-4′-etil-1,1′bifenil-4-carboxamida 429,5
- 74
- 4′-etil-N-{(1S)-1-[({(1S,2R)-2-hidroxi-1[(hidroxiamino)carbonil]propil}amino) carbonil]but-3-inil}-1,1′bifenil-4-carboxamida 438,5
- 75
- (2S,3R)-2-({(2S)-2-[(1,1′-bifenil-4ilacetil)amino]propanoil}amino)-N,3-dihidroxibutanamida 400,4
- 76
- (2S,4R)-1-(1,1′-bifenil-4-ilacetil)-4-hidroxi-N-{(1S,2R)-2hidroxi-1-[(hidroxiamino)carbonil]propil}pirrolidina-2carboxamida 442,5
- 77
- 4′-etil-N-{(1R,2R)-2-hidroxi-1-[(hidroxi {[(2hidroxietil)amino]carbonil}amino)metil] propil}-1,1′-bifenil-4carboxamida 416,5
- 78
- N-((2R,3R)-2-{[(4′-etil-1,1′-bifenil-4-il)carbonil]amino}-3hidroxibutil)-N-hidroximorfolina-4-carboxamida 442,5
- 79
- N-((2R,3R)-2-{[(4′-etil-1,1′-bifenil-4-il)carbonil]amino}-3hidroxibutil)-N-hidroxi-4-metilpiperazine-1-carboxamida 455,6
- 80
- N-((1R,2R)-1-{[[(ciclopropilamino)carbonil](hidroxi) amino]metil}-2-hidroxipropil)-4′-etil-1,1′-bifenil-4-carboxamida 412,5
- Ejemplo
- Estructura Nombre MH+
- 81
- 4′-etil-N-{(1R,2R)-2-hidroxi-1-[(hidroxi{[(piridin-3ilmetil)amino]carbonil}amino)metil] propil}-1,1′-bifenil-4carboxamida 463,5
- 82
- 4′-etil-N-{(1R,2R)-2-hidroxi-1-[(hidroxi{[(2-piridin-2iletil)amino]carbonil}amino)metil]propil} 1,1′-bifenil-4carboxamida 477,6
- 83
- 4′-etil-N-{(1R,2R)-2-hidroxi-1-[(hidroxi{[(4-morfolin-4ilfenil)amino]carbonil}amino)metil] propil}-1,1′-bifenil-4carboxamida 533,6
- 84
- N~1~-((2R,3R)-2-{[(4′-etil-1,1′-bifenil-4-il)carbonil]amino}-3hidroxibutil)-N~1~-hidroxipiperidine-1,4-dicarboxamida 483,6
- 85
- 4′-etil-N-[2-hidroxiamino)etil]-1,1′-bifenil-4-carboxamida 285,4
- 86
- N-{2-[(aminocarbonil)(hidroxi)amino]etil}-4′-etil-1,1′-bifenil-4carboxamida 328,4
- 87
- N-{2-[(aminocarbonotioil)(hidroxi)amino]etil}-4′-etil-1,1′-bifenil4-carboxamida 344,4
- 88
- N-{2-[({[2-(dimetilamino)etil]amino}carbonil) (hidroxi)amino]etil}-4′-etil-1,1′-bifenil-4-carboxamida 399,5
- 89
- N-{2-[{[(2-cianoetil)amino]carbonil}(hidroxi)amino] etil}-4′-etil1,1′-bifenil-4-carboxamida 381,4
- 90
- 4′-etil-N-[2-(hidroxi{[(2-hidroxietil)amino]carbonil}amino)etil]1,1′-bifenil-4-carboxamida 372,4
- 91
- N-(2-{[(4′-etil-1,1′-bifenil-4-il)carbonil]amino}etil)-Nhidroximorfolina-4-carboxamida 398,5
- Ejemplo
- Estructura Nombre MH+
- 92
- N-(2-{[(4′-etil-1,1′-bifenil-4-il)carbonil]amino}etil)-N-hidroxi-4metilpiperazina-1-carboxamida 411,5
- 93
-
imagen79 N~1~-(2-{[(4′-etil-1,1′-bifenil-4-il)carbonil]amino}etil)-N~1~hidroxipiperidine-1,4-dicarboxamida 439,5
- 94
- N-(2-{[(4′-etil-1,1′-bifenil-4-il)carbonil]amino}etil)-Nhidroxipirrolidina-1-carboxamida 382,5
- 95
- N-{2-[[(ciclopropilamino)carbonil](hidroxi) amino]etil}-4′-etil1,1′-bifenil-4-carboxamida 368,4
- 96
- 4′-etil-N-{2-[hidroxi({[2-(metiloxi)etil]amino}carboni)amino] etil}-1,1′-bifenil-4-carboxamida 386,5
- 97
- N-{2-[({[2-(acetilamino)etil]amino}carbonil)(hidroxi) amino]etil}4′-etil-1,1′-bifenil-4-carboxamida 413,5
- 98
- 4′-etil-N-{2-[hidroxi({[3-(2-oxopirrolidin-1il)propil]amino}carbonil)amino]etil}-1,1′-bifenil-4-carboxamida 453,6
- 99
- 4′-etil-N-[2-(hidroxi{[(3hidroxipropil)amino]carbonil}amino)etil]-1,1′-bifenil-4carboxamida 386,5
- 100
-
imagen80 4′-etil-N-{2-[hidroxi({[3-(metiloxi)propil]amino}carbonil)amino] etil}-1,1′-bifenil-4-carboxamida 400,5
- 101
-
imagen81 N-(2-{[(4′-etil-1,1′-bifenil-4-il)carbonil]amino}etil)-N-hidroxi-1,4′bipiperidina-1′-carboxamida 479,6
- 102
- 4′-etil-N-[2-(hidroxi{[(2-piridin-2iletil]amino]carbonil}amino)etil]-1,1′-bifenil-4-carboxamida 433,5
- Ejemplo
- Estructura Nombre MH+
- 103
- 4′-etil-N-[2-(hidroxi{[(piridin-3ilmetil)amino]carbonil}amino)etil]-1,1′-bifenil-4-carboxamida 419,5
- 104
-
imagen82 4′-etil-N-[2-(hidroxi{[(4-morfolin-4ilfenil)amino]carbonil}amino)etil]-1,1′-bifenil-4-carboxamida 489,6
- 105
-
imagen83 N-(2-{[(4′-etil-1,1′-bifenil-4-il)carbonil]amino}etil)-N,3dihidroxipiperidina-1-carboxamida 412,5
- 106
- N-{2-[{[(3-aminociclohexil)amino]carbonil}(hidroxi) amino]etil}4′-etil-1,1′-bifenil-4-carboxamida 425,5
- 107
- N-{2-[{[(2-aminoetil)amino]carbonil}(hidroxi)amino] etil}-4′-etil1,1′-bifenil-4-carboxamida 371,4
- 108
- N-{2-[{[(3-aminopropil)amino]carbonil}(hidroxi)amino] etil}-4′etil-1,1′-bifenil-4-carboxamida 385,5
- 109
- 1,1-dimetiletil 3-({[(2-{[(4′-etil-1,1′-bifenil-4il)carbonil]amino}etil)(hidroxi)amino] carbonil}amino)propilcarbamato 485,6
- 110
- 4′-etil-N-{2-[({[(4-fluorofenil)metil]amino}carbonil)(hidroxi) amino]etil}-1,1′-bifenil-4-carboxamida 436,5
- 111
- N-(2-{[(4′-etil-1,1′-bifenil-4-il)carbonil]amino}etil)-N-hidroxi-3[(trifluoroacetil)amino]pirrolidina-1-carboxamida 493,5
- 112
- N-{2-[{[(4-aminotien-3-il)amino]carbonil}(hidroxi)amino]etil}-4′etil-1,1′-bifenil-4-carboxamida 425,5
- 113
-
imagen84 4′-etil-N-(2-{hidroxi[(piperidin-3-ilamino)carbonil]amino}etil)1,1′-bifenil-4-carboxamida 411,5
- Ejemplo
- Estructura Nombre MH+
- 114
- 4′-etil-N-(2-{hidroxi[(piperidin-4-ilamino)carbonil]amino}etil)1,1′-bifenil-4-carboxamida 411,5
- 115
- 4′-etil-N-[2-(hidroxi{[(piperidin-2ilmetil)amino]carbonil}amino)etil]-1,1′-bifenil-4-carboxamida 425,5
- 116
- 4′-etil-N-[2-(hidroxi{[(piperidin-3ilmetil)amino]carbonil}amino)etil]-1,1′-bifenil-4-carboxamida 425,5
- 117
-
imagen85 3-amino-N-(2-{[(4′-etil-1,1′-bifenil-4-il)carbonil]amino}etil)-Nhidroxipirrolidina-1-carboxamida 397,5
- 118
- 1,1-dimetiletil 3-[({[(2-{[(4′-etil-1,1′-bifenil-4il)carbonil]amino}etil)(hidroxi)amino] carbonil}amino)metil]piperidina-1-carboxilate 525,7
- 119
- 1,1-dimetiletil 1-{[(2-{[(4′-etil-1,1′-bifenil-4il)carbonil]amino}etil)(hidroxi)amino] carbonil}pirrolidin-3ilcarbamato 497,6
- 120
- 4′-etil-N-[(1S,2R)-2-hidroxi-1-({[2(hidroxiamino)etil]amino}carbonil)propil]-1,1′-bifenil-4carboxamida 386,5
- 121
- N-{(1S,2R)-1-[({2-[(aminocarbonil)(hidroxi)amino]etil}amino) carbonil]-2-hidroxipropil}-4′-etil-1,1′-bifenil-4-carboxamida 429,5
- 122
- N-{(1S,2R)-1-[({2-[(aminocarbonotioil)(hidroxi)amino]etil} amino)carbonil]-2-hidroxipropil}-4′-etil-1,1′-bifenil-4carboxamida 445,6
- 123
- 4′-etil-N-[(1S,2R)-2-hidroxi-1-({[2-(hidroxi{[(2-hidroxietil) amino]carbonil}amino)etil]amino} carbonil)propil]-1,1′-bifenil-4carboxamida 473,5
- 124
- 4′-etil-N-{(1S)-6-hidroxi-1-[(1R)-1-hidroxietil]-2,7-dioxo-11-oxa3,6,8-triazadodec-1-il}-1,1′-bifenil-4-carboxamida 487,6
- Ejemplo
- Estructura Nombre MH+
- 125
- 4′-etil-N-{(1S)-6-hidroxi-1-[(1R)-1-hidroxietil]-11-metil-2,7dioxo-3,6,8,11-tetraazadodec-1-il}-1,1′-bifenil-4-carboxamida 500,6
- 126
- 4′-etil-N-{(1S)-6-hidroxi-1-[(1R)-1-hidroxietil]-2,7,12-trioxo3,6,8,11-tetraazatridec-1-il}-1,1′-bifenil-4-carboxamida 514,6
- 127
- 4′-etil-N-{(1S,2R)-2-hidroxi-1-[({2-[hidroxi({[3-(2-oxopirrolidin1-il)propil]amino}carbonil)amino]etil} amino)carbonil]propil}1,1′-bifenil-4-carboxamida 554,7
- 128
- N-{(1S,2R)-1-[({2-[{[(2-cianoetil)amino]carbonil}(hidroxi)amino] etil}amino)carbonil]-2-hidroxipropil}-4′-etil-1,1′-bifenil-4carboxamida 482,6
- 129
- N-{(1S,2R)-1-[({2-[[(ciclopropilamino)carbonil](hidroxi) amino]etil}amino)carbonil]-2-hidroxipropil}-4′-etil-1,1′-bifenil-4carboxamida 469,6
- 130
-
imagen86 N-{2-[((2S,3R)-2-{[(4′-etil-1,1′-bifenil-4-il)carbonil]amino}-3hidroxibutanoil)amino]etil}-N-hidroxipirrolidina-1-carboxamida 483,6
- 131
- N-{2-[((2S,3R)-2-{[(4′-etil-1,1′-bifenil-4-il)carbonil]amino}-3hidroxibutanoil)amino]etil}-N-hidroximorfolina-4-carboxamida 499,6
- 132
- N-{2-[((2S,3R)-2-{[(4′-etil-1,1′-bifenil-4-il)carbonil]amino}-3hidroxibutanoil)amino]etil}-N-hidroxi-4-metilpiperazina-1carboxamida 512,6
- 133
- 4′-etil-N-[(1S,2R)-2-hidroxi-1-({[2-(hidroxi{[(piridin-3ilmetil)amino]carbonil}amino)etil]amino} carbonil)propil]-1,1′bifenil-4-carboxamida 520,6
- 134
- 4′-etil-N-[(1S,2R)-2-hidroxi-1-({[2-(hidroxi{[(2-piridin-2iletil)amino]carbonil}amino)etil]amino} carbonil)propil]-1,1′bifenil-4-carboxamida 534,6
- 135
- 3-cloro-N-{(1S,2S)-2-hidroxi-1-[(hidroxiamino)carbonil]propil}4-[(trifluorometil)oxi]benzamida 357,7
- Ejemplo
- Estructura Nombre MH+
- 136
- N-{(1S,2R)-2-hidroxi-1-[(hidroxiamino)carbonil]propil}-4-{[(3nitrofenil)metil]oxi}benzamida 390,4
- 137
- (4R)-2-(4-fluoro-3-prop-2-enilfenil)-N-hidroxi-4,5-dihidro-1,3oxazol-4-carboxamida 265,3
- 138
-
imagen87 3-fluoro-N-{(1S,2R)-2-hidroxi-1-[(hidroxiamino)carbonil]propil}4-(metiloxi)benzamida 287,3
- 139
- 4-(but-3-eniloxi)-N-{(1S,2R)-2-hidroxi-1[(hidroxiamino)carbonil]propil}benzamida 309,3
- 140
- 3-bromo-5-fluoro-N-{(1S,2R)-2-hidroxi-1[(hidroxiamino)carbonil]propil}4-(prop-2-eniloxi)benzamida 392,2
- 141
- 4-fluoro-N-{(1S,2S)-2-hidroxi-1-[(hidroxiamino)carbonil]propil}3-prop-2-enilbenzamida 297,3
- 142
- N-{(1S,2R)-2-hidroxi-1-[(hidroxiamino)carbonil]propil}-4-(prop2-eniloxi)-3-(trifluorometil)benzamida 363,3
- 143
- N-{(1S,2R)-2-hidroxi-1-[(hidroxiamino)carbonil]propil}-4(metiloxi)benzamida 269,3
- 144
- N-{(1S,2R)-2-hidroxi-1-[(hidroxiamino)carbonil]propil}-3(feniloxi)benzamida 331,3
- 145
- N-{(1S,2R)-2-hidroxi-1-[(hidroxiamino)carbonil]propil}-4(metiloxi)-3-[(trifluorometil)oxi]benzamida 353,3
- Ejemplo
- Estructura Nombre MH+
- 146
- N-{(1S,2S)-2-hidroxi-1-[(hidroxiamino)carbonil]propil}-4[(trifluorometil)oxi]benzamida 323,2
- 147
- N-{(1S,2R)-2-hidroxi-1-[(hidroxiamino)carbonil]propil}-4[(trifluorometil)oxi]benzamida 323,2
- 148
- N-{(1S,2R)-2-hidroxi-1-[(hidroxiamino)carbonil]propil}-4(trifluorometil)benzamida 307,2
- 149
-
imagen88 3,4-difluoro-N-{(2R)-2-hidroxi-1[(hidroxiamino)carbonil]propil}benzamida 275,2
- 150
- N-{(1S,2S)-2-hidroxi-1-[(hidroxiamino)carbonil]propil}-4(metiloxi)benzamida 269,3
- 151
- N-{(1S,2R)-2-hidroxi-1-[(hidroxiamino)carbonil]propil}-4′propil-1,1′-bifenil-4-carboxamida 357,4
- 152
- N-{(1S,2R)-2-hidroxi-1-[(hidroxiamino)carbonil]propil}-4′propil-1,1′-bifenil-4-carboxamida 357,4
- 153
- N-{(1S,2R)-2-hidroxi-1-[(hidroxiamino)carbonil]propil}-4[trifluoro(metilidene)-lambda~6~-sulfanil]benzamida 341,3
- 154
- N-{(1S,2R)-2-hidroxi-1[(hidroxiamino)carbonil]propil}benzamida 239,2
- 155
- N-{(1S,2R)-2-hidroxi-1-[(hidroxiamino)carbonil]propil}-1,1'bifenil-4-carboxamida 315,3
- Ejemplo
- Estructura Nombre MH+
- 156
- 3-bromo-N-{(1S,2R)-2-hidroxi-1[(hidroxiamino)carbonil]propil}-4-(metiloxi)benzamida 348,2
- 157
- 4-fluoro-N-{(1S,2R)-2-hidroxi-1-[(hidroxiamino)carbonil]propil}3-(prop-2-eniloxi)benzamida 313,3
- 158
- 2,3,5,6-tetrafluoro-N-{(1S,2R)-2-hidroxi-1[(hidroxiamino)carbonil]propil}-4-prop-2-enilbenzamida 351,3
- 159
- 3-fluoro-N-{(1S,2R)-2-hidroxi-1-[(hidroxiamino)carbonil]propil}5-(trifluorometil)benzamida 325,2
- 160
- 4-bromo-2-fluoro-N-{(1S,2R)-2-hidroxi-1[(hidroxiamino)carbonil]propil}benzamida 336,1
- 161
- N-{(1S,2R)-2-hidroxi-1-[(hidroxiamino)carbonil]propil}-4(feniloxi)benzamida 331,3
- 162
- 4-(dimetilamino)-N-{(1S,2R)-2-hidroxi-1[(hidroxiamino)carbonil]propil}benzamida 282,3
- 163
-
imagen89 2-[3-fluoro-4-(metiloxi)-5-prop-2-enilfenil]-N-hidroxi-4,5dihidro-1,3-oxazol-4-carboxamida 295,3
- 164
-
imagen90 N-{(1S,2R)-2-hidroxi-1-[(hidroxiamino)carbonil]propil}-5-[3(trifluorometil)fenil]furan-2-carboxamida 373,3
- Ejemplo
- Estructura Nombre MH+
- 165
- 4-{[(1E)-1,2-difluorobuta-1,3-dienil]oxi}-N-{(1S,2R)-2-hidroxi1-[(hidroxiamino)carbonil]propil}benzamida 343,3
- 166
- N-{(1S,2R)-2-hidroxi-1-[(hidroxiamino)carbonil]propil}quinolin2-carboxamida 290,3
- 167
- N-[2-(hidroxiamino)-1-(hidroximetil)-2-oxoetil]-1,1′-bifenil-4carboxamida 301,3
- 168
- N-{(1S,2S)-2-hidroxi-1-[(hidroxiamino)carbonil]propil}-1,1'bifenil-4-carboxamida 315,3
- 169
- N-{(1S,2R)-2-hidroxi-1-[(hidroxiamino)carbonil]propil}-2'-metil1,1'-bifenil-4-carboxamida 329,4
- 170
- N-{(1S,2S)-2-hidroxi-1-[(hidroxiamino)carbonil]propil}-4(trifluorometil)benzamida 307,2
- 171
- 4-fluoro-N-{(1S,2R)-2-hidroxi-1-[(hidroxiamino)carbonil]propil}3-(trifluorometil)benzamida 325,2
- 172
- N-{(1S,2R)-2-hidroxi-1-[(hidroxiamino)carbonil]propil}-4-{[(3nitrofenil)oxi]metil}benzamida 390,4
- 173
-
imagen91 N-[(1R)-2-(hidroxiamino)-1-(mercaptometil)-2-oxoetil]-4[(trifluorometil)oxi]benzamida 325,3
- 174
- N-{(1S,2R)-2-hidroxi-1-[(hidroxiamino)carbonil]propil}-1,3benzodioxol-5-carboxamida 283,3
- Ejemplo
- Estructura Nombre MH+
- 175
- N-{(1S,2R)-2-hidroxi-1-[(hidroxiamino)carbonil]propil}-6(bifluorometil)piridina-3-carboxamida 308,2
- 176
- N-{3-hidroxi-1-[(hidroxiamino)carbonil]propil}-4[(trifluorometil)oxi]benzamida 323,2
- 177
- N-{3-hidroxi-1-[(hidroxiamino)carbonil]propil}-1,1′-bifenil-4carboxamida 315,3
- 178
- N-{(1S,2R)-2-hidroxi-1-[(hidroxiamino)carbonil]propil}-4[hidroxi(fenil)metil]benzamida 345,4
- 179
- N-{(1S,2R)-2-hidroxi-1-[(hidroxiamino)carbonil]propil}-[({4[(trifluorometil)oxi]fenil}oxi) metil]benzamida 429,4
- 180
-
imagen92 4-[({4-bromo-2-[(trifluorometil)oxi]fenil}oxi)metil]-N-{(1S,2R)2-hidroxi-1-[(hidroxiamino)carbonil]propil}benzamida 508,3
- 181
-
imagen93 N-{(1S,2R)-2-hidroxi-1-[(hidroxiamino)carbonil]propil}-3′-nitro1,1′-bifenil-4-carboxamida 360,3
- 182
-
imagen94 4-bromo-N-{(1S,2R)-2-hidroxi-1[(hidroxiamino)carbonil]propil}benzamida 318,1
- 183
-
imagen95 N-{(1S,2R)-2-hidroxi-1-[(hidroxiamino)carbonil]propil}-4'(metiloxi)-1,1'-bifenil-4-carboxamida 345,4
- Ejemplo
- Estructura Nombre MH+
- 184
- N-{(1S,2R)-2-hidroxi-1-[(hidroxiamino)carbonil]propil}-4'[(trifluorometil)oxi)-1,1'-bifenil-4-carboxamida 399,3
- 185
- 4'-(etiloxi)-N-{(1S,2R)-2-hidroxi-1[(hidroxiamino)carbonil]propil}-1,1'-bifenil-4-carboxamida 359,4
- 186
- N-{(1S,2R)-2-hidroxi-1-[(hidroxiamino)carbonil]propil}-4-{5[(Z)-(hidroxiimino)metil]tien-2-il}benzamida 364,4
- 187
- 3′-(etiloxi)-N-{(1S,2R)-2-hidroxi-1[(hidroxiamino)carbonil]propil}-1,1′-bifenil-4-carboxamida 359,4
- 188
-
imagen96 (2R,3R)-N,3-dihidroxi-1-({4-[(trifluorometil)oxi]fenil}carbonil) pirrolidina-2-carboxamida 335,2
- 189
-
imagen97 N-[2-(hidroxiamino)-1-(hidroximetil)-2-oxoetil]-3-(1-metiletil)-4(metiloxi)benzamida 297,3
- 190
- N-[2-(hidroxiamino)-1-(hidroximetil)-2-oxoetil]-3-(1-metiletil)-4(prop-2-eniloxi)benzamida 323,4
- 191
- N-[2-(hidroxiamino)-1-(hidroximetil)-2-oxoetil]-4-(metiloxi)-3propilbenzamida 297,3
- 192
- N-{(1S,2R)-2-hidroxi-1-[(hidroxiamino)carbonil]propil}-4′(metiltio)-1,1′-bifenil-4-carboxamida 361,4
- Ejemplo
- Estructura Nombre MH+
- 193
- 5-bromo-N-{(1S,2R)-2-hidroxi-1[(hidroxiamino)carbonil]propil}tiofeno-2-carboxamida 324,2
- 194
- N-{(1S,2R)-2-hidroxi-1-[(hidroxiamino)carbonil]propil}-5-{4[(trifluorometil)oxi]fenil}tiofeno-2-carboxamida 405,4
- 195
- N-{(1S,2R)-2-hidroxi-1-[(hidroxiamino)carbonil]propil}-1benzofurano-2-carboxamida 279,3
- 196
- N-{(1S,2R)-2-hidroxi-1-[(hidroxiamino)carbonil]propil}-5feniltiofeno-2-carboxamida 321,4
- 197
- 4'-(dimetilamino)-N-{(1S,2R)-2-hidroxi-1[(hidroxiamino)carbonil]propil}-1,1'-bifenil-4-carboxamida 358,4
- 198
- (2S,3R)-N,3-dihidroxi-2-[({2[(trifluorometil)oxi]fenil}acetil)amino] butanamida 337,3
- 199
-
imagen98 5-[4-(etiloxi)fenil]-N-{(1S,2R)-2-hidroxi-1[(hidroxiamino)carbonil]propil}tiofeno-2-carboxamida 365,4
- 200
- 5-[3-(etiloxi)fenil]-N-{(1S,2R)-2-hidroxi-1[(hidroxiamino)carbonil]propil}tiofeno-2-carboxamida 365,4
- 201
- (4R)-N-hidroxi-2-{2′-[(trifluorometil)oxi]-1,1′-bifenil-4-il}-4,5dihidro-1,3-oxazol-4-carboxamida 367,3
- Ejemplo
- Estructura Nombre MH+
- 202
- N-{(1S,2R)-2-hidroxi-1-[(hidroxiamino)carbonil]propil}-4'(hidroximetil)-1,1'-bifenil-4-carboxamida 345,4
- 203
- N-{(1S,2R)-2-hidroxi-1-[(hidroxiamino)carbonil]propil}-4-{5-[(4metilpiperazin-1-il)metil]tien-2-il}benzamida 433,5
- 204
- N-{(1S,2R)-2-hidroxi-1-[(hidroxiamino)carbonil]propil}-4-{[4(metiloxi)fenil]carbonil}benzamida 373,4
- 205
- N-{(1S,2R)-2-hidroxi-1-[(hidroxiamino)carbonil]propil}-4-[(E)fenildiazenil]benzamida 343,4
- 206
- (4R)-N-hidroxi-2-{4-(metiloxi)-3-[(trifluorometil)oxi]fenil}-4,5dihidro-1,3-oxazol-4-carboxamida 321,2
- 207
- 4'-etil-N-{(1S,2R)-2-hidroxi-1-[(hidroxiamino)carbonil]propil}1,1'-bifenil-4-carboxamida 343,4
- 208
- N-{(1S,2R)-2-hidroxi-1-[(hidroxiamino)carbonil]propil}-4'(trifluorometil)-1,1'-bifenil-4-carboxamida 383,3
- 209
- 5-(4-etilfenil)-N-{(1S,2R)-2-hidroxi-1[(hidroxiamino)carbonil]propil}tiofeno-2-carboxamida 349,4
- 210
- N-{(1S,2R)-2-hidroxi-1-[(hidroxiamino)carbonil]propil}-5-[4(metiloxi)fenil]tiofeno-2-carboxamida 351,4
- 211
- N-{(1S,2R)-2-hidroxi-1-[(hidroxiamino)carbonil]propil}-5-[4(metiltio)fenil]tiofeno-2-carboxamida 367,5
- Ejemplo
- Estructura Nombre MH+
- 212
- N-{(1S,2R)-2-hidroxi-1-[(hidroxiamino)carbonil]propil}-5-(3nitrofenil)tiofeno-2-carboxamida 366,4
- 213
-
imagen99 N-{(1S,2R)-2-hidroxi-1-[(hidroxiamino)carbonil]propil}-4-oxo4H-cromeno-2-carboxamida 307,3
- 214
-
imagen100 N-[1-[(hidroxiamino)carbonil]-1-(hidroximetil)-2-metilpropil]-4[(trifluorometil)oxi]benzamida 351,3
- 215
- N-[2-hidroxi-3-(hidroxiamino)-3-oxopropil]-1,1′-bifenil-4carboxamida 301,3
- 216
- N-{(1S,2R)-2-hidroxi-1-[(hidroxiamino)carbonil]propil}-4-[(E)-2feniletenil]benzamida 341,4
- 217
- N-{(1S,2R)-2-hidroxi-1-[(hidroxiamino)carbonil]propil}-9Hfluoreno-2-carboxamida 327,4
- 218
- ácido 4'-[({(1S,2R)-2-hidroxi-1[(hidroxiamino)carbonil]propil}amino)carbonil]-1,1'-bifenil-4carboxílico 359,3
- 219
-
imagen101 N-[2-(hidroxiamino)-1-(hidroximetil)-2-oxoetil]-4-(prop-2eniloxi)-3-propilbenzamida 323,4
- 220
- N-{(1S,2R)-2-hidroxi-1-[(hidroxiamino)carbonil]propil}-4iodobenzamida 365,1
- 221
-
imagen102 4'-hidroxi-N-{(1S,2R)-2-hidroxi-1[(hidroxiamino)carbonil]propil}-1,1'-bifenil-4-carboxamida 331,3
- Ejemplo
- Estructura Nombre MH+
- 222
- 6-bromo-N-{(1S,2R)-2-hidroxi-1[(hidroxiamino)carbonil]propil}piridina-2-carboxamida 319,1
- 223
- N-{(1S,2R)-2-hidroxi-1-[(hidroxiamino)carbonil]propil}-6fenilpiridina-2-carboxamida 316,3
- 224
- 4′-butil-N-{(1S,2R)-2-hidroxi-1-[(hidroxiamino)carbonil]propil}1,1′-bifenil-4-carboxamida 371,4
- 225
- 4′-(1,1-dimetiletil)-N-{(1S,2R)-2-hidroxi-1[(hidroxiamino)carbonil]propil}-1,1′-bifenil-4-carboxamida 371,4
- 226
-
imagen103 N-{(1S,2R)-2-hidroxi-1-[(hidroxiamino)carbonil]propil}-5-[3(metiloxi)fenil]tiofeno-2-carboxamida 351,4
- 227
- 4′-[({(1S,2R)-2-hidroxi-1-[(hidroxiamino)carbonil]propil}amino) carbonil]-1,1′-bifenil-4-il dihidrogen phosphate 411,3
- 228
- N-etil-N′-{(1S,2R)-2-hidroxi-1-[(hidroxiamino)carbonil]propil}1,1′-bifenil-4,4′-dicarboxamida 386,4
- 229
- N-[(1S,2R)-1-(hidrazinocarbonil)-2-hidroxipropil]-4′-propil-1,1′bifenil-4-carboxamida 356,4
- 230
- N-{(1S,2R)-2-hidroxi-1-[(metilamino)carbonil]propil}-4′-propil1,1′ bifenil-4-carboxamida 355,4
- Ejemplo
- Estructura Nombre MH+
- 231
- N-[(1S,2R)-1-(hidrazinocarbonil)-2-hidroxipropil]-4(metiloxi)benzamida 268,3
- 232
- (2S,3R)-2-[(1,1′-bifenil-4-ilsulfonil)amino]-N,3dihidroxibutanamida 351,4
- 233
- 4-hidroxi-N-{(1S,2R)-2-hidroxi-1[(hidroxiamino)carbonil]propil}benzamida 255,2
- 234
- 3′-ciano-N-{(1S,2R)-2-hidroxi-1[(hidroxiamino)carbonil]propil}-1,1′-bifenil-4-carboxamida 340,3
- 235
- 1,1-dimetiletil ({4-[({(1S,2R)-2-hidroxi-1[(hidroxiamino)carbonil]propil}amino) carbonil]fenil}oxi)acetato 369,4
- 236
- (2S,3R)-2-[(1,1′-bifenil-4-ilsulfonil)(metil)amino]-N,3dihidroxibutanamida 365,4
- 237
- N-{(1S,2R)-2-hidroxi-1-[(hidroxiamino)carbonil]propil}-3′-[(Z)(hidroxiimino)metil]-4′-(metiloxi)-1,1′-bifenil-4-carboxamida 388,4
- 238
- N-{(1S,2R)-2-hidroxi-1-[(hidroxiamino)carbonil]propil}-4[(fenilcarbonil)amino]benzamida 358,4
- 239
- N-hidroxi-2-[3-(1-metiletil)-4-(prop-2-eniloxi)fenil]-4,5-dihidro1,3-oxazol-4-carboxamida 305,3
- 240
- 4′-butil-N-{(1S,2R)-2-hidroxi-1-[(metilamino)carbonil]propil}1,1′-bifenil-4-carboxamida 369,5
- Ejemplo
- Estructura Nombre MH+
- 241
- N-{(1S,2R)-2-hidroxi-1-[(hidroxiamino)carbonil]propil}-4-(5metilpiridin-2-il)benzamida 330,4
- 242
- 5-bromo-N-{(1S,2R)-2-hidroxi-1[(hidroxiamino)carbonil]propil}piridina-3-carboxamida 319,1
- 243
-
imagen104 N-{(1S,2R)-2-hidroxi-1-[(hidroxiamino)carbonil]propil}-4piridin-3-ilbenzamida 316,3
- 244
- N-{(1R,2R)-2-hidroxi-1-[(hidroxiamino)carbonil]propil}-N′{(1S,2R)-2-hidroxi-1-[(hidroxiamino)carbonil]propil}-1,1′bifenil-4,4′-dicarboxamida 475,5
- 245
- (2S,3R)-N,3-dihidroxi-2-[({4-[(E)-2-feniletenil]fenil}metil)amino] butanamida 327,4
- 246
- 4-{[(4-bromofenil)sulfonil]amino}-N-{(1S,2R)-2-hidroxi-1[(hidroxiamino)carbonil]propil}benzamida 473,3
- 247
- 1,1-dimetiletil 4-({4-[({(1S,2R)-2-hidroxi-1-[(hidroxiamino) carbonil]propil}amino)carbonil] fenil}amino)-4oxobutilcarbamato 439,5
- 248
- 4-[(4-aminobutanoil)amino]-N-{(1S,2R)-2-hidroxi-1[(hidroxiamino)carbonil]propil}benzamida 339,4
- 249
- 1,1-dimetiletil {4′-[({(1S,2R)-2-hidroxi-1[(hidroxiamino)carbonil]propil}amino) metil]-1,1′-bifenil-4il}metilcarbamato 430,5
- 250
- N-{(1S,2R)-2-hidroxi-1-[(hidroxiamino)carbonil]propil}-4pyrimidin 5-ilbenzamida 317,3
- 251
- 1,1-dimetiletil 5-{4-[({(1S,2R)-2-hidroxi-1[(hidroxiamino)carbonil]propil}amino) carbonil]fenil}piridina-3carboxilate 416,4
- Ejemplo
- Estructura Nombre MH+
- 252
- ácido 5-{4-[({(1S,2R)-2-hidroxi-1[(hidroxiamino)carbonil]propil}amino) carbonil]fenil}piridina-3carboxilico 360,3
- 253
- (4S)-N-hidroxi-2-{4-(metiloxi)-3-[(trifluorometil)oxi]fenil}-4,5dihidro-1,3-oxazol-4-carboxamida 321,2
- 254
- (2S,3R)-2-({[4′-(aminometil)-1,1′-bifenil-4-il]metil}amino)-N,3dihidroxibutanamida 330,4
- 255
- (3S)-1-hidroxi-3-[(1R)-1-hidroxietil]-4-({4-[(E)-2feniletenil]fenil}metil)piperazina-2,6-diona 367,4
- 256
- (2S,3R)-N,3-dihidroxi-2-({[4-(feniletinil)fenil]metil}amino) butanamida 325,4
- 257
- N-(3-aminopropil)-N′-{(1S,2R)-2-hidroxi-1[(hidroxiamino)carbonil]propil}benzene-1,4-dicarboxamida 339,4
- 258
- N-{(1S,2R)-2-hidroxi-1-[(hidroxiamino)carbonil]propil}-4(propanoilamino)benzamida 310,3
- 259
- 1,1-dimetiletil 3-[({4-[({(1S,2R)-2-hidroxi-1-[(hidroxiamino) carbonil]propil}amino)carbonil] fenil}carbonil)amino]propilcarbamato 439,5
- 260
- N-{(1S,2R)-2-hidroxi-1-[(hidroxiamino)carbonil]propil}-4′(feniloxi)-1,1′-bifenil-4-carboxamida 407,4
- Ejemplo
- Estructura Nombre MH+
- 261
- N-[(1S,2R)-1-({[ciano(fenil)metil]amino}carbonil)-2hidroxipropil]-4′-hidroxi-1,1′-bifenil-4-carboxamida 430,5
- 262
- 4′-{[2-(hidroxiamino)-2-oxoetil]oxi}-N-{(1S,2R)-2-hidroxi-1[(hidroxiamino)carbonil]propil}-1,1′-bifenil-4-carboxamida 404,4
- 263
-
imagen105 4′-({[(1S,2R)-1-{[(cianometil)amino]carbonil}-2(propanoiloxi)propil]amino}carbonil)-1,1′-bifenil-4-il propanoato 466,5
- 264
- 4′-({[(1S,2R)-1-{[(cianometil)(propanoil)amino]carbonil}-2(propanoiloxi)propil]amino}carbonil)-1,1′-bifenil-4-il propanoato 522,6
- 265
- N-((1S,2R)-1-{[(cianometil)amino]carbonil}-2-hidroxipropil)-4′hidroxi-1,1′-bifenil-4-carboxamida 354,4
- 266
- (2S,3S)-2-[(1,1′-bifenil-4-ilmetil) amino]-N,3dihidroxibutanamida 301,4
- 267
- N-{2-hidroxi-1-[(hidroxiamino)carbonil]-2-feniletil}-1,1′-bifenil4-carboxamida 377,4
- 268
- (2S,3R)-2-[(difenilacetil)amino]-N,3-dihidroxibutanamida 329,4
- 269
- N-{(1S,2R)-2-hidroxi-1-[(hidroxiamino)carbonil]propil}-6[(fenilmetil)tio]piridina-3-carboxamida 362,4
- Ejemplo
- Estructura Nombre MH+
- 270
- N,3-dihidroxi-2-({[4-(feniloxi)fenil]metil}amino)butanamida 317,4
- 271
- N-{(1S,2R)-2-hidroxi-1-[(hidroxiamino)carbonil]propil)-2′[(trifluorometil)oxi]-1,1′-bifenil-4-carboxamida 399,3
- 272
- (2R,3S)-2-[(1,1′-bifenil-4-ilmetil)amino]-N,3dihidroxibutanamida 301,4
- 273
-
imagen106 ácido 4-[({(1S,2R)-2-hidroxi-1[(hidroxiamino)carbonil]propil}amino) carbonil]benzoico 283,3
- 274
- 1,1-dimetiletil 4-[({(1S,2R)-2-hidroxi-1[(hidroxiamino)carbonil]propil}amino) carbonil]benzoato 339,4
- 275
- ácido (4R)-4-{[(4′-etil-1,1′-bifenil-4-il)carbonil]amino}-5(hidroxiamino)-5-oxopentanoico 371,4
- 276
- 4′-etil-N-[(1R)-2-(hidroxiamino)-1-(hidroximetil)-2-oxoetil]-1,1′bifenil-4-carboxamida 329,4
- 277
- 4′-etil-N-[(1S)-2-(hidroxiamino)-1-(hidroximetil)-2-oxoetil]-1,1′bifenil-4-carboxamida 329,4
- 278
- (2S)-1-[(4′-etil-1,1′-bifenil-4-il)carbonil]-N,4-dihidroxipirrolidina2-carboxamida 355,4
- 279
- 4′-etil-N-{(1S)-1-[(hidroxiamino)carbonil]but-3-inil}-1,1′-bifenil4-carboxamida 337,4
- Ejemplo
- Estructura Nombre MH+
- 280
- N-[(1S)-1-(aminometil)-2-(hidroxiamino)-2-oxoetil]-4'-etil-1,1'bifenil-4-carboxamida 328,4
- 281
- N-{(1S)-1-[(hidroxiamino)carbonil]-2-metilpropil)-1,1′-bifenil-4carboxamida 313,4
- 282
- N-{(1S,2R)-2-hidroxi-1-[(hidroxiamino)carbonil]propil}-N-metil1,1′-bifenil-4-carboxamida 329,4
- 283
-
imagen107 4-etinil-N-{(1S,2R)-2-hidroxi-1[(hidroxiamino)carbonil]propil}benzamida 263,3
- 284
- 4-(1,3-benzodioxol-5-il)-N-{(1S,2R)-2-hidroxi-1[(hidroxiamino)carbonil]propil}benzamida 359,3
- 285
- N-{(1R,2S)-2-hidroxi-1-[(hidroxiamino)carbonil]propil}-4′propil-1,1′-bifenil-4-carboxamida 357,4
- 286
- 2-({[3′-(etiloxi)-1,1′-bifenil-4-il]metil}amino)-N,3dihidroxibutanamida 345,4
- 287
- N-{(1S,2R)-2-hidroxi-1-[(hidroxiamino)carbonil]propil}-3′,4′bis(metiloxi)-1,1′-bifenil-4-carboxamida 375,4
- 288
- 3′-formil-N-{(1S,2R)-2-hidroxi-1[(hidroxiamino)carbonil]propil)-4′-(metiloxi)-1,1′-bifenil-4carboxamida 373,4
- 289
- N-{(1S,2R)-2-hidroxi-1-[(hidroxiamino)carbonil]propil}-4-(4-{4[({(1S,2R)-2-hidroxi-1-[(hidroxiamino)carbonil]propil}amino) carbonil]fenil}buta-1,3-diinil)benzamida 523,5
- 290
- (2S,3R)-2-({[4′-(etiloxi)-1,1′-bifenil-4-il]metil}amino)-N,3dihidroxibutanamida 345,4
- Ejemplo
- Estructura Nombre MH+
- 291
- 3′-cloro-N-{(1S,2R)-2-hidroxi-1-[(hidroxiamino)carbonil]propil}4′-(metiloxi)-1,1′-bifenil-4-carboxamida 379,8
- 292
-
imagen108 (1R,2R)-N-{(1S,2R)-2-hidroxi-1[(hidroxiamino)carbonil]propil}-2fenilciclopropanecarboxamida 279,3
- 293
- N-{(1S,2R)-2-hidroxi-1-[(hidroxiamino)carbonil]propil}-4-(1Hpyrrol-1-il)benzamida 304,3
- 294
-
imagen109 N-{(1S,2R)-2-hidroxi-1-[(hidroxiamino)carbonil]propil}-4propilbenzamida 281,3
- 295
- N-{(1S,2R)-2-hidroxi-1-[(hidroxiamino)carbonil]propil}-4pentilbenzamida 309,4
- 296
- N-{(1S,2R)-2-hidroxi-1-[(hidroxiamino)carbonil]propil}-4octilbenzamida 351,5
- 297
- (2E)-N-{(1S,2R)-2-hidroxi-1-[(hidroxiamino)carbonil]propil}-3(4-metilfenil)prop-2-enamida 279,3
- 298
- (2E)-N-{(1S,2R)-2-hidroxi-1-[(hidroxiamino)carbonil]propil}-3[4-(trifluorometil)fenil]prop-2-enamida 333,3
- 299
- (2E)-3-(1,1'-bifenil-4-il)-N-{(1S,2R)-2-hidroxi-1[(hidroxiamino)carbonil]propil}prop-2-enamida 341,4
- 300
- (2S,3R)-2-[(1,1'-bifenil-4-ilacetil)amino]-N,3dihidroxibutanamida 329,4
- Ejemplo
- Estructura Nombre MH+
- 301
- (2S,3R)-2-{[(2S)-2-amino-3-(1,1′-bifenil-4-il)propanoil]amino}N,3-dihidroxibutanamida 358,4
- 302
- (2S,3R)-2-{[(2R)-2-amino-3-(1,1′-bifenil-4-il)propanoil]amino}N,3-dihidroxibutanamida 358,4
- 303
- (3S)-3-amino-N-{(1S,2R)-2-hidroxi-1[(hidroxiamino)carbonil]propil}-5-fenilpentanamida 310,4
- 304
-
imagen110 N-{(1S,2R)-2-hidroxi-1-[(hidroxiamino)carbonil]propil}-4[(fenilamino)metil]benzamida 344,4
- 305
- N-{(1S,2R)-2-hidroxi-1-[(hidroxiamino)carbonil]propil}-4{[(fenilmetil)amino]metil}benzamida 358,4
- 306
- 4′-etil-N-{(1S,2R)-2-hidroxi-1-[({(1S,2R)-2-hidroxi-1[(hidroxiamino)carbonil]propil}amino) carbonil]propil}-1,1′bifenil-4-carboxamida 444,5
- 307
-
imagen111 (2S,3R)-2-[(1,1′-bifenil-4-ilacetil)amino]-3-hidroxi-N-{(1S,2R)2-hidroxi-1-[(hidroxiamino)carbonil]propil}butanamida 430,5
- 308
- 4-(4-clorofenil)-N-{(1S,2R)-2-hidroxi-1[(hidroxiamino)carbonil]propil}ciclohexanocarboxamida 355,8
- 309
- N-{(1S,2R)-2-hidroxi-1-[(hidroxiamino)carbonil]propil}-4-(1Hpirazol-1-il)benzamida 305,3
- 310
- N-(1S,2R)-2-hidroxi-1-[(hidroxiamino)carbonil]propil}-4morfolin-4-ilbenzamida 324,3
- 311
- N-{(1S,2R)-2-hidroxi-1-[(hidroxiamino)carbonil]propil}-4(1,2,3-tiadiazol-4-il)benzamida 323,3
- 312
- N-{(1S,2R)-2-hidroxi-1-[(hidroxiamino)carbonil]propil}-4-[(4metilpiperazin-1-il)metil]benzamida 351,4
- Ejemplo
- Estructura Nombre MH+
- 313
- N-{(1S,2R)-2-hidroxi-1-[(hidroxiamino)carbonil]propil}-4-(1Himidazol-1-ilmetil)benzamida 319,3
- 314
- (2S,4S)-N-{(1S,2R)-2-hidroxi-1-[(hidroxiamino)carbonil]propil}4-fenilpirrolidina-2-carboxamida 308,3
- 315
-
imagen112 4'-bromo-N-{(1S,2R)-2-hidroxi-1[(hidroxiamino)carbonil]propil}-1,1'-bifenil-4-carboxamida 394,2
- 316
- 4'-bromo-N-{(1S,2R)-2-hidroxi-1[(hidroxiamino)carbonil]propil}-1,1'-bifenil-4-carboxamida 394,2
- 317
- 4'-bromo-N-{(1S,2R)-2-hidroxi-1[(hidroxiamino)carbonil]propil}-1,1'-bifenil-4-carboxamida 394,2
- 318
-
imagen113 (2R)-2-{[(4′-etil-1,1′-bifenil-4-il)carbonil]amino}-N~1~hidroxipentanediamida 370,4
- 319
- ácido (2S,3S)-1-[(4′-etil-1,1′-bifenil-4-il)carbonil]-3hidroxipirrolidina-2-carboxilico 340,4
- 320
- (2S,3S)-N-[(1,1-dimetiletil)oxi]-1-[(4′-etil-1,1′-bifenil-4il)carbonil]-3-hidroxipirrolidina-2-carboxamida 411,5
- 321
- (2S,3S)-1-[(4′-etil-1,1′-bifenil-4-il)carbonil]-N,3dihidroxipirrolidina-2-carboxamida 355,4
- 322
-
imagen114 N-{(1S,2R)-2-hidroxi-1-[(hidroxiamino)carbonil]propil}-4-[(4nitrofenil)etinil]benzamida 384,4
- 323
- N-{(1S,2R)-2-hidroxi-1-[(hidroxiamino)carbonil]propil}-4-{[4(1H-pirrol-1-il)fenil]etinil}benzamida 404,4
- Ejemplo
- Estructura Nombre MH+
- 324
- N-{(1S,2R)-2-hidroxi-1-[(hidroxiamino)carbonil]propil}-4′-nitro1,1′-bifenil-4-carboxamida 360,3
- 325
- (2S,3R)-N,3-dihidroxi-2-({[4′-(metiloxi)-3′-propil-1,1′-bifenil-4il]metil}amino)butanamida 373,5
- 326
-
imagen115 4'-ciano-N-{(1S,2R)-2-hidroxi-1-[(hidroxiamino)carbonil]propil}1,1'-bifenil-4-carboxamida 340,3
- 327
- (2S,3R)-2-({[4′-(etiloxi)-4-(metiloxi)-1,1′-bifenil-3il]metil}amino)-N,3-dihidroxibutanamida 375,4
- 328
- 2,5′-difluoro-N-{(1S,2R)-2-hidroxi-1[(hidroxiamino)carbonil]propil}-1,1′-bifenil-4-carboxamida 351,3
- 329
-
imagen116 N-[(1S)-1-[(acetilamino)metil]-2-(hidroxiamino)-2-oxoetil]-4′etil-1,1′-bifenil-4-carboxamida 370,4
- 330
- N-{(1S)-4-amino-1-[(hidroxiamino)carbonil]butil}-4′-etil-1,1′bifenil-4-carboxamida 356,4
- 331
- 4′-etil-N-[(1S)-2-(hidroxiamino)-1-(1H-imidazol-5-ilmetil)-2oxoetil]-1,1′-bifenil-4-carboxamida 379,4
- 332
- (2S,3R)-2-{[1-(1,1′-bifenil-4-il)etil]amino}-N,3dihidroxibutanamida 315,4
- 333
- (2S,3R)-2-{[1-(1,1′-bifenil-4-il)propil]amino}-N,3dihidroxibutanamida 329,4
- Ejemplo
- Estructura Nombre MH+
- 334
- (2S,3R)-2-{[1-{4′-bromo-1,1′-bifenil-4-il)etil]amino}-N,3dihidroxibutanamida 394,3
- 335
- (2S,3R)-N,3-dihidroxi-2-{[1-(4′-metil-1,1′-bifenil-4il)etil]amino}butanamida 329,4
- 336
- N-[(1S)-1-(aminometil)-2-(hidroxiamino)-2-oxoetil]-1,1′-bifenil4-carboxamida 300,3
- 337
- N-[(1S)-1-(aminometil)-2-(hidroxiamino)-2-oxoetil]-4-(1Hpirrol-1-il)benzamida 289,3
- 338
-
imagen117 N-[(1S)-1-(aminometil)-2-(hidroxiamino)-2-oxoetil]-4-(4clorofenil)ciclohexanecarboxamida 340,8
- 339
- N-[(1S)-1-(aminometil)-2-(hidroxiamino)-2-oxoetil]-4pentilbenzamida 294,4
- 340
- (2E)-N-[(1S)-1-(aminometil)-2-(hidroxiamino)-2-oxoetil]-3(1,1′-bifenil-4-il)prop-2-enamida 326,4
- 341
- (2S)-3-amino-2-{[(4′-etil-1,1′-bifenil-4-il)metil]amino}-Nhidroxipropanamida 314,4
- 342
- (2S)-3-amino-2-[(1,1′-bifenil-4-ilmetil)amino]-Nhidroxipropanamida 286,3
- 343
- (2S)-3-amino-2-{[1-(4′-bromo-1,1′-bifenil-4-il)etil]amino}-Nhidroxipropanamida 379,3
- Ejemplo
- Estructura Nombre MH+
- 344
- (2S)-3-amino-N-hidroxi-2-{[1-(4′-metil-1,1′-bifenil-4il)etil]amino}propanamida 314,4
- 345
- 4′-etil-N-[(1S)-2-({(1S,2R)-2-hidroxi-1[(hidroxiamino)carbonil]propil}amino)-1-(hidroximetil)-2oxoetil]-1,1′-bifenil-4-carboxamida 430,5
- 346
- 4′-etil-N-{(1S)-2-({(1S,2R)-2-hidroxi-1[(hidroxiamino)carbonil]propil}amino)-1-[(4-hidroxifenil)metil]2-oxoetil}-1,1′-bifenil-4-carboxamida 506,6
- 347
- (2S)-2-{[(4′-etil-1,1′-bifenil-4-il)carbonil]amino}-N~1~-{(1S,2R)2-hidroxi-1-[(hidroxiamino)carbonil]propil} pentanediamida 471,5
- 348
- ácido (4S)-4-{[(4′-etil-1,1′-bifenil-4-il)carbonil]amino}-5({(1S,2R)-2-hidroxi-1-[(hidroxiamino)carbonil]propil}amino)-5oxopentanoico 472,5
- 349
- ácido (3S)-3-{[(4′-etil-1,1′-bifenil-4-il)carbonil]amino}-4({(1S,2R)-2-hidroxi-1-[(hidroxiamino)carbonil]propil}amino)-4oxobutanoico 458,5
- 350
- (3S)-2-(1,1′-bifenil-4-ilacetil)-N-{(1S,2R)-2-hidroxi-1[(hidroxiamino)carbonil]propil}-1,2,3,4-tetrahidroisoquinoline3-carboxamida 488,6
- 351
- 4′-etil-N-[(1S)-2-({(1S,2R)-2-hidroxi-1(hidroxiamino)carbonil]propil}amino)-1-metil-2-oxoetil]-1,1′bifenil-4-carboxamida 414,5
- 352
- (2S,3R)-2-({(2S)-3-amino-2-[(1,1′-bifenil-4ilacetil)amino]propanoil}amino)-N,3-dihidroxibutanamida 415,5
- 353
- (2S)-2-[(1,1′-bifenil-4-ilacetil)amino]-N-{(1S,2R)-2-hidroxi-1[(hidroxiamino)carbonil]propil}pent-4-inamida 424,5
- 354
-
imagen118 (2S,3R)-2-{[(2S)-2-amino-2-(1,1′-bifenil-4-il)etanoil]amino}N,3-dihidroxibutanamida 344,4
- Ejemplo
- Estructura Nombre MH+
- 355
- (2S,3R)-2-{[(2R)-2-amino-2-(1,1′-bifenil-4-il)etanoil]amino}N,3-dihidroxibutanamida 344,4
- 356
- N-(3-aminopropil)-4′-etil-N-[2-(hidroxiamino)-2-oxoetil]-1,1′bifenil-4-carboxamida 356,4
- 357
- N-(2-cianoetil)-4′-etil-[2-(hidroxiamino)-2-oxoetil]-1,1′-bifenil-4carboxamida 352,4
- 358
- N-[2-(acetilamino)etil]-4′-etil-N[2-(hidroxiamino)-2-oxoetil]-1,1′bifenil-4-carboxamida 384,4
- 359
- 4′-etil-N-[2-(hidroxiamino)-2-oxoetil]-N-prop-2-inil-1,1′-bifenil4-carboxamida 337,4
- 360
- 4-ciano-N-{(1S,2R)-2-hidroxi-1[(hidroxiamino)carbonil]propil}benzamida 264,3
- 361
- N-[(1S)-1-(aminometil)-2-(hidroxiamino)-2-oxoetil]-4cianobenzamida 249,2
- 362
- 1,1-dimetiletil (2S)-2-{[(4-etinilfenil)carbonil]amino}-3(hidroxiamino)-3-oxopropilcarbamato 348,4
- 363
-
imagen119 1,1-dimetiletil (2S)-3-(hidroxiamino)-3-oxo-2-[({4-[(E)-2feniletenil]fenil}metil)amino] propilcarbamato 412,5
- 364
- N-{(1R,2S)-2-hidroxi-1-[(hidroxiamino)carbonil]propil}-3′(trifluorometil)-1,1′-bifenil-4-carboxamida 383,3
- Ejemplo
- Estructura Nombre MH+
- 365
- ácido (2S,3R)-2-[(1,1′-bifenil-4-ilmetil)amino]-3hidroxibutanoico 286,3
- 366
-
imagen120 N-[(1S)-1-(aminometil)-2-(hidroxiamino)-2-oxoetil]-4(feniletinil)benzamida 324,4
- 367
- 1,1-dimetiletil (2S)-3-(hidroxiamino)-3-oxo-2-({[4(feniletinil)fenil]carbonil}amino)propil carbamato 424,5
- 368
- N-[(1S)-1-(aminometil)-2-(hidroxiamino)-2-oxoetil]-4etinilbenzamida 248,3
- 369
- N-[(1S)-1-(aminometil)-2-(hidroxiamino)-2-oxoetil]-4etinilbenzamida 248,3
- 370
- N-{(1S,2R)-2-hidroxi-1-[(hidroxiamino)carbonil]propil}-4-{(4(metiloxi)fenil]etinil}benzamida 369,4
- 371
-
imagen121 (2S)-3-amino-N-hidroxi-2-[({4-[(E)-2feniletenil]fenil}metil)amino] propanamida 312,4
- 372
- 1,1-dimetiletil 2-{4′-[({(1S,2R)-2-hidroxi-1[(hidroxiamino)carbonil]propil}amino) carbonil]-1,1′-bifenil-4il}etilcarbamato 458,5
- 373
- (2S,3R)-N,3-dihidroxi-2-[({4′-[(2-pirrolidin-1-iletil)oxi]-1,1′bifenil-4-il}metil)amino]butanamida 414,5
- 374
- (1S)-4-({[(1,1-dimetiletil)oxi]carbonil}amino)-1-({[4-({4[({(1S,2R)-2-hidroxi-1[(hidroxiamino)carbonil]propil}amino)carbonil]fenil}etinil) fenil]amino}carbonil)butilcarbamato de 1,1-dimetiletilo 668,8
- 375
-
imagen122 4-(4-clorofenil)-N-[(1S)-2-({(1S,2R)-2-hidroxi-1[(hidroxiamino)carbonil]propil}amino)-1-metil-2oxoetil]ciclohexanecarboxamida 426,9
- Ejemplo
- Estructura Nombre MH+
- 376
- 4′-etil-N-[2-({(1S,2R)-2-hidroxi-1[(hidroxiamino)carbonil]propil}amino)-2-oxoetil]-1,1′-bifenil-4carboxamida 400,4
- 377
- 4′-etil-N-[3-({(1S,2R)-2-hidroxi-1[(hidroxiamino)carbonil]propil}amino)-3-oxopropil)-1,1′-bifenil4-carboxamida 414,5
- 378
- 4′-etil-N-[4-({(1S,2R)-2-hidroxi-1[(hidroxiamino)carbonil]propil}amino)-4-oxobutil]-1,1′-bifenil-4carboxamida 428,5
- 379
- N-((1S)-2-{[(1S)-1-(aminometil)-2-(hidroxiamino)-2oxoetil]amino}-1-metil-2-oxoetil)-4′-etil-1,1′-bifenil-4carboxamida 399,5
- 380
- N-(2-{[(1S)-1-(aminometil)-2-(hidroxiamino)-2-oxoetil]amino}2-oxoetil)-4′-etil-1,1′-bifenil-4-carboxamida 385,4
- 381
-
imagen123 N-(3-{[(1S)-1-(aminometil)-2-(hidroxiamino)-2-oxoetil]amino}3-oxopropil)-4′-etil-1,1′-bifenil-4-carboxamida 399,5
- 382
- N-(4-{[(1S)-1-(aminometil)-2-(hidroxianino)-2-oxoetil]amino}-4 -oxobutil)-4′-etil-1,1′-bifenil-4-carboxamida 413,5
- 383
- 4′-etil-N-[1-[(hidroxiamino)carbonil]-2-(metiloxi)propil]-1,1′bifenil-4-carboxamida 357,4
- 384
-
imagen124 4′-etil-N-[(1S,2R)-1-[(hidroxiamino)carbonil]-2(metiloxi)propil]-1,1′-bifenil-4-carboxamida 357,4
- 385
- N-[1-[(dimetilamino)metil]-2-(hidroxiamino)-2-oxoetil]-4′-etil1,1′-bifenil-4-carboxamida 356,4
- 386
- N-{(1S)-3-ciano-1-[(hidroxiamino)carbonil]propil}-4′-etil-1,1′bifenil-4-carboxamida 352,4
- 387
- N-{(1S)-5-amino-1-[(hidroxiamino)carbonil]pentil}-4′-etil-1,1′bifenil-4-carboxamida 370,5
- Ejemplo
- Estructura Nombre MH+
- 388
- N-{(1S)-3-amino-1-[(hidroxiamino)carbonil]propil}-4′-etil-1,1′bifenil-4-carboxamida 342,4
- 389
- 4′-etil-N-hidroxi-1,1′-bifenil-4-carboxamida 242,3
- 390
- 4′-etil-N-{2-hidroxi-1-[(hidroxiamino)carbonil]-2-metilpropil}1,1′-bifenil-4-carboxamida 357,4
- 391
- N-[(2S)-2-{[(4′-etil-1,1′-bifenil-4-il)carbonil]amino}-3(hidroxiamino)-3-oxopropil]morfolina-4-carboxamida 441,5
- 392
- N-[(1S)-1-{[(aminocarbonil)amino]metil}-2-(hidroxiamino)-2oxoetil)-4′-etil-1,1′-bifenil-4-carboxamida 371,4
- 393
- N-[(1S)-1-({[amino(imino)metil]amino}metil)-2-(hidroxiamino)2-oxoetil]-4′-etil-1,1′-bifenil-4-carboxamida 370,4
- 394
- N-[(2S)-2-amino-3-(hidroxiamino)-3-oxopropil]-4′-etil-1,1′bifenil-4-carboxamida 328,4
- 395
- 1-[(4′-etil-1,1′-bifenil-4-il)carbonil]-N-hidroxipiperazina-2carboxamida 354,4
- 396
- N-[(2S)-2-amino-3-(hidroxiamino)-3-oxopropil]-4(feniletinil)benzamida 324,4
- 397
- N-hidroxi-1-{[4-(feniletinil)fenil]carbonil}piperazina-2carboxamida 350,4
- 398
- N-{(1S,2R)-2-hidroxi-1-[(hidroxiamino)carbonil]propil}-4-[(4pentilfenil)etinil]benzamida 409,5
- 399
- N-{(1S,2R)-2-hidroxi-1-[(hidroxiamino)carbonil]propil}-4-{[3(metiloxi)fenil]etinil}benzamida 369,4
- Ejemplo
- Estructura Nombre MH+
- 400
- 4-[(3-fluoro-4-metilpheny)etinil]-N-{(1S,2R)-2-hidroxi-1[(hidroxiamino)carbonil]propil}benzamida 371,4
- 401
-
imagen125 4-[(2,4-difluorofenil)etinil]-N-{(1S,2R)-2-hidroxi-1[(hidroxiamino)carbonil]propil}benzamida 375,3
- 402
- metil (2E)-3-(etilamino)-2-({[4-(feniletinil)fenil]carbonil}amino) but-2-enoato 363,4
- 403
- 1,1-dimetiletil 4-{[(2S)-3-(hidroxiamino)-3-oxo-2-({[4(feniletinil)fenil]carbonil}amino) propil]amino}-4oxobutilcarbamato 509,6
- 404
-
imagen126 N-(1-(N-hidroxicarbamoil)-2-hidroxi-3-metilbutil)[4-(4etilfenil)fenil]carboxamida 371,4
- 405
- N-((1R,2R)-1-{[(aminocarbonil)(hidroxi)amino]metil}-2hidroxipropil)-4′-etil-1,1′-bifenil-4-carboxamida 372,4
- 406
- 4′-etil-N-((1R,2R)-1-{[formil(hidroxi)amino]metil}-2hidroxipropil)-1,1′-bifenil-4-carboxamida 357,4
- 407
-
imagen127 N-{(1S,2R)-2-hidroxi-1-[(hidroxiamino)carbonil]propil}-4-{[4(trifluorometil)fenil]etinil}benzamida 407,4
- 408
- 1,1-dimetiletil 2-{[(2S)-3-(hidroxiamino)-3-oxo-2-({[4(feniletinil)fenil]carbonil}amino) propil]amino}-2oxoetilcarbamato 481,5
- Ejemplo
- Estructura Nombre MH+
- 409
- N-[(1S)-1-{[(aminoacetil)amino]metil}-2-(hidroxiamino)-2oxoetil]-4-(feniletinil)benzamida 381,4
- 410
-
imagen128 N-[(1S)-1-{[(4-aminobutanoil)amino]metil}-2-(hidroxiamino)-2oxoetil]-4-(feniletinil)benzamida 409,5
- 411
- N-{(1S,2R)-2-hidroxi-1-[(hidroxiamino)carbonil]propil}-4-pent1-inilbenzamida 305,3
- 412
- N-{(1S,2R)-2-[(1,1-dimetiletil)oxi]-1[(hidroxiamino)carbonil]propil}-4′-propil-1,1′-bifenil-4carboxamida 413,5
- 413
- 1,1-dimetiletil (1S)-4-({[(1,1-dimetiletil)oxi]carbonil}amino)-1{[(2-{4′-[({(1S,2R)-2-hidroxi-1[(hidroxiamino)carbonil]propil}amino) carbonil]-1,1′-bifenil-4il}etil)amino]carbonil}butilcarbamato 672,8
- 414
- 4′-(2-aminoetil)-N-{(1S,2R)-2-hidroxi-1[(hidroxiamino)carbonil]propil)-1,1′-bifenil-4-carboxamida 358,4
- 415
- 4′-(2-{[(2S)-2,5-diaminopentanoil]amino}etil)-N-{(1S,2R)-2hidroxi-1-[(hidroxiamino)carbonil]propil}-1,1′-bifenil-4carboxamida 472,6
- 416
- 4-(ciclohex-1-en-1-iletinil)-N-{(1S,2R)-2-hidroxi-1[(hidroxiamino)carbonil]propil}benzamida 343,4
- 417
- 4-(3,3-dimetilbut-1-inil)-N-{(1S,2R)-2-hidroxi-1[(hidroxiamino)carbonil]propil}benzamida 319,4
- Ejemplo
- Estructura Nombre MH+
- 418
- N-{(1S)-1-[(aminoacetil)amino]metil}-2-[(2-{[(2S)-3(hidroxiamino)-3-oxo-2-({[4-(feniletinil)fenil]carbonil}amino) propil]amino}-2-oxoetil)amino]-2-oxoetil}-4(feniletinil)benzamida 728,8
- 419
- 4-[(4-{[(2S)-2,5-diaminopentanoil]amino}fenil)etinil]-N{(1S,2R)-2-hidroxi-1-[(hidroxiamino)carbonil]propil}benzamida 468,5
- 420
- 4′-(2-aminoetil)-N-{(1E)-1-[(hidroxiamino)carbonil]prop-1-enil}1,1′-bifenil-4-carboxamida 340,4
- 421
- 2′,4′-difluoro-N-{(1S,2R)-2-hidroxi-1[(hidroxiamino)carbonil]propil}-1,1′-bifenil-4-carboxamida 351,3
- 422
- N-[(1E)-1-formilprop-1-enil]-4′-propil-1,1′-bifenil-4carboxamida 308,4
- 423
- N-hidroxi-4-(piridin-3-iletinil)benzamida 239,2
- 424
- 4-(3-hidroxi-3,5-dimetilhex-1-inil)-N-{(1S,2R)-2-hidroxi-1[(hidroxiamino)carbonil]propil}benzamida 363,4
- 425
- 4′-etil-N-{(1R,2R)-2-hidroxi-1-[(hidroxiamino)metil]propil}-1,1′bifenil-4-carboxamida 329,4
- 426
-
imagen129 4′-etil-N-{(1R,2R)-1-[(hidroxiamino)metil]-2[(fenilmetil)oxi]propil}-1,1′-bifenil-4-carboxamida 419,5
- 427
- 4′-etil-N-[(5R,6R)-3-hidroxi-6-metil-2-oxo-1,3-oxazinan-5-il]1,1′-bifenil-4-carboxamida 355,4
- Ejemplo
- Estructura Nombre MH+
- 428
- N-((1R,2R)-1-{[({[2-(dimetilamino)etil]amino}carbonil) (hidroxi)amino]metil}-2-hidroxipropil)-4′-etil-1,1′-bifenil-4carboxamida 443,6
- 429
- N-((1R,2R)-1-{[{[(2-cianoetil)amino]carbonil}(hidroxi)amino] metil}-2-hidroxipropil)-4′-etil-1,1′-bifenil-4-carboxamida 425,5
- 430
- 4′-etil-N-((1R,2R)-2-hidroxi-1-{[hidroxi({[3-(2-oxopirrolidin-1-il) propil]amino}carbonil)amino]metil} propil)-1,1′-bifenil-4carboxamida 497,6
- 431
- (1R,2R)-3-[({[2-(dimetilamino)etil]amino}carbonil) (hidroxi)amino]-2-{[(4′-etil-1,1′-bifenil-4-il)carbonil]amino}-1metilpropil 2-(dimetilamino)etilcarbamato 557,7
- 432
- (1R,2R)-3-[{[(2-cianoetil)amino]carbonil}(hidroxi)amino]-2{[(4′-etil-1,1′-bifenil-4-il)carbonil]amino}-1-metilpropil 2cianoetilcarbamato 521,6
- 433
- N-{(1E)-1-[(E)-(hidroxiimino)metil]prop-1-enil}-4′-propil-1,1′bifenil-4-carboxamida 323,4
- 434
-
imagen130 N-{(1S,2R)-2-hidroxi-1-[(hidroxiamino)carbonil]propil}-4(piridin-3-iletinil)benzamida 340,3
- 435
- N-{(1S,2R)-2-hidroxi-1-[(hidroxiamino)carbonil]propil}-4-[3(metilamino)prop-1-inil]benzamida 306,3
- 436
- N-[(1S)-1-[(dimetilamino)metil]-2-(hidroxiamino)-2-oxoetil]-4′etil-1,1′-bifenil-4-carboxamida 356,4
- 437
- N-[1-(N-hidroxicarbamoilmetil)(1R,2R)-2-hidroxipropil][4-(4etilfenil)fenil]carboxamida 357,4
- 438
- N-[(1S)-1-[(dietilamino)metil]-2-(hidroxiamino)-2-oxoetil]-4′etil-1,1′-bifenil-4-carboxamida 384,5
- Ejemplo
- Estructura Nombre MH+
- 439
- 4-[(3-aminofenil)etinil]-N-{(1S,2R)-2-hidroxi-1[(hidroxiamino)carbonil]propil}benzamida 354,4
- 440
- 4-[3-(dimetilamino)prop-1-inil]-N-{(1S,2R)-2-hidroxi-1[(hidroxiamino)carbonil]propil}benzamida 320,4
- 441
- 4-[3-(dimetilamino)prop-1-inil]-N-{(1S,2R)-2-hidroxi-1[(hidroxiamino)carbonil]propil}benzamida 320,4
- 442
- 4-({4-[(aminoacetil)amino]fenil}etinil)-N{(1S,2R)-2-hidroxi-1[(hidroxiamino)carbonil]propil}benzamida 411,4
- 443
- 3′-fluoro-N-{(1S,2R)-2-hidroxi-1[(hidroxiamino)carbonil]propil}-4′-metil-1,1′-bifenil-4carboxamida 347,4
- 444
- N-[(1S)-1-formil-2-metilpropil]-1,1′-bifenil-4-carboxamida 282,4
- 445
- N-{(1S)-1-[(E)-(hidroxiimino)metil]-2-metilpropil}-1,1′-bifenil-4carboxamida 297,4
- 446
- N-((1E)-1-{(E)-[(aminocarbonil)hidrazono]metil}prop-1-enil)4′-propil-1,1′-bifenil-4-carboxamida 365,4
- 447
- 4-[(4-aminofenil)etinil]-N-{(1S,2R)-2-hidroxi-1[(hidroxiamino)carbonil]propil}benzamida 354,4
- 448
- 4-{[3-(aminometil)fenil]etinil}-N-{(1S,2R)-2-hidroxi-1[(hidroxiamino)carbonil]propil}benzamida 368,4
- Ejemplo
- Estructura Nombre MH+
- 449
- N-(2-aminoetil)-3-({4-[({(1S,2R)-2-hidroxi-1[(hidroxiamino)carbonil]propil}amino) carbonil]fenil}etinil)benzamida 425,5
- 450
-
imagen131 N-((1S)-1-{(E)-[(aminocarbonil)hidrazono]metil}-2-metilpropil)1,1′-bifenil-4-carboxamida 339,4
- 451
- N-{(1S,2R)-2-hidroxi-1-[(hidroxiamino)carbonil]propil}-4-{[3(propanoilamino)fenil]etinil}benzamida 410,4
- 452
-
imagen132 N-{(1S,2R)-2-hidroxi-1-[(hidroxiamino)carbonil]propil}-4-{[3(morfolin-4-ilmetil)fenil]etinil}benzamida 438,5
- 453
- 4-[(3-{[(2-aminoetil)amino]metil}pheny)etinil]-N-{(1S,2R)-2hidroxi-1-[(hidroxiamino)carbonil]propil}benzamida 411,5
- 454
- N-[(1R)-2-(hidroxiamino)-1-(hidroximetil)-2-oxoetil]-4′-propil1,1′-bifenil-4-carboxamida 343,4
- 455
- N-[1-(N-hidroxicarbamoil)metil)(1R,2R)-2-hidroxipropil][4-(2feniletinil)fenil]carboxamida 353,4
- 456
- 4′-etil-N-[(1R,2R)-1-[(hidroxiamino)carbonil]-2(metiloxi)propil]-1,1′-bifenil-4-carboxamida 357,4
- 457
- 4′-etil-N-[(1S)-1-[(etilamino)metil]-2-(hidroxiamino)-2-oxoetil]1,1′-bifenil-4-carboxamida 356,4
- 458
- 4′-etil-N-[(1S)-2-(hidroxiamino)-2-oxo-1-({[(2S)-pirrolidin-2ilmetil]amino}metil)etil]-1,1′-bifenil-4-carboxamida 411,5
- 459
- N-[(1S)-1-[(etilamino)metil]-2-(hidroxiamino)-2-oxoetil]-4(feniletinil)benzamida 352,4
- Ejemplo
- Estructura Nombre MH+
- 460
- N-[(1S)-2-(hidroxiamino)-2-oxo-1-({[(2S)-pirrolidin-2ilmetil]amino}metil)etil]-4-(feniletinil)benzamida 407,5
- 461
- 4′-etil-N-((1S)-2-(hidroxiamino)-1-{[(1-metiletil)amino]metil}-2oxoetil)-1,1′-bifenil-4-carboxamida 370,5
- 462
- 4′-etil-N-[(1S)-2-(hidroxiamino)-1-({[2(metilamino)etil]amino}metil)-2-oxoetil]-1,1′-bifenil-4carboxamida 385,5
- 463
- 4′-etil-N-((1S)-2-(hidroxiamino)-1-{[(1-metilpiperidin-4il)amino]metil}-2-oxoetil)-1,1′-bifenil-4-carboxamida 425,5
- 464
- N-((1S)-2-(hidroxiamino)-1-{[(1-metiletil)amino]metil}-2oxoetil)-4-(feniletinil)benzamida 366,4
- 465
- N-[(1S)-2-(hidroxiamino)-1-({[2-(metilamino)etil]amino}metil)2-oxoetil]-4-(feniletinil)benzamida 381,4
- 466
- N-((1S)-2-(hidroxiamino)-1-{[(1-metilpiperidin-4il)amino]metil}-2-oxoetil)-4-(feniletinil)benzamida 421,5
- 467
- N-[(1S)-1-{[(2-aminoetil)amino]metil}-2-(hidroxiamino)-2oxoetil]-4-(feniletinil)benzamida 367,4
- 468
- N-[(1S)-1-{[bis(2-aminoetil)amino]metil}-2-(hidroxiamino)-2oxoetil]-4-(feniletinil)benzamida 410,5
- 469
-
imagen133 N-{(1S,2R)-2-hidroxi-1-[(hidroxiamino)carbonil]propil}-4-({4[(morfolin-4-ilacetil)amino]fenil}etinil)benzamida 481,5
- 470
- N-{(1S,2R)-2-hidroxi-1-[(hidroxiamino)carbonil]propil}-4-{[4(propanoilamino)fenil]etinil}benzamida 410,4
- Ejemplo
- Estructura Nombre MH+
- 471
- N-{(1S,2R)-2-hidroxi-1-[(hidroxiamino)carbonil]propil}-4-({4[(triffuorometil)oxi]fenil}etinil)benzamida 423,4
- 472
-
imagen134 1,1-dimetiletil (2S)-3-(hidroxiamino)-3-oxo-2-{[(4-{[3(propanoilamino)fenil]etinil}fenil) carbonil]amino}propilcarbamato 495,5
- 473
-
imagen135 1,1-dimetiletil (2S)-3-(hidroxiamino)-3-oxo-2-{[(4-pent-1inilfenil)carbonil]amino}propilcarbamato 390,4
- 474
- N-[(1S)-1-(aminometil)-2-(hidroxiamino)-2-oxoetil]-4-{[3(propanoilamino)fenil]etinil}benzamida 395,4
- 475
- N-[(1S)-1-(aminometil)-2-(hidroxiamino)-2-oxoetil]-4-pent-1inilbenzamida 290,3
- 476
- 4-(feniloxi)benzaldehido tiosemicarbazona 272,3
- 477
- 4-(feniloxi)benzaldehido semicarbazona 256,3
- 478
-
imagen136 4-{[3-(trifluorometil)fenil]oxi}benzaldehido tiosemicarbazona 340,3
- 479
- 4-[(3,4-difluorofenil)etinil]-N-{(1S,2R)-2-hidroxi-1[(hidroxiamino)carbonil]propil}benzamida 375,3
- 480
- 4-[(2,4-dioxo-1,2,3,4-tetrahidropyrimidin-5-il)etinil]-N-{(1S,2R)2-hidroxi-1-[(hidroxiamino)carbonil]propil}benzamida 373,3
- Ejemplo
- Estructura Nombre MH+
- 481
- N-[(1S)-1-(aminometil)-2-(hidroxiamino)-2-oxoetil]-4-(4fenilbuta-1,3-diinil)benzamida 348,4
- 482
- N-[(1S)-1-(aminometil)-2-(hidroxiamino)-2-oxoetil]-4′-propil1,1′-bifenil-4-carboxamida 342,4
- 483
- N-[(1S)-1-(aminometil)-2-(hidroxiamino)-2-oxoetil]-1,1′:4′,1″terfenil-4-carboxamida 376,4
- 484
- N-{(1S,2R)-2-hidroxi-1-[(hidroxiamino)carbonil]propil}1,1′:4′,1″-terfenil-4-carboxamida 391,4
- 485
- 1,1-dimetiletil (2S)-2-[({4-[(4-{[({[(1,1dimetiletil)oxi]carbonil}amino)acetil] amino}fenil)etinil]fenil}carbonil) amino]-3-(hidroxiamino)-3oxopropilcarbamato 596,6
- 486
-
imagen137 N-[(1S,2R)-1-(hidrazinocarbonil)-2-hidroxipropil]-4(feniletinil)benzamida 338,4
- 487
-
imagen138 2-[(2S,3R)-3-hidroxi-2-({[4-(feniletinil)fenil]carbonil}amino) butanoil]hidrazinecarboxamida 381,4
- 488
- N-{(1S,2R)-2-hidroxi-1-[(hidroxiamino)carbonil]propil}-4-[(2metilfenil)etinil]benzamida 353,4
- 489
- N-{(1S,2R)-2-hidroxi-1-[(hidroxiamino)carbonil]propil}-4-[(3hidroxifenil)etinil]benzamida 355,4
- 490
- 4-({3-[(aminoacetil)amino]fenil}etinil)-N-{(1S,2R)-2-hidroxi-1[(hidroxiamino)carbonil]propil}benzamida 411,4
- Ejemplo
- Estructura Nombre MH+
- 491
- 4-{[4-({[(cianometil)amino]acetil}amino)fenil]etinil}-N-{(1S,2R)2-hidroxi-1-[(hidroxiamino)carbonil]propil}benzamida 450,5
- 492
- 4′-etil-N-{(1S)-2-(hidroxiamino)-2-oxo-1-[(tetrahidro-2H-pyran4-ilamino)metil]etil}-1,1′-bifenil-4-carboxamida 412,5
- 493
- N-{(1S)-2-(hidroxiamino)-2-oxo-1-[(tetrahidro-2H-pyran-4ilamino)metil]etil}-4-(feniletinil)benzamida 408,5
- 494
-
imagen139 4-[(4-clorofenil)etinil]-N-{(1S,2R)-2-hidroxi-1[(hidroxiamino)carbonil]propil}benzamida 373,8
- 495
-
imagen140 N-{(1S,2R)-2-hidroxi-1-[(hidroxiamino)carbonil]propil}-4-[(4metilfenil)etinil]benzamida 353,4
- 496
- 4-[(2-fluorofenil)etinil]-N-{(1S,2R)-2-hidroxi-1[(hidroxiamino)carbonil]propil}benzamida 357,4
- 497
- 4-[(3-fluorofenil)etinil]-N-{(1S,2R)-2-hidroxi-1[(hidroxiamino)carbonil]propil}benzamida 357,4
- 498
-
imagen141 4-[(4-fluorofenil)etinil]-N-{(1S,2R)-2-hidroxi-1[(hidroxiamino)carbonil]propil}benzamida 357,4
- 499
- 4-[(4-{[(ciclopropilamino)acetil]amino}fenil)etinil]-N-{(1S,2R)-2hidroxi-1-[(hidroxiamino)carbonil]propil}benzamida 451,5
- 500
- 4-({4-[({[2-(dimetilamino)etil]amino}acetil)amino]fenil}etinil)-N{(1S,2R)-2-hidroxi-1-[(hidroxiamino)carbonil]propil}benzamida 482,6
- 501
- 4-({4-[({[2-(acetilamino)etil]amino}acetil)amino]fenil}etinil)-N{(1S,2R)-2-hidroxi-1-[(hidroxiamino)carbonil]propil}benzamida 496,5
- 502
-
imagen142 N-{(1S,2R)-2-hidroxi-1-[(hidroxiamino)carbonil]propil)-4-({4[({[3-(2-oxopirrolidin-1il)propil]amino}acetil)amino]fenil}etinil)benzamida 536,6
- 503
- N-{(1S,2R)-2-hidroxi-1-[(hidroxiamino)carbonil]propil}-4-{[4({[(piridin-3-ilmetil)amino]acetil}amino)fenil]etinil}benzamida 502,5
- Ejemplo
- Estructura Nombre MH+
- 504
- N-{(1S,2R)-2-hidroxi-1-[(hidroxiamino)carbonil]propil}-4-{[4({[(2-piridin-2-iletil)amino]acetil}amino)fenil]etinil}benzamida 516,6
- 505
- N-{(1S,2R)-2-hidroxi-1-[(hidroxiamino)carbonil]propil}-4-[(4{[(4-metilpiperazin-1-il)acetil]amino}fenil)etinil]benzamida 494,6
- 506
- 4-({4-[(1,4'-bipiperidin-1'-ilacetil)amino]fenil}etinil)-N-{(1S,2R)2-hidroxi-1-[(hidroxiamino)carbonil]propil}benzamida 562,7
- 507
- 1-(2-{[4-({4-[({(1S,2R)-2-hidroxi-1[(hidroxiamino)carbonil]propil}amino)carbonil]fenil}etinil) fenil]amino}-2-oxoetil)piperidina-4-carboxamida 522,6
- 508
- N-{(1S,2R)-2-hidroxi-1-[(hidroxiamino)carbonil]propil}-4-[(4{[(piperidin-3-ilamino)acetil]amino}fenil)etinil]benzamida 494,6
- 509
- N-{(1S,2R)-2-hidroxi-1-[(hidroxiamino)carbonil]propil}-4-[(4{[(piperidin-4-ilamino)acetil]amino}fenil)etinil]benzamida 494,6
- 510
- N-{(1S,2R)-2-hidroxi-1-[(hidroxiamino)carbonil]propil}-4-{[4({[(piperidin-2-ilmetil)amino]acetil})amino)fenil]etinil}benzamida 508,6
- 511
- N-{(1S,2R)-2-hidroxi-1-[(hidroxiamino)carbonil]propil}-4-{[4({[(piperidin-3-ilmetil)amino]acetil}amino)fenil]etinil}benzamida 508,6
- 512
- 4-[(4-{[(3-aminopirrolidin-1-il)acetil]amino}fenil)etinil]-N{(1S,2R)-2-hidroxi-1-[(hidroxiamino)carbonil]propil}benzamida 480,5
- 513
- 4-({4-[(azepan-1-ilacetil)amino]fenil}etinil)-N-{(1S,2R)-2hidroxi-1-[(hidroxiamino)carbonil]propil}beazamida 493,6
- 514
- N-{(1S,2R)-2-hidroxi-1-[(hidroxiamino)carbonil]propil}-4-{[4({[(4-morfolin-4-ilfenil)amino]acetil}amino)fenil]etinil}benzamida 572,6
- 515
- N-[(1S)-1-(aminometil)-2-(hidroxiamino)-2-oxoetil]-4-{[4-({[(2hidroxietil)amino]acetil}amino)fenil] etinil}benzamida 440,5
- 516
- N-[(1S)-1-(aminometil)-2-(hidroxiamino)-2-oxoetil]-4-[(4{[(ciclopropilamino)acetil]amino}fenil)etinil]benzamida 436,5
- 517
- N-[(1S)-1-(aminometil)-2-(hidroxiamino)-2-oxoetil]-4-({4-[({[3(2-oxopirrolidin-1-il)propil]amino}acetil)amino]fenil} etinil)benzamida 521,6
- 518
- N-[(1S)-1-(aminometil)-2-(hidroxiamino)-2-oxoetil]-4-[(4-{[(4metilpiperazin-1-il)acetil]amino}fenil)etinil]benzamida 479,6
- Ejemplo
- Estructura Nombre MH+
- 519
- N-[(1S)-1-(aminometil)-2-(hidroxiamino)-2-oxoetil]-4-{[4({[(piridin-3-ilmetil)amino]acetil}amino)fenil] etinil}benzamida 487,5
- 520
- N-[(1S)-1-(aminometil)-2-(hidroxiamino)-2-oxoetil]-4-({4[(piperidin-1-ilacetil)amino]fenil}etinil)benzamida 464,5
- 521
- 4-{[4-({[(2-hidroxietil)amino]acetil}amino)fenil]etinil}-N{(1S,2R)-2-hidroxi-1-[(hidroxiamino)carbonil]propil}benzamida 455,5
- 522
-
imagen143 N-{(1S,2R)-2-hidroxi-1-[(hidroxiamino)carbonil]propil}-4-({4[({[2-(metiloxi)etil]amino}acetil)amino]fenil}etinil)benzamida 469,5
- 523
- N-{(1S,2R)-2-hidroxi-1-[(hidroxiamino)carbonil]propil}-4-({4[({metil[2(metiloxi)etil]amino}acetil)amino]fenil}etinil)benzamida 483,5
- 524
- 4-{[4-({[[2(dimetilamino)etil](metil)amino]acetil}amino)fenil]etinil}-N{(1S,2R)-2-hidroxi-1-[(hidroxiamino)carbonil]propil}benzamida 496,6
- 525
- 4-{[4-({[(3R)-3-(dimetilamino)pirrolidin-1il]acetil}amino)fenil]etinil}-N-{(1S,2R)-2-hidroxi-1[(hidroxiamino)carbonil]propil}benzamida 508,6
- 526
- 4-{[4-({[(3S)-3-(dimetilamino)pirrolidin-1il]acetil)amino)fenil]etinil}-N-{(1S,2R)-2-hidroxi-1[(hidroxiamino)carbonil]propil}benzamida 508,6
- 527
- 4-{[4-({[(3R)-3-(acetilamino)pirrolidin-1il]acetil)amino)fenil]etinil}-N-{(1S,2R)-2-hidroxi-1[(hidroxiamino)carbonil]propil}benzamida 522,6
- 528
- 4-{[4-({[(3S)-3-(acetilamino)pirrolidin-1il]acetil}amino)fenil]etinil}-N-{(1S,2R)-2-hidroxi-1[(hidroxiamino)carbonil]propil}benzamida 522,6
- 529
- 4-{[4-({[(3R)-1-azabiciclo[2.2.2]oct-3ilamino]acetil}amino)fenil]etinil}-N-{(1S,2R)-2-hidroxi-1[(hidroxiamino)carbonil]propil}benzamida 520,6
- 530
-
imagen144 4-{[4-({[(3S)-1-azabiciclo[2.2.2]oct-3ilamino]acetil}amino)fenil]etinil}-N-{(1S,2R)-2-hidroxi-1[(hidroxiamino)carbonil]propil}benzamida 520,6
- 531
- N-{(1S,2R)-2-hidroxi-1-[(hidroxiamino)carbonil]propil}-4-({4[({[(2R)-pirrolidin-2ilmetil]amino)acetil)amino]fenil}etinil)benzamida 494,6
- 532
- N-{(1S,2R)-2-hidroxi-1-[(hidroxiamino)carbonil]propil}-4({4[({[(2S)-pirrolidin-2ilmetil]amino)acetil)amino]fenil}etinil)benzamida 494,6
- Ejemplo
- Estructura Nombre MH+
- 533
- 4-{[4-({[(3-aminociclohexil)amino]acetil}amino)fenil]etinil}N{(1S,2R)-2-hidroxi-1-[(hidroxiamino)carbonil]propil)benzamida 508,6
- 534
- N-{(1S,2R)-2-hidroxi-1-[(hidroxiamino)carbonil]propil}-4-[(4{[(3-hidroxipiperidin-1-il)acetil]amino}fenil)etinil]benzamida 495,5
- 535
- N-{(1S,2R)-2-hidroxi-1-[(hidroxiamino)carbonil]propil}-4-{[4({[(3-morfolin-4ilpropil)amino]acetil}amino)fenil]etinil}benzamida 538,6
- 536
- N-{(1S,2R)-2-hidroxi-1-[(hidroxiamino)carbonil]propil}-4-{[4({[(2-metilpropil)amino]acetil}amino)fenil]etinil}benzamida 467,5
- 537
-
imagen145 4-[(4-{[(etilamino)acetil]amino}fenil)etinil]-N-{(1S,2R)-2-hidroxi1-[(hidroxiamino)carbonil]propil}benzamida 439,5
- 538
- N-{(1S,2R)-2-hidroxi-1-[(hidroxiamino)carbonil]propil}-4-({4[(piperidin-1-ilacetil)amino]fenil}etinil)benzamida 479,5
- 539
- N-{(1S,2R)-2-hidroxi-1-[(hidroxiamino)carbonil]propil}-1-{[4({[(3-hidroxipropil)amino]acetil}amino)fenil]etinil}benzamida 469,5
- 540
- N-{(1S,2R)-2-hidroxi-1-[(hidroxiamino)carbonil]propil}-4-({4[({[3-(metiloxi)propil]amino}acetil)amino]fenill}etinil)benzamida 483,5
- 541
- 4-{[4-({[(2-cianoetil)amino]acetil}amino)fenil]etinil}-N-{(1S,2R)2-hidroxi-1-[(hidroxiamino)carbonil]propil}benzamida 464,5
- 542
-
imagen146 N-{(1S,2R)-2-hidroxi-1-[(hidroxiamino)carbonil]propil}-4-{[4({[(2-pirrolidin-1-iletil)amino]acetil}amino)fenil]etinil}benzamida 508,6
- 543
- N-{(1S,2R)-2-hidroxi-1-[(hidroxiamino)carbonil]propil}-4-[(4{[(2-metil-1H-imidazol-1-il)acetil]amino}fenil)etinil]benzamida 476,5
- 544
- N-[(1S)-1-(aminometil)-2-(hidroxiamino)-2-oxoetil]-4-[(4{[(metilamino)acetil]amino}fenil) etinil]benzamida 410,4
- 545
- N-[(1S)-1-(aminometil)-2-(hidroxiamino)-2-oxoetil]-4-{[4-({[(2metilpropil)amino]acetil}amino)fenil] etinil}benzamida 452,5
- 546
-
imagen147 N-[(1S)-1-(aminometil)-2-(hidroxiamino)-2-oxoetil]-4-({4-[({[2(metiloxi)etil]amino}acetil)amino]fenil} etinil)benzamida 454,5
- 547
- N-[(1S)-1-(aminometil)-2-(hidroxiamino)-2-oxoetil]-4-({4[({metil[2-(metiloxi)etil]amino}acetil)amino] fenil}etinil)benzamida 468,5
- Ejemplo
- Estructura Nombre MH+
- 551
- N-[(1S)-1-(aminometil)-2-(hidroxiamino)-2-oxoetil]-4-{[4-({[[2(dimetilamino)etil](metil)amino]acetil} amino)fenil]etinil}benzamida 481,6
- 552
- 4-({4-[({[2-(acetilamino)etil]amino}acetil)amino] fenil}etinil)-N[(1S)-1-(aminometil)-2-(hidroxiamino)-2-oxoetil]benzamida 481,5
- 553
-
imagen148 N-[(1S)-1-(aminometil)-2-(hidroxiamino)-2-oxoetil]-4-{[4-({[(2cianoetil)amino]acetil}amino)fenil] etinil}benzamida 449,5
- 554
-
imagen149 N-[(1S)-1-(aminometil)-2-(hidroxiamino)-2-oxoetil]-4-{[4-({[(2pirrolidin-1-iletil)amino]acetil}amino)fenil]etinil} benzamida 493,6
- 555
- N-[(1S)-1-(aminometil)-2-(hidroxiamino)-2-oxoetil]-4-({4-[({[4(dimetilamino)butil]amino}acetil)amino] fenil}etinil)benzamida 495,6
- 556
- N-[(1S)-1-(aminometil)-2-(hidroxiamino)-2-oxoetil]-4-({4[(morfolin-4-ilacetil)amino]fenil}etinil)benzamida 466,5
- 557
- N-[(1S)-1-(aminometil)-2-(hidroxiamino)-2-oxoetil]-4-({4[(azepan-1-ilacetil)amino]fenil}etinil)benzamida 478,6
- 558
- N-[(1S)-1-(aminometil)-2-(hidroxiamino)-2-oxoetil]-4-({4[(pirrolidin-1-ilacetil)amino]fenil}etinil)benzamida 450,5
- 559
- 1-{2-[(4-{[4-({[(1S)-1-(aminometil)-2-(hidroxiamino)-2oxoetil]amino}carbonil)fenil]etinil} fenil)amino]-2oxoetil}piperidina-4-carboxamida 507,6
- 560
-
imagen150 4-{[4-({[(3R)-3-(acetilamino)pirrolidin-1il]acetil}amino)fenil]etinil}-N-[(1S)-1-(aminometil)-2(hidroxiamino)-2-oxoetil]benzamida 507,6
- 561
- N-[(1S)-1-(aminometil)-2-(hidroxiamino)-2-oxoetil]-4-{[4({[(3R)-3-(dimetilamino)pirrolidin-1il]acetil}amino)fenil]etinil}benzamida 493,6
- 562
- N-[(1S)-1-(aminometil)-2-(hidroxiamino)-2-oxoetil]-4-[(4-{[(3aminopirrolidin-1-il)acetil]amino}fenil)etinil]benzamida 465,5
- Ejemplo
- Estructura Nombre MH+
- 563
- N-[(1S)-1-(aminometil)-2-(hidroxiamino)-2-oxoetil]-4-[(4{[(piperidin-3-ilamino)acetil]amino}fenil)etinil] benzamida 479,6
- 564
-
imagen151 N-[(1S)-1-(aminometil)-2-(hidroxiamino)-2-oxoetil]-4-[(4{[(piperidin-4-ilamino)acetil]amino}fenil)etinil] benzamida 479,6
- 565
- N-[(1S)-1-(aminometil)-2-(hidroxiamino)-2-oxoetil]-4-{[4({[(piperidin-2-ilmetil)amino]acetil}amino)fenil]etinil} benzamida 493,6
- 566
-
imagen152 N-[(1S)-1-(aminometil)-2-(hidroxiamino)-2-oxoetil]-4-{[4({[(piperidin-3-ilmetil)amino]acetil}amino)fenil]etinil} benzamida 493,6
- 567
- N-[(1S)-1-(aminometil)-2-(hidroxiamino)-2-oxoetil]-4-{[4({[(piridin-2-ilmetil)amino]acetil}amino)fenil]etinil} benzamida 487,5
- 568
- N-[(1S)-1-(aminometil)-2-(hidroxiamino)-2-oxoetil]-4-{[4({[(piridin-4-ilmetil)amino]acetil}amino)fenil]etinil} benzamida 487,5
- 569
- N-[(1S)-1-(aminometil)-2-(hidroxiamino)-2-oxoetil]-4-{[4-({[(2piridin-2-iletil)amino]acetil}amino)fenil]etinil} benzamida 501,6
- 570
- N-[(1S)-1-(aminometil)-2-(hidroxiamino)-2-oxoetil]-4-{[4-({[(2piridin-3-iletil)amino]acetil}amino)fenil]etinil} benzamida 501,6
- 571
- N-[(1S)-1-(aminometil)-2-(hidroxiamino)-2-oxoetil]-4-{[4-({[(2piridin-4-iletil)amino]acetil}amino)fenil]etinil} benzamida 501,6
- 572
- N-[(1S)-1-(aminometil)-2-(hidroxiamino)-2-oxoetil]-4-[(4{[(fenilamino)acetil]amino}fenil)etinil]benzamida 472,5
- 573
-
imagen153 N-[(1S)-1-(aminometil)-2-(hidroxiamino)-2-oxoetil]-4-{[4({[(fenilmetil)amino]acetil}amino)fenil] etinil}benzamida 486,5
- 574
- N-[(1S)-1-(aminometil)-2-(hidroxiamino)-2-oxoetil]-4-{[4-({[(2feniletil)amino]acetil}amino)fenil] etinil}benzamida 500,6
- Ejemplo
- Estructura Nombre MH+
- 575
- N-[(1S)-1-(aminometil)-2-(hidroxiamino)-2-oxoetil]-4-({4-[(1Himidazol-1-ilacetil)amino]fenil}etinil)benzamida 447,5
- 576
- N-{(1S,2R)-2-hidroxi-1-[(hidroxiamino)carbonil]propil}-4-({4[(1H-imidazol-1-ilacetil)amino]fenil}etinil)benzamida 462,5
- 577
- N-{(1S,2R)-2-hidroxi-1-[(hidroxiamino)carbonil]propil}-4-[(4([(fenilamino)acetil]amino}fenil)etinil]benzamida 487,5
- 578
- N-{(1S,2R)-2-hidroxi-1-[(hidroxiamino)carbonil]propil}-4-{(4({[(2-feniletil)aminolacetil}amino)fenil]etinil}benzamida 515,6
- 579
- N-{(1S,2R)-2-hidroxi-1-[(hidroxiamino)carbonil]propil}-4-{[4({[(3-fenilpropil)amino]acetil}amino)fenil]etinil}benzamida 529,6
- 580
- 4-[(3-{[(aminoacetil)amino]metil}fenil)etinil]-N-{(1S,2R)-2hidroxi-1-[(hidroxiamino)carbonil]propil}benzamida 425,5
- 581
- 4-[(2-aminopyrimidin-5-il)etinil]-N-{(1S,2R)-2-hidroxi-1[(hidroxiamino)carbonil]propil}benzamida 356,4
- 582
- 4-[(4-acetilfenil)etinil]-N-{(1S,2R)-2-hidroxi-1[(hidroxiamino)carbonil]propil}benzamida 381,4
- 583
- N-{(1S,2R)-2-hidroxi-1-[(hidroxiamino)caibonil]propil}-4-[(4{[({2-[4-(fenilmetil)piperazin-1il]etil}amino)acetil]amino}fenil)etinil]benzamida 613,7
- 584
- 4-{[4-({[(aminoacetil)amino]acetil}amino)fenil]etinil}-N{(1S,2R)-2-hidroxi-1-[(hidroxiamino)carbonil]propil}benzamida 468,5
- 585
- 4-{[4-({[4-(2-hidroxietil)piperazin-1-il]acetil)amino)fenil]etinil}-N{(1S,2R)-2-hidroxi-1-[(hidroxiamino)carbonil]propil}benzamida 524,6
- 586
- N-{(1S,2R)-2-hidroxi-1-[(hidroxiamino)carbonil]propil}-4-({4[({(3R}-3-[(trifluoroacetil)amino]pirrolidin-1il)acetil)amino]fenil}etinil)benzamida 576,5
- 587
-
imagen154 N-{(1S,2R)-2-hidroxi-1-[(hidroxiamino)carbonil]propil}-4-[(4{[(metilamino)acetil]amino}fenil)etinil]benzamida 425,5
- Ejemplo
- Estructura Nombre MH+
- 589
- N-{(1S,2R)-2-hidroxi-1-[(hidroxiamino)carbonil]propil}-4-{[4({[(piridin-2-ilmetil)amino]acetil}amino)fenil]etinil}benzamida 502,5
- 590
-
imagen155 N-{(1S,2R)-2-hidroxi-1-[(hidroxiamino)carbonil]propil}-4-{(4({[(piridin-4-ilmetil)amino]acetil}amino)fenil]etinil}benzamida 502,5
- 591
- N-{(1S,2R)-2-hidroxi-1-[(hidroxiamino)carbonil]propil)-4-{[4({[(2-piridin-3-iletil)amino]acetil}amino)fenil]etinil}benzamida 516,6
- 592
- N-{(1S,2R)-2-hidroxi-1-[(hidroxiamino)carbonil]propil}-4-{[4({[(2-piridin-4-iletil)amino]acetil}amino)fenil]etinil}benzamida 516,6
- 593
- 4-({4-[({[(2-fluorofenil)metil]amino}acetil)amino]fenil}etinil)-N{(1S,2R)-2-hidroxi-1-[(hidroxiamino)carbonil]propil}benzamida 519,5
- 594
-
imagen156 4-({4-[({[(2-clorofenil)metil]amino}acetil)amino]fenil}etinil)-N{(1S,2R)-2-hidroxi-1-[(hidroxiamino)carbonil]propil}benzamida 536,0
- 595
-
imagen157 N-{(1S,2R)-2-hidroxi-1-[(hidroxiamino)carbonil]propil)-4-[(4{[({[2(metiloxi)fenil]metil}amino)acetil]amino}fenil)etinil]benzami da 531,6
- 596
-
imagen158 4-({4-[({[(3-fluorofenil)metil]amino}acetil)amino]fenil}etinil)-N{(1S,2R)-2-hidroxi-1-[(hidroxiamino)carbonil]propil}benzamida 519,5
- 597
- 4-({4-[({[(3-clorofenil)metil]amino}acetil)amino]fenil}etinil)-N{(1S,2R)-2-hidroxi-1-[(hidroxiamino)carbonil]propil}benzamida 536,0
- 598
- N-{(1S,2R)-2-hidroxi-1-[(hidroxiamino)carbonil]propil}-4-[(4{[({[3(metiloxi)fenil]metil}amino)acetil]amino}fenil)etinil]benzami da 531,6
- 599
- N-{(1S,2R)-2-hidroxi-1-[(hidroxiamino)carbonil]propil}-4-({4[({[(3(metilfenil)metil]amino}acetil)amino]fenil}etinil)benzamida 515,6
- 600
- N-{(1S,2R)-2-hidroxi-1-[(hidroxiamino)carbonil]propil}-4-[(4{[({[3(trifluorometil)fenil]metil}amino)acetil]amino}fenil) etinil]benzamida 569,5
- 601
- N-{(1S,2R)-2-hidroxi-1-[(hidroxiamino)carbonil]propil}-4-{[4({[({3-[(trifluorometil)oxi]fenil}metil)amino]acetil}amino)fenil] etinil}benzamida 585,5
- 602
- 4-({4-[({[(4-fluorofenil)metil]amino}acetil)amino]fenil}etinil)-N{(1S,2R)-2-hidroxi-1-[(hidroxiamino)carbonil]propil}benzamida 519,5
- Ejemplo
- Estructura Nombre MH+
- 603
- N-{(1S,2R)-2-hidroxi-1-[(hidroxiamino)carbonil]propil}-4-({4[({[(4-etilfenil)metil]amino}acetil)amino]fenil}etinil)benzamida 515,6
- 604
- 4-[(4-{[({[4(dimetilamino)fenil]metil}amino)acetil]amino}fenil)etinil]-N{(1S,2R)-2-hidroxi-1-[(hidroxiamino)carbonil]propil}benzamida 544,6
- 605
-
imagen159 N-{(1S,2R)-2-hidroxi-1-[(hidroxiamino)carbonil]propil}-4-[(4{[({[4(trifluorometil)fenil]metil}amino)acetil]amino}fenil)etinil]benzami da 569,5
- 606
- 4-[(4-{[({[4-fluoro-2(trifluorometil)fenil]metil}amino)acetil]amino}fenil)etinil]-N{(1S,2R)-2-hidroxi-1-[(hidroxiamino)carbonil]propil}benzamida 587,5
- 607
- 4-({4-[({[(2,4-difluorofenil)metil]amino}acetil)amino]fenil}etinil)N-{(1S,2R)-2-hidroxi-1[(hidroxiamino)carbonil]propil}benzamida 537,5
- 608
- 4-({4-[({[(2,4-diclorofenil)metil]amino}acetil)amino]fenil}etinil)N-{(1S,2R)-2-hidroxi-1[(hidroxiamino)carbonil]propil}benzamida 570,4
- 609
- 4-{[4-({[(2-fluorofenil)amino]acetil}amino)fenil]etinil}-N{(1S,2R)-2-hidroxi-1-[(hidroxiamino)carbonil]propil}benzamida 505,5
- 610
- 4-{[4-({[(4-fluorofenil)amino]acetil}amino)fenil]etinil}-N{(1S,2R)-2-hidroxi-1-[(hidroxiamino)carbonil]propil}benzamida 505,5
- 611
- 4-({4-[({[(3,5-difluorofenil)metil]amino}acetil)amino]fenil}etinil)N-{(1S,2R)-2-hidroxi-1[(hidroxiamino)carbonil]propil}benzamida 537,5
- 612
- 4-{[4-({[(4-bromofenil)amino]acetil}amino)fenil]etinil}-N{(1S,2R)-2-hidroxi-1-[(hidroxiamino)carbonil]propil}benzamida 566,4
- 613
- 4-({4-[({[4-(dimetilamino)fenil]amino}acetil)amino]fenil}etinil)-N{(1S,2R)-2-hidroxi-1-[(hidroxiamino)carbonil]propil}benzamida 530,6
- 614
- N-[(1S)-1-(aminometil)-2-(hidroxiamino)-2-oxoetil]-4-[(4-{[(2S)2-aminopropanoil]amino}fenil)etinil] benzamida 410,4
- 615
- N-[(1S)-1-(aminometil)-2-(hidroxiamino)-2-oxoetil]-4-[(4-{[(2R)2-aminopropanoil]amino}fenil)etinil] benzamida 410,4
- 616
- N-[(1S)-1-(aminometil)-2-(hidroxiamino)-2-oxoetil]-4-[(4-{[(2S)2-amino-4-metilpentanoil]amino}fenil)etinil] benzamida 452,5
- Ejemplo
- Estructura Nombre MH+
- 617
- 4-[(4-{[(2S,3R)-2-amino-3-hidroxibutanoil]amino}fenil)etinil]-N[(1S)-1-(aminometil)-2-(hidroxiamino)-2-oxoetil]benzamida 440,5
- 618
- 4-[(4-{[(2S)-2-amino-4-cianobutanoil]amino}fenil)etinil]-N[(1S)-1-(aminometil)-2-(hidroxiamino)-2-oxoetil]benzamida 449,5
- 619
- N-[(1S)-1-(aminometil)-2-(hidroxiamino)-2-oxoetil]-4-[(4-{[(2S)2,3-diaminopropanoil]amino}fenil)etinil] benzamida 425,5
- 620
- (2S)-N-(4-{[4-({[(1S)-1-(aminometil)-2-(hidroxiamino)-2oxoetil]amino}carbonil)fenil]etinil} fenil)pirrolidina-2carboxamida 436,5
- 621
- (2S)-N-(4-{[4-({[(1S)-1-(aminometil)-2-(hidroxiamino)-2oxoetil]amino}carbonil)fenil]etinil} fenil)piperidina-2carboxamida 450,5
- 622
- N-(4-{[4-({[(1S)-1-(aminometil)-2-(hidroxiamino)-2oxoetil]amino}carbonil)fenil]etinil} fenil)piperidina-3carboxamida 450,5
- 623
- 4-[(4-{[(2S)-2-amino-3-(1H-imidazol-4il)propanoil]amino}fenil)etinil]-N-[(1S)-1-(aminometil)-2(hidroxiamino)-2-oxoetil]benzamida 476,5
- 624
-
imagen160 N-[(1S)-1-(aminometil)-2-(hidroxiamino)-2-oxoetil]-4-[(4metilfenil)etinil]benzamida 338,4
- 625
- N-[(1S)-1-(aminometil)-2-(hidroxiamino)-2-oxoetil]-4-[(2fluorofenil)etinil]benzamida 342,3
- 626
- N-[(1S)-1-(aminometil)-2-(hidroxiamino)-2-oxoetil]-4-[(3fluorofenil)etinil]benzamida 342,3
- 627
- N-[(1S)-1-(aminometil)-2-(hidroxiamino)-2-oxoetil]-4-[(4fluorofenil)etinil]benzamida 342,3
- Ejemplo
- Estructura Nombre MH+
- 628
- N-[(1S)-1-(aminometil)-2-(hidroxiamino)-2-oxoetil]-4-[(4clorofenil)etinil]benzamida 358,8
- 629
- 4-[(4-{[(2S)-2-amino-4-metilpentanoil]amino}fenil)etinil]-N{(1S,2R)-2-hidroxi-1-[(hidroxiamino)carbonil]propil}benzamida 467,5
- 630
- 4-[(4-{[(2S)-2-amino-4-cianobutanoil]amino}fenil)etinil]-N{(1S,2R)-2-hidroxi-1-[(hidroxiamino)carbonil]propil}benzamida 464,5
- 631
- 4-[(4-{[(2S)-2,3-diaminopropanoil]amino}fenil)etinil]-N{(1S,2R)-2-hidroxi-1-[(hidroxiamino)carbonil]propil}benzamida 440,5
- 632
- N-[4-({4-[({(1S,2R)-2-hidroxi-1[(hidroxiamino)carbonil]propil}amino) carbonil]fenil}etinil)fenil]piperidina-3-carboxamida 465,5
- 633
- N-{(1S,2R)-2-hidroxi-1-[(hidroxiamino)carbonil]propil}-4-({3[(morfolin-4-ilacetil)amino]fenil}etinil)benzamida 481,5
- 634
- N-{(1S,2R)-2-hidroxi-1-[(hidroxiamino)carbonil]propil}-4(pirazin-2-iletinil)benzamida 341,3
- 635
- N-{(1S,2R)-2-hidroxi-1-[(hidroxiamino)carbonil]propil}-4-({4[({[3-(1H-imidazol-1il)propil]amino}acetil)amino]fenil}etinil)benzamida 519,6
- 637
-
imagen161 ácido 4-({4-[({(1S,2R)-2-hidroxi-1[(hidroxiamino)carbonil]propil}amino)carbonil]fenil}etinil)benzoi co 383,4
- 638
- N-(2-{[4-({4-[({(1S,2R)-2-hidroxi-1[(hidroxiaminocarbonil]propil}amino}carbonil]fenil}etinil) fenil]amino}-2-oxoetil)-1,3-benzodioxol-4-carboxamida 559,5
- 639
- 4-({4-[((2R)-2-{[(2R)-2,5-diaminopentanoil]amino}-4fenilbutanoil)amino]fenil}etinil)-N-{(1S,2R)-2-hidroxi-1[(hidroxiamino)carbonil]propil}benzamida 629,7
- Ejemplo
- Estructura Nombre MH+
- 640
- 4-[(4-{[(2R)-2-amino-4-fenilbutanoil}amino}fenil)etinil]-N{(1S,2R)-2-hidroxi-1-[(hidroxiamino)carbonil]propil}benzamida 515,6
- 641
- 4-[(4-{[(2S)-2-amino-3-fenilpropanoil]amino}fenil)etinil]-N{(1S,2R)-2-hidroxi-1-[(hidroxiamino)carbonil]propil}benzamida 501,6
- 642
- 4-{[4-({[(2-aminoetil)amino]acetil}amino)fenil]etinil}-N-{(1S,2R)2-hidroxi-1-[(hidroxiamino)carbonil]propil}benzamida 454,5
- 643
- N-{(1S)-2-(hidroxiamino)-1-[({[metil(1-metilpiperidin-4il)amino]acetil}amino)metil]-2-oxoetil)-4-(feniletinil)benzamida 492,6
- 644
- 4-[(4-{[(ciclobutilamino)acetil]amino}fenil)etinil]-N-{(1S,2R)-2hidroxi-1-[(hidroxiamino)carbonil]propil}benzamida 465,5
- 645
- 4-[(4-{[(ciclopentilamino)acetil]amino}fenil)etinil]-N-{(1S,2R)-2hidroxi-1-[(hidroxiamino)carbonil]propil}benzamida 479,5
- 646
- 4-[(4-{[(ciclohexilamino)acetil]amino}fenil)etinil]-N-{(1S,2R)-2hidroxi-1-[(hidroxiamino)carbonil]propil}benzamida 493,6
- 647
- 4-[(4-{[(cicloheptilamino)acetil]amino}fenil)etinil]-N-{(1S,2R)-2hidroxi-1-[(hidroxiamino)carbonil]propil}benzamida 507,6
- 648
- 4-[(4-{[(ciclooctilamino)acetil]amino}fenil)etinil]-N-{(1S,2R)-2hidroxi-1-[(hidroxiamino)carbonil]propil}benzamida 521,6
- 649
- N-{(1S,2R)-2-hidroxi-1-[(hidroxiamino)carbonil]propil}-4-[(4{[(propilamino)acetil]amino}fenil)etinil]benzamida 453,5
- 650
- 4-[(4-{[(hexilamino)acetil]amino}fenil)etinil]-N-{(1S,2R)-2hidroxi-1-[(hidroxiamino)carbonil]propil}benzamida 495,6
- 651
- N-{(1S,2R)-2-hidroxi-1-[(hidroxiamino)carbonil]propil}-4-{[4({[(1-metiletil)amino]acetil}amino)fenil]etinil}benzamida 453,5
- 652
- 4-{[4-({[(1,1-dimetiletil)amino]acetil}amino)fenil]etinil}-N{(1S,2R}-2-hidroxi-1-[(hidroxiamino)carbonil]propil}benzamida 467,5
- Ejemplo
- Estructura Nombre MH+
- 653
- 4-{[4-({[etil(metil)amino]acetil}amino)fenil]etinil}-N-{(1S,2R)-2hidroxi-1-[(hidroxiamino)carbonillpropil}benzamida 453,5
- 654
- 4-[(4-{[(dietilamino)acetil]amino}fenil)etinil]-N-{(1S,2R)-2hidroxi-1-[(hidroxiamino)carbonil]propil}benzamida 467,5
- 655
- 4-{[4-({[(1,1-dimetiletil)(metil)amino]acetil}amino)fenil]etinil}-N{(1S,2R)-2-hidroxi-1-[(hidroxiamino)carbonil]propil}benzamida 481,6
- 656
- 4-{[4-({[ciclohexil(metil)amino]acetil}amino)fenil]etinil}-N{(1S,2R)-2-hidroxi-1-[(hidroxiamino)carbonil]propil}benzamida 507,6
- 657
- 4-{[4-({[bis(1-metiletil)amino]acetil}amino)fenil]etinil}-N{(1S,2R)-2-hidroxi-1-[(hidroxiamino)carbonil]propil}benzamida 495,6
- 658
- 4-{[4-({[(ciclohexilmetil)amino]acetil}amino)fenil]etinil}-N{(1S,2R)-2-hidroxi-1-[(hidroxiamino)carbonil]propil}benzamida 507,6
- 659
- 4-{[4-({[(2,3-dimetilciclohexil)amino]acetil}amino)fenil]etinil}-N{(1S,2R)-2-hidroxi-1-[(hidroxiamino)carbonil]propil}benzamida 521,6
- 660
- 4-{[4-({[(1R,2R,4S)-biciclo[2.2.1]hept-2ilamino]acetil}amino)fenil]etinil-N-{(1S,2R)-2-hidroxi-1[(hidroxiamino)carbonil]propil}benzamida 505,6
- 661
- 4-[(4-{[({[(1S,2R,5S)-6,6-dimetilbiciclo[3.1.1]hept-2il]metil}amino)acetil]amino}fenil)etinil]-N-{(1S,2R)-2-hidroxi-1[(hidroxiamino)carbonil]propil}benzamida 547,7
- 662
- N-{(1S,2R)-2-hidroxi-1-[(hidroxiamino)carbonil]propil}-4-{[4({[4-(trifluorometil)piperidin-1il]acetil}amino)fenil]etinil}benzamida 547,5
- 663
- N-[(1S)-1-(aminometil)-2-(hidroxiamino)-2-oxoetil]-4-({4-[({[(2fluorofenil)metil]amino}acetil)amino] fenil}etinil)benzamida 504,5
- 664
- N-[(1S)-1-(aminometil)-2-(hidroxiamino)-2-oxoetil]-4-({4-[({[(2clorofenil)metil]amino}acetil)amino] fenil}etinil)benzamida 521,0
- 665
- N-[(1S)-1-(aminometil)-2-(hidroxiamino)-2-oxoetil]-4-({4-[({[(2metilfenil)metil]amino}acetil)amino] fenil}etinil)benzamida 500,6
- 666
- N-[(1S)-1-(aminometil)-2-(hidroxiamino)-2-oxoetil]-4-[(4-{[({[2(metiloxi)fenil]metil}amino)acetil] amino}fenil)etinil]benzamida 516,6
- Ejemplo
- Estructura Nombre MH+
- 667
- N-[(1S)-1-(aminometil)-2-(hidroxiamino)-2-oxoetil]-4-[(4-{[({[2(trifluorometil)fenil]metil}amino)acetil] amino}fenil)etinil]benzamida 554,5
- 668
- N-[(1S)-1-(aminometil)-2-(hidroxiamino)-2-oxoetil]-4-{[4-({[({2[(fluorometil)oxi]fenil}metil)amino] acetil}amino)fenil]etinil}benzamida 570,5
- 669
- N-[(1S)-1-(aminometil)-2-(hidroxiamino)-2-oxoetil]-4-({4-[({[(3fluorofenil)metil]amino}acetil)amino] fenil}etinil)benzamida 504,5
- 670
- N-[(1S)-1-(aminometil)-2-(hidroxiamino)-2-oxoetil]-4-({4-[({[(3clorofenil)metil]amino}acetil)amino] fenil}etinil)benzamida 521,0
- 671
-
imagen162 N-[(1S)-1-(aminometil)-2-(hidroxiamino)-2-oxoetil]-4-({4-[({[(3metilfenil)metil]amino}acetil)amino] fenil}etinil)benzamida 500,6
- 672
- N-[(1S)-1-(aminometil)-2-(hidroxiamino)-2-oxoetil]-4-[(4-{[({[3(metiloxi)fenil]metil}amino)acetil] amino}fenil)etinil]benzamida 516,6
- 673
- N-[(1S)-1-(aminometil)-2-(hidroxiamino)-2-oxoetil]-4-[(4-{[({[3(trifluorometil)fenil]metil}amino)acetil] amino}fenil)etinil]benzamida 554,5
- 674
- N-[(1S)-1-(aminometil)-2-(hidroxiamino)-2-oxoetil]-4-{[4-({[({3[(fluorometil)oxi]fenil}metil)amino] acetil}amino)fenil]etinil}benzamida 570,5
- 675
- N-[(1S)-1-(aminometil)-2-(hidroxiamino)-2-oxoetil]-4-({4-[({[(4fluorofenil)metil]amino}acetil)amino] fenil}etinil)benzamida 504,5
- 676
- N-[(1S)-1-(aminometil)-2-(hidroxiamino)-2-oxoetil]-4-({4-[({[(4clorofenil)metil]amino}acetil)amino] fenil}etinil)benzamida 521,0
- 677
- N-[(1S)-1-(aminometil)-2-(hidroxiamino)-2-oxoetil]-4-({4-[({[(4metilfenil)metil]amino}acetil)amino] fenil}etinil)benzamida 500,6
- 678
- N-[(1S)-1-(aminometil)-2-(hidroxiamino)-2-oxoetil]-4-[(4-{[({[4(metiloxi)fenil]metil}amino)acetil] amino}fenil)etinil]benzamida 516,6
- 679
- N-[(1S)-1-(aminometil)-2-(hidroxiamino)-2-oxoetil]-4-[(4-{[({[4(trifluorometil)fenil]metil}amino)acetil] amino}fenil)etinil]benzamida 554,5
- Ejemplo
- Estructura Nombre MH+
- 680
- N-[(1S)-1-(aminometil)-2-(hidroxiamino)-2-oxoetil]-4-[(4-{[({[4(1,1-dimetiletil)fenil]metil}amino)acetil] amino}fenil)etinil]benzamida 542,6
- 681
- N-[(1S)-1-(aminometil)-2-(hidroxiamino)-2-oxoetil]-4-({4[({[(1R)-1-feniletil]amino}acetil)amino]fenil} etinil)benzamida 500,6
- 682
- N-[(1S)-1-(aminometil)-2-(hidroxiamino)-2-oxoetil]-4-({4[({[(1S)-1-feniletil]amino}acetil)amino]fenil} etinil)benzamida 500,6
- 683
- N-[(1S)-1-(aminometil)-2-(hidroxiamino)-2-oxoetil]-4-{[4({[(ciclohexilmetil)amino]acetil}amino) fenil]etinil}benzamida 492,6
- 684
- N-[(1S)-1-(aminometil)-2-(hidroxiamino)-2-oxoetil]-4-[(4{[(ciclobutilamino)acetil]amino}fenil) etinil]benzamida 450,5
- 685
- N-[(1S)-1-(aminometil)-2-(hidroxiamino)-2-oxoetil]-4-[(4{[(ciclopentilamino)acetil]amino}fenil) etinil]benzamida 464,5
- 686
-
imagen163 N-[(1S)-1-(aminometil)-2-(hidroxiamino)-2-oxoetil]-4-[(4{[(ciclohexilamino)acetil]amino}fenil) etinil]benzamida 478,6
- 687
-
imagen164 N-[(1S)-1-(aminometil)-2-(hidroxiamino)-2-oxoetil]-4-[(4{[(cicloheptilamino)acetil]amino}fenil) etinil]benzamida 492,6
- 688
- N-[(1S)-1-(aminometil)-2-(hidroxiamino)-2-oxoetil]-4-[(4{[(ciclooctilamino)acetil]amino}fenil) etinil]benzamida 506,6
- 689
- N-[(1S)-1-(aminometil)-2-(hidroxiamino)-2-oxoetil]-4-[(4{[(etilamino)acetil]amino}fenil)etinil] benzamida 424,5
- 690
- N-[(1S)-1-(aminometil)-2-(hidroxiamino)-2-oxoetil]-4-[(4{[(propilamino)acetil]amino}fenil)etinil] benzamida 438,5
- 691
- N-[(1S)-1-(aminometil)-2-(hidroxiamino)-2-oxoetil]-4-[(4{[(butilamino)acetil]amino}fenil)etinil] benzamida 452,5
- Ejemplo
- Estructura Nombre MH+
- 692
- N-[(1S)-1-(aminometil)-2-(hidroxiamino)-2-oxoetil]-4-[(4{[(hexilamino)acetil]amino}fenil)etinil] benzamida 480,6
- 693
-
imagen165 N-[(1S)-1-(aminometil)-2-(hidroxiamino)-2-oxoetil]-4-{[4-({[(1metiletil)amino]acetil}amino)fenil] etinil}benzamida 438,5
- 694
-
imagen166 N-[(1S)-1-(aminometil)-2-(hidroxiamino)-2-oxoetil]-4-{[4({[(1,1-dimetiletil)amino]acetil}amino)fenil] etinil}benzamida 452,5
- 695
-
imagen167 N-[(1S)-1-(aminometil)-2-(hidroxiamino)-2-oxoetil]-4-{(4({[etil(metil)amino]acetil}amino)fenil] etinil}benzamida 438,5
- 696
-
imagen168 N-[(1S)-1-(aminometil)-2-(hidroxiamino)-2-oxoetil]-4-[(4{[(dietilamino)acetil]amino}fenil) etinil]benzamida 452,5
- 697
- N-[(1S)-1-(aminometil)-2-(hidroxiamino)-2-oxoetil]-4-{[4({[(1,1-dimetiletil)(metil)amino]acetil}amino) fenil]etinil}benzamida 466,6
- 698
- N-[(1S)-1-(aminometil)-2-(hidroxiamino)-2-oxoetil]-4-{[4({[ciclohexil(metil)amino]acetil}amino) fenil]etinil}benzamida 492,6
- 699
- N-[(1S)-1-(aminometil)-2-(hidroxiamino)-2-oxoetil]-4-({4-[({[2(2-fluorofenil)etil]amino}acetil)amino] fenil}etinil)benzamida 518,6
- 700
- N-[(1S)-1-(aminometil)-2-(hidroxiamino)-2-oxoetil]-4-({4-[({[2(3-fluorofenil)etil]amino}acetil)amino] fenil}etinil)benzamida 518,6
- 701
- N-[(1S)-1-(aminometil)-2-(hidroxiamino)-2-oxoetil]-4-({4-[({[2(4-fluorofenil)etil]amino}acetil)amino] fenil}etinil)benzamida 518,6
- 702
- N-[(1S)-1-(aminometil)-2-(hidroxiamino)-2-oxoetil]-4-({4[({[(1S,2R)-2-fenilciclopropil]amino}acetil)amino] fenil}etinil)benzamida 512,6
- 703
- N-[(1S)-1-(aminometil)-2-(hidroxiamino)-2-oxoetil]-4-({4[({[(2,4-difluorofenil)metil]amino}acetil)amino] fenil}etinil)benzamida 522,5
- Ejemplo
- Estructura Nombre MH+
- 704
- N-[(1S)-1-(aminometil)-2-(hidroxiamino)-2-oxoetil]-4-({4[({[(2,4-diclorofenil)metil]amino}acetil)amino] fenil}etinil)benzamida 555,4
- 705
- N-[(1S)-1-(aminometil)-2-(hidroxiamino)-2-oxoetil]-4-[(4-{[({[4fluoro-2-(trifluorometil)fenil]metil}amino)acetil] amino}fenil)etinil]benzamida 572,5
- 706
- N-[(1S)-1-(aminometil)-2-(hidroxiamino)-2-oxoetil]-4-({4[({[(2,5-difluorofenil)metil]amino}acetil)amino] fenil}etinil)benzamida 522,5
- 707
- N-[(1S)-1-(aminometil)-2-(hidroxiamino)-2-oxoetil]-4-({4[({[(3,4-difluorofenil)metil]amino}acetil)amino] fenil}etinil)benzamida 522,5
- 708
- N-[(1S)-1-(aminometil)-2-(hidroxiamino)-2-oxoetil]-4-({4[({[(3,4-diclorofenil)metil]amino}acetil)amino] fenil}etinil)benzamida 555,4
- 709
- N-[(1S)-1-(aminometil)-2-(hidroxiamino)-2-oxoetil]-4-({4[({[(3,4-dimetilfenil)metil]amino}acetil)amino] fenil}etinil)benzamida 514,6
- 710
- N-[(1S)-1-(aminometil)-2-(hidroxiamino)-2-oxoetil]-4-({4[({[(3,5-difluorofenil)metil]amino}acetil)amino] fenil}etinil)benzamida 522,5
- 711
-
imagen169 N-[(1S)-1-(aminometil)-2-(hidroxiamino)-2-oxoetil]-4-({4[({[(3,5-diclorofenil)metil]amino}acetil)amino] fenil}etinil)benzamida 555,4
- 712
- N-[(1S)-1-(aminometil)-2-(hidroxiamino)-2-oxoetil]-4-[(4{[({[3,5-bis(trifluorometil)fenil]metil}amino)acetil]amino} fenil)etinil]benzamida 622,5
- 713
- N-[(1S)-1-(aminometil)-2-(hidroxiamino)-2-oxoetil]-4-({4-[({[(4nitrofenil)metil]amino}acetil)amino] fenil}etinil)benzamida 531,5
- 714
- N-[(1S)-1-(aminometil)-2-(hidroxiamino)-2-oxoetil]-4-[(4{[(piridin-2-ilamino)acetil]amino}fenil)etinil] benzamida 473,5
- 715
- N-[(1S)-1-(aminometil)-2-(hidroxiamino)-2-oxoetil]-4-[(4{[(piridin-3-ilamino)acetil]amino}fenil)etinil] benzamida 473,5
- 716
- N-[(1S)-1-(aminometil)-2-(hidroxiamino)-2-oxoetil]-4-{[4-({[(2fluorofenil)amino]acetil}amino)fenil] etinil}benzamida 490,5
- Ejemplo
- Estructura Nombre MH+
- 717
- N-[(1S)-1-(aminometil)-2-(hidroxiamino)-2-oxoetil]-4-{[4-({[(3fluorofenil)amino]acetil}amino)fenil] etinil}benzamida 490,5
- 718
- N-[(1S)-1-(aminometil)-2-(hidroxiamino)-2-oxoetil]-4-{[4-({[(4fluorofenil)amino]acetil}amino)fenil] etinil}benzamida 490,5
- 719
- N-[(1S)-1-(aminometil)-2-(hidroxiamino)-2-oxoetil]-4-[(4{[(piridin-4-ilamino)acetil]amino}fenil)etinil] benzamida 473,5
- 720
- N-[(1S)-1-(aminometil)-2-(hidroxiamino)-2-oxoetil]-4-{[4({[(2,2,2-trifluoroetil)amino]acetil}amino)fenil] etinil}benzamida 478,4
- 721
- N-{(1S,2R)-2-hidroxi-1-[(hidroxiamino)carbonil]propil}-4-[(4{[(piridin-2-ilamino)acetil]amino}fenil)etinil]benzamida 488,5
- 722
- N-{(1S,2R)-2-hidroxi-1-[(hidroxiamino)carbonil]propil}-4-[(4{[(piridin-3-ilamino)acetil]amino}fenil)etinil]benzamida 488,5
- 723
- N-{(1S,2R)-2-hidroxi-1-[(hidroxiamino)carbonil]propil}-4-[(4{[(piridin-4-ilamino)acetil]amino}fenil)etinil]benzamida 488,5
- 724
- N-{(1S,2R)-2-hidroxi-1-[(hidroxiamino)carbonil]propil}-4-[(4{[(4-fenilpiperazin-1-il)acetil]amino}fenil)etinil]benzamida 556,6
- 725
- 4-{[4-({[4-(4-fluorofenil)piperazin-1-il]acetil}amino)fenil]etinil}-N{(1S,2R)-2-hidroxi-1-[(hidroxiamino)carbonil]propil}benzamida 574,6
- 726
- 4-{[4-({[(1-acetilpiperidin-4il)(ciclopropil)amino]acetil}amino)fenil]etinil}-N-{(1S,2R)-2hidroxi-1-[(hidroxiamino)carbonil]propil}benzamida 576,7
- 727
- 4-[(4-{[(butilamino)acetil]amino}fenil)etinil]-N-{(1S,2R)-2hidroxi-1-[(hidroxiamino)carbonil]propil}benzamida 467,5
- 728
-
imagen170 N-{(1S,2R)-2-hidroxi-1-[(hidroxiamino)carbonil]propil}-4-({4[({[(1R)-1-feniletil]amino}acetil)amino]fenil}etinil)benzamida 515,6
- 729
- N-{(1S,2R)-2-hidroxi-1-[(hidroxiamino)carbonil]propil}-4-({4[({[(1S)-1-feniletil]amino}acetil)amino]fenil}etinil)benzamida 515,6
- 730
- 4-{[4-({[ciclopropil(metil)amino]acetil}amino)fenil]etinil}-N{(1S,2R)-2-hidroxi-1-[(hidroxiamino)carbonil]propil}benzamida 465,5
- Ejemplo
- Estructura Nombre MH+
- 731
- N-{(1S,2R)-2-hidroxi-1-[(hidroxiamino)carbonil]propil}-4-{[4({[metil(fenilmetil)amino]acetil}amino)fenil]etinil}benzamida 515,6
- 732
- N-[(1S)-1-(aminometil)-2-(hidroxiamino)-2-oxoetil]-4-{[4({[ciclopropil(metil)amino]acetil}amino) fenil]etinil}benzamida 450,5
- 733
- 4-[(4-{[(2S)-2-aminopropanoil]amino}fenil)etinil]-N-{(1S,2R)-2hidroxi-1-[(hidroxiamino)carbonil]propil}benzamida 425,5
- 734
- 4-[(4-{[(2R)-2-aminopropanoil]amino}fenil)etinil]-N-{(1S,2R)-2hidroxi-1-[(hidroxiamino)carbonil]propil}benzamida 425,5
- 735
- 4-[(4-{[(2S)-2-amino-3-metilbutanoil]amino}fenil)etinil]-N{(1S,2R)-2-hidroxi-1-[(hidroxiamino)carbonil]propil}benzamida 453,5
- 736
-
imagen171 4-[(4-{[(2S,3R)-2-amino-3-hidroxibutanoil]amino}fenil)etinil]-N{(1S,2R)-2-hidroxi-1-[(hidroxiamino)carbonil]propil}benzamida 455,5
- 737
- (2S)-N-[4-({4-[({(1S,2R)-2-hidroxi-1[(hidroxiamino)carbonil]propil}amino)carbonil]fenil}etinil)fenil] pirrolidin-2-carboxamida 451,5
- 738
- 4-[(4-{[(2S)-2-amino-3-(1H-imidazol-4il)propanoil]amino}fenil)etinil]-N-{(1S,2R)-2-hidroxi-1[(hidroxiamino)carbonil]propil}benzamida 491,5
- 739
- N-{(1S,2R)-2-hidroxi-1-[(hidroxiamino)carbonil]propil}-4-[(4{[(metiloxi)acetil]amino}fenil)etinil] benzamida 426,4
- 740
- 4-[(4-{[(2S)-2-amino-3-metilbutanoil]amino}fenil)etinil]-N[(1S)-1-(aminometil)-2-(hidroxiamino)-2-oxoetil]benzamida 438,5
- 741
- N-[(1S)-1-(aminometil)-2-(hidroxiamino)-2-oxoetil]-4-{[4-({[(3fenilpropil)amino]acetil}amino)fenil] etinil}benzamida 514,6
- 742
- N-{(1S,2R)-2-hidroxi-1-[(hidroxiamino)carbonil]propil}-4-(tien2-iletinil)benzamida 345,4
- 743
- 4-({4-[((2S)-2-{[(2S)-2,5-diaminopentanoil]amino}-3-fenilpropanoil)amino]fenil}etinil)-N-{(1S,2R)-2-hidroxi-1[(hidroxiamino)carbonil]propil}benzamida 615,7
- Ejemplo
- Estructura Nombre MH+
- 744
- 3,4-dihidroxi-N-[(2S)-3-(hidroxiamino)-3-oxo-2-({[4(feniletinil)fenil]carbonil}amino) propil]benzamida 460,5
- 745
- 1,1-dimetiletil 3-[(2-{[(2S)-3-(hidroxiamino)-3-oxo-2-({[4(feniletinil)fenil]carbonil}amino)propil] amino}-2oxoetil)amino]propilcarbamato 538,6
- 746
- N-[(1S)-2-(hidroxiamino)-1-({[(4-metilpiperazin-1il)acetil]amino}metil)-2-oxoetil]-4-(feniletinil)benzamida 464,5
- 747
- 4-{[4-({2-[(2-aminoetil)amino]-2-oxoetil}oxi)fenil]etinil}-N{(1S,2R)-2-hidroxi-1[(hidroxiamino)carbonil]propil}benzamida 455,5
- 748
- N-[(1S)-1-(aminometil)-2-(hidroxiamino)-2-oxoetil]-4-{[3(aminometil)fenil]etinil}benzamida 353,4
- 749
- 1,1-dimetiletil (2S)-3-(hidroxiamino)-2-[({4-[(4-{[2(hidroxiamino)-2-oxoetil]oxi}fenil)etinil]fenil} carbonil)amino]-3oxopropilcarbamato 513,5
- 750
-
imagen172 N-[(1S)-1-(aminometil)-2-(hidroxiamino)-2-oxoetil]-4-[(4-{[2(hidroxiamino)-2-oxoetil]oxi}fenil)etinil]benzamida 413,4
- 751
- 3,4-dihidroxi-N-(2-{[4-({4-[({(1S,2R)-2-hidroxil-1[(hidroxiamino)carbonil]propil}amino)carbonil]fenil}etinil)fenil] amino}-2-oxoetil)benzamida 547,5
- 752
- 4-({4-[({[(2S)-2,5diaminopentanoil]amino}acetil)amino]fenil}etinil)-N-{(1S,2R)-2hidroxi-1-[(hidroxiamino)carbonil]propil}benzamida 525,6
- 753
-
imagen173 4-[(4-{[(2-aminoetil)amino]carbonil}fenil)etinil]-N-{(1S,2R)-2hidroxi-1-[(hidroxiamino)carbonil]propil}benzamida 425,5
- Ejemplo
- Estructura Nombre MH+
- 754
- N-[(1S)-1-[({[(3-aminopropil)amino]acetil}amino)metil]-2(hidroxiamino)-2-oxoetil]-4-(feniletinil)benzamida 438,5
- 755
- ácido 3-({4-[({(1S,2R)-2-hidroxi-1[(hidroxiamino)carbonil]propil}amino)carbonil]fenil}etinil)benzoi co 383,4
- 756
- 4-{[4-({[(3-aminopropil)amino]acetil}amino)fenil]etinil}-N{(1S,2R)-2-hidroxi-1-[(hidroxiamino)carbonil]propil}benzamida 468,5
- 757
-
imagen174 N-[(1S)-1-(aminometil)-2-(hidroxiamino)-2-oxoetil]-4-(pyrazin2-iletinil)benzamida 326,3
- 758
- 4-({3-[(4-aminobutanoil)amino]fenil}etinil)-N-[(1S)-1(aminometil)-2-(hidroxiamino)-2-oxoetil]benzamida 424,5
- 759
- N-[(1S)-1-(aminometil)-2-(hidroxiamino)-2-oxoetil]-4-[(4-{[(2S)2,5-diaminopentanoil]amino}fenil)etinil] benzamida 453,5
- 760
- 4-({2-[(aminoacetil)amino]fenil}etinil)-N-[(1S)-1-(aminometil)-2(hidroxiamino)-2-oxoetil]benzamida 396,4
- 761
- N-[(1S)-1-(aminometil)-2-(hidroxiamino)-2-oxoetil]-4-({4-[2(etilamino)-2-oxoetil]fenil}etinil)benzamida 409,5
- 762
- 4-({4-[(aminoacetil)amino]-3-metilfenil}etinil)-N-[(1S)-1(aminometil)-2-(hidroxiamino)-2-oxoetil]benzamida 410,4
- 763
- 4-({4-[(aminoacetil)amino]fenil}etinil)-N-[(1S)-1-(aminometil)-2(hidroxiamino)-2-oxoetil]-3-fluorobenzamida 414,4
- 764
-
imagen175 N-[(1S)-1-(aminometil)-2-(hidroxiamino)-2-oxoetil]-4-{[4({[(cianometil)amino]acetil}amino) fenil]etinil}benzamida 435,5
- Ejemplo
- Estructura Nombre MH+
- 765
- ácido [4-({4-[({(1S,2R)-2-hidroxi-1[(hidroxiamino)carbonil]propil}amino) carbonil]fenil}etinil)fenil]acético 397,4
- 766
- ácido 4-amino-2-({[4-({4-[({(1S,2R)-2-hidroxi-1[(hidroxiamino)carbonil]propil}amino) carbonil]fenil}etinil)fenil]carbonil} amino)-4-oxobutanoico 497,5
- 767
-
imagen176 ácido 4-amino-2-[({[4-({4-[({(1S,2R)-2-hidroxi-1[(hidroxiamino)carbonil]propil}amino) carbonil]fenil}etinil)fenil]oxi}acetil) amino]-4-oxobutanoico 527,5
- 768
- N-((1S)-2-(hidroxiamino)-1-{[(morfolin-4-ilacetil)amino]metil}2-oxoetil)-4-(feniletinil)benzamida 451,5
- 769
- N-[(1S)-1-[({[(2,3-dihidroxipropil)tio]acetil}amino)metil]-2(hidroxiamino)-2-oxoetil)-4-(feniletinil)benzamida 472,5
- 770
- metil (2S)-3-amino-2-({[4-(feniletinil)fenil]carbonil}amino) propanoato 323,4
- 771
- N-{(1S)-2-(hidroxiamino)-2-oxo-1-[({[(2feniletil)amino]acetil}amino)metil] etil}-4-(feniletinil)benzamida 485,6
- 772
- 4-[(4-{2-[(2-aminoetil)amino]-2-oxoetil}fenil)etinil]-N-{(1S,2R)2-hidroxi-1-[(hidroxiamino)carbonil]propil}benzamida 439,5
- 773
- 4-[(4-{[(6-aminohexil)amino]carbonil}fenil)etinil]-N-{(1S,2R)-2hidroxi-1-[(hidroxiamino)carbonil]propil}benzamida 481,6
- 774
- 4-[4-(4-{[(etilamino)acetil]amino}fenil)buta-1,3-diinil]-N{(1S,2R)-2-hidroxi-1-[(hidroxiamino)carbonil]propil}benzamida 463,5
- Ejemplo
- Estructura Nombre MH+
- 775
- 4-[4-(4-{[(ciclopropilamino)acetil]amino}fenil)buta-1,3-diinil]-N{(1S,2R)-2-hidroxi-1-[(hidroxiamino)carbonil]propil}benzamida 475,5
- 776
- N-{(1S,2R)-2-hidroxi-1-[(hidroxiamino)carbonil]propil}-4-(4-{4[(piperidin-1-ilacetil)amino]fenil}buta-1,3-diinil)benzamida 503,6
- 777
- N-{(1S,2R)-2-hidroxi-1-[(hidroxiamino)carbonil]propil}-4-[4-(4{[(fenilamino)acetil]amino}fenil)buta-1,3-diinil]benzamida 511,5
- 778
- N-{(1S,2R)-2-hidroxi-1-[(hidroxiamino)carbonil]propil}-4-{4-[4({[(fenilmetil)amino]acetil}amino)fenil]buta-1,3-diinil}benzamida 525,6
- 779
- N-{(1S,2R)-2-amino-1-[(hidroxiamino)carbonil]propil}-4'-etil1,1'-bifenil-4-carboxamida 342,4
- 780
- 4-[(4-{[(dimetilamino)acetil]amino}fenil)etinil]-N-{(1S,2R)-2hidroxi-1-[(hidroxiamino)carbonil]propil}benzamida 439,5
- 781
- N-{(1S,2R)-2-hidroxi-1-[(hidroxiamino)carbonil]propil}-4-({4[(pirrolidin-1-ilacetil)amino]fenil}etinil)benzamida 465,5
- 782
- N-{(1S,2R)-2-hidroxi-1-[(hidroxiamino)carbonil]propil}-4-{(4{[(pentilamino)acetil]amino}fenil)etinil]benzamida 481,6
- 783
- N-{(1S,2R)-2-hidroxi-1-[(hidroxiamino)carbonil]propil}-4-{[4({[(tien-2-ilmetil)amino]acetil}amino)fenil]etinil}benzamida 507,6
- 784
- 4-{[4-({[(1H-bencimidazol-2ilmetil)amino]acetil}amino)fenil]etinil}-N-{(1S,2R)-2-hidroxi-1[(hidroxiamino)carbonil]propil}benzamida 541,6
- 785
- 4-{[4-({[(1-benzotien-3-ilmetil)amino]acetil}amino)fenil]etinil}-N{(1S,2R)-2-hidroxi-1-[(hidroxiamino)carbonil]propil}benzamida 557,6
- 786
- 4-(4-{4-[({[(2-fluorofenil)metil]amino}acetil)amino]fenil}buta-1,3diinil)-N-{(1S,2R)-2-hidroxi-1[(hidroxiamino)carbonil]propil}benzamida 543,6
- 787
- 4-(4-{4-[({[(3-fluorofenil)metil]amino}acetil)amino]fenil}buta-1,3diinil)-N-{(1S,2R)-2-hidroxi-1[(hidroxiamino)carbonil]propil}benzamida 543,6
- 788
- 4-(4-{4-[({[(4-fluorofenil)metil]amino}acetil)amino]fenil}buta-1,3diinil)-N-{(1S,2R)-2-hidroxi-1[(hidroxiamino)carbonil]propil}benzamida 543,6
- 789
- N-{(1S,2R)-2-hidroxi-1-[(hidroxiamino)carbonil]propil}-4-(4-{4[({[(2-metilfenil)metil]amino}acetil)amino]fenil}buta-1,3diinil)benzamida 539,6
- Ejemplo
- Estructura Nombre MH+
- 790
- N-{(1S,2R)-2-hidroxi-1-[(hidroxiamino)carbonil]propil}-4-(4-{4[({[(3-metilfenil)metil]amino}acetil)amino]fenil}buta-1,3diinil)benzamida 539,6
- 791
- N-{(1S,2R)-2-hidroxi-1-[(hidroxiamino)carbonil]propil}-4-(4-{4[({[(4-metilfenil)metil]amino}acetil)amino]fenil}buta-1,3diinil)benzamida 539,6
- 792
- N-{(1S,2R)-2-hidroxi-1-[(hidroxiamino)carbonil]propil}-4-{4-[4({[(piridin-2-ilmetil)amino]acetil}atnino)fenil]buta-1,3diinil}benzamida 526,6
- 793
- N-{(1S,2R)-2-hidroxi-1-[(hidroxiamino)carbonil]propil}-4-{4-[4({[(piridin-3-ilmetil)amino]acetil}amino)fenil]buta-1,3diinil}benzamida 526,6
- 794
- N-{(1S,2R)-2-hidroxi-1-[(hidroxiamino)carbonil]propil}-4-{4-[4({[(piridin-4-ilmetil)amino]acetil}amino)fenil]buta-1,3diinil}benzamida 526,6
- 795
- N-{(1S,2R)-2-hidroxi-1-[(hidroxiamino)carbonil]propil}-4-[4-(4{[({[2-(metiloxi)fenil]metil}amino)acetil]amino}fenil)buta-1,3diinil]benzamida 555,6
- 796
- N-{(1S,2R)-2-hidroxi-1-[(hidroxiamino)carbonil]propil}-4-[4-(4{[({[3-(metiloxi)fenil]metil]amino)acetil]amino}fenil)buta-1,3diinil]benzamida 555,6
- 797
- N-{(1S,2R)-2-hidroxi-1-[(hidroxiamino)carbonil]propil}-4-[4-(4{[({[4-(metiloxi)fenil]metil]amino)acetil]amino}fenil)buta-1,3diinil]benzamida 555,6
- 798
-
imagen177 4-{4-[4-({[(2-fluorofenil)amino]acetil}amino)fenil]buta-1,3-diinil}N-{(1S,2R)-2-hidroxi-1[(hidroxiamino)carbonil]propil}benzamida 529,5
- 799
- 4-{4-[4-({[(3-fluorofenil)amino]acetil}amino)fenil]buta-1,3-diinil}N-{(1S,2R)-2-hidroxi-1[(hidroxiamino)carbonil]propil}benzamida 529,5
- 800
-
imagen178 4-{4-[4-({[(4-fluorofenil)amino]acetil]amino}fenillbuta-1,3-diinil}N-{(1S,2R)-2-hidroxi-1[(hidroxiamino)carbonil]propil}benzamida 529,5
- 801
- N-{(1S,2R)-2-hidroxi-1-[(hidroxiamino)carbonil]propil}-4-[4-(4{[(piridin-2-ilamino)acetil]amino}fenil)buta-1,3-diinil]benzamida 512,5
- 802
- N-{(1S,2R)-2-hidroxi-1-[(hidroxiamino)carbonil]propil}-4-[4-(4{[(piridin-3-ilamino)acetil]amino}fenil)buta-1,3-diinil]benzamida 512,5
- 803
- N-{(1S,2R)-2-hidroxi-1-[(hidroxiaminocarbonil]propil}-4-[4-(4{[(piridin-4-ilamino)acetil]amino}fenil)buta-1,3-diinil]benzamida 512,5
- Ejemplo
- Estructura Nombre MH+
- 804
- 4-[4-(4-{[(ciclobutilamino)acetil]amino}fenil)buta-1,3-diinil]-N{(1S,2R)-2-hidroxi-1-[(hidroxiamino)carbonil]propil}benzamida 489,5
- 805
- 4-[4-(4-{[(ciclopentilamino)acetil]amino}fenil)buta-1,3-diinil]-N{(1S,2R)-2-hidroxi-1-[(hidroxiamino)carbonil]propil}benzamida 503,6
- 806
- 4-[4-(4-{[(ciclohexilamino)acetil]amino}fenil)buta-1,3-diinil]-N{(1S,2R)-2-hidroxi-1-[(hidroxiamino)carbonil]propil}benzamida 517,6
- 807
- 4-[4-(4-{[(cicloheptilamino)acetil]amino}fenil)buta-1,3-diinil]-N{(1S,2R)-2-hidroxi-1-[(hidroxiamino)carbonil]propil}benzamida 531,6
- 808
- N-{(1S,2R)-2-hidroxi-1-[(hidroxiamino)carbonil]propil}-4-[4-(4{[(metilamino)acetil]amino}fenil)buta-1,3-diinil]benzamida 449,5
- 809
- N-{(1S,2R)-2-hidroxi-1-[(hidroxiamino)carbonil]propil}-4-[4-(4{[(propilamino)acetil]amino}fenil)buta-1,3-diinil]benzamida 477,5
- 810
- 4-[4-(4-{[(butilamino)acetil]amino}fenil)buta-1,3-diinil]-N{(1S,2R)-2-hidroxi-1-[(hidroxiamino)carbonil]propil}benzamida 491,6
- 811
- N-{(1S,2R)-2-hidroxi-1-[(hidroxiamino)carbonil]propil}-4-[4-(4{[(pentilamino)acetil]amino}fenil)buta-1,3-diinil]benzamida 505,6
- 812
-
imagen179 4-[4-(4-{[(hexilamino)acetil]amino}fenil)buta-1,3-diinil]-N{(1S,2R)-2-hidroxi-1-[(hidroxiamino)carbonil]propil}benzamida 519,6
- 813
- 4-{4-[4-({[etil](metil)amino]acetil}amino)fenil]buta-1,3-diinil}-N{(1S,2R)-2-hidroxi-1-[(hidroxiamino)carbonil]propil}benzamida 477,5
- 814
-
imagen180 N-{(1S,2R)-2-hidroxi-1-[(hidroxiamino)carbonil]propil}-4-{4-[4({[(1-metiletil)amino]acetil}amino)fenil]buta-1,3diinil}benzamida 477,5
- 815
-
imagen181 N-{(1S,2R)-2-hidroxi-1-[(hidroxiamino)carbonil]propil}-4-{4-[4({[(2-metilpropil)amino]acetil}amino)fenil]buta-1,3diinil}benzamida 491,6
- 816
- N-{(1S,2R)-2-hidroxi-1-[(hidroxiamino)carbonil]propil}-4-{4-[4({[(2,2,2-trifluoroetil)amino]acetil}amino)fenil]buta-1,3diinil}benzamida 517,5
- 817
- 4-{4-[4-({[(2-hidroxietil)amino]acetil}amino)fenil]buta-1,3-diinil}N-{(1S,2R)-2-hidroxi-1[(hidroxiamino)carbonil]propil}benzamida 479,5
- 818
- N-{(1S,2R)-2-hidroxi-1-[(hidroxiamino)carbonil]propil}-4-(4-{4[({[2-(metiloxi)etil]amino}acetil)amino]fenil}buta-1,3diinil)benzamida 493,5
- Ejemplo
- Estructura Nombre MH+
- 819
- 4-(4-{4-[({[2-(dimetilamino)etil]amino}acetil)amino]fenil}buta1,3-diinil)-N-{(1S,2R)-2-hidroxi-1[(hidroxiamino)carbonil]propil}benzamida 506,6
- 820
- 4-{4-[4-({[(2-cianoetil)amino]acetil}amino)fenil]buta-1,3-diinil}N-{(1S,2R)-2-hidroxi-1[(hidroxiamino)carbonil]propil}benzamida 488,5
- 821
- N-{(1S,2R)-2-hidroxi-1-[(hidroxiamino)carbonil]propil}-4-(4-{4[(pirrolidin-1-ilacetil)amino]fenil}buta-1,3-diinil)benzamida 489,5
- 822
- 4-(4-{4-[(azepan-1-ilacetil)amino]fenil}buta-1,3-diinil)-N{(1S,2R)-2-hidroxi-1-[(hidroxiamino)carbonil]propil}benzamida 517,6
- 823
-
imagen182 N-{(1S,2R)-2-hidroxi-1-(hidroxiamino)carbonil]propil}-4-[4-(4{[(4-metilpiperazin-1-il)acetil]amino}fenil)buta-1,3diinil]benzamida 518,6
- 824
- N-{(1S,2R)-2-hidroxi-1-[(hidroxiamino)carbonil]propil}-4-(4-{4[(morfolin-4-ilacetil)amino]fenil}buta-1,3-diinil)benzamida 505,5
- 825
- 4-{4-[4-({[ciclohexil(metil)amino]acetil}amino)fenil]buta-1,3diinil}-N-{(1S,2R)-2-hidroxi-1[(hidroxiamino)carbonil]propil}benzamida 531,6
- 826
- N-{(1S,2R)-2-hidroxi-1-[(hidroxiamino)carbonil]propil}-4-(4-{4[({[(1R)-1-feniletil]amino}acetil)amino]fenil)buta-1,3diinil)benzamida 539,6
- 827
- N-{(1S,2R)-2-hidroxi-1-[(hidroxiamino)carbonil]propil}-4-(4-{4[({[(1S)-1-feniletil]amino}acetil)amino]fenil}buta-1,3diinil)benzamida 539,6
- 828
- N-{(1S,2R)-2-hidroxi-1-[(hidroxiamino)carbonil]propil}-4-{4-[4({[(2-feniletil)amino]acetil}amino)fenil]buta-1,3-diinil}benzamida 539,6
- 829
-
imagen183 N-{(1S,2R)-2-hidroxi-1-[(hidroxiamino)carbonil]propil}-4-(4-{4[(1H-imidazol-1-ilacetil)amino]fenil}buta-1,3-diinil)benzamida 486,5
- 830
- 4-{4-[4-({[(1R,2R,4S}-biciclo[2.2.1]hept-2ilamino]acetil}amino)fenil]buta-1,3-diinil}-N-{(1S,2R)-2-hidroxi1-[(hidroxiamino)carbonil]propil}benzamida 529,6
- 831
- 4-{4-[4-({[(ciclohexilmetil)amino]acetil}amino)fenil]buta-1,3diinil}-N-{(1S,2R)-2-hidroxi-1[(hidroxiamino)carbonil]propil}benzamida 531,6
- 832
-
imagen184 N-[(1S)-1-(aminometil)-2-(hidroxiamino)-2-oxoetil]-4′-etil-2fluoro-1,1′-bifenil-4-carboxamida 346,4
- Ejemplo
- Estructura Nombre MH+
- 833
- 4-({4-[(aminoacetil)amino]fenil}etinil)-N-{(1S,2R)-2-hidroxi-1[(hidroxiamino)carbonil]propil}-3-(metiloxi)benzamida 441,5
- 834
- 4′-etil-N-{(1S,2R)-2-hidroxi-1-[(hidroxiamino)carbonil]propil}-2(metiloxi)-1,1′-bifenil-4-carboxamida 373,4
- 835
- N-{(1S,2R)-2-hidroxi-1-[(hidroxiamino)carbonil]propil}-3(metiloxi)-4-(feniletinil)benzamida 369,4
- 836
- 4-[(4-etilfenil)etinil]-N-{(1S,2R}-2-hidroxi-1[(hidroxiamino)carbonil]propil}benzamida 367,4
- 837
-
imagen185 N-{(1S,2R)-2-hidroxi-1-[(hidroxiamino)carbonil]propil}-4-[(4hidroxifenil)etinil]benzamida 355,4
- 838
- ácido 2-[(2-{[(2S)-3-(hidroxiamino)-3-oxo-2-({[4(feniletinil)fenil]carbonil}amino) propil]amino}-2oxoetil)tio]propanoico 470,5
- 839
- ácido 4-amino-2-[(2-{[(2S)-3-(hidroxiamino)-3-oxo-2-({[4(feniletinil)fenil]carbonil}amino) propil]amino}-2-oxoetil)amino]4-oxobutanoico 496,5
- 840
- 1,1-dimetiletil 4-amino-2-[(2-{[(2S)-3-(hidroxiamino)-3-oxo-2({[4-(feniletinil)fenil]carbonil}amino) propil]amino}-2oxoetil)amino]-4-oxobutanoato 552,6
- 841
- 2,6-dihidroxi-N-[(2S)-3-(hidroxiamino)-3-oxo-2-({[4(feniletinil)fenil]carbonil}amino) propil]piridina-4-carboxamida 461,4
- 842
- N-[(1S)-1-(aminometil)-2-(hidroxiamino)-2-oxoetil]-4-[(4aminofenil)etinil]benzamida 339,4
- Ejemplo
- Estructura Nombre MH+
- 843
-
imagen186 N-[(1S)-1-(aminometil)-2-(hidroxiamino)-2-oxoetil]-4-[(4etilfenil)etinil]benzamida 352,4
- 844
- N-[(1S)-1-(aminometil)-2-(hidroxiamino)-2-oxoetil]-4-[(4etilfenil)etinil]-3-fluorobenzamida 370,4
- 845
- N-[(1S)-1-(aminometil)-2-(hidroxiamino)-2-oxoetil]-4-({4-[(3aminopropanoil)amino]fenil}etinil) benzamida 410,4
- 846
- N-[(1S)-1-(aminometil)-2-(hidroxiamino)-2-oxoetil]-4-[(4{[(dimetilamino)acetil]amino}fenil) etinil]benzamida 424,5
- 847
- 4-({4-[(4-aminobutanoil)amino]fenil}etinil)-N-[(1S)-1(aminometil)-2-(hidroxiamino)-2-oxoetil]benzamida 424,5
- 848
- N-{(1S)-2-(hidroxiamino)-1-[({[2(metiloxi)fenil]metil}amino)metil]-2-oxoetil}-4(feniletinil)benzamida 444,5
- 849
- N-[(1S)-1-[diprop-2-enilamino)metil]-2-(hidroxiamino)-2oxoetil]-4-(feniletinil)benzamida 404,5
- 850
- N-[(1S)-2-(hidroxiamino)-1-({[({[2(metiloxi)fenil]metil}amino)acetil] amino}metil)-2-oxoetil]-4(feniletinil)benzamida 501,6
- 851
- N-((1S)-2-(hidroxiamino)-1-{[({[2(metiloxi)fenil]tio}acetil)amino]metil}-2-oxoetil)-4(feniletinil)benzamida 504,6
- Ejemplo
- Estructura Nombre MH+
- 852
- ácido (2S,3R)-3-amino-2-({[4-(feniletinil)fenil]carbonil}amino) butanoico 323,4
- 853
- N-[(1S)-1-(aminometil)-2-(hidroxiamino)-2-oxoetil]-4-[4-(4{[(dimetilanino)aceil]amino}fenil) buta-1,3-diinil]benzamida 448,5
- 854
- N-[(1S)-1-(aminometil)-2-(hidroxiamino)-2-oxoetil]-4-[4-(4{[(etilamino)acetil]amino}fenil) buta-1,3-diinil]benzamida 448,5
- 855
- N-[(1S)-1-(aminometil)-2-(hidroxiamino)-2-oxoetil]-4-[4-(4{[(ciclopropilamino)acetil]amino}fenil) buta-1,3-diinil]benzamida 460,5
- 856
- N-[(1S)-1-(aminometil)-2-(hidroxiamino)-2-oxoetil]-4-(4-{4[(piperidin-1-ilacetil)amino]fenil}buta-1,3-diinil)benzamida 488,6
- 857
-
imagen187 N-[(1S)-1-(aminometil)-2-(hidroxiamino)-2-oxoetil]-4-[4-(4{[(fenilamino)acetil]amino}fenil) buta-1,3-diinil]benzamida 496,5
- 858
- N-[(1S)-1-(aminometil)-2-(hidroxiamino)-2-oxoetil]-4-{4-[4({[(fenilmetil)amino]acetil}amino) fenil]buta-1,3diinil}benzamida 510,6
- 859
- N-[(1S)-1-(aminometil)-2-(hidroxiamino)-2-oxoetil]-4-[4-(4aminofenil)buta-1,3-diinil]benzamida 363,4
- 860
- N-{(1S,2R)-2-hidroxi-1-[(hidroxiamino)carbonil]propil}-4-[(4{[(pirazin-2-ilamino)acetil]amino}fenil)etinil]benzamida 489,5
- 861
- N-{(1S,2R}-2-hidroxi-1-[(hidroxiamino)carbonil]propil}-4-[(4{[(4-fenilpiperidin-1-il)acetil]amino}fenil)etinil]benzamida 555,6
- 862
-
imagen188 4-{[4-({[4-(2-fluorofenil)piperazin-1-il]acetil}amino)fenil]etinil}-N{(1S,2R)-2-hidroxi-1-[(hidroxiamino)carbonil]propil}benzamida 574,6
- 863
- 4-{[4-({[(1S,4R)-biciclo[2.2.1]hept-2ilamino]acetil)amino)fenil]etinil}-N-{(1S,2R)-2-hidroxi-1[(hidroxiamino)carbonil]propil}benzamida 505,6
- 864
- N-{(1S,2R)-2-hidroxi-1-[(hidroxiamino)carbonil]propil}-4-({4[({[(1S,2S,3S,5R)-2,6,6-trimetilbiciclo[3.1.1]hept-3il]amino}acetil)amino]fenil}etinil)benzamida 547,7
- Ejemplo
- Estructura Nombre MH+
- 865
- N-{(1S,2R)-2-hidroxi-1-[(hidroxiamino)carbonil]propil}-4-{[4({[(triciclo[3,3,1,1~3,7~]dec-1ilmetil)amino]acetil}amino)fenil]etinil}benzamida 559,7
- 866
- N-{(1S,2R)-2-hidroxi-1-[(hidroxiamino)carbonil]propil}-4-{[4({[(4-metilciclohexil)amino]acetil}amino)fenil]etinil}benzamida 507,6
- 867
-
imagen189 N-{(1S,2R)-2-hidroxi-1-[(hidroxiamino)carbonil]propil}-4-{[4({[(2,2,2-trifluoroetil)amino]acetil}amino)fenil]etinil}benzamida 493,5
- 868
- 4-({4-[({[2-(2-fluorofenil)etil]amino}acetil)amino]fenil}etinil)-N{(1S,2R)-2-hidroxi-1-[(hidroxiamino)carbonil]propil}benzamida 533,6
- 869
- 4-({4-[({[2-(3-fluorofenil)etil]amino}acetil}amino]fenil}etinil}-N{(1S,2R)-2-hidroxi-1-[(hidroxiamino)carbonil]propil}benzamida 533,6
- 870
- 4-({4-[({[2-(4-fluorofenil)etil]amino}acetil]amino]fenil}etinil)-N{(1S,2R)-2-hidroxi-1-[(hidroxiamino)carbonil]propil}benzamida 533,6
- 871
- N-{(1S,2R)-2-hidroxi-1-[(hidroxiamino)carbonil]propil}-4-({4[({[(1S,2R)-2fenilciclopropil]aminolacetil)amino]fenil}etinil)benzamida 527,6
- 872
- N-{1S,2R)-2-hidroxi-1-[(hidroxiamino)carbonil]propil}-4-({4[({[(2-metilfenil)metil]amino}acetil)amino]fenil}etinil)benzamida 515,6
- 873
-
imagen190 N-{(1S,2R)-2-hidroxi-1-[(hidroxiamino)carbonil]propil}-4-[(4{[({[2(trifluorometil)fenil]metil}amino)acetil]amino}fenil)etinil]benzami da 569,5
- 874
- N-{(1S,2R)-2-hidroxi-1-[(hidroxiamino)carbonil]propil}-4-{[4({[({2-[(trifluorometil)oxi]fenil}metil)amino]acetil}amino)fenil] etinil}benzamida 585,5
- 875
-
imagen191 4-({4-[({[(4-clorofenil)metil]amino}acetil)amino]fenil}etinil)-N{(1S,2R)-2-hidroxi-1-[(hidroxiamino)carbonil]propil}benzamida 536,0
- 876
- N-{(1S,2R)-2-hidroxi-1-[(hidroxiamino)carbonil]propil}-4-[(4{({(4(metiloxi)fenil]metil}amino)acetil]amino}fenil)etinil]benzamida 531,6
- 877
-
imagen192 4-[(4-{[({[4-(1,1dimetiletil)fenil]metil}amino)acetil]amino}fenil)etinil]-N-{(1S,2R)2-hidroxi-1-[(hidroxiamino)carbonil]propil}benzamida 557,7
- 878
- N-{(1S,2R)-2-hidroxi-1-[(hidroxiamino)carbonil]propil}-4-({4[({[(4-nitrofenil)metil]amino}acetil)amino]fenil}etinil)benzamida 546,5
- Ejemplo
- Estructura Nombre MH+
- 879
- N-{(1S,2R)-2-hidroxi-1-[(hidroxiamino)carbonil]propil}-4-{[4({[({4-[(trifluorometil)oxi)fenil]metil)amino]acetil}amino)fenil] etinil}benzamida 585,5
- 880
- N-{(1S,2R)-2-hidroxi-1-[(hidroxiamino)carbonil]propil}-4-[(4{[({[4(metiltio)fenil]metil]amino)acetil]amino}fenil)etinil]benzamida 547,6
- 881
- N-{(1S,2R)-2-hidroxi-1-[(hidroxiamino)carbonil]propil}-4-{[4({[({4-[(trifluorometil)tio]fenil}metil)amino]acetil}amino)fenil] etinil}benzamida 601,6
- 882
-
imagen193 N-{(1S,2R)-2-hidroxi-1-[(hidroxiamino)carbonil]propil}-4-[(4{[({[4(metilsulfonil)fenil]metil}amino)acetil]amino}fenil)etinil]benzami da 579,6
- 883
- 4-({4-[({[(2,5-difluorofenil)metil]amino}acetil)amino]fenil}etinil)N-{(1S,2R)-2-hidroxi-1[(hidroxiamino)carbonil]propil}benzamida 537,5
- 884
- 4-1({4-[({[2,6-difluorofenil)metil]amino}acetil)amino]fenil}etinil)N-{(1S,2R)-2-hidroxi-1[(hidroxiamino)carbonil]propil}benzamida 537,5
- 885
-
imagen194 4-({4-({[(3,4-difluorofenil)metil]amino}acetil)amino]fenil}etinil)N-{(1S,2R)-2-hidroxi-1[(hidroxiamino)carbonil)carpropil}benzamida 537,5
- 886
- 4-({4-[({[(3,4-diclorofenil)metil]amino}acetil)amino]fenil}etinil)N-{(1S,2R)-2-hidroxi-1[(hidroxiamino)carbonil]propil}benzamida 570,4
- 887
- 4-({4-[({[(3,4-dimetilfenil)metil)amino}acetil]amino]fenil}etinil)N-{(1S,2R)-2-hidroxi-1[(hidroxiamino)carbonil}propil}benzamida 529,6
- 888
- 4-({4-[({[(3,5-diclorofenil)metil]amino}acetil)amino]fenil}etinil)N-{(1S,2R}-2-hidroxi-1[(hidroxiamino)carbonil)propil}benzamida 570,4
- 889
-
imagen195 4-L(4-{[({[3,5bis(trifluorometil)fenil]metil}amino)acetil]amino}fenil)etinil]-N{(1S,2R)-2-hidroxi-1-[(hidroxiamino)carbonil]propil}benzamida 637,5
- 890
- N-{(1S,2R)-2-hidroxi-1-[(hidroxiamino)carbonil]propil}-4-({4[({[(2,3,4trifluorofenil)metil]amino}acetil)amino]fenil}etinil)benzamida 555,5
- 891
- N-{(1S,2R)-2-hidroxi-1-[(hidroxiamino)carbopil]propil}-4-({4[({[(2,4,5trifluorofenil)metil]amino)acetil)amino]fenil}etinil)benzamida 555,5
- 892
-
imagen196 N-{(1S,2R]-2-hidroxi-1-[(hidroxiamino)carbonil}propil}-4-({4[({[(3,4,5trifluorofenil)metil]amino)acetil)amino]fenil}etinil)benzamida 555,5
- Ejemplo
- Estructura Nombre MH+
- 893
-
imagen197 N-[(1S)-1-(aminometil)-2-(hidroxiamino)-2-oxoetil]-4-[(4{[(pentilamino)acetil]amino}fenil) etinil]benzamida 466,6
- 894
- N-[(1S)-1-(aminometil)-2-(hidroxiamino)-2-oxoetil]-4-{[4({[(tien-2-ilmetil)amino]acetil}amino)fenil] etinil}benzamida 492,6
- 895
- N-[(1S)-1-(aminometil)-2-(hidroxiamino)-2-oxoetil]-4-[(4-{[(4fenilpiperidin-1-il)acetil]amino}fenil)etinil]benzamida 540,6
- 896
-
imagen198 N-[(1S)-1-(aminometil)-2-(hidroxiamino)-2-oxoetil]-4-[(4-{[(4fenilpiperazin-1-il)acetil]amino}fenil)etinil]benzamida 541,6
- 897
- N-[(1S)-1-(aminometil)-2-(hidroxiamino)-2-oxoetil]-4-{[4-({[4(2-fluorofenil)piperazin-1-il]acetil}amino)fenil]etinil}benzamida 559,6
- 898
- N-[(1S)-1-(aminometil)-2-(hidroxiamino)-2-oxoetil]-4-{[4-({[4(4-fluorofenil)piperazin-1-il]acetil}amino)fenil]etinil}benzamida 559,6
- 899
- 4-{[4-({[(1-acetilpiperidin-4il)(ciclopropil)amino]acetil}amino)fenil] etinil}-N-[(1S)-1(aminometil)-2-(hidroxiamino)-2-oxoetil]benzamida 561,7
- 900
- N-[(1S)-1-(aminometil)-2-(hidroxiamino)-2-oxoetil]-4-{[4-({[(2,3dimetilciclohexil)amino]acetil}amino) fenil]etinil}benzamida 506,6
- 901
- N-[(1S)-1-(aminometil)-2-(hidroxiamino)-2-oxoetil]-4-{[4({[(1R,2R,4S)-biciclo[2,2,1]hept-2ilamino]acetil}amino)fenil]etinil} benzamida 490,6
- 902
- N-[(1S)-1-(aminometil)-2-(hidroxiamino)-2-oxoetil]-4-[(4{[({[(1S,2R,5S)-6,6-dimetilbiciclo[3,1,1]hept-2il]metil}amino)acetil]amino}fenil) etinil]benzamida 532,7
- 903
- N-[(1S)-1-(aminometil)-2-(hidroxiamino)-2-oxoetil]-4-{[4({[(1S,4R)-biciclo[2,2,1] hept-2-ilamino]acetil}amino)fenil]etinil} benzamida 490,6
- 904
- N-[(1S)-1-(aminometil)-2-(hidroxiamino)-2-oxoetil]-4-({4[({[(1S,2S,3S,5R)-2,6,6-trimetilbiciclo[3,1,1]hept-3il]amino}acetil)amino]fenil}etinil) benzamida 532,7
- Ejemplo
- Estructura Nombre MH+
- 905
- N-[(1S)-1-(aminometil)-2-(hidroxiamino)-2-oxoetil]-4-{[4({[(triciclo[3,3,1,1~3,7~] dec-1ilmetil)amino]acetil}amino)fenil]etinil} benzamida 544,7
- 906
- N-[(1S)-1-(aminometil)-2-(hidroxiamino)-2-oxoetil]-4-({4[({[(2,6-difluorofenil)metil]amino}acetil)amino] fenil}etinil)benzamida 522,5
- 907
- N-[(1S)-1-(aminometil)-2-(hidroxiamino)-2-oxoetil]-4-[(4-{[({[4(metiltio)fenil]metil}amino)acetil] amino}fenil)etinil]benzamida 532,6
- 908
- N-[(1S)-1-(aminometil)-2-(hidroxiamino)-2-oxoetil]-4-[(4-{[({[4(metilsulfonil)fenil]metil}amino)acetil] amino}fenil)etinil]benzamida 564,6
- 909
- N-[(1S)-1-(aminometil)-2-(hidroxiamino)-2-oxoetil]-4-{[4-({[({4[(trifluorometil)tio]fenil}metil)amino] acetil}amino)fenil]etinil}benzamida 586,6
- 910
- N-[(1S)-1-(aminometil)-2-(hidroxiamino)-2-oxoetil]-4-{[4-({[({4[(trifluorometil)oxi]fenil}metil)amino] acetil}amino)fenil]etinil}benzamida 570,5
- 911
- N-[(1S)-1-(aminometil)-2-(hidroxiamino)-2-oxoetil]-4-({4[({[(2,4,5-trifluorofenil)metil]amino}acetil)amino] fenil}etinil)benzamida 540,5
- 912
- N-[(1S)-1-(aminometil)-2-(hidroxiamino)-2-oxoetil]-4-({4[({[(2,3,4-trifluorofenil)metil]amino}acetil)amino] fenil}etinil)benzamida 540,5
- 913
- N-[(1S)-1-(aminometil)-2-(hidroxiamino)-2-oxoetil]-4-({4[({[(3,4,5-trifluorofenil)metil]amino}acetil)amino] fenil}etinil)benzamida 540,5
- 914
- N-[(1S)-1-(aminometil)-2-(hidroxiamino)-2-oxoetil]-4-(4-{4[(pirrolidin-1-ilacetil)amino]fenil}buta-1,3-diinil)benzamida 474,5
- 915
- N-[(1S)-1-(aminometil)-2-(hidroxiamino)-2-oxoetil]-4-(4-{4[(azepan-1-ilacetil)amino]fenil}buta-1,3-diinil)benzamida 502,6
- 916
- N-[(1S)-1-(aminometil)-2-(hidroxiamino)-2-oxoetil]-4-(4-{4[(piperazin-1-ilacetil)amino]fenil}buta-1,3-diinil)benzamida 489,5
- Ejemplo
- Estructura Nombre MH+
- 917
- N-[(1S)-1-(aminometil)-2-(hidroxiamino)-2-oxoetil]-4-[4-(4-{[(4metilpiperazin-1-il)acetil]amino}fenil)buta-1,3-diinil]benzamida 503,6
- 918
- N-[(1S)-1-(aminometil)-2-(hidroxiamino)-2-oxoetil]-4-(4-{4[(morfolin-4-ilacetil)amino]fenil}buta-1,3-diinil)benzamida 490,5
- 919
- N-[(1S)-1-(aminometil)-2-(hidroxiamino)-2-oxoetil]-4-{4-[4({[ciclohexil(metil)amino]acetil}amino) fenil]buta-1,3diinil}benzamida 516,6
- 920
- N-[(1S)-1-(aminometil)-2-(hidroxiamino)-2-oxoetil]-4-(4-{4[({[(2-fluorofenil)metil]amino}acetil)amino] fenil}buta-1,3diinil)benzamida 528,6
- 921
-
imagen199 N-[(1S)-1-(aminometil)-2-(hidroxiamino)-2-oxoetil]-4-(4-{4[({[(3-fluorofenil)metil]amino}acetil)amino] fenil}buta-1,3diinil)benzamida 528,6
- 922
- N-[(1S)-1-(aminometil)-2-(hidroxiamino)-2-oxoetil]-4-(4-{4[({[(4-fluorofenil)metil]amino}acetil)amino] fenil}buta-1,3diinil)benzamida 528,6
- 923
- N-[(1S)-1-(aminometil)-2-(hidroxiamino)-2-oxoetil]-4-(4-{4[({[(2-metilfenil)metil]amino}acetil)amino] fenil}buta-1,3diinil)benzamida 524,6
- 924
- N-[(1S)-1-(aminometil)-2-(hidroxiamino)-2-oxoetil]-4-(4-{4[({[(3-metilfenil)metil]amino}acetil)amino] fenil}buta-1,3diinil)benzamida 524,6
- 925
-
imagen200 N-[(1S)-1-(aminometil)-2-(hidroxiamino)-2-oxoetil]-4-(4-{4[({[(4-metilfenil)metil]amino)acetil)amino]fenil}buta-1,3diinil)benzamida 524,6
- 926
-
imagen201 N-[(1S)-1-(aminometil)-2-(hidroxiamino)-2-oxoetil]-4-{4-[4({[(piridin-2-ilmetil)amino]acetil}amino)fenil] buta-1,3diinil}benzamida 511,6
- 927
- N-[(1S)-1-(aminometil)-2-(hidroxiamino)-2-oxoetil]-4-{4-[4({[(piridin-3-ilmetil)amino]acetil}amino)fenil] buta-1,3diinil}benzamida 511,6
- 928
- N-[(1S)-1-(aminometil)-2-(hidroxiamino)-2-oxoetil]-4-{4-[4({[(piridin-4-ilmetil)amino]acetil}amino)fenil] buta-1,3diinil}benzamida 511,6
- Ejemplo
- Estructura Nombre MH+
- 929
- N-[(1S)-1-(aminometil)-2-(hidroxiamino)-2-oxoetil]-4-[4-(4{[({[2-(metiloxi)fenil]metil}amino)acetil] amino}fenil)buta-1,3diinil]benzamida 540,6
- 930
- N-[(1S)-1-(aminometil)-2-(hidroxiamino)-2-oxoetil]-4-[4-(4{[({[3-(metiloxi)fenil]metil}amino)acetil] amino}fenil)buta-1,3diinil]benzamida 540,6
- 931
- N-[(1S)-1-(aminometil)-2-(hidroxiamino)-2-oxoetil]-4-[4-(4{[({[4-(metiloxi)fenil]metil}amino)acetil] amino}fenil)buta-1,3diinil]benzamida 540,6
- 932
- N-[(1S)-1-(aminometil)-2-(hidroxiamino)-2-oxoetil]-4-{4-[4({[(2-fluorofenil)amino]acetil}amino)fenil] buta-1,3diinil}benzamida 514,5
- 933
-
imagen202 N-[(1S)-1-(aminometil)-2-(hidroxiamino)-2-oxoetil]-4-{4-[4({[(3-fluorofenil)amino]acetil}amino)fenil] buta-1,3diinil}benzamida 514,5
- 934
- N-[(1S)-1-(aminometil)-2-(hidroxiamino)-2-oxoetil]-4-{4-[4({[(4-fluorofenil)amino]acetil}amino)fenil] buta-1,3diinil}benzamida 514,5
- 935
- N-[(1S)-1-(aminometil)-2-(hidroxiamino)-2-oxoetil]-4-[4-(4{[(piridin-2-ilamino)acetil]amino}fenil) buta-1,3diinil]benzamida 497,5
- 936
- N-[(1S)-1-(aminometil)-2-(hidroxiamino)-2-oxoetil]-4-[4-(4{[(piridin-3-ilamino)acetil]amino}fenil) buta-1,3diinil]benzamida 497,5
- 937
- N-[(1S)-1-(aminometil)-2-(hidroxiamino)-2-oxoetil]-4-[4-(4{[(piridin-4-ilamino)acetil]amino}fenil) buta-1,3diinil]benzamida 497,5
- 938
- N-[(1S)-1-(aminometil)-2-(hidroxiamino)-2-oxoetil]-4-[4-(4{[(ciclobutilamino)acetil]amino}fenil) buta-1,3-diinil]benzamida 474,5
- 939
- N-[(1S)-1-(aminometil)-2-(hidroxiamino)-2-oxoetil]-4-[4-(4{[(ciclopentilamino)acetil]amino}fenil) buta-1,3-diinil]benzamida 488,6
- Ejemplo
- Estructura Nombre MH+
- 940
- N-[(1S)-1-(aminometil)-2-(hidroxiamino)-2-oxoetil]-4-[4-(4{[(ciclohexilamino)acetil]amino}fenil) buta-1,3-diinil]benzamida 502,6
- 941
- N-[(1S)-1-(aminometil)-2-(hidroxiamino)-2-oxoetil]-4-[4-(4{[(cicloheptilamino)acetil]amino}fenil) buta-1,3-diinil]benzamida 516,6
- 942
- N-[(1S)-1-(aminometil)-2-(hidroxiamino)-2-oxoetil]-4-[4-(4{[(metilamino)acetil]amino}fenil) buta-1,3-diinil]benzamida 434,5
- 943
- N-[(1S)-1-(aminometil)-2-(hidroxiamino)-2-oxoetil]-4-[4-(4{[(propilamino)acetil]amino}fenil) buta-1,3-diinil]benzamida 462,5
- 944
- N-[(1S)-1-(aminometil)-2-(hidroxiamino)-2-oxoetil]-4-[4-(4{[(butilamino)acetil]amino}fenil) buta-1,3-diinil]benzamida 476,5
- 945
- N-[(1S)-1-(aminometil)-2-(hidroxiamino)-2-oxoetil]-4-[4-(4{[(pentilamino)acetil]amino}fenil) buta-1,3-diinil]benzamida 490,6
- 946
- N-[(1S)-1-(aminometil)-2-(hidroxiamino)-2-oxoetil]-4-[4-(4{[(hexilamino)acetil]amino}fenil) buta-1,3-diinil]benzamida 504,6
- 947
- N-[(1S)-1-(aminometil)-2-(hidroxiamino)-2-oxoetil]-4-{4-[4({[etil(metil)amino]acetil}amino)fenil] buta-1,3-diinil}benzamida 462,5
- 948
- N-[(1S)-1-(aminometil)-2-(hidroxiamino)-2-oxoetil]-4-{4-[4({[(1-metiletil)amino]acetil}amino)fenil] buta-1,3diinil}benzamida 462,5
- 949
- N-[(1S)-1-(aminometil)-2-(hidroxiamino)-2-oxoetil]-4-{4-[4({[(2-metilpropil)amino]acetil}amino)fenil] buta-1,3diinil}benzamida 476,5
- 950
- N-[(1S)-1-(aminometil)-2-(hidroxiamino)-2-oxoetil]-4-{4-[4({[(2-hidroxietil)amino]acetil}amino)fenil] buta-1,3diinil}benzamida 464,5
- 951
- N-[(1S)-1-(aminometil)-2-(hidroxiamino)-2-oxoetil]-4-(4-{4[({[2-(metiloxi)etil]amino}acetil)amino] fenil}buta-1,3diinil)benzamida 478,5
- 952
- N-[(1S)-1-(aminometil)-2-(hidroxiamino)-2-oxoetil]-4-(4-{4[({[2-(dimetilamino)etil]amino}acetil)amino] fenil}buta-1,3diinil)benzamida 491,6
- Ejemplo
- Estructura Nombre MH+
- 953
- N-[(1S)-1-(aminometil)-2-(hidroxiamino)-2-oxoetil]-4-{4-[4({[(2-cianoetil)amino]acetil}amino)fenil] buta-1,3diinil}benzamida 473,5
- 954
-
imagen203 N-[(1S)-1-(aminometil)-2-(hidroxiamino)-2-oxoetil]-4-{4-[4({[(tien-2-ilmetil)amino]acetil}amino)fenil] buta-1,3diinil}benzamida 516,6
- 955
- N-[(1S)-1-(aminometil)-2-(hidroxiamino)-2-oxoetil]-4-(4-{4[({[(1R)-1-feniletil]amino}acetil)amino]fenil} buta-1,3diinil)benzamida 524,6
- 956
- N-[(1S)-1-(aminometil)-2-(hidroxiamino)-2-oxoetil]-4-(4-{4[({[(1S)-1-feniletil]amino}acetil)amino]fenil} buta-1,3diinil)benzamida 524,6
- 957
- N-[(1S)-1-(aminometil)-2-(hidroxiamino)-2-oxoetil]-4-{4-[4({[(2-feniletil)amino]acetil}amino)fenil] buta-1,3diinil}benzamida 524,6
- 958
- N-[(1S)-1-(aminometil)-2-(hidroxiamino)-2-oxoetil]-4-(4-{4[(1H-imidazol-1-ilacetil)amino]fenil}buta-1,3-diinil)benzamida 471,5
- 959
- N-[(1S)-1-(aminometil)-2-(hidroxiamino)-2-oxoetil]-4-{4-[4({[(1R,2R,4S)-biciclo[2,2,1]hept-2-ilamino]acetil}amino)fenil] buta-1,3-diinil}benzamida 514,6
- 960
- N-[(1S)-1-(aminometil)-2-(hidroxiamino)-2-oxoetil]-4-{4-[4({[(ciclohexilmetil)amino]acetil}amino) fenil]buta-1,3diinil}benzamida 516,6
- 961
- N-{(1S,2R)-2-hidroxi-1-[(hidroxiamino)carbonil]propil}-4-[(6piperidin-1-ilpiridin-3-il)etinil]henzamida 423,5
- 962
- N-{(1S,2R)-2-hidroxi-1-[(hidroxiamino)carbonil]propil}-4-{[6-(4metilpiperazin-1-il)piridin-3-il]etinil}benzamida 438,5
- 963
-
imagen204 N-{(1S,2R)-2-hidroxi-1-[(hidroxiamino)carbonil]propil}-4-[(6piperazin-1-ilpiridin-3-il)etinil]benzamida 424,5
- 964
-
imagen205 4-[(6-azepan-1-ilpiridin-3-il)etinil]-N-{(1S,2R)-2-hidroxi-1[(hidroxiamino)carbonil]propil}benzamida 437,5
- 965
- 4-{[6-(ciclobutilamino)piridin-3-il]etinil}-N-{(1S,2R)-2-hidroxi-1[(hidroxiamino)carbonil]propil}benzamida 409,5
- Ejemplo
- Estructura Nombre MH+
- 966
- 4-{[6-(ciclohexilamino)piridin-3-il]etinil}-N-{(1S,2R)-2-hidroxi-1[(hidroxiamino)carbonil]propil}benzamida 437,5
- 967
- 4-{[6-(butilamino)piridin-3-il]etinil}-N-{(1S,2R)-2-hidroxi-1[(hidroxiamino)carbonil]propil}benzamida 411,5
- 968
- 4-({6-[(2-hidroxietil)amino]piridin-3-il}etinil)-N-{(1S,2R)-2hidroxi-1-[(hidroxiamino)carbonil]propil}benzamida 399,4
- 969
- 4-[(6-{[2-(dimetilamino)etil]amino}piridin-3-il)etinil)-N-{(1S,2R)2-hidroxi-1-[(hidroxiamino)carbonil]propil}benzamida 426,5
- 970
- N-{(1S,2R)-2-hidroxi-1-[(hidroxiamino)carbonil]propil}-4-({6[(fenilmetil)amino]piridin-3-il}etinil)benzamida 445,5
- 971
-
imagen206 4-[(6-{[(4-fluorofenil)metil]amino}piridin-3-il)etinil]-N-{(1S,2R)2-hidroxi-1-[(hidroxiamino)carbonil]propil}benzamida 463,5
- 972
- N-{(1S,2R)-2-hidroxi-1-[(hidroxiamino)carbonil]propil}-4-{[6(piridin-4-ilamino)piridin-3-il]etinil}benzamida 432,4
- 973
- 4-[(6-cloropiridin-3-il)etinil]-N-{(1S,2R)-2-hidroxi-1[(hidroxiamino)carbonil]propil}benzamida 374,8
- 974
- 1,1-dimetiletil (2S)-2-[({4-[(4etilfenil)etinil]fenil}carbonil)amino]-3-(hidroxiamino)-3oxopropilcarbamato 452,5
- 975
-
imagen207 N-[(1S)-1-(aminometil)-2-(hidroxiamino)-2-oxoetil]-4-{4-[4({[(1S)-1-(aminometil)-2-(hidroxiamino)-2oxoetil]amino}carbonil)fenil] buta-1,3-diinil}benzamida 493,5
- 976
- N-{(1S,2R)-2-hidroxi-1-[(hidroxiamino)carbonil]propil}-4-{[4(morfolin-4-ilmetil)fenil]etinil}benzamida 438,5
- Ejemplo
- Estructura Nombre MH+
- 977
- 4-[(4-{[(2-aminoetil)amino]metil}fenil)etinil]-N-{(1S,2R)-2hidroxi-1-[(hidroxiamino)carbonil]propil}benzamida 411,5
- 978
- 4-({4-[((2S)-2-amino-5-{[amino(imino)metil]amino}pentanoil) amino]fenil}etinil)-N-[(1S)-1-(aminometil)-2-(hidroxiamino)-2oxoetil] benzamida 495,6
- 979
- ácido (2S)-6-amino-2-({[4-({4-[({(1S,2R)-2-hidroxi-1[(hidroxiamino)carbonil]propil}amino) carbonil]fenil}etinil)fenil]carbonil} amino)hexanoico 511,5
- 980
- ácido (2S)-6-amino-2-({[4-({4-[({(1S,2R)-2-hidroxi-1[(hidroxiamino)carbonil]propil}amino) carbonil]fenil}etinil)fenil]acetil} amino)hexanoico 525,6
- 981
- ácido 5-{[(2S)-3-(hidroxiamino)-3-oxo-2-({[4(feniletinil)fenil]carbonil}amino) propil]amino}-5-oxopentanoico 438,4
- 982
- N-(2-aminoetil)-N′-[(2S)-3-(hidroxiamino)-3-oxo-2-({[4(feniletinil)fenil]carbonil}amino) propil]pentanediamida 480,5
- 983
- N-[(1S)-1-[(2,6-dioxopiperidin-1-il)metil]-2-(hidroxiamino)-2oxoetil]-4-(feniletinil)benzamida 420,4
- 984
-
imagen208 N,N′-bis[(2S)-3-(hidroxiamino)-3-oxo-2-({[4(feniletinil)fenil]carbonil}amino) propil]pentanediamida 743,8
- 985
- N-((1S)-2-(hidroxiamino)-2-oxo-1-{[({[(1S)-1feniletil]amino}acetil)amino]metil} etil)-4-(feniletinil)benzamida 485,6
- 986
- N-{(1S)-2-hidroxi-1-[(hidroxiamino)carbonil]-2-metilpropil}-4(feniletinil)benzamida 353,4
- Ejemplo
- Estructura Nombre MH+
- 987
- N-[(1S)-1-(aminometil)-2-(hidroxiamino)-2-oxoetil]-4-[(6piperidin-1-ilpiridin-3-il)etinil]benzamida 408,5
- 988
- N-[(1S)-1-(aminometil)-2-(hidroxiamino)-2-oxoetil]-4-[(6morfolin-4-ilpiridin-3-il)etinil]benzamida 410,4
- 989
-
imagen209 N-[(1S)-1-(aminometil)-2-(hidroxiamino)-2-oxoetil]-4-{[6-(4metilpiperazin-1-il)piridin-3-il]etinil}benzamida 423,5
- 990
- N-[(1S)-1-(aminometil)-2-(hidroxiamino)-2-oxoetil]-4-[(6piperazin-1-ilpiridin-3-il)etinil]benzamida 409,5
- 991
- N-[(1S)-1-(aminometil)-2-(hidroxiamino)-2-oxoetil]-4-[(6azepan-1-ilpiridin-3-il)etinil]benzamida 422,5
- 992
- N-[(1S)-1-(aminometil)-2-(hidroxiamino)-2-oxoetil]-4-{[6(ciclobutilamino)piridin-3-il]etinil}benzamida 394,4
- 993
- N-[(1S)-1-(aminometil)-2-(hidroxiamino)-2-oxoetil]-4-{[6(ciclohexilamino)piridin-3-il]etinil}benzamida 422,5
- 994
-
imagen210 N-[(1S)-1-(aminometil)-2-(hidroxiamino)-2-oxoetil]-4-{[6(butilamino)piridin-3-il]etinil}benzamida 396,5
- 995
- N-[(1S)-1-(aminometil)-2-(hidroxiamino)-2-oxoetil]-4-[(6-{[2(metiloxi)etil]amino}piridin-3-il)etinil]benzamida 398,4
- 996
- N-{(1S,2R)-2-hidroxi-1-[(hidroxiamino)carbonil]propil}-4-{[4(piperidin-1-ilmetil)fenil]etinil}benzamida 436,5
- 997
-
imagen211 4-[(4-{[(2S)-2-amino-3-(4aminofenil)propanoil]amino)fenil)etinil]-N-{(1S,2R)-2-hidroxi-1[(hidroxiamino)carbonil)propil}benzamida 516,6
- Ejemplo
- Estructura Nombre MH+
- 998
- ácido 4-((2S)-2-amino-3-{[4-({4-[({(1S,2R)-2-hidroxi-1[(hidroxiamino)carbonil]propil)amino)carbonil]fenil}etinil)fenil] amino}-3-oxopropil)benzoico 545,6
- 999
- 1000
-
imagen212 N-{(1S,2R)-2-hidroxi-1-[(hidroxiamino)carbonil]propil}-4-({4[({[1-(hidroximetil)-2metilpropil]aminol]acetil)amino)fenil}etinil)benzamida 497,6
- 1001
- 4-[4-(3-aminofenil)buta-1,3-diinil)-N-{(1S,2R)-2-hidroxi-1[(hidroxiamino)carbonil]propil}benzamida 378,4
- 1002
-
imagen213 4-[4-(3-{[(2-aminoetil)amino]metil}fenil) buta-1,3-diinil]-N{(1S,2R)-2-hidroxi-1-[(hidroxiamino)carbonil]propil}benzamida 435,5
- 1003
-
imagen214 ácido 5-[(4-{[4-({[(1S)-1-(aminometil)-2-(hidroxiamino)-2oxoetil]amino}carbonil)fenil]etinil} fenil)amino]-5-oxopentanoico 453,5
- 1004
-
imagen215 N-(2-aminoetil)-3-{4-[4-({[(1S)-1-(aminometil)-2(hidroxiamino)-2-oxoetil]amino}carbonil)fenil] buta-1,3diinil}benzamida 434,5
- 1005
- N-[(1S)-1-(aminometil)-2-(hidroxiamino)-2-oxoetil]-4-{4-[3(aminometil)fenil] buta-1,3-diinil}benzamida 377,4
- 1006
- N-[(1S)-1-(aminometil)-2-(hidroxiamino)-2-oxoetil]-4-{4-[3(trifluorometil)fenil]buta-1,3-diinil}benzamida 416,4
- 1007
- N-[(1S)-1-(aminometil)-2-(hidroxiamino)-2-oxoetil]-4-buta-1,3diinilbenzamida 272,3
- Ejemplo
- Estructura Nombre MH+
- 1008
- N-[(1S)-1-(aminometil)-2-(hidroxiamino)-2-oxoetil]-4-[4-(2metilfenil)buta-1,3-diinil]benzamida 362,4
- 1009
-
imagen216 4-(4-{4-[(3-aminopropanoil)amino]fenil}buta-1,3-diinil)-N{(1S,2R)-2-hidroxi-1-[(hidroxiamino)carbonil]propil}benzamida 449,5
- 1010
- 4-[4-(3-{[(aminoacetil)amino]metil}fenil) buta-1,3-diinil]-N{(1S,2R)-2-hidroxi-1-[(hidroxiamino)carbonil]propil}benzamida 449,5
- 1011
- 4-(4-{3-[(aminoacetil)amino]fenil}buta-1,3-diinil)-N-{(1S,2R)-2hidroxi-1-[(hidroxiamino)carbonil]propil}benzamida 435,4
- 1012
-
imagen217 4-[4-(4-{[(2S)-2-aminopropanoil]animo}fenil)buta-1,3-diinil]-N{(1S,2R)-2-hidroxi-1-[(hidroxiamino)carbonil]propil}benzamida 449,5
- 1013
- 4-(4-{4-[(aminoacetil)amino]fenil}buta-1,3-diinil)-N-[(1S)-1(aminometil)-2-(hidroxiamino)-2-oxoetil]benzamida 420,4
- 1014
-
imagen218 4-[4-(3-{[(aminoacetil)amino]metil}fenil) buta-1,3-diinil]-N[(1S)-1-(aminometil)-2-(hidroxiamino)-2-oxoetil]benzamida 434,5
- 1015
- N-[(1S)-1-(aminometil)-2-(hidroxiamino)-2-oxoetil]-4-(4-{4-[(3aminopropanoil)amino]fenil}buta-1,3-diinil)benzamida 434,5
- 1016
-
imagen219 4-(4-{3-[(aminoacetil)amino]fenil} buta-1,3-diinil)-N-[(1S)-1(aminometil)-2-(hidroxiamino)-2-oxoetil]benzamida 420,4
- 1017
- 4-[(4-{[(2S)-2-amino-3-(4hidroxifenil)propanoil]amino}fenil)etinill-N-{(1S,2R)-2-hidroxi-1[(hidroxiamino)carbonil]propil}benzamida 517,6
- Ejemplo
- Estructura Nombre MH+
- 1018
- 4-(4-{4-[(aminoacetil)amino]fenil}buta-1,3-diinil)-N-{(1S,2R)-2hidroxi-1-[(hidroxiamino)carbonil]propil}benzamida 435,4
- 1019
- N-[(1S)-1-(aminometil)-2-(hidroxiamino)-2-oxoetil]-4-({4[(butilamino)metil]fenil}etinil) benzamida 409,5
- 1020
- N-[(1S)-1-(aminometil)-2-(hidroxiamino)-2-oxoetil]-4-{[4(piperidin-1-ilmetil)fenil]etinil}benzamida 421,5
- 1021
- N-[(1S)-1-(aminometil)-2-(hidroxiamino)-2-oxoetil]-4-[(4formilfenil)etinil]benzamida 352,4
- 1022
- N-{(1S,2R)-2-hidroxi-1-[(hidroxiamino)carbonil]propil}-4-({4[(metilsulfonil)amino]fenil}etinil)benzamida 432,5
- 1023
-
imagen220 N-[(1S)-1-(aminometil)-2-(hidroxiamino)-2-oxoetil]-4-({4[(metilsulfonil)amino]fenil}etinil) benzamida 417,5
- 1024
- N-[(1S)-1-(aminometil)-2-(hidroxiamino)-2-oxoetil]-4-({4[(fenilsulfonil)amino]fenil}etinil) benzamida 479,5
- 1025
- N-[(1S)-1-(aminometil)-2-(hidroxiamino)-2-oxoetil]-4-(4-{4[(fenilsulfonil)amino]fenil} buta-1,3-diinil)benzamida 503,5
- 1026
-
imagen221 N-[(1S)-1-(aminometil)-2-(hidroxiamino)-2-oxoetil]-4-{[4(morfolin-4-ilmetil)fenil]etinil}benzamida 423,5
- 1027
-
imagen222 N-[(1S)-1-(aminometil)-2-(hidroxiamino)-2-oxoetil]-4-({4-[(4metilpiperazin-1-il)metil]fenil}etinil)benzamida 436,5
- 1028
- N-[(1S)-1-(aminometil)-2-(hidroxiamino)-2-oxoetil]-4-[(4-{[(2hidroxietil)amino]metil}fenil)etinil] benzamida 397,4
- Ejemplo
- Estructura Nombre MH+
- 1029
- N-[(1S)-1-(aminometil)-2-(hidroxiamino)-2-oxoetil]-4-{[4-({[2(metiloxi)etil]amino}metil)fenil] etinil}benzamida 411,5
- 1030
- N-[(1S)-1-(aminometil)-2-(hidroxiamino)-2-oxoetil]-4-({4[(ciclohexilamino)metil]fenil}etinil) benzamida 435,5
- 1031
-
imagen223 N-[(1S)-1-(aminometil)-2-(hidroxiamino)-2-oxoetil]-4-[(4{[(fenilmetil)amino]metil}fenil) etinil]benzamida 443,5
- 1032
- N-[(1S)-1-(aminometil)-2-(hidroxiamino)-2-oxoetil]-4-[(6cloropiridin-3-il)etinil]benzamida 359,8
- 1033
-
imagen224 N-{(1S,2R)-2-hidroxi-1-[(hidroxiamino)carbonil]propil}-4-(4-{4[({[6-(metiloxi)piridin-3-il]amino}acetil)amino]fenil}buta-1,3diinil)benzamida 542,6
- 1034
- 4-{4-[4-({[(6-cloropiridin-3-il)amino]acetil}amino)fenil]buta-1,3diinil}-N-{(1S,2R)-2-hidroxi-1[(hidroxiamino)carbonil]propil}benzamida 547,0
- 1035
- N-{(1S,2R)-2-hidroxi-1-[(hidroxiamino)carbonil]propil}-4-{[4(pirrolidin-1-ilmetil)fenil]etinil}benzamida 422,5
- 1036
- 4-({4-[(etilamino)metil]fenil}etinil)-N-{(1S,2R)-2-hidroxi-1[(hidroxiamino)carbonil]propil}benzamida 396,5
- 1037
- 4-({4-[(dimetilamino)metil]fenil}etinil)-N-{(1S,2R)-2-hidroxi-1[(hidroxiamino)carbonil]propil}benzamida 396,5
- 1038
- N-{(1S,2R)-2-hidroxi-1-[(hidroxiamino)carbonil]propil}-4-({4[(4-metilpiperazin-1-il)metil]fenil}etinil)benzamida 451,5
- 1039
- N-{(1S,2R)-2-hidroxi-1-[(hidroxiamino)carbonil]propil}-4-{[4({[3-(1H-imidazol-1-il)propil]amino}metil)fenil]etinil} benzamida 476,5
- 1040
- N-[(1S)-1-(aminometil)-2-(hidroxiamino)-2-oxoetil]-4-(4-tien-2ilbuta-1,3-diinil)benzamida 354,4
- Ejemplo
- Estructura Nombre MH+
- 1041
- 1042
- 4-[4-(2-aminofenil)buta-1,3-diinil]-N-{(1S,2R)-2-hidroxi-1[(hidroxiamino)carbonil]propil}benzamida 378,4
- 1043
- 4-[4-(3-{[(2-aminoetil)amino]metil}fenil)buta-1,3-diinil]-N-[(1S)1-(aminometil)-2-(hidroxiamino)-2-oxoetil]benzamida 420,5
- 1044
- 4-buta-1,3-diinil-N-{(1S,2R)-2-hidroxi-1[(hidroxiamino)carbonil]propil}benzamida 287,3
- 1045
- 4-[4-(4-{[(2S)-2-amino-4-metilpentanoil]amino}fenil)buta-1,3diinil]-N-{(1S,2R)-2-hidroxi-1[(hidroxiamino)carbonil]propil}benzamida 491,6
- 1046
- (2S)N-[4-(4-{4-[({(1S,2R)-2-hidroxi-1[(hidroxiamino)carbonil]propil)amino)carbonil]fenil}buta-1,3diinil)fenil]pirrolidin-2-carboxamida 475,5
- 1047
- (2S)-N-[4-(4-{4-[({(1S,2R)-2-hidroxi-1[(hidroxiamino)carbonil]propil}amino)carbonil]fenil}buta-1,3diinil)fenil]piperidin-2-carboxamida 489,5
- 1048
- 4-[4-(4-{[(2S)-2,3-diaminopropanoil]amino}fenil)buta-1,3-diinil]N-{(1S,2R)-2-hidroxi-1[(hidroxiamino)carbonil]propil}benzamida 464,5
- 1049
- 4-[4-(4-{[(2S)-2-amino-3-(1H-imidazol-4il)propanoil]amino}fenil)buta-1,3-diinil]-N-{(1S,2R)-2-hidroxi-1[(hidroxiamino)carbonil]propil}beazamida 515,5
- 1050
-
imagen225 N-[1-[(hidroxiamino)carbonil]-2-(propilamino)propil]-4-[(4{[(propilamino)acetil]amino}fenil) etinil]benzamida 494,6
- 1051
- 4-[(4-{[(ciclobutilamino)acetil]amino}fenil) etinil]-N-{2(ciclobutilamino)-1-[(hidroxiamino)carbonil]propil}benzamida 518,6
- Ejemplo
- Estructura Nombre MH+
- 1052
- N-{(1S,2R)-2-amino-1-[(hidroxiamino)carbonil]propil}-4-[(4{[(ciclopropilamino)acetil]amino}fenil) etinil]benzamida 450,5
- 1053
-
imagen226 1-[(1R,2S)-2-[({4-[(4-{[(ciclopropilamino)acetil]amino}fenil) etinil]fenil}carbonil)amino]-3-(hidroxiamino)-1-metil-3oxopropil] triaza-1,2-dien-2-ium 477,5
- 1054
- N-{(1S,2R)-2-amino-1-[(hidroxiamino)carbonil]propil}-4-({4[({[(4-fluorofenil)metil]amino}acetil)amino] fenil}etinil)benzamida 518,6
- 1055
- N-{(1S,2R)-2-amino-1-[(hidroxiamino)carbonil]propil}-4-({4[({[(3-fluorofenil)metil]amino}acetil)amino] fenil}etinil)benzamida 518,6
- 1056
-
imagen227 N-{(1S,2R)-2-amino-1-[(hidroxiamino)carbonil]propil}-4-[(4{[(propilamino)acetil]amino}fenil) etinil]benzamida 452,5
- 1057
- N-{(1S,2R)-2-amino-1-[(hidroxiamino)carbonil]propil}-4-{[4({[(fenilmetil)amino]acetil}amino) fenil]etinil}benzamida 500,6
- 1058
- 1-((1R,2S)-3-(hidroxiamino)-1-metil-3-oxo-2-{[(4-{[4({[(fenilmetil)amino]acetil}amino) fenil]etinil}fenil)carbonil]amino} propil)triaza-1,2-dien-2-ium 527,6
- 1059
-
imagen228 N-{(1S,2R)-2-amino-1-[(hidroxiamino)carbonil]propil}-4-[(4{[(ciclobutilamino)acetil]amino}fenil) etinil]benzamida 464,5
- 1060
- 1-[(1R,2S)-2-[({4-[(4-{[(ciclobutilamino)acetil]amino}fenil) etinil]fenil}carbonil)amino]-3-(hidroxiamino)-1-metil-3oxopropil] triaza-1,2-dien-2-ium 491,5
- 1061
- 4-[(4-etilfenil)etinil]-N-{(1S)-1-[(hidroxiamino)carbonil]-2metilpropil}benzamida 365,4
- 1062
- 4-(4-{4-[(etilamino)metil]fenil}buta-1,3-diinil)-N-{(1S,2R)-2hidroxi-1-[(hidroxiamino)carbonil]propil}benzamida 420,5
- Ejemplo
- Estructura Nombre MH+
- 1063
-
imagen229 N-[(1S)-1-(aminometil)-2-(hidroxiamino)-2-oxoetil]-4-[4-(3aminofenil)buta-1,3-diinil]benzamida 363,4
- 1064
- 4-(4-{3-[(4-aminobutanoil)amino]fenil} buta-1,3-diinil)-N{(1S,2R)-2-hidroxi-1-[(hidroxiamino)carbonil]propil}benzamida 463,5
- 1065
- N-{(1S,2R)-2-hidroxi-1-[(hidroxiamino)carbonil]propil}-4-[4-(3hidroxifenil)buta-1,3-diinil]benzamida 379,4
- 1066
- 4-(4-{2-[(aminoacetil)amino]fenil}buta-1,3-diinil)-N-{(1S,2R)-2hidroxi-1-[(hidroxiamino)carbonil]propil}benzamida 435,4
- 1067
- N-[(1S)-1-(aminometil)-2-(hidroxiamino)-2-oxoetil]-4-{4-[2,4bis(metiloxi)pyrimidin-5-il]buta-1,3-diinil}benzamida 410,4
- 1068
- ácido (2S)-6-amino-2-{[(4-{4-[4-({[(1S)-1-(aminometil)-2(hidroxiamino)-2-oxoetil]amino}carbonil)fenil]buta-1,3diinil}fenil)carbonil]amino}hexanoico 520,6
- 1069
- N-[(1S)-1-(aminometil)-2-(hidroxiamino)-2-oxoetil]-4-[4-(2aminofenil)buta-1,3-diinil]benzamida 363,4
- 1070
-
imagen230 4-[4-(4-{2-[(2-aminoetil)amino]-2-oxoetil}fenil)buta-1,3-diinil]-N[(1S)-1-(aminometil)-2-(hidroxiamino)-2-oxoetil]benzamida 448,5
- 1071
- N-[(1S)-1-(aminometil)-2-(hidroxiamino)-2-oxoetil]-4-[4-(2aminopyrimidin-5-il)buta-1,3-diinil]benzamida 365,4
- 1072
- 4-(4-{3-[(4-aminobutanoil)amino]fenil} buta-1,3-diinil)-N-[(1S)1-(aminometil)-2-(hidroxiamino)-2-oxoetil]benzamida 448,5
- Ejemplo
- Estructura Nombre MH+
- 1073
- 4-(4-{2-[(aminoacetil)amino]fenil}buta-1,3-diinil)-N-[(1S)-1(aminometil)-2-(hidroxiamino)-2-oxoetil]benzamida 420,4
- 1074
-
imagen231 4-[4-(4-{2-[(2-aminoetil)amino]-2-oxoetil}fenil)buta-1,3-diinil]-N{(1S,2R)-2-hidroxi-1-[(hidroxiamino)carbonil]propil}benzamida 463,5
- 1075
- 4-[4-(4-{[(2,3-dihidroxipropil)amino]metil}fenil)buta-1,3-diinil]N-{(1S,2R)-2-hidroxi-1[(hidroxiamino)carbonil]propil}benzamida 466,5
- 1076
- N-{(1S,2R)-2-hidroxi-1-[(hidroxiamino)carbonil]propil}-4-(4-{4[({[2-(metiloxi)fenil]metil}amino)metil] fenil}buta-1,3diinil)benzamida 512,6
- 1077
- N-{(1S,2R)-2-hidroxi-1-[(hidroxiamino)carbonil]propil}-4-(4-{4[(piridin-2-ilamino)metil]fenil}buta-1,3-diinil)benzamida 469,5
- 1078
- 4-[4-(4-{[(2-aminoetil)amino]metil}fenil)buta-1,3-diinil]-N{(1S,2R)-2-hidroxi-1-[(hidroxiamino)carbonil]propil}benzamida 435,5
- 1079
- 4-[(4-etilfenil)etinil]-N-[(1R)-1-[(etiltio)metil]-2-(hidroxiamino)-2oxoetil]benzamida 397,5
- 1080
-
imagen232 4-[(4-{[(2S)-2-aminopropanoil]amino}fenil)etinil]-N-[(1R)-1[(etiltio)metil]-2-(hidroxiamino)-2-oxoetil]benzamida 455,5
- 1081
-
imagen233 N-[(1S)-1-(aminometil)-2-(hidroxiamino)-2-oxoetil]-4-[4-(3clorofenil)buta-1,3-diinil]benzamida 382,8
- 1082
- N-[(1S)-1-(aminometil)-2-(hidroxiamino)-2-oxoetil]-4-{4-[3(metiloxi)fenil]buta-1,3-diinil}benzamida 378,4
- Ejemplo
- Estructura Nombre MH+
- 1083
-
imagen234 N-{(1S,2R)-2-hidroxi-1-[(hidroxiamino)carbonil]propil}-0-(4-{4[(metilsulfonil)amino]fenil}buta-1,3-diinil)benzamida 456,5
- 1084
- N-{(1S,2R,2-hidroxi-1-[(hidroxiamino)carbonil]propil}-4-(4-{3[(metilsulfonil)amino]fenil}buta-1,3-diinil)benzamida 456,5.
- 1085
- N-[(1S)-1-(aminometil)-2-(hidroxiamino)-2-oxoetil]-4-(4pyrazin-2-ilbuta-1,3-diinil)benzamida 350,3
- 1086
- N-{(1S,2R)-2-hidroxi-1-[(hidroxiamino)carbonil]propil}-4-[4-(3ntrofenil)buta-1,3-diinil]benzamida 408,4
- 1087
-
imagen235 N-{(1S,2R)-2-hidroxi-1-[(hidroxiamino)carbonil]propil}-4-[(3{[(metilsulfonil)amino]metil}fenil) etinil]benzamida 446,5
- 1088
- 4-[(2-formilfenil)etinil]-N-{(1S,2R)-2-hidroxi-1[(hidroxiamino)carbonil]propil}benzamida 367,4
- 1089
- N-{(1R,2R)-2-hidroxi-1-[(hidroxiamino)carbonil]propil}-4-[(3{[(metilsulfonil)amino]metil}fenil) etinil]benzamida 446,5
- 1090
- 4-({2-[(aminoacetil)amino]fenil}etinil)-N-{(1S,2R)-2-hidroxi-1[(hidroxiamino)carbonil]propil}benzamida 411,4
- 1091
-
imagen236 N-{(1S)-2-hidroxi-1-[(hidroxiamino)carbonil]propil}-4-{4-[3(morfolin-4-ilmetil)fenil]buta-1,3-diinil}benzamida 462,5
- 1092
-
imagen237 N-[(1S)-1-(aminometil)-2-(hidroxiamino)-2-oxoetil]-4-({4[(metilamino)metil]fenil}etinil) benzamida 367,4
- Ejemplo
- Estructura Nombre MH+
- 1093
- N-[(1S)-1-(aminometil)-2-(hidroxiamino)-2-oxoetil]-4-({4[(etilamino)metil]fenil}etinil) benzamida 381,4
- 1094
- N-[(1S)-1-(aminometil)-2-(hidroxiamino)-2-oxoetil]-4-({4[(propilamino)metil]fenil}etinil) benzamida 395,5
- 1095
- N-[(1S)-1-(aminometil)-2-(hidroxiamino)-2-oxoetil]-4-({4[(pentilamino)metil]fenil}etinil) benzamida 423,5
- 1096
- N-[(1S)-1-(aminometil)-2-(hidroxiamino)-2-oxoetil]-4-({4[(hexilamino)metil]fenil}etinil) benzamida 437,6
- 1097
- N-[(1S)-1-(aminometil)-2-(hidroxiamino)-2-oxoetil]-4-[(4-{[(1metiletil)amino]metil}fenil)etinil] benzamida 395,5
- 1098
- N-[(1S)-1-(aminometil)-2-(hidroxiamino)-2-oxoetil]-4-[(4-{[(2metilpropil)amino]metil}fenil)etinil] benzamida 409,5
- 1099
- N-[(1S)-1-(aminometil)-2-(hidroxiamino)-2-oxoetil]-4-[(4-{[(1,1dimetiletil)amino]metil}fenil)etinil] benzamida 409,5
- 1100
- N-[(1S)-1-(aminometil)-2-(hidroxiamino)-2-oxoetil]-4-({4[(dimetilamino)metil]fenil}etinil) benzamida 381,4
- 1101
- N-[(1S)-1-(aminometil)-2-(hidroxiamino)-2-oxoetil]-4-[(4{[etil(metil)amino]metil}fenil) etinil]benzamida 395,5
- 1102
- N-[(1S)-1-(aminometil)-2-(hidroxiamino)-2-oxoetil]-4-{[4-({[2(dimetilamino)etil]amino}metil)fenil] etinil}benzamida 424,5
- 1103
- N-[(1S)-1-(aminometil)-2-(hidroxiamino)-2-oxoetil]-4-{[4-({[4(dimetilamino)butil]amino}metil)fenil] etinil}benzamida 452,6
- 1104
- N-[(1S)-1-(aminometil)-2-(hidroxiamino)-2-oxoetil]-4-[(4-{[(2cianoetil)amino]metil}fenil)etinil] benzamida 406,5
- Ejemplo
- Estructura Nombre MH+
- 1105
- 4-{[4-({[2-(acetilamino)etil]amino}metil)fenil] etinil}-N-[(1S)-1(aminometil)-2-(hidroxiamino)-2-oxoetil]benzamida 438,5
- 1106
- 4-[(4-{[(2-aminoetil)amino]metil}fenil)etinil]-N-[(1S)-1(aminometil)-2-(hidroxiamino)-2-oxoetil]benzamida 396,5
- 1107
- N-[(1S)-1-(aminometil)-2-(hidroxiamino)-2-oxoetil]-4-[(4-{[(3hidroxipropil)amino]metil}fenil) etinil]benzamida 411,5
- 1108
- N-[(1S)-1-(aminometil)-2-(hidroxiamino)-2-oxoetil]-4-{[4-({[3(metiloxi)propil]amino}metil)fenil] etinil}benzamida 425,5
- 1109
- N-[(1S)-1-(aminometil)-2-(hidroxiamino)-2-oxoetil]-4-{[4({metil[2-(metiloxi)etil]amino}metil)fenil] etinil}benzamida 425,5
- 1110
- N-[(1S)-1-(aminometil)-2-(hidroxiamino)-2-oxoetil]-4-{[4-({[3(2-oxopirrolidin-1-il)propil]amino}metil)fenil] etinil}benzamida 478,6
- 1111
- N-[(1S)-1-(aminometil)-2-(hidroxiamino)-2-oxoetil]-4-[(4-{[(3morfolin-4-ilpropil)amino]metil}fenil) etinil]benzamida 480,6
- 1112
- N-[(1S)-1-(aminometil)-2-(hidroxiamino)-2-oxoetil]-4-({4[(ciclopropilamino)metil]fenil} etinil)benzamida 393,5
- 1113
-
imagen238 N-[(1S)-1-(aminometil)-2-(hidroxiamino)-2-oxoetil]-4-({4[(ciclobutilamino)metil]fenil} etinil)benzamida 407,5
- 1114
- N-[(1S)-1-(aminometil)-2-(hidroxiamino)-2-oxoetil]-4-({4[(ciclopentilamino)metil]fenil} etinil)benzamida 421,5
- 1115
- N-[(1S)-1-(aminometil)-2-(hidroxiamino)-2-oxoetil]-4-({4[(cicloheptilamino)metil]fenil} etinil)benzamida 449,6
- Ejemplo
- Estructura Nombre MH+
- 1116
-
imagen239 N-[(1S)-1-(aminometil)-2-(hidroxiamino)-2-oxoetil]-4-({4[(ciclooctilamino)metil]fenil} etinil)benzamida 463,6
- 1117
-
imagen240 N-[(1S)-1-(aminometil)-2-(hidroxiamino)-2-oxoetil]-4-{[4(pirrolidin-1-ilmetil)fenil]etinil}benzamida 407,5
- 1118
- N-[(1S)-1-(aminometil)-2-(hidroxiamino)-2-oxoetil]-4-{[4(azepan-1-ilmetil)fenil]etinil}benzamida 435,5
- 1119
- N-[(1S)-1-(aminometil)-2-(hidroxiamino)-2-oxoetil]-4-[(4-{[(3R)3-(dimetilamino)pirrolidin-1-il]metil}fenil)etinil]benzamida 450,6
- 1120
- N-[(1S)-1-(aminometil)-2-(hidroxiamino)-2-oxoetil]-4-[(4-{[(3S)3-(dimetilamino)pirrolidin-1-il]metil}fenil)etinil]benzamida 450,6
- 1121
- 4-[(4-{[(3R)-3-(acetilamino)pirrolidin-1-il]metil}fenil)etinil]-N[(1S)-1-(aminometil)-2-(hidroxiamino)-2-oxoetil]benzamida 464,5
- 1122
- 4-[(4-{[(3S)-3-(acetilamino)pirrolidin-1-il]metil}fenil)etinil]-N[(1S)-1-(aminometil)-2-(hidroxiamino)-2-oxoetil]benzamida 464,5
- 1123
- N-[(1S)-1-(aminometil)-2-(hidroxiamino)-2-oxoetil]-4-{[4-(1,4′bipiperidin-1′-ilmetil)fenil]etinil}benzamida 504,6
- 1124
-
imagen241 N-[(1S)-1-(aminometil)-2-(hidroxiamino)-2-oxoetil]-4-[(4{[(ciclohexilmetil)amino]metil}fenil) etinil]benzamida 449,6
- 1125
- N-[(1S)-1-(aminometil)-2-(hidroxiamino)-2-oxoetil]-4-[(4{[ciclohexil(metil)amino]metil}fenil) etinil]benzamida 449,6
- 1126
- N-[(1S)-1-(aminometil)-2-(hidroxiamino)-2-oxoetil]-4-{[4({[(1R)-1-feniletil]amino}metil)fenil]etinil} benzamida 457,5
- 1127
- N-[(1S)-1-(aminometil)-2-(hidroxiamino)-2-oxoetil]-4-{[4({[(1S)-1-feniletil]amino}metil)fenil]etinil} benzamida 457,5
- Ejemplo
- Estructura Nombre MH+
- 1128
- N-[(1S)-1-(aminometil)-2-(hidroxiamino)-2-oxoetil]-4-[(4-{[(tien2-ilmetil)amino]metil}fenil)etinil] benzamida 449,5
- 1129
- N-[(1S)-1-(aminometil)-2-(hidroxiamino)-2-oxoetil]-4-[(4-{[(2feniletil)amino]metil}fenil)etinil] benzamida 457,5
- 1130
- N-[(1S)-1-(aminometil)-2-(hidroxiamino)-2-oxoetil]-4-({4[(piperidin-3-ilamino)metil]fenil}etinil)benzamida 436,5
- 1131
- N-[(1S)-1-(aminometil)-2-(hidroxiamino)-2-oxoetil]-4-({4[(piperidin-4-ilamino)metil]fenil}etinil)benzamida 436,5
- 1132
-
imagen242 N-[(1S)-1-(aminometil)-2-(hidroxiamino)-2-oxoetil]-4-[(4{[(piperidin-2-ilmetil)amino]metil}fenil)etinil] benzamida 450,6
- 1133
- N-[(1S)-1-(aminometil)-2-(hidroxiamino)-2-oxoetil]-4-[(4{[(piperidin-3-ilmetil)amino]metil}fenil)etinil] benzamida 450,6
- 1134
-
imagen243 N-[(1S)-1-(aminometil)-2-(hidroxiamino)-2-oxoetil]-4-{[4({[(2R)-pirrolidin-2-ilmetil]amino}metil)fenil]etinil} benzamida 436,5
- 1135
- N-[(1S)-1-(aminometil)-2-(hidroxiamino)-2-oxoetil]-4-{[4({[(2S)-pirrolidin-2-ilmetil]amino}metil)fenil]etinil} benzamida 436,5
- 1136
-
imagen244 N-[(1S)-1-(aminometil)-2-(hidroxiamino)-2-oxoetil]-4-({4[(pirrolidin-3-ilamino)metil]fenil}etinil)benzamida 422,5
- 1137
- N-[(1S)-1-(aminometil)-2-(hidroxiamino)-2-oxoetil]-4-{[4-({[(2fluorofenil)metil]amino}metil)fenil] etinil}benzamida 461,5
- 1138
- N-[(1S)-1-(aminometil)-2-(hidroxiamino)-2-oxoetil]-4-{[4-({[(3fluorofenil)metil]amino}metil)fenil] etinil}benzamida 461,5
- 1139
- N-[(1S)-1-(aminometil)-2-(hidroxiamino)-2-oxoetil]-4-{[4-({[(4fluorofenil)metil]amino}metil)fenil] etinil}benzamida 461,5
- Ejemplo
- Estructura Nombre MH+
- 1140
- N-[(1S)-1-(aminometil)-2-(hidroxiamino)-2-oxoetil]-4-{[4-({[(2metilfenil)metil]amino}metil)fenil] etinil}benzamida 457,5
- 1141
- N-[(1S)-1-(aminometil)-2-(hidroxiamino)-2-oxoetil]-4-{[4-({[(3metilfenil)metil]amino}metil)fenil] etinil}benzamida 457,5
- 1142
- N-[(1S)-1-(aminometil)-2-(hidroxiamino)-2-oxoetil]-4-{[4-({[(4metilfenil)metil]amino}metil)fenil] etinil}benzamida 457,5
- 1143
- N-[(1S)-1-(aminometil)-2-(hidroxiamino)-2-oxoetil]-4-({4-[({[2(metiloxi)fenil]metil}amino)metil] fenil}etinil)benzamida 473,5
- 1144
- N-[(1S)-1-(aminometil)-2-(hidroxiamino)-2-oxoetil]-4-({4-[({[3(metiloxi)fenil]metil}amino)metil] fenil}etinil)benzamida 473,5
- 1145
- N-[(1S)-1-(aminometil)-2-(hidroxiamino)-2-oxoetil]-4-({4-[({[4(metiloxi)fenil]metil}amino)metil] fenil}etinil)benzamida 473,5
- 1146
- N-[(1S)-1-(aminometil)-2-(hidroxiamino)-2-oxoetil]-4-({4[(fenilamino)metil]fenil}etinil) benzamida 429,5
- 1147
- N-[(1S)-1-(aminometil)-2-(hidroxiamino)-2-oxoetil]-4-[(4{[(piridin-3-ilmetil)amino]metil}fenil)etinil] benzamida 444,5
- 1148
- N-[(1S)-1-(aminometil)-2-(hidroxiamino)-2-oxoetil]-4-({4-[(4fenilpiperidin-1-il)metil]fenil}etinil)benzamida 497,6
- 1149
-
imagen245 N-[(1S)-1-(aminometil)-2-(hidroxiamino)-2-oxoetil]-4-({4-[(4fenilpiperazin-1-il)metil]fenil}etinil)benzamida 498,6
- 1150
- N-[(1S)-1-(aminometil)-2-(hidroxiamino)-2-oxoetil]-4-[(4{[(1R,2R,4S)-biciclo[2,2,1]hept-2ilamino]metil}fenil)etinil]benzamida 447,5
- 1151
- N-[(1S)-1-(aminometil)-2-(hidroxiamino)-2-oxoetil]-4-({4[({[(1S,2R,5S)-6,6-dimetilbiciclo[3,1,1]hept-2il]metil}amino)metil]fenil} etinil)benzamida 489,6
- Ejemplo
- Estructura Nombre MH+
- 1152
- N-[(1S)-1-(aminometil)-2-(hidroxiamino)-2-oxoetil]-4-[(4{[(1S,4R)-biciclo[2,2,1]hept-2ilamino]metil}fenil)etinil]benzamida 447,5
- 1153
- N-[(1S)-1-(aminometil)-2-(hidroxiamino)-2-oxoetil]-4-{[4({[(1S,2S,3S,5R)-2,6,6-trimetilbiciclo[3,1,1]hept-3il]amino}metil)fenil]etinil}benzamida 489,6
- 1154
- 1-((1R,2S)-3-(hidroxiamino)-1-metil-3-oxo-2-{[(4-{[4-({[(piridin4-ilmetil)amino]acetil}amino)fenil]etinil} fenil)carbonil]amino}propil)triaza-1,2-dien-2-ium 528,6
- 1155
- 1-((1R,2S)-3-(hidroxiamino)-1-metil-3-oxo-2-{[(4-{[4-({[(piridin3-ilmetil)amino]acetil}amino)fenil]etinil} fenil)carbonil]amino}propil)triaza-1,2-dien-2-ium 528,6
- 1156
- N-{(1S,2R)-2-amino-1-[(hidroxiamino)carbonil]propil}-4-{[4({[(piridin-4-ilmetil)amino]acetil}amino)fenil]etinil} benzamida 501,6
- 1157
- N-{(1S,2R)-2-amino-1-[(hidroxiamino)carbonil]propil}-4-{[4({[(piridin-3-ilmetil)amino]acetil}amino)fenil]etinil} benzamida 501,6
- 1158
- N-[1-[(hidroxiamino)carbonil]-2-(metilamino)propil]-4-{[4({[(fenilmetil)amino]acetil}amino) fenil]etinil}benzamida 514,6
- 1159
- 4-[(4-{[(ciclobutilamino)acetil]amino}pheny) etinil]-N-[1[(hidroxiamino)carbonil]-2-(metilamino)propil]benzamida 478,6
- 1160
- 4-[(4-{[(2S)-2-aminopropanoil]amino}fenil)etinil]-N-[(1R)-1{[etil(hidroxi)-lambda~4~-sulfanil]metil}-2-(hidroxiamino)-2oxoetil]benzamida 473,6
- 1161
- 4-[(4-etilfenil)etinil]-N-hidroxibenzamida 266,3
- Ejemplo
- Estructura Nombre MH+
- 1162
- N-[(1S)-1-(aminometil)-2-(hidroxiamino)-2-oxoetil]-4-[4-(2,4difluorofenil)buta-1,3-diinil]benzamida 384,4
- 1163
- N-[(1S)-1-(aminometil)-2-(hidroxiamino)-2-oxoetil]-4-[(2aminofenil)etinil]benzamida 339,4
- 1164
- N-[(1S)-1-(aminometil)-2-(hidroxiamino)-2-oxoetil]-4-[4-(3{[(metilsulfonil)amino]metil}fenil) buta-1,3-diinil]benzamida 455,5
- 1165
- N-[(1S)-1-(aminometil)-2-(hidroxiamino)-2-oxoetil]-4-[4-(3{[(metilsulfonil)amino]metil}fenil) buta-1,3-diinil]benzamida 455,5
- 1166
- N-[(1S)-1-(aminometil)-2-(hidroxiamino)-2-oxoetil]-4-({3[(metilsulfonil)amino]fenil}etinil) benzamida 417,5
- 1167
- 4-[(4-{[(2S)-2-aminopropanoil]amino}fenil)etinil]-Nhidroxibenzamida 324,4
- 1168
-
imagen246 4-[(2-{[(2-aminoetil)amino]metil}fenil)etinil]-N-{(1S,2R)-2hidroxi-1-[(hidroxiamino)carbonil]propil}benzamida 411,5
- 1169
- N-{(1R,2R)-2-amino-1-[(hidroxiamino)carbonil]propil}-4(feniletinil)benzamida 338,4
- 1170
- N-{(1S,2R)-2-amino-1-[(hidroxiamino)carbonil]propil}-4-[4-(4aminofenil)buta-1,3-diinil]benzamida 377,4
- 1171
-
imagen247 N-[(1S)-1-(aminometil)-2-(hidroxiamino)-2-oxoetil]-4-[4-(3hidroxifenil)buta-1,3-diinil]benzamida 364,4
- Ejemplo
- Estructura Nombre MH+
- 1172
- N-[(1S)-1-(aminometil)-2-(hidroxiamino)-2-oxoetil]-4-{4-[3(morfolin-4-ilmetil)fenil]buta-1,3-diinil}benzamida 447,5
- 1173
- N-{(1S,2R)-2-hidroxi-1-[(hidroxiamino)carbonil]propil}-4-({4[({[2-(metiloxi)fenil]metil}amino)metil] fenil}etinil)benzamida 488,6
- 1174
- 4-[(4-{[(2,3-dihidroxipropil)amino]metil}fenil) etinil]-N-{(1S,2R)2-hidroxi-1-[(hidroxiamino)carbonil]propil}benzamida 442,5
- 1175
- 4-({2-[(dimetilamino)metil]fenil}etinil)-N-{(1S,2R)-2-hidroxi-1[(hidroxiamino)carbonil]propil}benzamida 396,5
- 1176
-
imagen248 N-{(1S,2R)-2-hidroxi-1-[(hidroxiamino)carbonil]propil}-4-({4[(metilamino)metil]fenil}etinil) benzamida 382,4
- 1177
- N-{(1S,2R)-2-hidroxi-1-[(hidroxiamino)carbonil]propil}-4-({4[(propilamino)metil]fenil}etinil) benzamida 410,5
- 1178
- 4-({4-[(butilamino)metil]fenil}etinil)-N-{(1S,2R)-2-hidroxi-1[(hidroxiamino)carbonil]propil}benzamida 424,5
- 1179
- N-{(1S,2R)-2-hidroxi-1-[(hidroxiamino)carbonil]propil}-4-({4[(pentilamino)metil]fenil}etinil) benzamida 438,5
- 1180
- 4-({4-[(hexilamino)metil]fenil}etinil)-N-{(1S,2R)-2-hidroxi-1[(hidroxiamino)carbonil]propil}benzamida 452,6
- 1181
- N-{(1S,2R)-2-hidroxi-1-[(hidroxiamino)carbonil]propil}-4-[(4{[(1-metiletil)amino]metil}fenil)etinil] benzamida 410,5
- 1182
- N-{(1S,2R)-2-hidroxi-1-[(hidroxiamino)carbonil]propil}-4-[(4{[(2-metilpropil)amino]metil}fenil)etinil] benzamida 424,5
- 1183
- 4-[(4-{[(1,1-dimetiletil)amino]metil}fenil) etinil]-N-{(1S,2R)-2hidroxi-1-[(hidroxiamino)carbonil]propil}benzamida 424,5
- 1184
-
imagen249 4-[(4-{[etil(metil)amino]metil}fenil) etinil]-N-{(1S,2R)-2-hidroxi1-[(hidroxiamino)carbonil]propil}benzamida 410,5
- Ejemplo
- Estructura Nombre MH+
- 1185
-
imagen250 4-{[4-({[2-(dimetilamino)etil]amino}metil)fenil] etinil}-N{(1S,2R)-2-hidroxi-1-[(hidroxiamino)carbonil]propil}benzamida 439,5
- 1186
- 4-{[4-({[4-(dimetilamino)butil]amino}metil)fenil] etinil}-N{(1S,2R)-2-hidroxi-1-[(hidroxiamino)carbonil]propil}benzamida 467,6
- 1187
- 4-[(4-{[(2-hidroxietil)amino]metil}fenil)etinil]-N-{(1S,2R)-2hidroxi-1-[(hidroxiamino)carbonil]propil}benzamida 412,5
- 1188
- N-{(1S,2R)-2-hidroxi-1-[(hidroxiamino)carbonil]propil}-4-[(4{[(3-hidroxipropil)amino]metil}fenil)etinil] benzamida 426,5
- 1189
- N-{(1S,2R)-2-hidroxi-1-[(hidroxiamino)carbonil]propil}-4-{[4({metil[2-(metiloxi)etil]amino}metil)fenil] etinil}benzamida 440,5
- 1190
- N-{(1S,2R)-2-hidroxi-1-[(hidroxiamino)carbonil]propil}-4-{[4({[2-(metiloxi)etil]amino}metil)fenil] etinil}benzamida 426,5
- 1191
- N-{(1S,2R)-2-hidroxi-1-[(hidroxiamino)carbonil]propil}-4-{[4({[3-(metiloxi)propil]amino}metil)fenil] etinil}benzamida 440,5
- 1192
- 4-[(4-{[(2-cianoetil)amino]metil}fenil)etinil]-N-{(1S,2R)-2hidroxi-1-[(hidroxiamino)carbonil]propil}benzamida 421,5
- 1193
- 4-{[4-({[2-(acetilamino)etil]amino}metil)fenil] etinil}-N-{(1S,2R)2-hidroxi-1-[(hidroxiamino)carbonil]propil}benzamida 453,5
- 1194
- N-{(1S,2R)-2-hidroxi-1-[(hidroxiamino)carbonil]propil}-4-{[4({[3-(2-oxopirrolidin-1-il)propil]amino}metil)fenil]etinil} benzamida 493,6
- 1195
- N-{(1S,2R)-2-hidroxi-1-[(hidroxiamino)carbonil]propil}-4-[(4{[(3-morfolin-4-ilpropil)amino]metil}fenil)etinil] benzamida 495,6
- 1196
- 4-({4-[(ciclopropilamino)metil]fenil}etinil)-N-{(1S,2R)-2-hidroxi1-[(hidroxiamino)carbonil]propil}benzamida 408,5
- 1197
- 4-({4-[(ciclobutilamino)metil]fenil}etinil)-N-{(1S,2R)-2-hidroxi1-[(hidroxiamino)carbonil]propil}benzamida 422,5
- Ejemplo
- Estructura Nombre MH+
- 1198
- 4-({4-[(ciclopentilamino)metil]fenil}etinil)-N-{(1S,2R)-2-hidroxi1-[(hidroxiamino)carbonil]propil}benzamida 436,5
- 1199
- 4-({4-[(ciclohexilamino)metil]fenil}etinil)-N-{(1S,2R)-2-hidroxi1-[(hidroxiamino)carbonil]propil}benzamida 450,5
- 1200
- 4-({4-[(cicloheptilamino)metil]fenil}etinil)-N-{(1S,2R)-2-hidroxi1-[(hidroxiamino)carbonil]propil}benzamida 464,6
- 1201
- 4-({4-[(ciclooctilamino)metil]fenil}etinil)-N-{(1S,2R)-2-hidroxi1-[(hidroxiamino)carbonil]propil}benzamida 478,6
- 1202
- 4-{[4-(azepan-1-ilmetil)fenil]etinil}-N-{(1S,2R)-2-hidroxi-1[(hidroxiamino)carbonil]propil}benzamida 450,5
- 1203
- 4-[(4-{[(3R)-3-(dimetilamino)pirrolidin-1-il]metil}fenil)etinil]-N{(1S,2R)-2-hidroxi-1-[(hidroxiamino)carbonil]propil}benzamida 465,6
- 1204
- 4-[(4-{[(3S)-3-(dimetilamino)pirrolidin-1-il]metil}fenil)etinil]-N{(1S,2R)-2-hidroxi-1-[(hidroxiamino)carbonil]propil}benzamida 465,6
- 1205
- 4-[(4-{[(3R)-3-(acetilamino)pirrolidin-1-il]metil}fenil)etinil]-N{(1S,2R)-2-hidroxi-1-[(hidroxiamino)carbonil]propil}benzamida 479,5
- 1206
- 4-[(4-{[(3S)-3-(acetilamino)pirrolidin-1-il]metil}fenil)etinil]-N{(1S,2R)-2-hidroxi-1-[(hidroxiamino)carbonil]propil}benzamida 479,5
- 1207
- 4-{[4-(1,4′-bipiperidin-1′-ilmetil)fenil]etinil}-N-{(1S,2R)-2hidroxi-1-[(hidroxiamino)carbonil]propil}benzamida 519,7
- 1208
- 4-[(4-{[(ciclohexilmetil)amino]metil}fenil) etinil]-N-{(1S,2R)-2hidroxi-1-[(hidroxiamino)carbonil]propil}benzamida 464,6
- 1209
- N-{(1S,2R)-2-hidroxi-1-[(hidroxiamino)carbonil]propil}-4-({4[(4-fenilpiperazin-1-il)metil]fenil}etinil)benzamida 513,6
- 1210
- N-{(1S,2R)-2-hidroxi-1-[(hidroxiamino)carbonil]propil}-4-[(4{[(2-feniletil)amino]metil}fenil)etinil] benzamida 472,6
- Ejemplo
- Estructura Nombre MH+
- 1211
- N-{(1S,2R)-2-hidroxi-1-[(hidroxiamino)carbonil]propil}-4-{[4({[(1R)-1-feniletil]amino}metil)fenil] etinil}benzamida 472,6
- 1212
- N-{(1S,2R)-2-hidroxi-1-[(hidroxiamino)carbonil]propil}-4-{[4({[(1S)-1-feniletil]amino}metil)fenil] etinil}benzamida 472,6
- 1213
- N-{(1S,2R)-2-hidroxi-1-[(hidroxiamino)carbonil]propil}-4-[(4{[(tien-2-ilmetil)amino]metil}fenil)etinil] benzamida 464,6
- 1214
-
imagen251 N-{(1S,2R)-2-hidroxi-1-[(hidroxiamino)carbonil]propil}-4-({4[(piperidin-3-ilamino)metil]fenil}etinil)benzamida 451,5
- 1215
- N-{(1S,2R)-2-hidroxi-1-[(hidroxiamino)carbonil]propil}-4-({4[(piperidin-4-ilamino)metil]fenil}etinil)benzamida 451,5
- 1216
- N-{(1S,2R)-2-hidroxi-1-[(hidroxiamino)carbonil]propil}-4-[(4{[(piperidin-2-ilmetil)amino]metil}fenil) etinil]benzamida 465,6
- 1217
- N-{(1S,2R)-2-hidroxi-1-[(hidroxiamino)carbonil]propil}-4-[(4{[(piperidin-3-ilmetil)amino]metil}fenil) etinil]benzamida 465,6
- 1218
- N-{(1S,2R)-2-hidroxi-1-[(hidroxiamino)carbonil]propil}-4-{[4({[(2R)-pirrolidin-2-ilmetil]amino}metil)fenil] etinil}benzamida 451,5
- 1219
- N-{(1S,2R)-2-hidroxi-1-[(hidroxiamino)carbonil]propil}-4-{[4({[(2S)-pirrolidin-2-ilmetil]amino}metil)fenil] etinil}benzamida 451,5
- 1220
- N-{(1S,2R)-2-hidroxi-1-[(hidroxiamino)carbonil]propil}-4-({4[(pirrolidin-3-ilamino)metil]fenil}etinil)benzamida 437,5
- 1221
- 4-{[4-({[(2-fluorofenil)metil]amino}metil)fenil] etinil}-N-{(1S,2R)2-hidroxi-1-[(hidroxiamino)carbonil]propil}benzamida 476,5
- Ejemplo
- Estructura Nombre MH+
- 1222
- 4-{[4-({[(3-fluorofenil)metil]amino}metil)fenil] etinil}-N-{(1S,2R)2-hidroxi-1-[(hidroxiamino)carbonil]propil}benzamida 476,5
- 1223
- 4-{[4-({[(4-fluorofenil)metil]amino}metil)fenil] etinil}-N-{(1S,2R)2-hidroxi-1-[(hidroxiamino)carbonil]propil}benzamida 476,5
- 1224
- N-{(1S,2R)-2-hidroxi-1-[(hidroxiamino)carbonil]propil}-4-{[4({[(2-metilfenil)metil]amino}metil)fenil] etinil}benzamida 472,6
- 1225
- N-{(1S,2R)-2-hidroxi-1-[(hidroxiamino)carbonil]propil}-4-{[4({[(3-metilfenil)metil]amino}metil)fenil] etinil}benzamida 472,6
- 1226
- N-{(1S,2R)-2-hidroxi-1-[(hidroxiamino)carbonil]propil}-4-{[4({[(4-metilfenil)metil]amino}metil)fenil] etinil}benzamida 472,6
- 1227
-
imagen252 N-{(1S,2R)-2-hidroxi-1-[(hidroxiamino)carbonil]propil}-4-[(4{[(fenilmetil)amino]metil}fenil) etinil]benzamida 458,5
- 1228
- N-{(1S,2R)-2-hidroxi-1-[(hidroxiamino)carbonil]propil}-4-({4[(fenilamino)metil]fenil} etinil)benzamida 444,5
- 1229
- N-{(1S,2R)-2-hidroxi-1-[(hidroxiamino)carbonil]propil}-4-[(4{[(piridin-3-ilmetil)amino]metil}fenil) etinil]benzamida 459,5
- 1230
- 4-[(4-{[(1R,2R,4S)-biciclo[2,2,1]hept-2ilamino]metil}fenil)etinil]-N-{(1S,2R)-2-hidroxi-1[(hidroxiamino)carbonil]propil}benzamida 462,6
- 1231
- (3R)-N-hidroxi-3-({[4-(feniletinil)fenil]carbonil}amino) piperidina-3-carboxamida 364,4
- 1232
- ácido 4-({[4-(feniletinil)fenil]carbonil}amino) piperidina-4carboxilico 349,4
- 1233
- N-{(1S)-2-(hidroxiamino)-2-oxo-1-[(2S)-pirrolidin-2-ilmetil]etil}4-(feniletinil)benzamida 378,4
- Ejemplo
- Estructura Nombre MH+
- 1234
- (3R)-3-{[(4′-etil-1,1′-bifenil-4-il)carbonil]amino}-Nhidroxipiperidina-3-carboxamida 368,4
- 1235
- 1,1-dimetiletil 3-(4-{4-[({(1S,2R)-2-hidroxi-1[(hidroxiamino)carbonil]propil}amino) carbonil]fenil}buta-1,3diinil) fenilcarbamato 478,5
- 1236
- 4-[4-(3-amino-4-metilfenil)buta-1,3-diinil]-N-{(1S,2R)-2-hidroxi1-[(hidroxiamino)carbonil]propil}benzamida 392,4
- 1237
- N-[(1S)-1-(aminometil)-2-(hidroxiamino)-2-oxoetil]-4-[4-(3amino-4-metilfenil) buta-1,3-diinil]benzamida 377,4
- 1238
- 4-(4-{4-[(aminoacetil)amino]-3-metilfenil}buta-1,3-diinil)-N[(1S)-1-(aminometil)-2-(hidroxiamino)-2-oxoetil]benzamida 434,5
- 1239
-
imagen253 N-{(1S,2R)-2-amino-1-[(hidroxiamino)carbonil]propil}-4-(2feniletenil)benzamida 340,4
- 1240
-
imagen254 N-[(2R)-2-amino-3-(hidroxiamino)-3-oxopropil]-4′-etil-1,1′bifenil-4-carboxamida 328,4
- 1241
-
imagen255 N-[(2R)-2-amino-3-(hidroxiamino)-3-oxopropil]-4(feniletinil)benzamida 324,4
- 1242
- N-[(2R)-2-amino-3-(hidroxiamino)-3-oxopropil]-4-(4clorofenil)ciclohexanecarboxamida 340,8
- 1243
- N-[(2S)-2-amino-3-(hidroxiamino)-3-oxopropil]-4-(4clorofenil)ciclohexanecarboxamida 340,8
- 1244
-
imagen256 N-[(1S)-1-(aminometil)-2-(hidroxiamino)-2-oxoetil]-4-[2-(4metilfenil)etil]benzamida 342,4
- 1245
- N-[(1S)-1-(aminometil)-2-(hidroxiamino)-2-oxoetil]-4-[4-(4aminofenil)butil]benzamida 371,4
- Ejemplo
- Estructura Nombre MH+
- 1246
- N-(1S,2R)-2-hidroxi-1-[(hidroxiamino)carbonil]propil}-4-{[4({[metil(piridin-2ilmetil)amino]acetil}amino)fenil]etinil}benzamida 516,6
- 1247
- 4-{(4-({[(2fluorofenil)metil](metil)amino]acetil}amino)fenil]etinil)-N((1S,2R)-2-hidroxi-1-[(hidroxiamino)carbonil]propil}benzamida 533,6
- 1248
- 4-{[4-({[[(3fluorofenil)metil](metil]amino]acetil)amino)fenil]etinil)-N{(1S,2R)-2-hidroxi-1-[(hidroxiamino)carbonil]propil}benzamida 533,6
- 1249
- 4-{[4-({[[(4fluorofenil)metil](metil)amino]acetil}amino)fenil]etinil)-N{(1S,2R)-2-hidroxi-1-[(hidroxiamino)carbonil]propil}benzamida 533,6
- 1250
-
imagen257 N-[(1S)-1-(aminometil)-2-(hidroxiamino)-2-oxoetil]-4-{[4-({[[(2fluorofenil)metil](metil)amino]acetil} amino)fenil]etinil}benzamida 518,6
- 1251
- N-[(1S)-1-(aminometil)-2-(hidroxiamino)-2-oxoetil]-4-{[4-({[[(3fluorofenil)metil](metil)amino]acetil} amino)fenil]etinil}benzamida 518,6
- 1252
- N-[(1S)-1-(aminometil)-2-(hidroxiamino)-2-oxoetil]-4-{[4-({[[(4fluorofenil)metil](metil)amino]acetil} amino)fenil]etinil}benzamida 518,6
- 1253
-
imagen258 N-[(1S)-1-(aminometil)-2-(hidroxiamino)-2-oxoetil]-4-({4[({metil[(2-metilfenil)metil]amino}acetil)amino] fenil}etinil)benzamida 514,6
- 1254
- N-[(1S)-1-(aminometil)-2-(hidroxiamino)-2-oxoetil]-4-({4[({metil[(4-metilfenil)metil]amino}acetil)amino] fenil}etinil)benzamida 514,6
- 1255
- N-[(1S)-1-(aminometil)-2-(hidroxiamino)-2-oxoetil]-4-{[4({[metil(fenilmetil)amino]acetil} amino)fenil]etinil}benzamida 500,6
- 1256
- N-{(1S,2R)-2-hidroxi-1-[(hidroxiamino)carbonil]propil)-4-{[4({(metil(propil)amino)acetil}amino)fenil]etinil}benzamida 467,5
- 1257
- 4-{[4-({[butil(metil)amino]acetil}fenil]etinil}-N-{(1S,2R)-2-hidroxi1-[(hidroxiamino)carbonil]propil}benzamida 481,6
- 1258
- N-{(1S,2R)-2-hidroxi-1-[(hidroxiamino)carbonil]propil}-4-{[4({[metil(pentil)amino]acetil}amino)fenil]etinil}benzamida 495,6
- Ejemplo
- Estructura Nombre MH+
- 1259
- 4-{[4-({[hexil(metil)amino]acetil}amino)fenil]etinil}-N-{(1S,2R)-2hidroxi-1-[(hidroxiamino)carbonil]propil}benzamida 509,6
- 1260
- N-{(1S,2R)-2-hidroxi-1-[(hidroxiamino)carbonil]propil)-4-([4({[metil(1-metiletil)amino]acetil]amino)fenil]etinil}benzamida 467,5
- 1261
- N-{(1S,2R)-2-hidroxi-1-[(hidroxiamino)carbonil]propil}-4-{[4({[metil(2-metilpropil)amino]acetil]amino)fenil]etinil}benzamida 481,6
- 1262
-
imagen259 N-{(1S,2R)-2-hidroxi-1-[(hidroxiamino)carbonil]propil)4-({4[({metil[(2metilfenil)metil]amino)acetil)amino]fenil}etinil)benzamida 529,6
- 1263
-
imagen260 N-{(1S,2R)-2-hidroxi-1-[(hidroxiamino)carbonil]propil}-0-({4[({metil[(4metilfenil)metil]amino}acetil)amino]fenil}etinil)benzamida 529,6
- 1264
- N-[(1S)-1-(aminometil)-2-(hidroxiamino)-2-oxoetil]-4-{[4({[metil(propil)amino]acetil}amino) fenil]etinil}benzamida 452,5
- 1265
- N-[(1S)-1-(aminometil)-2-(hidroxiamino)-2-oxoetil]-4-{[4({[butil(metil)amino]acetil}amino) fenil]etinil}benzamida 466,6
- 1266
- N-[(1S)-1-(aminometil)-2-(hidroxiamino)-2-oxoetil]-4-{[4({[metil(pentil)amino]acetil}amino) fenil]etinil}benzamida 480,6
- 1267
- N-[(1S)-1-(aminometil)-2-(hidroxiamino)-2-oxoetil]-4-{[4({[hexil(metil)amino]acetil}amino) fenil]etinil}benzamida 494,6
- 1268
- N-[(1S)-1-(aminometil)-2-(hidroxiamino)-2-oxoetil]-4-{[4({[metil(1-metiletil)amino]acetil}amino) fenil]etinil}benzamida 452,5
- 1269
- N-[(1S)-1-(aminometil)-2-(hidroxiamino)-2-oxoetil]-4-{[4({[metil(2-metilpropil)amino]acetil}amino) fenil]etinil}benzamida 466,6
- 1270
- N-[(1S)-1-(aminometil)-2-(hidroxiamino)-2-oxoetil]-4-{[4({[metil(piridin-2-ilmetil)amino]acetil}amino) fenil]etinil}benzamida 501,6
- Ejemplo
- Estructura Nombre MH+
- 1271
- 4-{[4-({[(3,4-dihidroxifenil)metil]amino}metil) fenil]etinil}-N{(1S,2R)-2-hidroxi-1-[(hidroxiamino)carbonil]propil}benzamida 490,5
- 1272
- 4-({2-[(aminoacetil)amino]fenil}etinil)-N-{(1S,2S)-2-hidroxi-1[(hidroxiamino)carbonil]propil}benzamida 411,4
- 1273
- 4-[(4-{[(2S)-2-aminopropanoil]amino}fenil)etinil]-N-{(1S,2S)-2hidroxi-1-[(hidroxiamino)carbonil]propil}benzamida 425,5
- 1274
- N-[(1S)-1-(aminometil)-2-(hidroxiamino)-2-oxoetil]-4-{[4(dietilamino)fenil]etinil}benzamida 395,5
- 1275
- N-[(1S)-1-(aminometil)-2-(hidroxiamino)-2-oxoetil]-4-{4-[4(etilamino)fenil] buta-1,3-diinil}benzamida 391,4
- 1276
- N-[(1S)-1-(aminometil)-2-(hidroxiamino)-2-oxoetil]-4-[(4-{[(2amino-2-oxoetil)amino]metil}fenil)etinil] benzamida 410,4
- 1277
- N-[(1S)-1-(aminometil)-2-(hidroxiamino)-2-oxoetil]-4-{[4-({[1(hidroximetil)-2-metilpropil]amino}metil)fenil] etinil}benzamida 439,5
- 1278
- N-[(1S)-1-(aminometil)-2-(hidroxiamino)-2-oxoetil]-4-({4[(piridin-2-ilamino)metil]fenil}etinil)benzamida 430,5
- 1279
- N-[(1S)-1-(aminometil)-2-(hidroxiamino)-2-oxoetil]-4-{4-[3(etilamino)fenil] buta-1,3-diinil}benzamida 391,4
- 1280
- N-[(1S)-1-(aminometil)-2-(hidroxiamino)-2-oxoetil]-4-{[3(etilamino)fenil]etinil}benzamida 367,4
- Ejemplo
- Estructura Nombre MH+
- 1281
-
imagen261 N-[(1S)-1-(aminometil)-2-(hidroxiamino)-2-oxoetil]-4-{[4(hidroximetil)fenil]etinil}benzamida 354,4
- 1282
- N-[(1S)-1-(aminometil)-2-(hidroxiamino)-2-oxoetil]-4-{[3(dietilamino)fenil]etinil}benzamida 395,5
- 1283
-
imagen262 N-{(1S,2S)-2-hidroxi-1-[(hidroxiamino)carbonil]propil}-4-{[4(morfolin-4-ilmetil)fenil]etinil}benzamida 438,5
- 1284
- 4-({4-[(dimetilamino)metil]fenil}etinil)-N-{(1S,2S)-2-hidroxi-1[(hidroxiamino)carbonil]propil}benzamida 396,5
- 1285
- 4-[(4-aminofenil)etinil]-N-I(1S,2S)-2-hidroxi-1[(hidroxiamino)carbonil]propil}benzamida 354,4
- 1286
- 4-[4-(4-aminofenil)buta-1,3-diinil]-N-{(1S,2S)-2-hidroxi-1[(hidroxiamino)carbonil)propil}benzamida 378,4
- 1287
-
imagen263 1,1-dimetiletil 4-(4-{4-[({(1S,2R)-2-hidroxi-1[(hidroxiamino)carbonil]propil}amino) carbonil]fenil}buta-1,3diinil) fenilcarbamato 478,5
- 1288
- N-[(1S)-1-(aminometil)-2-(hidroxiamino)-2-oxoetil]-4-{4-[4-({[1(hidroximetil)-2-metilpropil]amino}metil)fenil] buta-1,3diinil}benzamida 463,5
- 1289
- N-[(1S)-1-(aminometil)-2-(hidroxiamino)-2-oxoetil]-4-[4-(4hidroxifenil)buta-1,3-diinil]benzamida 364,4
- 1290
- 4-[(2,4-difluorofenil)etinil]-N-{(1S,2S)-2-hidroxi-1[(hidroxiamino)carbonil]propil}benzamida 375,3
- Ejemplo
- Estructura Nombre MH+
- 1291
- N-[(1S)-1-(aminometil)-2-(hidroxiamino)-2-oxoetil]-4-{4-[4(morfolin-4-ilmetil)fenil]buta-1,3-diinil}benzamida 447,5
- 1292
- N-[(1S)-1-(aminometil)-2-(hidroxiamino)-2-oxoetil]-4-{4-[4(hidroximetil)fenil]buta-1,3-diinil}benzamida 378,4
- 1293
- 4-({3-[(2-aminoetil)amino]fenil}etinil)-N-{(1S,2R)-2-hidroxi-1[(hidroxiamino)carbonil]propil}benzamida 397,4
- 1294
- N-[(1S)-1-(aminometil)-2-(hidroxiamino)-2-oxoetil]-4-{[4(trifluorometil)fenil]etinil}benzamida 392,3
- 1295
- ácido (2S,3R)-3-hidroxi-2-({[4-(feniletinil)fenil]carbonil}amino) butanoico 324,3
- 1296
- N-((1S,2R)-1-{[(2-aminoetil)amino]carbonil}-2-hidroxipropil)-4(feniletinil)benzamida 366,4
- 1297
- 1,1-dimetiletil (2S)-3-(hidroxiamino)-3-oxo-2-({[4-(4-fenilbuta1,3-diinil)fenil]carbonil}amino) propilcarbamato 448,5
- 1298
- N-{(1S,2R)-2-hidroxi-1-[(hidroxiamino)carbonil]propil}-4-(4-{4[(3-morfolin-4-ilpropil)amino]fenil}buta-1,3-diinil)benzamida 505,6
- 1299
-
imagen264 N-[(1S,2R)-2-hidroxi-1-({[2(metiltio)fenil]amino}carbonil)propil]-4-(feniletinil)benzamida 445,6
- Ejemplo
- Estructura Nombre MH+
- 1300
- N-((1S)-1-(aminometil)-2-{[(1,1-dimetiletil)oxi]amino}-2oxoetil)-4-(4-fenilbuta-1,3-diinil)benzamida 404,5
- 1301
- N-{(1S,2S)-2-hidroxi-1-[(hidroxiamino)carbonil]propil}-4-(4fenilbuta-1,3-diinil)benzamida 363,4
- 1302
- N-{(1S,2S)-2-hidroxi-1-[(hidroxiamino)carbonil]propil}-4-(4fenilbuta-1,3-diinil)benzamida 363,4
- 1303
- (2S,3R)-N,3-dihidroxi-2-({[4-(4-fenilbuta-1,3diinil)fenil]metil}amino)butanamida 349,4
- 1304
-
imagen265 1,1-dimetiletil (2S)-3-(hidroxiamino)-3-oxo-2-({[4-(4-fenilbuta1,3-diinil)fenil]metil}amino)propilcarbamato 434,5
- 1305
- (2S)-3-amino-N-hidroxi-2-({[4-(4-fenilbuta-1,3diinil)fenil]metil}amino)propanamida 334,4
- 1306
- N-[(1S)-2-(hidroxiamino)-1-(hidroximetil)-2-oxoetil]-4[(trifluorometil)oxi]benzamida 309,2
- 1307
- N-{2-hidroxi-1-[(hidroxiamino)carbonil]-2-feniletil}-4[(trifluorometil)oxi]benzamida 385,3
Claims (4)
-
imagen1 imagen2 imagen3 imagen4 imagen5 X está seleccionado de los grupos que consisten en- (1)
- -(C=O)-,
- (2)
- -alquilo C1-C6-(C=O)-, y
- (3)
- -alquenilo C2-C6-(C=O)
- 4. Un compuesto de la reivindicación 1 de acuerdo con la fórmula VII:
imagen6 o un estereoisómero, sal farmacéuticamente aceptable o éster del mismo, en la que E está ausente o está seleccionado del grupo que consiste en- (1)
- H,
- (2)
- alquilo C1-C6 sustituido o sin sustituir,
- (3)
- arilo sustituido o sin sustituir,
- (4)
- heterociclilo sustituido o sin sustituir, y
- (5)
- heteroarilo sustituido o sin sustituir,
- o E y R3L, junto con los átomos a los que están unidos, pueden formar un anillo heterocíclico sustituido o sin sustituir que tiene de 3 a 10 átomos de anillo, en el que 1-4 átomos de anillo del sistema de anillo heterocíclico están seleccionados de N, O y S;
R1L, R3L están seleccionados independientemente del grupo que consiste en- (1)
- H,
- (2)
- alquilo C1-C6 sustituido o sin sustituir,
- (3)
- alquilo C1-C6 sustituido con arilo,
- (4)
- alquilo C1-C6 sustituido con heterociclilo, y
- (5)
- alquilo C1-C6 sustituido con heteroarilo,
- o R1L y R3L, junto con los átomos a los que están unidos, pueden formar un anillo heterocíclico sustituido o sin sustituir que tiene de 3 a 8 átomos de anillo, en el que 1-2 átomos de anillo del sistema de anillo heterocíclico están seleccionados de N, O y S.
- 5. Un compuesto de la reivindicación 1 de acuerdo con la fórmula IX:
imagen7 o un estereoisómero, sal farmacéuticamente aceptable o éster del mismo, en la que E está ausente o está seleccionado del grupo que consiste en- (1)
- H,
- (2)
- alquilo C1-C6 sustituido o sin sustituir,
- (3)
- arilo sustituido o sin sustituir,
194imagen8 - 9. Un compuesto de cualquiera de las reivindicaciones 1-6 para su uso en el tratamiento de una infección bacteriana.196
Applications Claiming Priority (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US43852303P | 2003-01-08 | 2003-01-08 | |
US438523P | 2003-01-08 | ||
US46697403P | 2003-04-30 | 2003-04-30 | |
US466974P | 2003-04-30 | ||
US52021103P | 2003-11-13 | 2003-11-13 | |
US520211P | 2003-11-13 |
Publications (1)
Publication Number | Publication Date |
---|---|
ES2552247T3 true ES2552247T3 (es) | 2015-11-26 |
Family
ID=32719190
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES04700887T Expired - Lifetime ES2387803T3 (es) | 2003-01-08 | 2004-01-08 | Agentes antibacterianos |
ES10179798.3T Expired - Lifetime ES2552247T3 (es) | 2003-01-08 | 2004-01-08 | Agentes antibacterianos |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES04700887T Expired - Lifetime ES2387803T3 (es) | 2003-01-08 | 2004-01-08 | Agentes antibacterianos |
Country Status (14)
Country | Link |
---|---|
US (8) | US20040229955A1 (es) |
EP (2) | EP1618087B1 (es) |
JP (2) | JP5086635B2 (es) |
KR (2) | KR101145252B1 (es) |
CN (2) | CN1777577B (es) |
AU (2) | AU2004204760C1 (es) |
CA (2) | CA2851462A1 (es) |
EA (1) | EA011808B1 (es) |
ES (2) | ES2387803T3 (es) |
HK (1) | HK1155718A1 (es) |
IL (2) | IL169475A (es) |
MX (1) | MXPA05007394A (es) |
SG (2) | SG159388A1 (es) |
WO (1) | WO2004062601A2 (es) |
Families Citing this family (142)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6777217B1 (en) | 1996-03-26 | 2004-08-17 | President And Fellows Of Harvard College | Histone deacetylases, and uses related thereto |
US20030129724A1 (en) | 2000-03-03 | 2003-07-10 | Grozinger Christina M. | Class II human histone deacetylases, and uses related thereto |
JP4617449B2 (ja) * | 2002-07-11 | 2011-01-26 | ヴィキュロン ファーマシューティカルズ インコーポレイテッド | 抗菌活性を有するn−ヒドロキシアミド誘導体 |
KR101145252B1 (ko) | 2003-01-08 | 2012-05-24 | 유니버시티 오브 워싱톤 | 항균제 |
CA2532965C (en) | 2003-07-22 | 2013-05-14 | Astex Therapeutics Limited | 3, 4-disubstituted 1h-pyrazole compounds and their use as cyclin dependent kinases (cdk) and glycogen synthase kinase-3 (gsk-3) modulators |
EP1680109A4 (en) * | 2003-10-07 | 2009-05-06 | Renovis Inc | AMIDE DERIVATIVES AS ION CHANNEL LIGANDS AND PHARMACEUTICAL COMPOSITIONS AND METHODS OF USING THE DERIVATIVES |
CN1894202A (zh) * | 2003-12-19 | 2007-01-10 | 巴斯福股份公司 | 苯甲酰基取代的苯基丙氨酸酰胺 |
US7638513B2 (en) | 2004-06-02 | 2009-12-29 | Schering Corporation | Compounds for the treatment of inflammatory disorders |
WO2006022442A1 (ja) * | 2004-08-24 | 2006-03-02 | Santen Pharmaceutical Co., Ltd. | ジヒドロオロテートデヒドロゲナーゼ阻害活性を有する新規複素環アミド誘導体 |
US7776869B2 (en) | 2004-10-18 | 2010-08-17 | Amgen Inc. | Heteroaryl-substituted alkyne compounds and method of use |
US8404718B2 (en) | 2005-01-21 | 2013-03-26 | Astex Therapeutics Limited | Combinations of pyrazole kinase inhibitors |
JP5042040B2 (ja) | 2005-01-26 | 2012-10-03 | アラーガン、インコーポレイテッド | 鎮痛活性および/または免疫賦活活性を有する1−アリール−1−ヒドロキシ−2,3−ジアミノ−プロピルアミン、1−ヘテロアリール−1−ヒドロキシ−2,3−ジアミノ−プロピルアミンおよび関連化合物 |
BRPI0606365A2 (pt) * | 2005-02-28 | 2017-06-27 | Renovis Inc | composto ou um sal, solvato ou pró-droga farmaceuticamente aceitável do mesmo e estereoisômeros e tautômeros do mesmo, composição farmacêutica, métodos para prevenir, tratar, melhorar ou controlar uma doença ou condição e para preparar um composto, uso de um composto ou um sal, solvato ou composição farmaceuticamente aceitável do mesmo, método de tratamento de um mamífero, e, combinação |
US7576099B2 (en) | 2005-02-28 | 2009-08-18 | Renovis, Inc. | Amide derivatives as ion-channel ligands and pharmaceutical compositions and methods of using the same |
EP2491926B1 (en) | 2005-03-22 | 2018-05-09 | President and Fellows of Harvard College | Treatment of protein degradation disorders |
TW200800209A (en) * | 2005-07-11 | 2008-01-01 | Wyeth Corp | Glutamate aggrecanase inhibitors |
JP4961773B2 (ja) * | 2005-07-29 | 2012-06-27 | 住友ベークライト株式会社 | 芳香族カルボン酸及びその酸ハロゲン化物 |
EP2338878A3 (en) * | 2005-12-15 | 2011-11-16 | Vicuron Pharmaceuticals, Inc. | N-hydroxyamide derivatives possessing antibacterial activity |
WO2008091349A1 (en) * | 2006-02-14 | 2008-07-31 | The President And Fellows Of Harvard College | Bifunctional histone deacetylase inhibitors |
CA2654540C (en) | 2006-05-03 | 2017-01-17 | President And Fellows Of Harvard College | Histone deacetylase and tubulin deacetylase inhibitors |
WO2007138304A1 (en) | 2006-05-30 | 2007-12-06 | Astrazeneca Ab | 1, 3, 4 -oxadiazole derivatives as dgat1 inhibitors |
DE102006033321A1 (de) * | 2006-07-17 | 2008-01-24 | Westfälische Wilhelms-Universität Münster | Medizinische Verwendung von N-Phenylpropenoyl-Aminosäurederivaten und verwandten Verbindungen |
JP2009544611A (ja) | 2006-07-20 | 2009-12-17 | メルク エンド カムパニー インコーポレーテッド | ヒストン脱アセチル化酵素阻害剤としてのリン誘導体 |
EP2046122A4 (en) * | 2006-07-24 | 2009-12-23 | Univ Maryland | HEMOXYGENASE INHIBITORS AND METHOD FOR THEIR THERAPEUTIC APPLICATION |
TW200821276A (en) * | 2006-08-18 | 2008-05-16 | Leo Pharma As | Substituted acetylenic compounds useful for the treatment of diseases |
CN101528711A (zh) | 2006-08-31 | 2009-09-09 | 先灵公司 | 可用作抗细菌剂的乙内酰脲衍生物 |
CA2680507A1 (en) * | 2006-10-13 | 2008-04-24 | Xtl Biopharmaceuticals Ltd. | Compounds and methods for treatment of hcv |
CA2668070A1 (en) | 2006-10-30 | 2008-05-08 | Chroma Therapeutics Ltd. | Hydroxamates as inhibitors of histone deacetylase |
US8563573B2 (en) | 2007-11-02 | 2013-10-22 | Vertex Pharmaceuticals Incorporated | Azaindole derivatives as CFTR modulators |
JP5227304B2 (ja) * | 2007-02-28 | 2013-07-03 | 大正製薬株式会社 | 新規なヒドロキサム酸誘導体 |
ES2576643T3 (es) | 2007-03-09 | 2016-07-08 | Second Genome, Inc. | Compuestos de bicicloheteroarilo como moduladores de P2X7 y usos de los mismos |
TWI519508B (zh) * | 2007-06-12 | 2016-02-01 | Achaogen Inc | 抗菌劑 |
CN101417937B (zh) * | 2007-10-23 | 2013-05-29 | 中山大学 | β-醛酮类抗菌化合物及其应用 |
WO2009105140A2 (en) | 2007-12-11 | 2009-08-27 | Viamet Pharmaceuticals, Inc. | Metalloenzyme inhibitors using metal binding moieties in combination with targeting moieties |
ES2535083T3 (es) | 2007-12-20 | 2015-05-05 | Astrazeneca Ab | Compuestos de carbamoilo como inhibidores 190 de DGAT1 |
JP2011525927A (ja) | 2008-06-25 | 2011-09-29 | シェーリング コーポレイション | 複素環式抗菌剤の合成および使用 |
WO2010011296A2 (en) | 2008-07-23 | 2010-01-28 | President And Fellows Of Harvard College | Deacetylase inhibitors and uses thereof |
CN102171185A (zh) * | 2008-08-01 | 2011-08-31 | 拜奥西尼斯医药股份有限公司 | 甲硫氨酸类似物及其使用方法 |
AU2009279949A1 (en) * | 2008-08-04 | 2010-02-11 | Merck Sharp & Dohme Corp. | Urea derivatives as antibacterial agents |
US8273900B2 (en) | 2008-08-07 | 2012-09-25 | Novartis Ag | Organic compounds |
US8372885B2 (en) * | 2008-09-17 | 2013-02-12 | Novartis Ag | Organic compounds and their uses |
JP5524215B2 (ja) * | 2008-09-19 | 2014-06-18 | ファイザー・インク | 抗菌剤として有用なヒドロキサム酸誘導体 |
EP2177502A1 (en) * | 2008-10-17 | 2010-04-21 | Oryzon Genomics, S.A. | Compounds and their use |
EP2361242B1 (en) | 2008-10-17 | 2018-08-01 | Oryzon Genomics, S.A. | Oxidase inhibitors and their use |
WO2010084160A1 (en) | 2009-01-21 | 2010-07-29 | Oryzon Genomics S.A. | Phenylcyclopropylamine derivatives and their medical use |
WO2011005355A1 (en) | 2009-05-07 | 2011-01-13 | Achaogen, Inc. | Combinations comprising a lpxc inhibitor and an antibiotic for use in the treatment of infections caused by gram-negative bacteria |
EP2435081B1 (en) * | 2009-05-25 | 2013-04-17 | Chiesi Farmaceutici S.p.A. | A therapeutic combination comprising a pulmonary surfactant and a steroid |
EP2443096A1 (en) | 2009-06-19 | 2012-04-25 | AstraZeneca AB | Pyrazine carboxamides as inhibitors of dgat1 |
WO2011019393A2 (en) | 2009-08-11 | 2011-02-17 | President And Fellows Of Harvard College | Class- and isoform-specific hdac inhibitors and uses thereof |
FR2950057B1 (fr) | 2009-09-17 | 2011-08-26 | Galderma Res & Dev | Nouveaux composes benzene-carboxylamides, leur procede de synthese et leur utilisation en medecine ainsi qu'en cosmetique |
FR2950056B1 (fr) | 2009-09-17 | 2011-08-26 | Galderma Res & Dev | Nouveaux composes benzene-carboxylamides, leur procede de synthese et leur utilisation en medecine ainsi qu'en cosmetique |
MX338041B (es) | 2009-09-25 | 2016-03-30 | Oryzon Genomics Sa | Inhibidores de demetilasa-1 especificos de lisina y su uso. |
EP2486002B1 (en) | 2009-10-09 | 2019-03-27 | Oryzon Genomics, S.A. | Substituted heteroaryl- and aryl- cyclopropylamine acetamides and their use |
PL2512474T3 (pl) * | 2009-12-16 | 2015-03-31 | Pfizer | N-przyłączone pochodne kwasu hydroksamowego użyteczne jako środki przeciwbakteryjne |
US9186337B2 (en) | 2010-02-24 | 2015-11-17 | Oryzon Genomics S.A. | Lysine demethylase inhibitors for diseases and disorders associated with Hepadnaviridae |
US9616058B2 (en) | 2010-02-24 | 2017-04-11 | Oryzon Genomics, S.A. | Potent selective LSD1 inhibitors and dual LSD1/MAO-B inhibitors for antiviral use |
US8802868B2 (en) | 2010-03-25 | 2014-08-12 | Vertex Pharmaceuticals Incorporated | Solid forms of (R)-1(2,2-difluorobenzo[D][1,3]dioxo1-5-yl)-N-(1-(2,3-dihydroxypropyl-6-fluoro-2-(1-hydroxy-2-methylpropan2-yl)-1H-Indol-5-yl)-Cyclopropanecarboxamide |
MX2012012111A (es) | 2010-04-19 | 2013-05-30 | Oryzon Genomics Sa | Inhibidores de demetilasa-1 especifica de lisina y su uso. |
US9073821B2 (en) * | 2010-04-20 | 2015-07-07 | Taisho Pharmaceutical Co., Ltd | Hydroxamic acid derivative |
KR101984225B1 (ko) | 2010-04-22 | 2019-05-30 | 버텍스 파마슈티칼스 인코포레이티드 | 시클로알킬카르복스아미도-인돌 화합물의 제조 방법 |
RS57331B1 (sr) | 2010-07-29 | 2018-08-31 | Oryzon Genomics Sa | Inhibitori demetilaze za lsd1 zasnovani na arilciklopropilaminu i njihova medicinska upotreba |
US9006449B2 (en) | 2010-07-29 | 2015-04-14 | Oryzon Genomics, S.A. | Cyclopropylamine derivatives useful as LSD1 inhibitors |
US9738604B2 (en) | 2010-09-03 | 2017-08-22 | Duke University | Ethynylbenzene derivatives |
US9061966B2 (en) | 2010-10-08 | 2015-06-23 | Oryzon Genomics S.A. | Cyclopropylamine inhibitors of oxidases |
EP2638006A1 (en) | 2010-11-10 | 2013-09-18 | Achaogen, Inc. | Hydroxamic acid derivatives and their use in the treatment of bacterial infections |
WO2012072713A2 (en) | 2010-11-30 | 2012-06-07 | Oryzon Genomics, S.A. | Lysine demethylase inhibitors for diseases and disorders associated with flaviviridae |
BR112013017316A2 (pt) | 2011-01-04 | 2019-09-24 | Novartis Ag | compostos de indol ou análogos dos mesmos para o tratamento de degeneração macular relacionada à idade (amd) |
EP3981395A1 (en) | 2011-02-08 | 2022-04-13 | Oryzon Genomics, S.A. | Lysine demethylase inhibitors for myeloproliferative disorders |
US8877940B2 (en) | 2011-02-22 | 2014-11-04 | Institut National De La Recherche Scientifique | Antibiotic tolerance inhibitors |
UA107423C2 (en) | 2011-03-07 | 2014-12-25 | Pfizer | Fluoro-pyridinone derivatives useful as antibacterial agents |
DK2694488T3 (en) | 2011-04-08 | 2014-12-15 | Pfizer | Isoxazole derivatives useful as antibacterial SUBSTANCES |
JP2014514299A (ja) | 2011-04-08 | 2014-06-19 | ファイザー・インク | 抗菌剤として有用なイミダゾール、ピラゾールおよびトリアゾール誘導体 |
WO2013039947A1 (en) | 2011-09-12 | 2013-03-21 | Achaogen, Inc. | Polymorphs of n-((s)-3-amino-1-(hydroxyamino)-3-methyl-1-oxobutan-2-yl)-4-(((1r,2r)-2-(hydroxymethyl)cyclopropyl)buta-1,3-diynyl)benzamide |
JP6006609B2 (ja) * | 2011-10-19 | 2016-10-12 | 大正製薬株式会社 | 新規なヒドロキサム酸誘導体を含有する医薬 |
PE20141692A1 (es) | 2011-10-20 | 2014-11-08 | Oryzon Genomics Sa | Compuestos de (hetero) aril ciclopropilamina como inhibidores de lsd1 |
CN107266345B (zh) | 2011-10-20 | 2021-08-17 | 奥瑞泽恩基因组学股份有限公司 | 作为lsd1抑制剂的(杂)芳基环丙胺化合物 |
US8999922B2 (en) * | 2012-02-16 | 2015-04-07 | Rqx Pharmaceuticals, Inc. | Linear peptide antibiotics |
EP2847168A1 (en) | 2012-05-10 | 2015-03-18 | Achaogen, Inc. | Antibacterial agents |
WO2014002052A1 (en) | 2012-06-28 | 2014-01-03 | Novartis Ag | Pyrrolidine derivatives and their use as complement pathway modulators |
CN104603126B (zh) | 2012-06-28 | 2017-05-31 | 诺华股份有限公司 | 吡咯烷衍生物及其作为补体途径调节剂的用途 |
ES2710491T3 (es) | 2012-06-28 | 2019-04-25 | Novartis Ag | Moduladores de la vía del complemento y sus usos |
JP6155332B2 (ja) | 2012-06-28 | 2017-06-28 | ノバルティス アーゲー | ピロリジン誘導体、および補体経路調節因子としてのその使用 |
WO2014002058A2 (en) | 2012-06-28 | 2014-01-03 | Novartis Ag | Complement pathway modulators and uses thereof |
JP6238980B2 (ja) | 2012-07-12 | 2017-11-29 | ノバルティス アーゲー | 補体経路モジュレーターおよびその使用 |
CN103012207B (zh) * | 2012-12-29 | 2015-05-27 | 吉首大学 | 二芳基丙酰-n-甲基氧肟酸类尿素酶抑制剂及其合成和用途 |
WO2014165075A1 (en) * | 2013-03-12 | 2014-10-09 | Achaogen, Inc. | Antibacterial agents |
LT2975022T (lt) | 2013-03-15 | 2019-07-25 | Fujifilm Toyama Chemical Co., Ltd. | Naujas hidroksamo rūgšties darinys arba jo druska |
WO2014160649A1 (en) * | 2013-03-29 | 2014-10-02 | Novartis Ag | Hydroxamic acid derivatives as lpxc inhibitors for the treatment of bacterial infections |
WO2015024021A2 (en) | 2013-08-16 | 2015-02-19 | Duke University | Antibacterial compounds |
WO2015024010A2 (en) * | 2013-08-16 | 2015-02-19 | Duke University | Substituted hydroxamic acid compounds |
WO2015024016A2 (en) | 2013-08-16 | 2015-02-19 | Duke University | 2-piperidinyl substituted n,3-dihydroxybutanamides |
GB201315335D0 (en) | 2013-08-29 | 2013-10-09 | Of Singapore | Amino diacids containing peptide modifiers |
US9539305B1 (en) | 2014-03-14 | 2017-01-10 | Fleurir Abx Llc | Pristinamycin compositions, LpxC compositions, their improvements, and combinations thereof |
PT3925607T (pt) | 2014-04-15 | 2023-09-26 | Vertex Pharma | Composições farmacêuticas para o tratamento de doenças mediadas pelo regulador de condutância transmembranar da fibrose quística |
JP6514716B2 (ja) | 2014-04-22 | 2019-05-15 | ノバルティス アーゲー | LpxC阻害剤としてのイソオキサゾリンヒドロキサム酸誘導体 |
BR112017004796A2 (pt) | 2014-09-12 | 2017-12-12 | Toyama Chemical Co Ltd | método para utilizar derivados de ácido hidroxâmico e substância antibacterial em combinação |
MX2017002967A (es) | 2014-09-12 | 2017-05-30 | Toyama Chemical Co Ltd | Composicion farmaceutica novedosa que contiene derivado de acido hidroxamico o sal del mismo. |
CN104262433B (zh) * | 2014-10-11 | 2016-06-15 | 吉首大学 | 噁二唑-腺苷型化合物作为TyrRS抑制剂及其制法和用途 |
CN104231024B (zh) * | 2014-10-11 | 2016-06-15 | 吉首大学 | 噁二唑-肌苷型化合物作为TyrRS抑制剂及其制法和用途 |
CN104327140B (zh) * | 2014-10-11 | 2016-06-15 | 吉首大学 | 噁唑烷酮-腺苷型多靶点抗菌化合物及其制法和用途 |
CN104341476A (zh) * | 2014-10-11 | 2015-02-11 | 吉首大学 | 利奈唑胺-肌苷型多靶点抗菌化合物及其制法和用途 |
CN104341475A (zh) * | 2014-10-11 | 2015-02-11 | 吉首大学 | 利奈唑胺-腺苷型多靶点抗菌化合物及其制法和用途 |
US9549916B2 (en) | 2014-12-16 | 2017-01-24 | Novartis Ag | Isoxazole hydroxamic acid compounds as LpxC inhibitors |
CN105777464B (zh) * | 2014-12-26 | 2020-09-29 | 中国科学院上海药物研究所 | 异羟肟酸衍生物及其制备方法和应用 |
AU2016275764B8 (en) | 2015-06-11 | 2021-03-04 | Basilea Pharmaceutica International AG | Efflux-pump inhibitors and therapeutic uses thereof |
WO2017042099A1 (en) * | 2015-09-09 | 2017-03-16 | Basilea Pharmaceutica Ag | Efflux-pump inhibitors and therapeutic uses thereof |
WO2017083434A1 (en) | 2015-11-09 | 2017-05-18 | Forge Therapeutics, Inc. | Pyrone based compounds for treating bacterial infections |
WO2017083431A2 (en) | 2015-11-09 | 2017-05-18 | Forge Therapeutics, Inc. | Hydroxypyridinone and hydroxypyrimidinone based compounds for treating bacterial infections |
JP2019501896A (ja) * | 2015-12-08 | 2019-01-24 | グラクソスミスクライン、インテレクチュアル、プロパティー、ディベロップメント、リミテッドGlaxosmithkline Intellectual Property Development Limited | 抗菌化合物としての置換ベンザジノン |
EP3426674A4 (en) | 2016-03-09 | 2019-08-14 | Blade Therapeutics, Inc. | CYCLIC KETO AMID COMPOUNDS AS CALPAIN MODULATORS AND METHOD FOR THE PRODUCTION AND USE THEREOF |
KR102410199B1 (ko) * | 2016-04-18 | 2022-06-17 | 프라운호퍼-게젤샤프트 츄어 푀르더룽 데어 안게반텐 포르슝에.파우. | 새로운 메프린 알파 및 베타 저해제 |
CA3022102A1 (en) * | 2016-04-25 | 2017-11-02 | Duke University | Benzoylglycine derivatives and methods of making and using same |
SI3468957T1 (sl) | 2016-06-14 | 2020-11-30 | Novartis Ag | Kristalna oblika (R)-4-(5-(ciklopropiletinil) izoksazol-3-IL)-N- hidroksi-2-metil-2-(metilsul fonil) butanamida kot antibakterijsko sredstvo |
CN109563033B (zh) | 2016-06-21 | 2023-04-04 | 奥瑞恩眼科有限责任公司 | 脂族脯氨酰胺衍生物 |
DK3472149T3 (da) | 2016-06-21 | 2023-11-27 | Orion Ophthalmology LLC | Heterocykliske prolinamidderivater |
JP7164521B2 (ja) | 2016-06-21 | 2022-11-01 | オリオン・オフサルモロジー・エルエルシー | 炭素環式プロリンアミド誘導体 |
WO2017223349A1 (en) | 2016-06-23 | 2017-12-28 | Achaogen, Inc. | Antibacterial agents |
AU2017292646A1 (en) | 2016-07-05 | 2019-02-07 | Blade Therapeutics, Inc. | Calpain modulators and therapeutic uses thereof |
CA3038331A1 (en) | 2016-09-28 | 2018-04-05 | Blade Therapeutics, Inc. | Calpain modulators and therapeutic uses thereof |
US11406617B2 (en) | 2016-12-23 | 2022-08-09 | Intervet Inc. | Compounds for the treatment of bovine or swine respiratory disease |
WO2018115421A1 (en) * | 2016-12-23 | 2018-06-28 | Intervet International B.V. | Compounds useful for treating a mannheimia haemolytica or histophilus somni infection |
US11021471B2 (en) | 2017-05-10 | 2021-06-01 | Forge Therapeutics, Inc. | Antibacterial compounds |
WO2018213185A1 (en) * | 2017-05-17 | 2018-11-22 | Drexel University | Rela inhibitors for biofilm disruption |
TW201920081A (zh) | 2017-07-11 | 2019-06-01 | 美商維泰克斯製藥公司 | 作為鈉通道調節劑的羧醯胺 |
IL272188B (en) * | 2017-07-27 | 2022-08-01 | Biomendics Llc | Claws replaced for bacterial colony regulation |
JP7412004B2 (ja) * | 2018-02-10 | 2024-01-12 | 山東亨利醫藥科技有限責任公司 | 抗菌剤化合物 |
CA3113226A1 (en) | 2018-09-20 | 2020-03-26 | Forge Therapeutics, Inc. | Antibacterial compounds |
CA3114240C (en) | 2018-10-30 | 2023-09-05 | Gilead Sciences, Inc. | Imidazopyridine derivatives as alpha4beta7 integrin inhibitors |
CN112969504B (zh) | 2018-10-30 | 2024-04-09 | 吉利德科学公司 | 用于抑制α4β7整合素的化合物 |
WO2020092375A1 (en) | 2018-10-30 | 2020-05-07 | Gilead Sciences, Inc. | Quinoline derivatives as alpha4beta7 integrin inhibitors |
CA3115820A1 (en) | 2018-10-30 | 2020-05-07 | Gilead Sciences, Inc. | Compounds for inhibition of .alpha.4.beta.7 integrin |
CA3131712A1 (en) * | 2019-02-22 | 2020-08-27 | Cila Therapeutic Inc. | Inhalable therapeutic agent |
CA3148613A1 (en) | 2019-08-14 | 2021-02-18 | Gilead Sciences, Inc. | Phenylalanine derived compounds and their use as inhinitors of alpha 4 beta 7 integrin |
CN110563611B (zh) | 2019-09-19 | 2021-02-02 | 中国医学科学院医药生物技术研究所 | 一种异羟肟酸类衍生物及其制备方法和应用 |
CR20220316A (es) | 2019-12-06 | 2022-10-07 | Vertex Pharma | Tetrahidrofuranos sustituidos como moduladores de canales de sodio |
CN111254091B (zh) * | 2020-01-20 | 2022-04-19 | 浙江工业大学 | 一种嗜麦芽窄食单胞菌gyh及其在降解氯代烃类污染物中的应用 |
WO2021195260A1 (en) | 2020-03-25 | 2021-09-30 | Forge Therapeutics, Inc. | Lpxc inhibitor and methods of making |
EP4165037A4 (en) | 2020-06-10 | 2024-07-03 | Aligos Therapeutics Inc | ANTIVIRAL COMPOUNDS FOR THE TREATMENT OF CORONAVIRUS, PICORNAVIRUS AND NOROVIRUS INFECTIONS |
CN117794920A (zh) | 2021-06-04 | 2024-03-29 | 沃泰克斯药物股份有限公司 | N-(羟烷基(杂)芳基)四氢呋喃甲酰胺作为钠通道调节剂 |
IL309732A (en) | 2021-07-09 | 2024-02-01 | Aligos Therapeutics Inc | Antiviral compounds |
WO2023128033A1 (ko) * | 2021-12-31 | 2023-07-06 | (주)앰틱스바이오 | 감염성 진균의 바이오필름 생성을 억제하는 신규한 항진균용 조성물 |
CN116730870B (zh) * | 2023-08-08 | 2023-10-13 | 中国医学科学院医药生物技术研究所 | 异羟肟酸类化合物或其可药用盐、及其用途和制备方法 |
Family Cites Families (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US628988A (en) * | 1898-11-21 | 1899-07-18 | F B Fargo & Company | Combined churn and butter-worker. |
US2772281A (en) * | 1954-12-23 | 1956-11-27 | Merck & Co Inc | Synthesis of 4-amino-3-isoxazolidone and its derivatives |
GB9503749D0 (en) | 1995-02-24 | 1995-04-12 | British Biotech Pharm | Synthesis of hydroxamic acid derivatives |
AU711755B2 (en) * | 1995-07-26 | 1999-10-21 | Pfizer Inc. | N-(aroyl)glycine hydroxamic acid derivatives and related compounds |
US5925659A (en) * | 1996-05-07 | 1999-07-20 | Merck & Co., Inc. | Antibacterial agents |
EP0915086A4 (en) * | 1996-05-24 | 2001-01-17 | Ono Pharmaceutical Co | PHENYLSULFONAMIDE DERIVATIVES |
WO1998015525A1 (fr) * | 1996-10-07 | 1998-04-16 | Sumitomo Pharmaceuticals Co., Ltd. | Acides hydroxamiques |
US6281245B1 (en) * | 1996-10-28 | 2001-08-28 | Versicor, Inc. | Methods for solid-phase synthesis of hydroxylamine compounds and derivatives, and combinatorial libraries thereof |
WO1998018754A1 (en) | 1996-10-28 | 1998-05-07 | Versicor, Inc. | Methods for solid-phase synthesis of hydroxylamine compounds and derivatives, and combinatorial libraries thereof |
AR016751A1 (es) * | 1996-11-22 | 2001-08-01 | Athena Neurosciences Inc | Metodo para inhibir la liberacion del peptido beta-amiloide en una celula, composicion farmaceutica y compuestos utiles en dicho metodo |
GB9715030D0 (en) * | 1997-07-18 | 1997-09-24 | British Biotech Pharm | Metalloproteinase inhibitors |
BR9810841A (pt) * | 1997-07-31 | 2001-07-10 | Procter & Gamble | Inibidores de metaloprotease alicìclicos |
CA2320476A1 (en) | 1998-02-07 | 1999-08-12 | British Biotech Pharmaceuticals Limited | Antibacterial agents |
AU5034699A (en) * | 1998-07-08 | 2000-02-01 | Dirk Krumme | Matrix metalloproteinase inhibitors containing aminomalonic acid derivatives andpeptide backbone modified derivatives thereof |
GB9901863D0 (en) | 1999-01-29 | 1999-03-17 | British Biotech Pharm | Antibacterial agents |
WO2000059874A1 (en) * | 1999-04-02 | 2000-10-12 | Du Pont Pharmaceuticals Company | NOVEL AMIDE DERIVATIVES AS INHIBITORS OF MATRIX METALLOPROTEINASES, TNF-α, AND AGGRECANASE |
JP2002541197A (ja) | 1999-04-09 | 2002-12-03 | ブリティッシュ バイオテック ファーマシューティカルズ リミテッド | 抗菌剤 |
WO2002030873A1 (fr) * | 2000-10-10 | 2002-04-18 | Fujisawa Pharmaceutical Co., Ltd. | Inhibiteur des mmp |
EP1343753A2 (en) * | 2000-12-21 | 2003-09-17 | De Novo Pharmaceuticals Ltd. | Antimicrobial agents |
GB0115195D0 (en) | 2001-06-21 | 2001-08-15 | Bae Systems Plc | Split-pin drill jig |
WO2003004488A1 (en) * | 2001-07-03 | 2003-01-16 | Chiron Corporation | Indazole benzimidazole compounds as tyrosine and serine/threonine kinase inhibitors |
JP4617449B2 (ja) | 2002-07-11 | 2011-01-26 | ヴィキュロン ファーマシューティカルズ インコーポレイテッド | 抗菌活性を有するn−ヒドロキシアミド誘導体 |
KR101145252B1 (ko) * | 2003-01-08 | 2012-05-24 | 유니버시티 오브 워싱톤 | 항균제 |
-
2004
- 2004-01-08 KR KR1020117003175A patent/KR101145252B1/ko not_active IP Right Cessation
- 2004-01-08 EP EP04700887A patent/EP1618087B1/en not_active Expired - Lifetime
- 2004-01-08 AU AU2004204760A patent/AU2004204760C1/en not_active Ceased
- 2004-01-08 SG SG200705115-4A patent/SG159388A1/en unknown
- 2004-01-08 EA EA200501098A patent/EA011808B1/ru not_active IP Right Cessation
- 2004-01-08 CA CA2851462A patent/CA2851462A1/en not_active Abandoned
- 2004-01-08 ES ES04700887T patent/ES2387803T3/es not_active Expired - Lifetime
- 2004-01-08 CA CA2512582A patent/CA2512582C/en not_active Expired - Fee Related
- 2004-01-08 EP EP10179798.3A patent/EP2295402B1/en not_active Expired - Lifetime
- 2004-01-08 JP JP2006500858A patent/JP5086635B2/ja not_active Expired - Fee Related
- 2004-01-08 ES ES10179798.3T patent/ES2552247T3/es not_active Expired - Lifetime
- 2004-01-08 KR KR1020057012807A patent/KR101076018B1/ko not_active IP Right Cessation
- 2004-01-08 WO PCT/US2004/000433 patent/WO2004062601A2/en active Application Filing
- 2004-01-08 SG SG2012000667A patent/SG2012000667A/en unknown
- 2004-01-08 CN CN2004800059353A patent/CN1777577B/zh not_active Expired - Fee Related
- 2004-01-08 CN CN2011101442462A patent/CN102267924A/zh active Pending
- 2004-01-08 US US10/754,928 patent/US20040229955A1/en not_active Abandoned
- 2004-01-08 MX MXPA05007394A patent/MXPA05007394A/es active IP Right Grant
-
2005
- 2005-06-30 IL IL169475A patent/IL169475A/en active IP Right Grant
- 2005-07-22 US US11/187,708 patent/US7358359B2/en not_active Expired - Fee Related
-
2006
- 2006-05-03 US US11/417,346 patent/US20070244197A1/en not_active Abandoned
-
2007
- 2007-08-10 US US11/837,327 patent/US7989660B2/en not_active Expired - Fee Related
- 2007-08-20 US US11/894,208 patent/US20090247506A1/en not_active Abandoned
- 2007-10-30 US US11/928,122 patent/US8084615B2/en not_active Expired - Fee Related
- 2007-10-31 US US11/981,279 patent/US8101640B2/en not_active Expired - Fee Related
-
2009
- 2009-09-01 AU AU2009212909A patent/AU2009212909B2/en not_active Ceased
- 2009-09-21 US US12/563,697 patent/US8153843B2/en not_active Expired - Fee Related
-
2010
- 2010-07-26 JP JP2010167639A patent/JP5277213B2/ja not_active Expired - Fee Related
-
2011
- 2011-06-16 IL IL213597A patent/IL213597A0/en unknown
- 2011-09-14 HK HK11109668.9A patent/HK1155718A1/zh not_active IP Right Cessation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2552247T3 (es) | Agentes antibacterianos | |
AU2004281536B9 (en) | Novel alanyl-amino peptidase inhibitors for functionally influencing different cells and treating immunological, inflammatory, neuronal, and other diseases | |
AU2004281959B9 (en) | Novel dipeptidyl peptidase IV inhibitors used for functionally influencing different cells and treating immunological, inflammatory, neuronal, and other diseases | |
JP2768554B2 (ja) | 金属タンパク質加水分解酵素阻害剤であるヒドロキサム酸誘導体 | |
JP2006519772A5 (es) | ||
CA2476065A1 (en) | Inhibitors of histone deacetylase | |
US20230105108A1 (en) | Compounds for the treatment of bacterial infections and potentiation of antibiotics | |
JPH09508363A (ja) | アミノ酸誘導体およびそのホスホリパーゼa▲下2▼阻害剤としての用途 | |
EP2326619B1 (en) | Methionine analogs and methods of using same | |
MXPA01002563A (es) | Derivados de benceno y uso mecinal de los mismos |